data_1gfd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gfd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.579 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 113.98 1.104 . . . . 1.7 113.98 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.39 -168.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 113.391 -1.731 . . . . 0.080000000000000002 108.298 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.2 mt-30 -140.29 104.12 4.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.336 -1.357 . . . . 0.70999999999999996 107.336 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.71 114.21 0.11 Allowed 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 113.666 0.987 . . . . 0.19 113.666 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 9.7 tp -69.39 -34.1 74.02 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.388 -0.824 . . . . 3.0 108.917 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.63 -174.2 4.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.943 -1.026 . . . . 0.59999999999999998 109.669 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -86.4 126.48 34.41 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 113.434 -1.712 . . . . 0.44 110.336 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.11 106.32 13.6 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.307 -0.957 . . . . 0.28000000000000003 112.804 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 p-10 . . . . . 0 C--N 1.304 -1.391 0 C-N-CA 117.734 -1.586 . . . . 3.3399999999999999 108.336 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.504 -0.798 0 CA-C-O 123.231 1.491 . . . . 2.3300000000000001 114.253 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tp -101.54 158.19 16.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 111.797 -2.456 . . . . 0.93000000000000005 110.407 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.36 113.07 0.65 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.606 -1.283 . . . . 0.41999999999999998 110.726 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 p90 -139.94 -172.7 3.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.841 -1.144 . . . . 0.33000000000000002 112.192 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' ARG . 5.0 mmm-85 -139.61 126.08 20.34 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.574 -0.85 . . . . 3.0099999999999998 113.187 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -7.65 132.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.493 1.121 . . . . 2.7599999999999998 113.887 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -19.27 20.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.218 -1.553 . . . . 0.62 109.218 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.79 123.7 19.12 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.791 -1.164 . . . . 0.57999999999999996 108.52 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.92 107.66 10.62 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.647 -1.221 . . . . 0.38 112.657 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.471 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.32 147.62 7.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.84 -1.17 . . . . 0.32000000000000001 107.84 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.579 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 9.1 t-160 -105.65 96.21 6.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.687 -1.227 . . . . 0.20000000000000001 107.687 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 t -63.29 91.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 114.584 -1.189 . . . . 0.57999999999999996 110.219 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.46 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.3 ttm -78.31 -27.32 47.21 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.945 -1.479 . . . . 0.68000000000000005 112.011 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.11 96.65 0.6 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.43 -1.708 . . . . 1.75 111.794 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.583 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -55.47 104.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.113 -1.435 . . . . 3.0899999999999999 107.914 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m -90.86 -64.9 1.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.649 -1.22 . . . . 1.0700000000000001 111.761 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -103.89 161.71 22.12 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 115.189 -0.914 . . . . 0.65000000000000002 111.812 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' O ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 Cg_endo -57.95 -63.34 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.737 1.625 . . . . 0.70999999999999996 111.478 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.2 t30 -92.15 6.8 45.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.558 -0.857 . . . . 2.9199999999999999 111.392 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 20.0 m95 -139.23 139.32 37.43 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.75 -1.204 . . . . 0.34999999999999998 107.75 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -141.86 169.38 17.7 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.281 -0.968 . . . . 0.88 112.939 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -101.78 146.53 27.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.332 -1.729 . . . . 0.68000000000000005 106.332 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.1 -158.42 9.75 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 116.784 -2.627 . . . . 0.5 110.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.33 137.94 4.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.031 -1.067 . . . . 1.1799999999999999 111.278 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' GLY . 32.9 t -145.03 -94.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.114 -1.035 . . . . 1.5900000000000001 111.807 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.559 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.5 p80 -60.69 75.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.434 -0.907 . . . . 0.70999999999999996 111.3 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.45 21.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.333 -0.937 . . . . 0.60999999999999999 111.575 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' HIS . 70.2 mt-30 -144.49 134.95 24.56 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.011 -1.076 . . . . 2.7000000000000002 111.096 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -90.97 -178.33 5.18 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.73 -0.788 . . . . 1.2 111.056 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.4 -172.77 27.72 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.377 -1.392 . . . . 0.35999999999999999 110.884 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mtp -101.22 157.39 16.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.824 -0.751 . . . . 0.34999999999999998 111.268 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 27' ' ' ILE . 3.1 p90 -159.36 144.25 11.45 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 115.124 -0.944 . . . . 0.41999999999999998 109.06 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.2 125.96 20.57 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 120.264 0.643 . . . . 0.38 110.801 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -64.53 -20.44 66.22 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.562 -0.855 . . . . 3.1400000000000001 110.968 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.99 1.59 49.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.915 -1.114 . . . . 1.4099999999999999 111.082 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.74 13.5 33.45 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.616 -0.834 . . . . 0.94999999999999996 109.006 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 31.5 m -140.98 171.54 12.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.646 -1.161 . . . . 1.1399999999999999 109.905 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 C-N-CA 119.441 -0.904 . . . . 0.40000000000000002 109.242 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.481 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 69.9 m-85 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.039 0.923 . . . . 2.4100000000000001 113.118 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 m -140.22 -172.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 113.823 -1.535 . . . . 0.34000000000000002 108.057 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -142.07 98.17 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.058 -1.089 . . . . 0.91000000000000003 108.058 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -20.93 111.97 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.916 -1.493 . . . . 0.10000000000000001 113.487 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.44 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -67.38 -36.42 81.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.167 -0.679 . . . . 0.89000000000000001 109.167 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.16 -174.73 4.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.844 -1.071 . . . . 0.82999999999999996 109.183 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.86 131.44 34.52 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 113.614 -1.63 . . . . 0.47999999999999998 109.446 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -120.71 109.47 15.23 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.987 -1.085 . . . . 0.37 113.364 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 . . . . . 0 C--N 1.302 -1.474 0 N-CA-C 106.819 -1.548 . . . . 1.48 106.819 179.442 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.213 -0.839 0 CA-C-O 123.343 1.544 . . . . 2.3100000000000001 115.087 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 tp -97.69 157.04 16.27 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 111.397 -2.638 . . . . 0.87 110.544 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -143.71 112.89 0.72 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.261 -1.447 . . . . 0.48999999999999999 111.142 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 p90 -135.5 -179.25 5.52 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.266 -0.973 . . . . 0.44 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 23' ' ' ARG . 2.9 mmt85 -137.29 124.32 21.52 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.537 -0.865 . . . . 3.6699999999999999 112.22 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -10.08 128.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.283 0.989 . . . . 3.9700000000000002 113.281 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.48 -20.08 50.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.287 -1.525 . . . . 0.19 109.287 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.0 126.02 28.42 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.856 -1.138 . . . . 1.7 108.234 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 2.3 m-85 -78.39 108.39 11.71 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.92000000000000004 113.38 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.504 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.12 142.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 105.765 -1.939 . . . . 0.29999999999999999 105.765 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.481 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 9.9 t-160 -101.55 97.78 8.18 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.173 -1.411 . . . . 0.33000000000000002 107.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.55 84.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.546 -1.207 . . . . 0.39000000000000001 110.842 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 28' ' ' HIS . 3.7 ttm -69.14 -30.79 69.11 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.112 -1.403 . . . . 0.93000000000000005 111.547 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -169.3 90.99 0.22 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.707 -1.597 . . . . 1.6399999999999999 111.983 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.2 104.35 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.075 -1.45 . . . . 2.6099999999999999 108.386 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 m -94.6 -37.16 11.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.168 -1.013 . . . . 2.2400000000000002 113.534 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -124.58 160.43 53.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.373 -0.931 . . . . 1.1799999999999999 111.471 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.65 -68.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.736 1.624 . . . . 0.55000000000000004 111.604 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.1 t30 -91.25 12.94 18.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.539 -0.864 . . . . 2.6400000000000001 111.094 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.5 m95 -145.46 144.79 30.8 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.773 -0.825 . . . . 0.46999999999999997 108.773 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 20.5 m0 -144.62 172.86 12.39 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.4 -0.92 . . . . 0.27000000000000002 111.82 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -115.09 123.82 49.97 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.559 -1.645 . . . . 1.3400000000000001 106.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.94 -148.03 4.67 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 118.241 -1.933 . . . . 0.17000000000000001 108.831 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.52 20.62 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.117 -1.433 . . . . 0.23999999999999999 111.95 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 23.4 t -161.14 -108.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 116.597 -2.041 . . . . 0.28000000000000003 114.471 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 2.2 p80 -26.96 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.348 -0.842 . . . . 3.0800000000000001 113.213 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 161.98 18.08 0.03 OUTLIER Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.046 -1.549 . . . . 2.1499999999999999 109.991 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.5 162.21 37.44 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.153 -1.019 . . . . 4.1600000000000001 110.221 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -95.66 -171.17 2.3 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.195 -1.002 . . . . 1.5700000000000001 111.393 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.42 -170.89 28.91 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.657 -1.156 . . . . 0.22 110.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.3 mtp -105.25 143.35 33.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.827 -0.749 . . . . 0.70999999999999996 110.746 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.9 p90 -147.65 146.02 23.2 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 119.705 -0.798 . . . . 0.25 108.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.99 126.9 23.06 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 N-CA-C 110.458 -0.632 . . . . 0.22 110.458 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -60.77 -36.16 78.25 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.462 -0.79 . . . . 4.4400000000000004 111.045 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -74.25 -0.73 17.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.058 -1.057 . . . . 4.1100000000000003 112.692 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -93.45 6.39 48.35 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 118.719 -1.192 . . . . 1.6000000000000001 110.092 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.44 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.3 m -134.27 171.39 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 115.457 -0.792 . . . . 0.26000000000000001 109.827 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 119.338 -0.945 . . . . 1.3899999999999999 109.132 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.576 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 79.7 m-85 . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.928 0.87 . . . . 0.77000000000000002 112.84 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.61 -170.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.821 -1.536 . . . . 0.23000000000000001 108.275 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -138.78 102.7 4.64 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.936 -1.135 . . . . 0.39000000000000001 107.936 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.27 110.61 0.06 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.326 -0.852 . . . . 0.20000000000000001 112.396 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -64.2 -37.14 86.41 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -174.4 4.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.146 0.974 . . . . 1.5900000000000001 109.74 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -83.33 127.62 33.82 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.496 -1.684 . . . . 0.38 110.815 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -115.84 106.42 13.81 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.633 -0.827 . . . . 0.28000000000000003 111.905 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.313 0 C-N-CA 117.724 -1.591 . . . . 3.8799999999999999 109.439 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.374 0.607 . . . . 1.8100000000000001 112.102 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.555 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -84.08 172.41 12.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 116.026 1.861 . . . . 0.47999999999999998 116.026 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.08 120.97 1.01 Allowed Glycine 0 N--CA 1.497 2.743 0 CA-C-N 113.645 -1.616 . . . . 0.16 110.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.1 p90 -145.78 -170.94 3.59 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.319 -1.352 . . . . 0.28999999999999998 112.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.0 mmt-85 -138.72 129.8 26.83 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.4 -0.818 . . . . 5.2999999999999998 112.222 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -16.61 137.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.194 0.934 . . . . 3.5600000000000001 113.239 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -21.65 10.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.816 -1.714 . . . . 0.26000000000000001 108.816 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' ARG . 20.8 m-20 -65.64 118.88 10.18 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.94 -1.104 . . . . 1.1100000000000001 108.055 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -76.55 112.92 13.61 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.662 -1.215 . . . . 1.05 112.482 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.472 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.26 147.62 7.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.702 -1.222 . . . . 0.23999999999999999 107.702 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.7 t-80 -103.9 101.61 11.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.761 -1.175 . . . . 0.34000000000000002 107.83 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.39 98.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.5 -1.227 . . . . 0.26000000000000001 111.505 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -30.22 41.42 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.09 -1.414 . . . . 3.0800000000000001 110.959 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.24 114.48 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.334 -1.346 . . . . 2.29 111.014 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 19.6 p30 -56.72 109.82 0.69 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.223 -1.391 . . . . 1.8100000000000001 109.69 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 p -91.75 -38.58 12.3 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.04 -1.064 . . . . 3.6699999999999999 112.049 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -138.63 161.91 56.02 Favored Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.496 -0.881 . . . . 1.1599999999999999 110.747 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.27 -64.43 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.224 1.283 . . . . 0.69999999999999996 111.254 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.8 t-20 -90.49 4.07 52.14 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.244 -0.982 . . . . 0.39000000000000001 111.191 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 26.5 m95 -138.73 140.87 38.85 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 108.801 -0.815 . . . . 0.45000000000000001 108.801 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -138.59 -177.72 4.99 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.68 -0.808 . . . . 1.04 111.928 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -124.2 124.74 43.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.578 -1.267 . . . . 1.02 107.578 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -155.86 -144.97 4.06 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 108.724 -1.751 . . . . 0.10000000000000001 108.724 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.7 173.74 11.53 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.375 -1.33 . . . . 0.17999999999999999 111.735 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 13.8 t -166.06 -103.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 116.871 -1.932 . . . . 1.0 114.407 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.605 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.9 p80 -29.92 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.403 -0.817 . . . . 2.8199999999999998 112.943 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 152.51 13.7 0.07 OUTLIER Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.278 -1.529 . . . . 2.1299999999999999 109.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.73 164.21 35.87 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.714 -0.794 . . . . 5.3700000000000001 110.382 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 p -97.52 -175.03 3.08 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.116 -1.034 . . . . 0.73999999999999999 111.556 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.59 -174.58 29.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.112 -1.195 . . . . 0.14000000000000001 110.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 mtp -102.59 146.56 27.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.705 -0.798 . . . . 1.27 110.748 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.472 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.3 p90 -151.39 147.24 19.99 Favored Pre-proline 0 C--N 1.303 -1.439 0 C-N-CA 119.441 -0.903 . . . . 0.37 109.892 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.38 124.77 15.83 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.051 -0.788 . . . . 0.32000000000000001 110.051 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -17.87 63.89 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.632 -0.827 . . . . 4.4900000000000002 111.526 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.97 -1.3 54.38 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.583 -1.247 . . . . 3.3300000000000001 111.552 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -96.61 7.57 46.23 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.314 -0.955 . . . . 1.05 108.894 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.8 m -137.32 169.58 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.935 -1.029 . . . . 0.29999999999999999 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 119.118 -1.033 . . . . 0.70999999999999996 109.646 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.62 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 54.1 m-85 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.993 0.902 . . . . 2.6099999999999999 113.218 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.14 -167.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.921 -1.491 . . . . 0.19 108.741 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -142.78 97.81 3.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.895 -1.15 . . . . 0.32000000000000001 107.895 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.69 110.93 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.496 -1.229 . . . . 0.27000000000000002 113.915 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 2.9 tp -56.46 -50.04 72.88 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.573 -0.74 . . . . 2.27 109.634 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -174.52 4.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.987 -1.006 . . . . 1.79 108.451 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 126.53 31.18 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.086 -1.416 . . . . 0.64000000000000001 110.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -111.77 102.42 10.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.428 -0.909 . . . . 0.34000000000000002 111.892 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 117.312 -1.755 . . . . 3.7999999999999998 109.052 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.373 0.606 . . . . 1.5900000000000001 111.775 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.536 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -82.09 168.07 18.13 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 116.053 1.871 . . . . 1.8999999999999999 116.053 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -156.94 123.19 1.26 Allowed Glycine 0 N--CA 1.496 2.69 0 CA-C-N 113.819 -1.537 . . . . 0.13 109.751 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 p90 -148.82 -175.68 5.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.369 -1.332 . . . . 0.28999999999999998 112.377 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 23' ' ' ARG . 19.7 mmt180 -132.19 129.85 40.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.414 -0.812 . . . . 4.3899999999999997 111.742 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -19.72 138.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 124.184 0.928 . . . . 4.3099999999999996 113.256 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.73 39.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.528 -1.429 . . . . 0.12 109.528 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -73.71 120.36 19.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.356 -1.35 . . . . 0.52000000000000002 107.356 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -74.23 112.99 10.92 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.711 -1.196 . . . . 1.3500000000000001 113.195 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.464 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.74 141.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.517 -1.66 . . . . 0.23000000000000001 106.517 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.62 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 12.2 t-160 -100.5 95.82 6.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.388 -1.325 . . . . 0.34999999999999998 108.307 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.63 97.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 114.465 -1.243 . . . . 0.28000000000000003 111.115 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.495 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 2.8 mmt -72.77 -32.14 65.41 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.209 -1.359 . . . . 3.2799999999999998 110.983 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 101.2 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.053 -1.459 . . . . 3.21 111.213 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 7.4 p-10 -51.34 100.88 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.541 -1.264 . . . . 2.7000000000000002 109.553 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.22 -77.34 0.46 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.953 -1.099 . . . . 1.6799999999999999 110.674 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -78.22 159.09 76.06 Favored Pre-proline 0 C--N 1.296 -1.752 0 C-N-CA 119.255 -0.978 . . . . 0.98999999999999999 110.696 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.47 -64.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.659 1.573 . . . . 0.65000000000000002 111.399 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.1 t-20 -86.16 -1.81 57.77 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.711 -0.796 . . . . 0.57999999999999996 111.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 16.2 m95 -132.01 153.49 50.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.022 -1.103 . . . . 0.53000000000000003 108.022 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.5 m0 -148.34 176.12 10.53 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.256 -0.978 . . . . 0.68000000000000005 111.728 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.4 131.1 55.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.466 -1.309 . . . . 1.2 107.466 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.495 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.01 -145.87 4.3 Favored Glycine 0 C--N 1.302 -1.31 0 C-N-CA 118.123 -1.989 . . . . 0.32000000000000001 109.608 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.45 154.99 12.57 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 118.517 -1.273 . . . . 0.70999999999999996 111.847 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.4 t -152.31 -94.62 0.05 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.875 -1.13 . . . . 0.53000000000000003 111.33 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.625 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.6 p80 -59.96 77.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.509 -0.876 . . . . 0.33000000000000002 110.878 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 24.53 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.177 -1.011 . . . . 0.20000000000000001 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' HIS . 59.8 mt-30 -147.44 144.98 29.02 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.781 -1.167 . . . . 1.8600000000000001 111.49 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -95.96 -177.06 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.811 -0.756 . . . . 0.76000000000000001 110.335 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -174.91 27.66 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.45 -1.357 . . . . 0.16 110.62 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 mtp -102.18 146.79 27.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.854 -0.738 . . . . 0.97999999999999998 111.477 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 7.5 p90 -149.32 143.94 17.43 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.137 -0.938 . . . . 0.25 108.958 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.81 126.62 22.84 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 N-CA-C 110.705 -0.537 . . . . 0.35999999999999999 110.705 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -27.68 68.59 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.454 -0.794 . . . . 2.5600000000000001 112.055 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 2.46 33.59 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.31 -1.356 . . . . 1.8200000000000001 112.175 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.03 6.33 49.1 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.248 -0.981 . . . . 0.70999999999999996 109.213 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.6 m -135.32 176.26 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.582 -1.19 . . . . 0.26000000000000001 108.997 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.878 0 C-N-CA 119.236 -0.985 . . . . 1.6899999999999999 109.205 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.5 m-85 . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 121.923 0.868 . . . . 2.02 113.197 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.1 -170.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.087 -1.415 . . . . 0.91000000000000003 108.684 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -140.83 97.14 3.13 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.428 -0.952 . . . . 0.17000000000000001 108.428 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -22.25 110.69 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.899 -1.501 . . . . 0.14999999999999999 113.269 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.479 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 tp -64.52 -50.59 66.78 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.454 -0.794 . . . . 2.3100000000000001 109.852 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -131.93 -178.81 5.05 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.279 -1.008 . . . . 1.4199999999999999 108.279 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 131.62 35.21 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.159 -1.382 . . . . 0.22 108.325 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -118.51 107.14 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.194 -1.002 . . . . 0.41999999999999998 112.746 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 117.725 -1.59 . . . . 3.9199999999999999 109.307 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.562 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.456 0.646 . . . . 1.52 111.943 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.562 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -79.18 169.64 17.84 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 115.647 1.721 . . . . 0.5 115.647 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.08 121.42 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-N 113.848 -1.524 . . . . 0.17000000000000001 110.743 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.6 p90 -147.61 -172.86 4.13 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.515 -1.274 . . . . 0.14999999999999999 112.007 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.6 mmm180 -136.35 130.06 32.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.614 -0.721 . . . . 3.2400000000000002 111.61 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 22' ' ' ARG . 4.3 ttp180 -19.11 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.126 0.891 . . . . 5.2999999999999998 112.922 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.8 62.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.25 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.93 117.79 20.34 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.801 -1.185 . . . . 0.40000000000000002 107.801 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -73.72 111.73 9.14 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.809 -1.156 . . . . 0.80000000000000004 112.722 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.27 146.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.009 -1.478 . . . . 0.16 107.009 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 10.4 t-80 -103.43 100.21 10.07 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.463 -1.31 . . . . 0.46999999999999997 107.463 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.46 89.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.771 -1.104 . . . . 0.23999999999999999 110.949 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.446 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 7.7 tpp -78.55 -28.07 45.98 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 113.889 -1.505 . . . . 3.0699999999999998 111.874 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 33' ' ' SER . 1.6 t70 -161.28 82.29 0.62 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 117.771 -1.572 . . . . 1.3300000000000001 111.663 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 10.1 p-10 -54.1 96.62 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.689 -1.205 . . . . 0.81999999999999995 109.038 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' ASP . 45.9 m -96.94 -84.96 0.36 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.225 -0.99 . . . . 1.1899999999999999 111.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -65.45 158.88 71.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 C-N-CA 119.299 -0.96 . . . . 0.53000000000000003 111.575 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.39 -65.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.616 1.544 . . . . 0.48999999999999999 111.22 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 6.3 t-20 -82.23 -0.07 43.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.411 -0.813 . . . . 0.63 111.348 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.8 m95 -137.19 148.99 46.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.657 -0.868 . . . . 0.33000000000000002 108.657 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 7.7 m0 -144.51 169.57 17.71 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.141 -1.023 . . . . 0.69999999999999996 112.378 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.96 123.65 50.01 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 106.854 -1.536 . . . . 3.1699999999999999 106.854 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -154.09 -150.26 5.44 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.296 -1.907 . . . . 0.17000000000000001 109.188 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.36 172.97 12.76 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 117.983 -1.487 . . . . 0.28000000000000003 112.448 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' GLY . 13.1 t -169.96 -96.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.826 -1.15 . . . . 0.77000000000000002 111.478 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.569 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.1 p80 -57.85 77.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.762 -0.775 . . . . 0.48999999999999999 111.378 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.6 22.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.318 -0.944 . . . . 0.28000000000000003 111.765 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.9 mt-30 -146.6 136.24 23.08 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.927 -1.109 . . . . 2.8500000000000001 111.121 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -88.93 -179.49 5.96 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.655 -0.818 . . . . 0.34000000000000002 109.593 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.72 -172.97 31.79 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.623 -1.751 . . . . 0.14999999999999999 111.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtp -103.98 141.04 36.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.311 -0.556 . . . . 1.24 110.716 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 5.3 p90 -145.76 145.89 27.06 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.558 -0.857 . . . . 0.17000000000000001 109.835 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.43 128.89 31.96 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 N-CA-C 110.098 -0.77 . . . . 0.20999999999999999 110.098 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.44 -30.97 71.83 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.392 -0.923 . . . . 3.75 111.672 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -77.34 4.38 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.79 -1.164 . . . . 2.8500000000000001 112.018 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.48 11.09 39.69 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.405 -0.918 . . . . 0.71999999999999997 109.431 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.6 m -139.98 173.65 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.835 -1.075 . . . . 0.17000000000000001 109.076 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.292 -1.911 0 C-N-CA 118.57 -1.252 . . . . 1.8400000000000001 109.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.643 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 63.6 m-85 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.399 0.618 . . . . 2.1000000000000001 110.373 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 54' ' ' VAL . 11.4 m -123.29 -165.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.928 -1.033 . . . . 0.44 110.354 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 26' ' ' PHE . 3.0 mt-30 -143.92 100.08 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.169 -1.419 . . . . 0.81000000000000005 107.169 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -25.5 111.76 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.366 -1.288 . . . . 0.12 113.279 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.0 tp -66.51 -47.74 72.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.58 -0.736 . . . . 2.4700000000000002 109.671 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -131.06 -179.28 5.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.617 -1.253 . . . . 1.1000000000000001 107.617 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.05 135.55 35.85 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 106.758 -1.571 . . . . 0.29999999999999999 106.758 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -122.48 112.68 18.33 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.405 -1.318 . . . . 0.17999999999999999 114.31 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 106.783 -1.562 . . . . 4.5499999999999998 106.783 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.596 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.213 -0.826 0 N-CA-C 109.482 -0.562 . . . . 0.83999999999999997 109.482 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.596 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 7.2 tp -77.91 158.35 29.42 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.549 0.944 . . . . 1.3999999999999999 113.549 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -149.96 123.51 1.59 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.531 -1.428 . . . . 0.40000000000000002 109.531 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.9 p90 -147.78 -168.39 3.05 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.783 -1.167 . . . . 0.28999999999999998 111.91 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.8 mmm-85 -139.08 133.94 32.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.907 -0.717 . . . . 3.27 111.599 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -18.83 139.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.15 0.907 . . . . 4.5 113.224 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -19.37 31.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.291 -1.524 . . . . 0.17000000000000001 109.291 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.74 121.66 15.92 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.871 -1.132 . . . . 0.56000000000000005 108.947 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m-85 -77.13 104.65 7.74 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.687 -1.205 . . . . 1.0 112.175 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.466 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -74.31 147.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.412 -1.329 . . . . 0.13 107.412 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.643 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.6 t-160 -107.76 96.73 6.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.865 -1.134 . . . . 0.65000000000000002 108.425 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.04 90.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.777 -1.101 . . . . 0.64000000000000001 113.336 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.462 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -61.62 -33.86 74.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.033 -1.067 . . . . 2.2400000000000002 109.984 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -178.56 111.74 0.06 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.676 -1.21 . . . . 2.2999999999999998 111.105 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.411 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -57.29 99.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.232 -1.387 . . . . 3.21 109.272 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -94.19 -68.16 0.82 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.143 -1.023 . . . . 2.9100000000000001 111.434 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.512 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -86.61 160.07 51.28 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 118.851 -1.139 . . . . 0.81000000000000005 110.888 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.08 -68.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.428 1.419 . . . . 0.53000000000000003 111.021 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.5 t-20 -81.85 -2.61 51.66 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.391 -0.822 . . . . 0.76000000000000001 111.43 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 28.9 m95 -133.1 153.94 51.04 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 108.738 -0.838 . . . . 0.40000000000000002 108.738 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.1 m0 -149.04 168.04 24.22 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.957 -0.697 . . . . 0.5 111.129 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -108.03 130.52 55.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.41 -1.33 . . . . 0.76000000000000001 107.41 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.71 -152.19 6.34 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 117.71 -2.186 . . . . 0.19 110.106 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.54 27.18 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 117.921 -1.511 . . . . 0.40000000000000002 112.425 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 41.7 t -158.39 -89.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.895 -1.122 . . . . 1.96 111.853 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.2 p80 -60.73 73.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.849 -0.74 . . . . 0.46000000000000002 111.039 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.47 19.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.026 -1.083 . . . . 0.37 111.006 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' HIS . 9.1 mm100 -144.08 135.1 25.37 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.021 -1.071 . . . . 4.1299999999999999 111.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 ' H ' ' HG1' ' A' ' 46' ' ' THR . 5.1 p -84.24 -174.78 5.47 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.724 -0.79 . . . . 1.5700000000000001 110.727 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.96 -167.62 27.73 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.56 -1.305 . . . . 0.31 111.013 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.9 mtp -109.3 144.28 37.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.168 -0.613 . . . . 0.90000000000000002 111.517 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 9.5 p90 -145.54 144.3 22.38 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 115.384 -0.826 . . . . 0.40999999999999998 109.567 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.71 126.2 21.65 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.303 0.668 . . . . 0.32000000000000001 110.386 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -61.91 -30.77 71.11 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.428 -0.806 . . . . 4.0199999999999996 111.543 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.79 1.93 18.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.848 -1.141 . . . . 3.2799999999999998 112.595 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.92 12.8 36.94 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.301 -0.96 . . . . 0.58999999999999997 109.635 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -139.93 174.74 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.265 -0.879 . . . . 0.14999999999999999 110.347 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 C-N-CA 119.035 -1.066 . . . . 0.22 109.679 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 58.7 m-85 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.485 0.66 . . . . 1.6499999999999999 110.916 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.57 -165.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 114.821 -1.081 . . . . 0.93000000000000005 109.555 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.517 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -145.46 94.52 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.818 -1.179 . . . . 0.33000000000000002 107.818 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.46 110.97 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.251 -1.341 . . . . 0.14999999999999999 113.211 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.462 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.52 -46.16 80.7 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.045 -0.525 . . . . 1.78 109.944 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.25 -179.32 5.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.028 -1.101 . . . . 1.03 108.028 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.72 136.3 36.74 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.278 -1.328 . . . . 0.67000000000000004 108.225 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -127.61 109.37 11.63 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.755 -1.178 . . . . 0.25 114.002 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.306 -1.293 0 C-N-CA 117.722 -1.591 . . . . 1.8 106.744 179.469 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.733 0 N-CA-C 107.891 -1.152 . . . . 0.28000000000000003 107.891 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.581 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -69.64 164.05 24.22 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 119.941 -0.704 . . . . 0.28000000000000003 112.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.92 121.81 1.1 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.545 -1.022 . . . . 0.12 110.545 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 6.3 p90 -147.01 -170.49 3.55 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.465 -1.294 . . . . 0.17999999999999999 112.516 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.5 mmt180 -136.51 130.74 32.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.181 -0.918 . . . . 4.2400000000000002 111.435 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' ARG . 3.3 ttp85 -16.42 138.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.03 1.122 . . . . 3.48 114.03 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.32 -22.38 13.12 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.412 -1.475 . . . . 0.40999999999999998 109.412 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.84 121.53 13.71 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.957 -1.097 . . . . 1.3300000000000001 108.261 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -77.36 106.83 9.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.439 -1.304 . . . . 1.21 112.174 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.461 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.77 143.82 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.356 -1.349 . . . . 0.20000000000000001 107.356 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.633 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.1 t-160 -103.56 94.01 5.24 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.6 -1.24 . . . . 0.35999999999999999 108.796 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.24 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 114.56 -1.2 . . . . 0.76000000000000001 112.783 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.488 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 30.7 mtt -72.5 -30.66 64.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.999 -1.0 . . . . 2.7799999999999998 111.052 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -159.21 93.58 1.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.283 -1.367 . . . . 1.1499999999999999 111.404 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.644 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -68.71 94.11 0.57 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.868 -1.133 . . . . 3.8100000000000001 109.333 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t -98.16 -74.34 0.58 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.326 -0.95 . . . . 3.6699999999999999 112.209 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -69.24 157.27 89.78 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.763 -1.175 . . . . 0.46000000000000002 111.48 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.54 -65.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.176 1.918 . . . . 0.58999999999999997 111.961 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 5.7 t30 -87.53 5.78 37.48 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.768 -0.773 . . . . 2.98 111.396 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 14.9 m95 -139.73 147.64 41.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.259 -1.015 . . . . 0.39000000000000001 108.259 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.3 m0 -147.29 172.11 14.37 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.36 -0.936 . . . . 0.51000000000000001 111.383 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -112.75 129.4 56.43 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.639 -1.245 . . . . 0.89000000000000001 107.639 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.43 -144.71 4.06 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 118.261 -1.923 . . . . 0.13 109.335 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.09 174.96 9.82 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 117.824 -1.55 . . . . 0.089999999999999997 112.704 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' GLY . 38.9 t -170.52 -95.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.147 -1.021 . . . . 1.5800000000000001 112.071 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 6.5 p80 -58.61 78.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.458 -0.897 . . . . 0.70999999999999996 111.415 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.75 25.64 0.22 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.101 -1.047 . . . . 0.42999999999999999 111.956 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.48 149.24 25.31 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 117.941 -1.503 . . . . 4.7800000000000002 111.902 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -95.68 -175.75 3.53 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.799 -0.76 . . . . 1.6399999999999999 110.839 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.51 -164.73 29.08 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.237 -1.459 . . . . 0.14000000000000001 111.392 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.4 mtp -109.39 145.66 35.74 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.466 -0.494 . . . . 0.35999999999999999 111.258 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 8.2 p90 -148.82 142.49 16.2 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.369 -0.932 . . . . 0.22 109.408 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.46 123.81 14.75 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.712 -0.919 . . . . 0.27000000000000002 109.712 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -29.82 70.44 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.078 -1.049 . . . . 4.2999999999999998 111.354 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -73.26 -5.0 36.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.839 -1.144 . . . . 3.8500000000000001 112.176 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.82 10.4 35.41 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.052 -1.059 . . . . 0.28000000000000003 109.778 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.462 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.8 m -136.85 172.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.335 -0.848 . . . . 0.19 109.859 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.466 0 C-N-CA 119.554 -0.859 . . . . 0.80000000000000004 109.142 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 113.192 0.812 . . . . 1.9099999999999999 113.192 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.75 -170.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.788 -1.097 . . . . 0.75 108.557 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.499 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -141.8 100.63 3.79 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.762 -1.199 . . . . 0.5 107.762 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -26.49 113.45 0.05 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.582 -1.19 . . . . 0.16 112.913 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.428 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.6 -39.55 91.67 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.565 0.698 . . . . 2.1600000000000001 109.753 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.62 -174.72 4.68 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.895 -1.048 . . . . 1.9299999999999999 108.827 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.2 122.4 26.8 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.218 -1.355 . . . . 0.82999999999999996 109.363 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -111.28 99.23 8.08 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.897 -1.121 . . . . 0.40000000000000002 113.578 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.294 -1.819 0 C-N-CA 115.916 -2.314 . . . . 1.51 104.805 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.216 -0.708 0 N-CA-C 108.386 -0.968 . . . . 0.35999999999999999 108.386 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.8 tp -71.93 164.21 26.48 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.75 0.786 . . . . 0.28999999999999998 112.757 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.42 117.89 0.8 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.395 -1.882 . . . . 0.28999999999999998 108.395 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.7 p90 -140.62 -168.94 2.68 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.66 -1.216 . . . . 0.23000000000000001 113.029 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' ARG . 9.6 mmm-85 -137.07 129.58 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.75 . . . . 3.3100000000000001 112.775 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -13.68 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.458 1.098 . . . . 4.0599999999999996 113.633 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.28 -22.73 5.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.802 -1.719 . . . . 0.48999999999999999 108.802 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' ARG . 4.4 m-20 -61.46 121.51 12.86 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 118.607 -1.237 . . . . 0.66000000000000003 107.968 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -77.81 112.24 14.47 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.874 -1.13 . . . . 1.3999999999999999 112.703 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.51 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -79.04 142.15 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.733 -1.21 . . . . 0.29999999999999999 107.733 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.454 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 20.4 t-80 -99.44 99.66 10.6 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.244 -1.382 . . . . 1.3400000000000001 107.87 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.33 92.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 C-N-CA 118.7 -1.2 . . . . 0.89000000000000001 110.35 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.426 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 5.1 mmt -71.9 -28.96 63.85 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.159 -1.382 . . . . 3.6200000000000001 111.729 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.48 104.81 0.21 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.1 -1.44 . . . . 1.6799999999999999 111.462 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -58.4 104.55 0.22 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.587 -1.245 . . . . 2.3900000000000001 109.173 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -66.94 0.87 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.094 -1.042 . . . . 3.4399999999999999 111.478 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -98.65 159.49 30.29 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 119.404 -0.919 . . . . 0.62 111.266 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.95 -60.88 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.965 1.777 . . . . 0.56999999999999995 110.963 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -89.47 4.25 49.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.348 -0.842 . . . . 0.45000000000000001 111.408 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' ASP . 21.9 m95 -142.0 141.72 32.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.881 -0.785 . . . . 0.16 108.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.6 m0 -141.92 169.72 17.06 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.651 -0.82 . . . . 0.67000000000000004 111.805 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -108.41 134.12 51.64 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.07 -1.085 . . . . 2.5299999999999998 108.07 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -163.87 -148.7 5.5 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 117.812 -2.137 . . . . 0.29999999999999999 109.7 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.01 172.81 13.36 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.222 -1.391 . . . . 0.20000000000000001 112.114 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -172.01 -94.0 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.733 -1.187 . . . . 0.72999999999999998 112.005 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.554 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.9 p80 -58.42 77.64 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.539 -0.864 . . . . 0.72999999999999998 111.397 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.32 27.36 0.25 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.115 -1.041 . . . . 0.78000000000000003 111.499 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -156.61 151.83 26.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.162 -1.415 . . . . 1.04 111.757 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.516 ' H ' ' HG1' ' A' ' 46' ' ' THR . 3.1 p -97.51 -176.48 3.51 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.669 -0.812 . . . . 1.8400000000000001 110.473 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.69 -176.83 24.46 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.337 -1.411 . . . . 0.39000000000000001 111.628 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.9 mtp -100.45 150.63 22.44 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.327 0.584 . . . . 0.54000000000000004 111.378 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.7 p90 -151.7 146.2 18.55 Favored Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.311 -0.858 . . . . 0.14999999999999999 109.607 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.29 123.17 12.84 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 110.367 -0.666 . . . . 0.17999999999999999 110.367 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.05 -18.45 60.67 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.396 -0.922 . . . . 3.8199999999999998 111.078 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -86.64 0.4 54.6 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.737 -1.185 . . . . 3.46 111.733 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -100.27 9.64 42.42 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.365 -0.934 . . . . 0.85999999999999999 109.407 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -136.2 171.6 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 114.886 -1.052 . . . . 0.28000000000000003 108.989 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 C-N-CA 119.231 -0.988 . . . . 0.5 108.759 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.274 0.559 . . . . 1.97 111.996 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.22 -164.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.16 -0.927 . . . . 0.87 109.88 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.87 101.45 3.65 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.304 -1.369 . . . . 0.41999999999999998 107.304 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -28.13 115.66 0.09 Allowed 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.938 1.088 . . . . 0.29999999999999999 113.938 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.81 -34.33 69.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -174.62 4.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.639 -1.164 . . . . 1.1899999999999999 109.292 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 127.94 35.61 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.757 -1.565 . . . . 0.39000000000000001 109.453 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.58 108.23 16.88 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.332 -0.947 . . . . 0.34000000000000002 113.458 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.31 -1.145 0 C-N-CA 117.773 -1.571 . . . . 1.05 108.631 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.214 -0.775 0 N-CA-C 115.633 1.716 . . . . 2.4199999999999999 115.633 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.33 170.06 8.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 110.747 -2.933 . . . . 2.02 110.528 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.69 113.94 0.59 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.851 -1.166 . . . . 0.37 110.21 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 p90 -138.49 -162.05 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.937 -1.105 . . . . 0.31 112.196 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -147.82 133.14 18.49 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.961 -1.096 . . . . 7.4100000000000001 113.307 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.56 127.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.641 1.213 . . . . 3.7400000000000002 112.259 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . 91.16 -32.62 5.09 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 119.715 -1.231 . . . . 0.84999999999999998 110.484 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.59 125.99 24.66 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.393 -1.323 . . . . 2.04 108.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.94 113.66 14.88 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.024 -1.07 . . . . 0.91000000000000003 113.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.481 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -77.53 140.85 16.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.668 -1.213 . . . . 0.28000000000000003 108.062 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.6 t-80 -96.0 96.84 9.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.189 -1.404 . . . . 1.52 108.53 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -64.8 100.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 119.018 -1.073 . . . . 0.52000000000000002 111.293 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.436 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mtt -67.08 -39.22 86.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.004 -1.078 . . . . 1.5900000000000001 108.547 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -179.23 116.29 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.98 -1.009 . . . . 1.46 109.654 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -47.17 111.64 0.43 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.297 -1.361 . . . . 3.29 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -42.43 11.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.138 -1.025 . . . . 1.3200000000000001 112.208 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.94 162.12 58.67 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 119.906 -0.718 . . . . 1.4099999999999999 111.015 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 -61.05 0.48 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.894 1.729 . . . . 1.0 111.985 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -99.65 17.83 19.57 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.604 -0.839 . . . . 0.95999999999999996 110.667 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 23.4 m95 -151.47 139.46 20.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.414 -0.958 . . . . 0.54000000000000004 108.414 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 26.4 m0 -138.79 175.9 9.16 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.334 -0.947 . . . . 0.28000000000000003 112.128 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 129.91 56.53 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.784 -1.561 . . . . 0.90000000000000002 106.784 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.24 -152.92 6.56 Favored Glycine 0 C--N 1.298 -1.573 0 C-N-CA 117.888 -2.101 . . . . 0.23999999999999999 109.834 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.44 168.28 18.65 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 118.225 -1.39 . . . . 0.35999999999999999 111.763 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 36.4 t -163.89 -91.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.689 -1.205 . . . . 1.55 111.522 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.634 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 2.9 p80 -59.98 77.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.63 -0.828 . . . . 0.53000000000000003 111.429 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.93 23.74 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.098 -1.048 . . . . 0.5 111.93 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -152.96 153.44 32.96 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.071 -1.452 . . . . 4.4500000000000002 111.201 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 p -99.44 -174.89 2.84 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.652 -0.819 . . . . 1.99 111.37 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.23 -172.09 28.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.356 -1.098 . . . . 0.22 110.356 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.3 mtp -105.03 157.99 16.86 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.747 -0.781 . . . . 1.5700000000000001 110.387 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.7 p90 -159.21 142.72 10.76 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.134 -1.061 . . . . 0.34000000000000002 108.134 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -54.76 127.0 24.33 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 CA-C-N 118.613 0.541 . . . . 0.40000000000000002 111.239 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.535 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -40.22 85.84 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.574 -0.851 . . . . 3.1800000000000002 109.578 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.5 2.39 1.8 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.529 -0.868 . . . . 3.0499999999999998 112.867 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.79 10.39 41.2 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.101 -1.039 . . . . 1.22 109.328 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.2 m -141.58 175.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.25 109.463 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.545 0 C-N-CA 119.23 -0.988 . . . . 0.87 109.324 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.318 0.58 . . . . 1.8200000000000001 112.553 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 m -143.81 -170.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.078 -0.964 . . . . 0.35999999999999999 110.011 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.512 ' NE2' ' CE2' ' A' ' 26' ' ' PHE . 1.9 mt-30 -141.72 101.13 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.678 -1.23 . . . . 0.45000000000000001 107.678 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.26 110.55 0.06 Allowed 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.188 -0.915 . . . . 0.19 113.116 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.442 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.53 -42.04 87.82 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.469 0.652 . . . . 1.8400000000000001 109.978 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.56 -178.24 4.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.741 -1.118 . . . . 2.0499999999999998 108.758 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 140.59 32.44 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 113.435 -1.711 . . . . 1.01 106.995 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.57 106.99 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.031 1.493 . . . . 0.48999999999999999 115.031 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.305 -1.343 0 N-CA-C 105.925 -1.88 . . . . 2.0099999999999998 105.925 179.385 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 108.089 -1.078 . . . . 1.28 108.089 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.598 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.4 tp -69.0 154.61 41.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 112.858 0.688 . . . . 1.0800000000000001 112.858 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.15 123.13 1.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.659 -1.377 . . . . 0.28999999999999998 109.659 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 p90 -146.44 -176.11 5.05 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.582 -1.247 . . . . 0.17999999999999999 112.03 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.5 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.9 mmt85 -135.73 127.72 29.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.498 -0.774 . . . . 4.0899999999999999 111.305 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.5 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -13.56 135.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.03 1.122 . . . . 1.5600000000000001 114.03 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.39 -21.82 30.11 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.23000000000000001 109.402 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -69.09 117.52 10.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.731 -1.211 . . . . 0.93999999999999995 107.731 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 67.3 m-85 -73.28 108.3 6.08 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.978 -1.089 . . . . 1.1499999999999999 112.174 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.472 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.38 142.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.068 -1.456 . . . . 0.19 107.068 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 31.8 t-80 -101.45 99.17 9.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.861 -1.536 . . . . 1.8600000000000001 108.125 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 t -64.74 102.43 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 C-N-CA 118.731 -1.187 . . . . 0.76000000000000001 110.12 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.41 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.6 ttp -93.32 -21.96 19.26 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.825 -1.08 . . . . 1.9299999999999999 111.216 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.01 87.82 0.94 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.092 -1.443 . . . . 1.97 111.734 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.15 82.78 0.23 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.78 -1.168 . . . . 2.3700000000000001 108.755 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -95.7 -83.14 0.37 Allowed 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.191 -1.003 . . . . 2.9100000000000001 111.855 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.1 m-20 -57.85 156.15 19.93 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 118.675 -1.21 . . . . 0.84999999999999998 111.352 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.17 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.896 1.731 . . . . 0.40999999999999998 111.833 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.88 -3.26 53.72 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.225 -0.898 . . . . 0.38 111.556 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 32.8 m95 -129.67 151.8 49.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.18 -1.044 . . . . 0.94999999999999996 108.18 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.2 m0 -151.81 164.85 36.17 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.04 -0.664 . . . . 0.76000000000000001 110.905 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -108.16 137.79 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.579 -1.267 . . . . 1.27 107.579 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -160.52 -148.71 5.35 Favored Glycine 0 C--O 1.214 -1.145 0 C-N-CA 118.078 -2.01 . . . . 0.38 109.54 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.17 154.39 10.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.403 -1.319 . . . . 0.76000000000000001 112.185 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 44' ' ' GLY . 35.1 t -155.25 -100.93 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.956 -1.098 . . . . 1.4399999999999999 111.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.558 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.4 p80 -53.65 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.571 -0.74 . . . . 0.51000000000000001 111.715 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 26.66 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.139 -1.029 . . . . 0.46000000000000002 112.268 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -156.73 149.9 24.11 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.408 -1.317 . . . . 5.0800000000000001 111.982 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.476 ' N ' ' NE2' ' A' ' 45' ' ' GLN . 7.1 p -97.27 -172.9 2.53 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.604 -0.726 . . . . 0.93000000000000005 110.855 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.52 -171.15 26.65 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.374 -1.393 . . . . 0.20000000000000001 111.422 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 18.7 mtp -104.9 145.46 30.38 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.241 -0.584 . . . . 0.84999999999999998 111.489 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.472 ' CE2' HG23 ' A' ' 27' ' ' ILE . 7.4 p90 -149.42 141.17 14.81 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 119.516 -0.874 . . . . 0.20000000000000001 109.94 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.31 128.31 29.91 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 N-CA-C 110.067 -0.782 . . . . 0.29999999999999999 110.067 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -23.01 64.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.411 -0.916 . . . . 3.48 111.56 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -84.38 10.18 11.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.712 -1.195 . . . . 5.7800000000000002 111.383 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.01 6.85 29.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.814 -0.755 . . . . 1.1399999999999999 109.112 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.442 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.0 m -134.7 175.07 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.553 -1.203 . . . . 0.26000000000000001 109.603 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.344 0 C-N-CA 119.414 -0.914 . . . . 0.54000000000000004 108.949 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 113.24 0.83 . . . . 3.2000000000000002 113.24 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.87 -164.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 115.174 -0.921 . . . . 1.03 109.218 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.511 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -145.26 97.48 3.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.286 -1.005 . . . . 0.55000000000000004 108.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.4 115.25 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.729 -1.123 . . . . 0.16 113.282 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 17.2 tp -64.95 -41.27 95.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.666 -0.697 . . . . 3.4500000000000002 109.425 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.68 -174.92 4.6 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.962 -1.017 . . . . 1.6499999999999999 109.489 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.57 127.63 33.56 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 113.903 -1.499 . . . . 0.59999999999999998 107.456 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -114.44 103.89 11.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.453 1.279 . . . . 0.42999999999999999 114.453 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 105.687 -1.968 . . . . 1.8200000000000001 105.687 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.739 0 CA-C-O 121.429 0.633 . . . . 0.88 109.545 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.563 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 11.3 tp -72.16 155.99 39.65 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.003 -0.999 . . . . 2.0299999999999998 113.291 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.48 117.2 0.86 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 107.999 -2.04 . . . . 0.42999999999999999 107.999 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 7.9 p90 -139.52 -169.3 2.66 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.889 -1.124 . . . . 0.39000000000000001 113.064 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -133.97 130.14 37.23 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.463 -0.79 . . . . 4.1500000000000004 112.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -18.71 137.92 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.829 0.706 . . . . 4.0599999999999996 112.879 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 -21.5 15.23 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.916 -1.674 . . . . 0.33000000000000002 108.916 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -64.85 121.73 15.29 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.935 -1.106 . . . . 0.34000000000000002 108.308 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 110.2 11.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.986 -1.086 . . . . 1.0700000000000001 112.763 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.463 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -76.18 146.85 8.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.784 -1.191 . . . . 0.20000000000000001 107.784 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -103.49 89.78 3.47 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.277 -1.369 . . . . 1.24 109.408 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.83 94.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 118.677 -1.209 . . . . 0.90000000000000002 110.285 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.415 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 15.4 mtp -74.88 -29.57 61.05 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.655 -1.157 . . . . 2.8399999999999999 110.482 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.25 99.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 117.946 -1.502 . . . . 2.3199999999999998 111.805 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -54.56 101.53 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.103 -1.439 . . . . 2.0699999999999998 108.326 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -94.04 -72.89 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.007 -1.077 . . . . 1.9299999999999999 111.735 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.1 m-20 -80.34 160.55 67.53 Favored Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.049 -1.06 . . . . 0.64000000000000001 111.0 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.34 -68.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.577 1.518 . . . . 0.53000000000000003 111.127 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.5 t-20 -87.13 4.13 43.54 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.712 -0.795 . . . . 0.32000000000000001 111.577 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.2 m95 -136.66 148.62 47.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.465 -0.939 . . . . 0.14999999999999999 108.465 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 22.8 m0 -142.37 175.55 9.68 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.616 -0.834 . . . . 0.20000000000000001 111.5 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 133.03 56.32 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.965 -1.494 . . . . 1.29 106.965 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.71 -150.68 5.91 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 117.918 -2.086 . . . . 0.20000000000000001 109.261 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.68 159.66 19.1 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 118.226 -1.389 . . . . 0.53000000000000003 111.662 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' GLY . 40.6 t -155.37 -100.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.553 -1.259 . . . . 0.33000000000000002 112.097 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 5.7 p80 -52.77 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.584 -0.735 . . . . 0.87 111.899 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.2 24.05 0.1 OUTLIER Glycine 0 N--CA 1.489 2.216 0 CA-C-N 115.167 -0.924 . . . . 0.51000000000000001 112.252 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 tp60 -156.16 163.71 39.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.814 -1.554 . . . . 5.7699999999999996 111.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 p -99.82 -177.26 3.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.341 -0.845 . . . . 2.1800000000000002 111.313 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.99 171.39 18.36 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.01 -1.567 . . . . 0.76000000000000001 111.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 mtp -95.92 146.28 24.72 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 120.218 -0.593 . . . . 1.24 110.394 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 10.1 p90 -148.78 145.54 20.06 Favored Pre-proline 0 C--N 1.296 -1.743 0 C-N-CA 119.403 -0.919 . . . . 0.32000000000000001 108.859 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.93 128.04 27.43 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.008 0.472 . . . . 0.20999999999999999 110.973 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -59.16 -36.56 75.5 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 4.4900000000000002 110.253 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 26.7 t-20 -75.13 3.32 8.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.473 -0.891 . . . . 3.6899999999999999 112.787 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.12 9.16 43.25 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.905 -1.118 . . . . 0.97999999999999998 109.598 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.5 m -138.42 177.94 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.943 -1.026 . . . . 0.20000000000000001 109.03 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 C-N-CA 119.18 -1.008 . . . . 1.6699999999999999 109.259 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 113.091 0.775 . . . . 1.6100000000000001 113.091 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.45 -167.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 115.062 -0.972 . . . . 0.78000000000000003 109.9 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.88 97.08 2.96 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.588 -1.264 . . . . 0.38 107.588 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.22 115.54 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.359 -1.291 . . . . 0.22 113.663 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -70.77 -42.09 70.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.809 -0.632 . . . . 1.0700000000000001 109.888 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 -179.94 5.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.478 1.132 . . . . 1.3500000000000001 109.155 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -85.31 124.76 32.3 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.107 -1.86 . . . . 0.71999999999999997 107.412 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -111.96 104.54 12.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.262 -0.975 . . . . 0.52000000000000002 112.798 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.4 p-10 . . . . . 0 C--N 1.304 -1.37 0 C-N-CA 117.514 -1.675 . . . . 3.3500000000000001 108.765 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.2 pt-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.327 0.584 . . . . 1.8400000000000001 111.732 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -84.82 170.22 13.39 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 116.138 1.903 . . . . 0.40000000000000002 116.138 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -158.93 119.66 0.91 Allowed Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.168 -1.833 . . . . 0.17000000000000001 109.209 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.5 p90 -144.97 -170.81 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.367 -1.333 . . . . 0.16 112.455 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 23' ' ' ARG . 5.1 mmt85 -136.88 126.91 25.98 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.544 -0.753 . . . . 3.0800000000000001 111.743 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.3 ttp85 -12.8 135.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.398 1.259 . . . . 4.0199999999999996 114.398 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.11 -23.81 10.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.52000000000000002 109.6 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -61.26 117.07 5.14 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.388 -1.325 . . . . 0.84999999999999998 107.891 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -71.89 107.57 4.72 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.48 -1.288 . . . . 1.1499999999999999 112.376 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.85 136.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.362 -1.347 . . . . 0.38 107.362 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.409 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 25.5 t-80 -94.36 94.12 8.09 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.454 -1.699 . . . . 1.7 108.29 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.01 100.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 C-N-CA 118.967 -1.093 . . . . 0.64000000000000001 111.388 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.6 tpp -61.51 -36.0 79.29 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.062 -1.055 . . . . 2.2400000000000002 108.931 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 p30 171.58 126.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.026 -0.988 . . . . 3.5899999999999999 109.39 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.559 ' ND2' ' N ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -49.97 109.78 0.32 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.914 -1.514 . . . . 3.54 109.716 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -92.51 -65.69 0.98 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.422 -0.911 . . . . 3.1000000000000001 110.162 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -102.57 160.75 25.36 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.021 -0.99 . . . . 0.84999999999999998 110.315 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -59.47 -60.57 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.309 1.34 . . . . 0.67000000000000004 111.087 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -92.53 -3.58 54.87 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.666 -0.813 . . . . 0.54000000000000004 111.708 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 17.0 m95 -131.01 152.85 49.88 Favored 'General case' 0 C--O 1.204 -1.327 0 N-CA-C 108.343 -0.984 . . . . 0.42999999999999999 108.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.677 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 15.2 m0 -145.24 177.91 8.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.69 -0.804 . . . . 0.44 111.825 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -118.02 135.95 53.85 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.943 -1.132 . . . . 4.3700000000000001 107.943 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.409 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -165.89 -150.36 6.26 Favored Glycine 0 C--N 1.3 -1.451 0 C-N-CA 118.031 -2.033 . . . . 0.20999999999999999 109.268 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.44 174.27 12.95 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 118.264 -1.374 . . . . 0.17999999999999999 111.877 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -170.33 -93.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.832 -1.147 . . . . 1.0 112.156 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 7.7 p80 -59.69 78.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.259 -0.977 . . . . 1.0600000000000001 111.049 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.76 20.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.132 -0.94 . . . . 0.65000000000000002 111.688 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' HIS . 54.8 mt-30 -148.3 151.79 35.99 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.393 -1.323 . . . . 1.76 111.745 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -96.14 -179.46 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.629 -0.828 . . . . 1.8200000000000001 110.239 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -179.06 28.21 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.019 -1.562 . . . . 0.37 111.092 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.6 mtp -102.79 147.04 27.36 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.398 0.618 . . . . 0.53000000000000003 110.81 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 5.0 p90 -149.16 149.7 30.2 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.359 -0.837 . . . . 0.28000000000000003 108.799 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.11 131.16 37.6 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 N-CA-C 110.564 -0.591 . . . . 0.42999999999999999 110.564 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.677 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.39 -51.41 68.91 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.204 -0.998 . . . . 4.7000000000000002 109.755 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -61.1 9.12 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.522 0.934 . . . . 4.5099999999999998 113.522 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -104.39 3.75 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.112 -1.035 . . . . 0.5 109.26 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.9 m -134.06 175.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.29999999999999999 108.875 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.305 -0.958 . . . . 0.46000000000000002 108.693 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.12 0.486 . . . . 2.7400000000000002 112.068 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.75 -168.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.556 -0.747 . . . . 0.85999999999999999 109.52 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.6 mt-30 -143.05 89.67 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.828 -0.749 . . . . 0.28000000000000003 109.031 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -14.55 111.69 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.023 -1.444 . . . . 0.23999999999999999 114.139 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.46 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 6.1 tp -63.75 -52.98 57.97 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.639 -0.71 . . . . 2.6400000000000001 109.537 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.23 -178.92 5.05 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.865 -1.161 . . . . 0.75 107.865 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.85 136.48 36.7 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 114.328 -1.305 . . . . 0.31 109.088 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -123.69 109.55 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.958 -1.097 . . . . 0.28999999999999998 113.391 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.306 -1.297 0 C-N-CA 117.816 -1.554 . . . . 1.27 108.452 179.595 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.519 0.676 . . . . 1.5800000000000001 112.049 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.536 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.6 tp -76.71 166.06 23.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 115.492 1.664 . . . . 1.8 115.492 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.08 120.9 1.05 Allowed Glycine 0 N--CA 1.499 2.88 0 CA-C-N 114.237 -1.347 . . . . 0.20999999999999999 110.437 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.05 -175.54 5.0 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.073 -1.451 . . . . 0.26000000000000001 112.861 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' ARG . 31.3 mmt-85 -135.6 130.55 34.62 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.189 -0.914 . . . . 7.1100000000000003 111.603 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.98 140.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.456 1.28 . . . . 2.0600000000000001 114.456 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.11 -15.07 29.67 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 114.067 -1.424 . . . . 0.23000000000000001 109.594 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -72.68 118.81 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.555 -1.276 . . . . 0.40999999999999998 107.555 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.69 107.21 5.8 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.687 -1.205 . . . . 0.90000000000000002 113.276 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.454 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -73.04 142.84 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.819 -1.548 . . . . 0.26000000000000001 106.819 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -100.6 93.92 5.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.17 -1.412 . . . . 1.27 108.887 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.07 96.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 118.135 -1.426 . . . . 0.90000000000000002 110.5 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.6 ttm -82.48 -25.87 33.12 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.51 -1.223 . . . . 0.83999999999999997 110.706 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.9 85.06 0.95 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.15 -1.42 . . . . 2.0600000000000001 111.766 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.676 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.18 91.78 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.027 -1.069 . . . . 3.8300000000000001 109.0 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.2 m -103.1 -85.86 0.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.285 -0.966 . . . . 2.0600000000000001 111.936 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 8.4 m-20 -55.58 154.52 12.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 118.488 -1.285 . . . . 1.1299999999999999 110.753 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.05 -71.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.876 1.717 . . . . 0.44 112.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.47 7.82 13.28 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.721 -0.792 . . . . 2.7400000000000002 111.387 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.3 m95 -139.85 146.19 39.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.617 -0.882 . . . . 0.52000000000000002 108.617 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.8 m0 -145.59 167.34 23.28 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.378 -0.929 . . . . 0.47999999999999998 111.447 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -108.21 132.1 54.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.241 -1.022 . . . . 0.27000000000000002 108.241 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.09 -146.66 4.62 Favored Glycine 0 C--N 1.3 -1.443 0 C-N-CA 117.883 -2.103 . . . . 0.16 109.116 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.76 159.21 21.11 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.173 -1.811 . . . . 0.41999999999999998 113.495 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 8.2 t -175.61 -179.72 1.28 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 2.9100000000000001 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.609 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 10.8 p80 40.78 26.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.802 -0.636 . . . . 1.8700000000000001 111.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 81.27 31.04 35.38 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.732 -1.223 . . . . 0.85999999999999999 112.778 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.6 tt0 -164.91 155.23 13.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.832 -1.547 . . . . 1.97 112.19 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -95.04 -179.5 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.399 -0.921 . . . . 0.88 110.814 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 -159.2 28.27 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.14 -1.505 . . . . 0.32000000000000001 111.255 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.5 mtp -120.03 148.37 43.66 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.167 0.508 . . . . 0.47999999999999998 110.759 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 8.5 p90 -151.08 143.9 16.64 Favored Pre-proline 0 C--N 1.297 -1.712 0 C-N-CA 119.563 -0.855 . . . . 0.32000000000000001 109.146 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.91 126.92 24.02 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 109.864 -0.86 . . . . 0.28000000000000003 109.864 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -32.59 72.03 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.149 -1.02 . . . . 4.21 111.58 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 -74.54 0.12 15.86 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.494 -1.283 . . . . 2.23 112.349 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.39 12.56 32.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.93 -1.108 . . . . 1.76 109.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.6 m -139.38 171.0 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.983 -1.008 . . . . 0.27000000000000002 109.741 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.576 -0.898 . . . . 1.28 108.576 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 112.66 0.615 . . . . 1.55 112.66 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.42 -167.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.266 -0.879 . . . . 1.1499999999999999 110.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 7' ' ' ALA . 4.4 mt-30 -141.83 109.34 5.64 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.673 -1.603 . . . . 0.41999999999999998 106.673 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -34.79 115.73 0.29 Allowed 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.927 -1.109 . . . . 0.40999999999999998 111.79 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 1.4 tt -73.71 -39.82 64.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.018 -0.992 . . . . 1.8400000000000001 109.837 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.99 -179.9 5.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.781 -1.1 . . . . 1.24 108.582 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.61 135.47 36.06 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.294 -1.775 . . . . 0.55000000000000004 107.702 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -131.07 111.93 12.44 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.475 -1.29 . . . . 0.55000000000000004 113.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.311 -1.077 0 C-N-CA 118.023 -1.471 . . . . 3.79 107.928 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.638 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.75 0 CA-C-O 121.28 0.562 . . . . 1.22 110.147 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.638 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -73.74 167.35 21.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.107 -0.951 . . . . 0.38 112.109 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.76 130.12 2.68 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.598 -1.001 . . . . 0.23999999999999999 110.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -156.75 -172.05 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.682 -1.607 . . . . 0.40999999999999998 113.075 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . 10.8 mmm180 -138.77 128.57 24.98 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.278 -0.874 . . . . 5.9100000000000001 112.153 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -12.7 135.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.295 1.22 . . . . 4.1399999999999997 114.295 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.63 -19.51 32.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.095 -1.602 . . . . 0.16 109.095 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -65.39 118.81 9.92 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.166 -1.014 . . . . 0.81000000000000005 108.777 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.78 107.79 7.1 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.068 -1.053 . . . . 1.75 112.696 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -77.92 143.4 12.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.139 -1.43 . . . . 0.39000000000000001 107.139 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -100.82 95.24 6.5 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.739 -1.585 . . . . 1.79 108.767 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -64.83 106.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 118.114 -1.434 . . . . 0.91000000000000003 109.613 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.3 tpp -88.75 -26.34 21.8 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.122 -0.944 . . . . 2.3500000000000001 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -172.06 108.52 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.691 -1.604 . . . . 1.6000000000000001 111.595 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 3.7 p30 -62.33 100.01 0.16 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.381 -1.328 . . . . 1.76 109.249 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -91.25 -66.55 0.92 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.782 -1.167 . . . . 1.3500000000000001 111.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 4.3 m-20 -90.19 159.9 41.2 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 119.226 -0.99 . . . . 2.3500000000000001 110.726 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.54 -65.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.443 1.429 . . . . 0.41999999999999998 111.066 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -83.14 -8.93 59.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.489 -0.778 . . . . 0.92000000000000004 111.559 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 18.9 m95 -126.57 155.94 41.65 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.768 -0.827 . . . . 0.46999999999999997 108.768 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.6 m0 -149.84 -179.31 7.03 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.507 -0.877 . . . . 0.71999999999999997 112.151 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -122.43 128.13 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.879 -1.156 . . . . 1.1699999999999999 107.879 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.87 -148.43 4.99 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.587 -1.805 . . . . 0.19 108.587 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.91 159.05 17.82 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 117.303 -1.759 . . . . 0.57999999999999996 113.763 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' GLY . 43.2 t -172.7 -178.85 1.99 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.543 -1.208 . . . . 2.5299999999999998 111.041 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 4.0 p80 39.6 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.874 -0.603 . . . . 2.21 111.616 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 85.9 30.47 23.31 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.718 -1.229 . . . . 0.53000000000000003 112.907 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 46' ' ' THR . 1.3 tm0? -164.37 151.72 11.81 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.119 -1.433 . . . . 5.5800000000000001 111.814 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.517 ' N ' ' OE1' ' A' ' 45' ' ' GLN . 6.1 p -94.28 -175.69 3.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.55 -0.86 . . . . 0.57999999999999996 110.689 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.15 -170.07 29.49 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.462 -1.351 . . . . 0.20000000000000001 110.933 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.0 mtp -107.76 143.91 35.63 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.975 -0.69 . . . . 1.0900000000000001 111.095 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 3.5 p90 -148.52 145.59 20.55 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 119.701 -0.8 . . . . 0.28999999999999998 110.093 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.43 125.64 19.46 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 N-CA-C 109.966 -0.821 . . . . 0.34999999999999998 109.966 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.31 -25.22 67.53 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.626 -0.829 . . . . 2.6099999999999999 112.211 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.25 7.44 16.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.367 -1.333 . . . . 3.9300000000000002 111.876 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.96 7.37 39.17 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.506 -0.878 . . . . 0.93000000000000005 109.547 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.475 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 11.6 m -135.18 179.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.767 -1.106 . . . . 0.37 109.033 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 118.745 -1.182 . . . . 0.38 110.818 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.466 ' CE2' ' CD2' ' A' ' 28' ' ' HIS . 82.9 m-85 . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.765 0.793 . . . . 3.3100000000000001 112.666 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -130.93 -166.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.308 -1.315 . . . . 1.0700000000000001 108.708 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.1 mt-30 -144.45 95.41 2.71 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.928 -1.138 . . . . 0.19 107.928 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.54 111.15 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.481 -1.236 . . . . 0.14999999999999999 113.186 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.484 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 14.0 tp -61.98 -45.72 92.39 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.514 0.673 . . . . 2.9700000000000002 109.682 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.09 -174.44 3.85 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.709 -1.132 . . . . 1.3100000000000001 108.252 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.84 148.31 30.02 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 114.168 -1.378 . . . . 0.27000000000000002 107.805 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -139.21 119.35 13.56 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.125 -1.43 . . . . 0.68999999999999995 113.704 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--N 1.311 -1.066 0 C-N-CA 118.643 -1.223 . . . . 1.73 108.64 179.571 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.636 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.76 0 CA-C-O 121.399 0.619 . . . . 1.1200000000000001 110.103 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.636 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -74.88 161.62 29.38 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.674 0.99 . . . . 2.6000000000000001 113.674 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -153.2 120.92 1.09 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.072 -1.211 . . . . 0.23999999999999999 110.072 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.7 p90 -144.16 -169.61 3.16 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.778 -1.169 . . . . 0.26000000000000001 111.796 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.1 mmm-85 -138.7 125.05 20.4 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.937 -0.705 . . . . 3.4100000000000001 112.0 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.63 130.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.143 0.902 . . . . 3.8599999999999999 113.282 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.52 -19.61 53.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.23000000000000001 109.381 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' OD1' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -72.84 120.73 18.87 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.961 -1.096 . . . . 1.8400000000000001 108.925 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -76.01 109.46 9.67 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.96 -1.096 . . . . 0.55000000000000004 112.65 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.454 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -74.58 142.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.677 -1.231 . . . . 0.31 107.677 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.466 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 12.2 t-80 -100.74 97.99 8.57 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 118.29 -1.364 . . . . 0.87 108.032 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.12 94.81 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.908 -1.042 . . . . 0.62 110.884 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 ttm -82.28 -27.21 32.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.56 -1.2 . . . . 1.3700000000000001 111.343 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' SER . 11.8 t70 -160.46 83.44 0.69 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 117.701 -1.6 . . . . 1.8700000000000001 111.903 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 1.6 p-10 -52.93 99.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.456 -1.297 . . . . 2.71 108.904 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 1.1 t -95.17 -78.06 0.46 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.126 -1.03 . . . . 2.23 111.554 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -72.63 158.48 87.27 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.064 -1.054 . . . . 0.62 111.498 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.49 -65.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.783 1.655 . . . . 0.23000000000000001 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 6.67 35.33 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.689 -0.804 . . . . 2.7999999999999998 111.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' ASP . 15.8 m95 -139.65 147.53 41.15 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.704 -1.221 . . . . 0.25 107.704 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -145.8 174.83 10.88 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.254 -0.978 . . . . 0.52000000000000002 112.024 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.31 135.94 53.44 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.621 -1.251 . . . . 2.6499999999999999 107.621 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -162.31 -145.11 4.22 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 117.895 -2.097 . . . . 0.42999999999999999 109.643 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.12 155.58 11.8 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.543 -1.263 . . . . 0.73999999999999999 112.237 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 44' ' ' GLY . 28.7 t -155.81 -98.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.012 -1.075 . . . . 0.55000000000000004 111.751 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.609 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.9 p80 -55.47 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.563 -0.855 . . . . 0.59999999999999998 111.029 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.56 26.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.327 -0.94 . . . . 0.47999999999999998 111.866 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -154.78 153.01 30.54 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.15 -1.42 . . . . 3.8399999999999999 111.792 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.528 ' H ' ' HG1' ' A' ' 46' ' ' THR . 3.0 p -98.15 -174.25 2.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.638 -0.71 . . . . 1.95 110.692 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.45 -169.55 27.0 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.371 -1.395 . . . . 0.31 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.5 mtp -110.2 151.41 27.35 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.355 0.598 . . . . 0.47999999999999998 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.9 p90 -152.53 147.99 20.19 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.165 -0.925 . . . . 0.34000000000000002 109.067 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.56 128.39 27.0 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 110.006 -0.805 . . . . 0.23000000000000001 110.006 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -39.1 90.89 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.877 -1.129 . . . . 2.5800000000000001 110.674 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.03 2.43 2.71 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.017 -1.073 . . . . 3.0600000000000001 112.694 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.29 9.23 41.94 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.275 -0.97 . . . . 0.28999999999999998 109.342 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.484 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.7 m -138.28 176.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.972 -1.013 . . . . 0.22 109.451 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.292 -1.913 0 C-N-CA 118.555 -1.258 . . . . 0.46999999999999997 109.627 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.529 0.681 . . . . 2.1299999999999999 112.546 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.8 -171.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 114.738 -1.119 . . . . 0.20000000000000001 109.328 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.5 mt-30 -140.66 93.63 2.63 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.821 -0.752 . . . . 0.39000000000000001 109.341 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -19.92 110.57 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.864 -1.516 . . . . 0.17999999999999999 114.739 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' ' NE ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -71.67 -44.35 64.42 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.102 -0.954 . . . . 2.02 109.291 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.85 -179.98 5.24 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.128 -1.064 . . . . 2.0499999999999998 108.128 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.37 143.32 26.87 Favored 'General case' 0 C--N 1.268 -2.941 0 N-CA-C 106.848 -1.538 . . . . 0.64000000000000001 106.848 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -131.41 115.09 15.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.205 -1.398 . . . . 0.46999999999999997 114.415 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.307 -1.28 0 C-N-CA 118.638 -1.225 . . . . 4.0899999999999999 107.915 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.499 -0.998 0 CA-C-O 123.113 1.435 . . . . 2.3900000000000001 113.697 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -104.06 160.11 15.12 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 111.385 -2.643 . . . . 1.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.77 105.23 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.933 -1.603 . . . . 0.5 110.767 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.2 p90 -132.03 -170.19 2.36 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.38 -0.928 . . . . 0.33000000000000002 111.178 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 23' ' ' ARG . 1.3 mmm180 -144.04 124.9 14.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.398 -0.921 . . . . 4.4299999999999997 112.046 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.5 ttt-85 -11.68 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 124.351 1.032 . . . . 2.3199999999999998 113.542 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.7 -17.78 55.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.262 -1.535 . . . . 0.33000000000000002 109.262 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.93 126.17 29.86 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.578 -1.249 . . . . 1.25 108.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -77.36 111.5 13.09 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.601 -1.24 . . . . 0.55000000000000004 112.816 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.451 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.46 144.19 11.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 118.618 -1.233 . . . . 0.17000000000000001 107.965 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 13.0 t-80 -101.16 101.24 11.93 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 106.658 -1.608 . . . . 0.68999999999999995 106.658 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.26 91.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 115.106 -0.952 . . . . 0.64000000000000001 112.781 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.456 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 4.4 mtt -57.68 -39.35 76.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.538 -1.21 . . . . 1.78 109.529 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.7 OUTLIER 179.8 119.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.591 -1.244 . . . . 3.23 110.594 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.46 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 6.4 p-10 -49.13 108.55 0.19 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.372 -1.331 . . . . 3.2799999999999998 110.154 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.7 t -92.28 -47.78 7.02 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.186 -1.006 . . . . 1.9299999999999999 111.481 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -125.73 161.19 52.36 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.397 -0.82 . . . . 1.4399999999999999 110.181 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -58.27 -67.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.505 1.47 . . . . 0.66000000000000003 111.648 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -87.9 7.05 32.65 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.65000000000000002 111.348 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASP . 24.4 m95 -141.42 145.08 34.87 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.815 . . . . 0.41999999999999998 108.801 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.549 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -143.93 173.05 12.04 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.402 -0.919 . . . . 0.66000000000000003 112.218 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -116.15 132.44 56.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.936 -1.135 . . . . 1.0800000000000001 107.936 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -157.08 -144.16 3.86 Favored Glycine 0 C--N 1.297 -1.594 0 C-N-CA 118.004 -2.046 . . . . 0.16 109.163 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.82 161.58 15.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.397 -1.321 . . . . 0.40000000000000002 111.419 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 44' ' ' GLY . 47.1 t -161.29 -112.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.039 -1.865 . . . . 0.56000000000000005 113.771 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.536 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 p80 -21.93 -42.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.413 1.071 . . . . 2.75 113.052 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 164.39 18.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.137 -1.506 . . . . 2.5600000000000001 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -157.12 161.96 39.4 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.452 -0.899 . . . . 2.1899999999999999 110.749 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 p -96.79 -174.11 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.313 -0.955 . . . . 0.57999999999999996 110.475 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.19 -172.3 30.04 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.584 -1.293 . . . . 0.5 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtp -104.83 138.82 40.51 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.333 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.4 p90 -142.19 146.06 38.2 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 119.777 -0.769 . . . . 0.28000000000000003 109.32 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.78 127.06 24.53 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 110.141 -0.754 . . . . 0.39000000000000001 110.141 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -29.53 70.69 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.282 -0.967 . . . . 4.4699999999999998 111.747 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -76.51 -8.37 57.05 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.58 -1.248 . . . . 4.1799999999999997 111.736 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.91 15.56 7.02 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.962 -1.095 . . . . 1.1599999999999999 109.947 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.5 m -144.16 174.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 110.322 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.551 0 C-N-CA 119.673 -0.811 . . . . 0.64000000000000001 109.121 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.353 0.597 . . . . 1.54 111.968 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -143.81 -169.16 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 0.81999999999999995 109.851 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.5 mt-30 -143.57 105.36 4.34 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.228 -1.397 . . . . 0.45000000000000001 107.228 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -33.84 111.69 0.11 Allowed 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.01 -1.076 . . . . 0.40000000000000002 112.162 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.03 -37.21 86.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.934 -0.706 . . . . 1.8200000000000001 109.376 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.29 -173.55 4.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.891 -1.049 . . . . 2.0600000000000001 109.522 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 129.13 34.19 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.383 -1.735 . . . . 0.53000000000000003 109.731 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.28 109.56 17.0 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.85 -1.14 . . . . 0.34999999999999998 113.133 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 . . . . . 0 C--N 1.295 -1.781 0 C-N-CA 117.234 -1.786 . . . . 1.5800000000000001 106.848 179.451 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.618 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.561 0.696 . . . . 2.71 111.861 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.618 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -77.33 161.65 27.9 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 115.187 1.551 . . . . 1.25 115.187 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -150.58 131.57 3.61 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.138 -1.185 . . . . 0.34999999999999998 110.138 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 8.2 p90 -152.57 -168.43 3.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.432 -1.307 . . . . 0.34000000000000002 112.029 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 23' ' ' ARG . 8.5 mmm180 -140.38 131.28 26.03 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.618 -0.833 . . . . 6.0800000000000001 112.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -13.13 135.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.016 1.117 . . . . 3.1499999999999999 114.016 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.13 14.01 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.367 -1.493 . . . . 0.37 109.367 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.26 119.23 7.52 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.841 -1.144 . . . . 0.65000000000000002 108.435 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.458 ' CZ ' ' NE2' ' A' ' 6' ' ' GLN . 26.9 m-85 -77.07 105.36 8.1 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.568 -1.253 . . . . 2.9100000000000001 112.569 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.487 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -75.54 144.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.017 -1.475 . . . . 0.26000000000000001 107.017 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -104.1 98.88 8.63 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.772 -1.171 . . . . 1.1299999999999999 108.149 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.16 92.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 118.346 -1.342 . . . . 0.80000000000000004 111.311 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.466 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -68.62 -36.09 78.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.803 -1.544 . . . . 2.8900000000000001 110.372 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -164.23 92.53 0.65 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.582 -1.247 . . . . 2.2200000000000002 111.106 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.75 99.24 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.346 -1.342 . . . . 2.1299999999999999 109.282 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -96.47 -82.64 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.314 -0.954 . . . . 2.5899999999999999 111.636 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.3 m-20 -64.27 158.23 66.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.052 -1.059 . . . . 0.63 110.86 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.06 -68.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.54 1.493 . . . . 0.29999999999999999 111.539 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.6 t30 -84.13 3.71 33.68 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.577 -0.849 . . . . 3.1400000000000001 111.332 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.447 ' O ' ' O ' ' A' ' 34' ' ' ASP . 22.9 m95 -136.47 144.4 44.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.541 -0.911 . . . . 0.56999999999999995 108.541 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.6 m0 -143.01 171.63 13.79 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.679 -0.808 . . . . 0.42999999999999999 111.692 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.08 130.33 55.55 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.533 -1.654 . . . . 0.98999999999999999 106.533 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.48 -154.56 7.14 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 117.952 -2.071 . . . . 0.20000000000000001 109.535 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.67 155.36 21.6 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 117.458 -1.697 . . . . 0.55000000000000004 112.926 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 44' ' ' GLY . 5.7 t -167.55 178.8 5.21 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.658 -1.156 . . . . 2.3399999999999999 110.777 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 42' ' ' CYS . 10.8 p80 41.01 23.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.096 -0.641 . . . . 2.3900000000000001 110.75 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 79.13 35.59 29.99 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.804 -1.189 . . . . 0.81999999999999995 111.812 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.7 mt-30 -160.23 144.16 14.14 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.895 -1.122 . . . . 1.8600000000000001 111.352 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -93.6 -177.91 4.54 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.272 -0.971 . . . . 0.84999999999999998 111.684 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.98 -163.88 28.6 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.642 -1.266 . . . . 0.38 111.066 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.2 mtp -113.89 147.98 37.52 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.263 -0.575 . . . . 0.91000000000000003 111.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 4.0 p90 -151.25 145.74 18.32 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.527 -0.869 . . . . 0.31 109.317 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.23 128.32 29.17 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 N-CA-C 109.884 -0.852 . . . . 0.41999999999999998 109.884 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -34.89 77.07 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.898 -0.721 . . . . 1.6499999999999999 112.565 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.457 ' OD1' ' OD1' ' A' ' 36' ' ' ASN . 18.4 m120 -75.05 12.15 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.148 -1.021 . . . . 2.73 113.253 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.92 7.09 27.84 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.505 -0.878 . . . . 0.63 109.089 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -136.86 173.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 114.57 -1.196 . . . . 0.28000000000000003 109.578 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 108.392 -0.966 . . . . 0.84999999999999998 108.392 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 113.003 0.742 . . . . 2.2400000000000002 113.003 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.05 -166.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.823 -1.08 . . . . 0.81000000000000005 109.36 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 7' ' ' ALA . 4.6 mt-30 -145.37 105.07 3.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.975 -1.011 . . . . 0.84999999999999998 108.438 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.05 116.63 0.11 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.793 -1.094 . . . . 0.20999999999999999 113.681 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.42 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.38 -52.89 22.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.233 -1.025 . . . . 0.66000000000000003 108.233 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -132.04 177.64 7.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.77 -1.196 . . . . 0.92000000000000004 107.77 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -75.38 134.36 40.97 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.284 -1.325 . . . . 1.1399999999999999 108.953 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -121.53 109.87 15.34 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.021 -1.072 . . . . 0.31 113.073 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 . . . . . 0 C--N 1.307 -1.265 0 C-N-CA 118.167 -1.413 . . . . 1.1000000000000001 108.387 179.692 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 123.328 1.537 . . . . 2.52 114.412 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.4 161.29 14.95 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.043 -2.799 . . . . 1.0800000000000001 109.4 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -145.11 115.19 0.82 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.364 -1.398 . . . . 0.34000000000000002 110.768 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.3 p90 -138.95 -174.49 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.984 -1.086 . . . . 0.31 111.65 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -139.77 125.92 19.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.595 -0.842 . . . . 3.3799999999999999 112.322 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.1 ttt180 -4.01 135.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.13 1.53 . . . . 2.1400000000000001 115.13 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 -21.68 3.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.289 -1.524 . . . . 0.60999999999999999 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -59.19 119.38 7.24 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.705 -1.198 . . . . 0.46000000000000002 108.399 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 48.1 m-85 -75.32 107.51 7.48 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.971 -1.092 . . . . 1.1399999999999999 113.525 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.494 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.17 143.92 12.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.029 -1.471 . . . . 0.28999999999999998 107.029 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 39.2 t-80 -101.0 102.39 13.38 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 117.79 -1.564 . . . . 1.95 107.773 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.0 101.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 C-N-CA 118.444 -1.303 . . . . 0.68000000000000005 110.751 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.7 ttm -77.6 -32.42 53.55 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.029 -0.987 . . . . 1.27 110.591 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.21 108.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.447 -1.301 . . . . 3.5699999999999998 110.975 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 12.4 p-10 -58.03 107.6 0.49 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.985 -1.486 . . . . 1.0900000000000001 108.695 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -93.46 -57.08 2.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.85 -1.14 . . . . 2.2799999999999998 111.804 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -107.05 161.1 24.02 Favored Pre-proline 0 C--N 1.299 -1.615 0 C-N-CA 119.625 -0.83 . . . . 0.75 111.461 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.33 -58.25 0.82 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.063 1.842 . . . . 0.39000000000000001 111.606 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 8.0 t-20 -98.96 13.35 32.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.725 -0.79 . . . . 0.40999999999999998 111.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 34.6 m95 -147.51 136.62 22.31 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.543 -0.863 . . . . 0.38 109.478 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.659 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 34.4 m0 -139.44 168.35 20.01 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.889 -0.724 . . . . 0.42999999999999999 111.27 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -106.85 135.5 48.29 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.942 -1.503 . . . . 1.8300000000000001 106.942 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -161.34 -152.0 6.48 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 117.839 -2.124 . . . . 0.28000000000000003 109.519 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.12 160.08 18.36 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 117.772 -1.571 . . . . 0.56999999999999995 113.138 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.1 t -158.79 -86.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.127 -1.029 . . . . 0.62 112.104 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.587 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 6.4 p80 -62.95 74.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.325 -0.95 . . . . 0.72999999999999998 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.29 23.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.715 -1.231 . . . . 0.60999999999999999 111.095 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' HIS . 12.7 mt-30 -149.41 139.7 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.372 -1.331 . . . . 2.5099999999999998 111.499 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -91.39 -172.46 3.27 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.665 -0.814 . . . . 0.59999999999999998 110.849 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.84 -167.91 27.61 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.288 -1.434 . . . . 0.20000000000000001 111.956 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 31.1 mtp -107.35 143.55 35.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.235 -0.586 . . . . 0.78000000000000003 110.753 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.0 p90 -147.4 147.06 27.04 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.622 -0.831 . . . . 0.13 109.049 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.05 124.72 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 120.189 0.592 . . . . 0.25 111.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.659 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.36 -27.36 55.77 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.309 -0.86 . . . . 2.6899999999999999 110.227 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -1.1 52.34 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.17 -1.012 . . . . 5.4900000000000002 113.091 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.7 12.68 31.02 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.811 -1.156 . . . . 1.77 109.931 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -141.45 172.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.404 -1.271 . . . . 0.25 108.157 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.847 0 C-N-CA 118.963 -1.095 . . . . 0.97999999999999998 108.853 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 1.97 111.645 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.14 174.69 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.835 -1.075 . . . . 0.65000000000000002 109.453 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.498 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.9 mt-30 -123.48 109.12 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.389 -1.337 . . . . 0.48999999999999999 107.389 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -32.2 116.13 0.19 Allowed 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.552 -0.859 . . . . 0.28000000000000003 112.371 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.482 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 11.8 tp -74.52 -42.26 59.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.435 -0.802 . . . . 3.1899999999999999 109.836 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.67 176.42 8.2 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.758 -1.11 . . . . 1.98 108.129 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.37 125.46 32.98 Favored 'General case' 0 C--N 1.265 -3.107 0 N-CA-C 105.909 -1.886 . . . . 0.82999999999999996 105.909 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.29 106.56 17.06 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.869 -1.132 . . . . 0.23000000000000001 113.658 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.306 -1.293 0 C-N-CA 118.298 -1.361 . . . . 0.95999999999999996 107.856 179.56 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.9 pt-20 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 113.711 1.004 . . . . 2.02 113.711 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.513 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -78.52 170.12 17.15 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 116.414 2.005 . . . . 0.55000000000000004 116.414 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.34 122.0 1.1 Allowed Glycine 0 N--CA 1.499 2.889 0 CA-C-N 113.286 -1.779 . . . . 0.23999999999999999 109.292 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.14 -169.99 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.705 -1.198 . . . . 0.23000000000000001 112.393 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' A' ' 23' ' ' ARG . 6.2 mmm180 -135.45 134.57 39.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.52 -0.763 . . . . 5.0499999999999998 112.361 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.4 ttp180 -20.53 141.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.229 0.956 . . . . 3.7200000000000002 113.146 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.41 -27.1 4.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.643 -1.383 . . . . 0.38 109.643 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' ARG . 13.6 m-20 -60.49 125.8 25.05 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.589 -1.245 . . . . 1.0600000000000001 108.127 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.58 111.62 14.83 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.302 -1.359 . . . . 1.1799999999999999 113.585 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.89 141.88 14.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.872 -1.529 . . . . 0.22 106.872 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -100.07 97.18 8.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 117.598 -1.641 . . . . 1.5800000000000001 108.026 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.13 99.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 C-N-CA 118.624 -1.231 . . . . 0.35999999999999999 111.021 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.4 mtt -82.75 -26.22 32.1 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.274 -0.875 . . . . 2.1299999999999999 110.44 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -163.81 80.34 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 118.223 -1.391 . . . . 1.5900000000000001 111.656 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.04 87.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.46 -1.296 . . . . 3.5800000000000001 108.521 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 31' ' ' ASP . 6.4 t -103.76 -72.59 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.755 -0.778 . . . . 3.3799999999999999 112.705 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 3.0 m-20 -60.59 153.96 58.73 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 118.859 -1.136 . . . . 1.77 111.021 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.26 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.106 1.871 . . . . 0.60999999999999999 112.87 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.39 14.38 3.69 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.599 -0.728 . . . . 0.84999999999999998 110.681 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 55.4 m95 -147.47 149.38 32.57 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.276 -0.875 . . . . 1.25 109.227 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.8 m0 -148.75 161.6 41.45 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.484 -0.886 . . . . 0.48999999999999999 111.302 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 132.33 48.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.929 -1.137 . . . . 1.8400000000000001 107.929 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 -152.58 6.98 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 118.255 -1.926 . . . . 0.31 109.731 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.35 175.38 11.63 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.595 -1.242 . . . . 0.17000000000000001 111.202 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.565 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.8 t -168.81 -79.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.001 -1.88 . . . . 1.51 114.679 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 2.4 p80 -65.07 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.85 -0.614 . . . . 1.47 112.622 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 89.77 6.12 70.41 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.048 -1.549 . . . . 0.97999999999999998 109.75 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.04 151.22 47.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.656 -0.818 . . . . 5.8799999999999999 109.868 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -92.41 -175.71 4.09 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.871 -1.131 . . . . 1.3999999999999999 110.823 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.49 179.05 25.02 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.777 -1.202 . . . . 0.46999999999999997 110.13 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.3 mtp -100.87 147.16 26.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 1.03 110.886 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 7.0 p90 -147.57 147.02 26.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.702 -0.799 . . . . 0.32000000000000001 109.345 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.11 126.53 22.46 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.786 0.991 . . . . 0.13 111.484 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -34.34 72.31 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.426 -0.806 . . . . 4.3499999999999996 111.223 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.53 3.03 14.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.918 -1.113 . . . . 3.5299999999999998 112.763 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.54 8.45 44.88 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.085 -1.046 . . . . 1.71 109.774 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.9 m -136.28 171.65 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 114.853 -1.067 . . . . 0.17000000000000001 109.113 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 119.102 -1.039 . . . . 1.1299999999999999 110.286 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.725 0.774 . . . . 2.5699999999999998 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.94 -162.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.442 -1.253 . . . . 0.84999999999999998 109.781 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.2 mt-30 -146.9 100.27 3.29 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.841 -1.17 . . . . 1.24 107.841 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.09 111.52 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.58 -1.191 . . . . 0.28000000000000003 113.11 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.81 -41.53 91.77 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.62 -0.718 . . . . 0.44 109.104 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -173.09 3.59 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.602 -1.181 . . . . 1.3600000000000001 108.453 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.47 120.48 27.84 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.705 -1.589 . . . . 0.68000000000000005 109.583 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -104.68 103.15 12.74 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.228 -0.989 . . . . 0.28999999999999998 111.724 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 C-N-CA 117.243 -1.783 . . . . 4.5899999999999999 109.838 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.3 pt-20 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.263 0.554 . . . . 1.8999999999999999 112.01 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.541 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -87.04 175.73 7.97 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 115.454 1.65 . . . . 2.0099999999999998 115.454 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -162.19 128.61 1.91 Allowed Glycine 0 N--CA 1.502 3.045 0 CA-C-N 114.319 -1.309 . . . . 0.26000000000000001 110.072 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 7.9 p90 -158.11 -174.8 5.0 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.081 -1.448 . . . . 0.27000000000000002 112.095 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' ARG . 23.4 mmt-85 -133.96 133.65 41.61 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.796 -0.762 . . . . 5.0800000000000001 112.698 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.42 138.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.418 1.074 . . . . 5.9500000000000002 113.731 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.6 5.98 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.469 -1.452 . . . . 0.46999999999999997 109.469 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.17 122.35 13.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.993 -1.083 . . . . 0.63 109.242 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 73.5 m-85 -78.74 108.91 12.5 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.054 -1.058 . . . . 1.3600000000000001 113.114 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.446 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -78.42 148.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.338 -0.986 . . . . 0.23000000000000001 108.338 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 30' ' ' MET . 11.7 t-160 -106.26 94.07 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.045 -1.062 . . . . 0.85999999999999999 108.857 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.64 85.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 C-N-CA 119.297 -0.961 . . . . 0.56999999999999995 112.43 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.512 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mmt -59.23 -35.89 74.47 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.893 -1.048 . . . . 3.0099999999999998 110.402 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 33' ' ' SER . 67.6 t0 -170.56 99.75 0.25 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.176 -1.409 . . . . 1.54 111.749 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.18 97.78 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.095 -1.442 . . . . 2.9700000000000002 108.784 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 31' ' ' ASP . 65.8 m -96.26 -71.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.307 -0.957 . . . . 1.3799999999999999 111.832 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.4 m-20 -81.93 161.17 61.63 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 119.249 -0.98 . . . . 0.68999999999999995 111.679 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.53 -69.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.743 1.629 . . . . 0.39000000000000001 110.92 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 4.9 t-20 -80.2 -5.01 55.37 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 110.949 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' ASP . 28.4 m95 -131.99 150.59 52.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.092 -0.643 . . . . 0.38 109.625 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 9.8 m0 -145.9 162.56 37.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.381 -0.827 . . . . 0.68000000000000005 111.722 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.05 129.46 46.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.867 -1.531 . . . . 0.42999999999999999 106.867 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.26 -156.79 7.99 Favored Glycine 0 C--N 1.304 -1.224 0 C-N-CA 117.835 -2.126 . . . . 0.26000000000000001 110.349 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.8 162.81 32.44 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 118.452 -1.299 . . . . 0.54000000000000004 111.46 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 43.7 t -160.58 -114.55 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.295 -1.762 . . . . 1.1000000000000001 113.853 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.556 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.1 p80 -20.95 -45.11 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.277 0.985 . . . . 2.8900000000000001 113.044 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 167.1 18.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.338 -1.411 . . . . 2.4399999999999999 109.884 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -150.34 161.19 42.95 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.637 -0.825 . . . . 2.54 110.049 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 p -100.33 -175.94 3.07 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.424 -0.911 . . . . 0.79000000000000004 109.812 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.69 -169.14 29.89 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.132 -1.508 . . . . 0.31 111.225 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 mtp -108.28 136.66 47.56 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.071 -0.652 . . . . 1.01 110.963 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.0 p90 -139.11 146.48 49.49 Favored Pre-proline 0 C--N 1.304 -1.387 0 C-N-CA 119.714 -0.795 . . . . 0.19 110.143 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.38 122.86 12.21 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 120.292 0.661 . . . . 0.19 110.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -11.45 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.397 -0.921 . . . . 4.79 110.983 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -88.01 -9.1 54.48 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.041 -1.064 . . . . 2.3399999999999999 111.655 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -94.13 14.28 20.5 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.187 -1.005 . . . . 1.5800000000000001 109.415 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.7 m -139.62 166.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.986 -1.006 . . . . 0.32000000000000001 109.439 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 119.738 -0.785 . . . . 0.82999999999999996 109.565 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 110.308 -1.117 . . . . 2.3500000000000001 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t -155.68 106.37 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.608 -0.837 . . . . 3.4399999999999999 110.629 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.487 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -135.07 30.66 3.31 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.842 -0.743 . . . . 0.81000000000000005 110.685 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.579 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 -88.62 160.07 17.58 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.658 -1.217 . . . . 1.7 113.98 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.39 -168.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 113.391 -1.731 . . . . 0.080000000000000002 108.298 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.497 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.2 mt-30 -140.29 104.12 4.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.336 -1.357 . . . . 0.70999999999999996 107.336 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.71 114.21 0.11 Allowed 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 113.666 0.987 . . . . 0.19 113.666 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 9.7 tp -69.39 -34.1 74.02 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.388 -0.824 . . . . 3.0 108.917 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.63 -174.2 4.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.943 -1.026 . . . . 0.59999999999999998 109.669 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -86.4 126.48 34.41 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 113.434 -1.712 . . . . 0.44 110.336 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.11 106.32 13.6 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.307 -0.957 . . . . 0.28000000000000003 112.804 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 2.4 p-10 -90.0 133.73 33.15 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 117.734 -1.586 . . . . 3.3399999999999999 108.336 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -43.91 152.85 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 120.532 0.821 . . . . 0.53000000000000003 112.105 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 35.2 mt-30 -150.84 7.98 0.56 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.084 -1.08 . . . . 2.8199999999999998 108.084 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -141.13 162.01 36.49 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.284 -1.325 . . . . 3.6299999999999999 110.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.13 100.1 5.62 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.007 -1.077 . . . . 1.6699999999999999 110.572 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' GLU . . . 113.14 -18.38 21.32 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.92 -1.134 . . . . 1.27 110.268 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.1 tt0 -42.34 177.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.231 1.491 . . . . 2.3300000000000001 114.253 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tp -101.54 158.19 16.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 111.797 -2.456 . . . . 0.93000000000000005 110.407 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.36 113.07 0.65 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.606 -1.283 . . . . 0.41999999999999998 110.726 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 p90 -139.94 -172.7 3.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.841 -1.144 . . . . 0.33000000000000002 112.192 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' ARG . 5.0 mmm-85 -139.61 126.08 20.34 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.574 -0.85 . . . . 3.0099999999999998 113.187 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -7.65 132.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.493 1.121 . . . . 2.7599999999999998 113.887 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -19.27 20.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.218 -1.553 . . . . 0.62 109.218 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.79 123.7 19.12 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.791 -1.164 . . . . 0.57999999999999996 108.52 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.92 107.66 10.62 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.647 -1.221 . . . . 0.38 112.657 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.471 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.32 147.62 7.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.84 -1.17 . . . . 0.32000000000000001 107.84 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.579 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 9.1 t-160 -105.65 96.21 6.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.687 -1.227 . . . . 0.20000000000000001 107.687 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.456 ' O ' ' OG1' ' A' ' 3' ' ' THR . 4.1 t -63.29 91.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 114.584 -1.189 . . . . 0.57999999999999996 110.219 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.46 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.3 ttm -78.31 -27.32 47.21 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.945 -1.479 . . . . 0.68000000000000005 112.011 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.11 96.65 0.6 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.43 -1.708 . . . . 1.75 111.794 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.583 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -55.47 104.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.113 -1.435 . . . . 3.0899999999999999 107.914 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m -90.86 -64.9 1.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.649 -1.22 . . . . 1.0700000000000001 111.761 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -103.89 161.71 22.12 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 115.189 -0.914 . . . . 0.65000000000000002 111.812 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' O ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 Cg_endo -57.95 -63.34 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.737 1.625 . . . . 0.70999999999999996 111.478 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.2 t30 -92.15 6.8 45.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.558 -0.857 . . . . 2.9199999999999999 111.392 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 20.0 m95 -139.23 139.32 37.43 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.75 -1.204 . . . . 0.34999999999999998 107.75 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -141.86 169.38 17.7 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.281 -0.968 . . . . 0.88 112.939 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -101.78 146.53 27.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.332 -1.729 . . . . 0.68000000000000005 106.332 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.1 -158.42 9.75 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 116.784 -2.627 . . . . 0.5 110.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.33 137.94 4.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.031 -1.067 . . . . 1.1799999999999999 111.278 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' GLY . 32.9 t -145.03 -94.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.114 -1.035 . . . . 1.5900000000000001 111.807 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.559 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.5 p80 -60.69 75.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.434 -0.907 . . . . 0.70999999999999996 111.3 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.45 21.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.333 -0.937 . . . . 0.60999999999999999 111.575 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' HIS . 70.2 mt-30 -144.49 134.95 24.56 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.011 -1.076 . . . . 2.7000000000000002 111.096 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -90.97 -178.33 5.18 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.73 -0.788 . . . . 1.2 111.056 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.4 -172.77 27.72 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.377 -1.392 . . . . 0.35999999999999999 110.884 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mtp -101.22 157.39 16.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.824 -0.751 . . . . 0.34999999999999998 111.268 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 27' ' ' ILE . 3.1 p90 -159.36 144.25 11.45 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 115.124 -0.944 . . . . 0.41999999999999998 109.06 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.2 125.96 20.57 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 120.264 0.643 . . . . 0.38 110.801 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -64.53 -20.44 66.22 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.562 -0.855 . . . . 3.1400000000000001 110.968 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.99 1.59 49.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.915 -1.114 . . . . 1.4099999999999999 111.082 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.74 13.5 33.45 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.616 -0.834 . . . . 0.94999999999999996 109.006 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 31.5 m -140.98 171.54 12.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.646 -1.161 . . . . 1.1399999999999999 109.905 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -143.07 139.79 17.16 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 119.441 -0.904 . . . . 0.40000000000000002 109.242 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.15 148.17 93.69 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 120.854 1.036 . . . . 0.84999999999999998 112.44 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.83 -29.24 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.445 -0.798 . . . . 1.6100000000000001 109.911 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -94.29 79.5 3.96 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.713 -0.795 . . . . 3.46 110.248 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 116.221 -1.847 . . . . 7.7800000000000002 110.681 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.943 -1.263 . . . . 6.7599999999999998 109.943 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.12 169.29 14.61 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.39 -0.924 . . . . 2.9300000000000002 111.088 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.62 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -143.12 36.07 1.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.879 -0.728 . . . . 1.9399999999999999 110.063 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.481 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 69.9 m-85 -104.97 153.96 20.74 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.966 -1.094 . . . . 2.4100000000000001 113.118 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.1 m -140.22 -172.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 113.823 -1.535 . . . . 0.34000000000000002 108.057 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -142.07 98.17 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.058 -1.089 . . . . 0.91000000000000003 108.058 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -20.93 111.97 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.916 -1.493 . . . . 0.10000000000000001 113.487 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -67.38 -36.42 81.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.167 -0.679 . . . . 0.89000000000000001 109.167 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.16 -174.73 4.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.844 -1.071 . . . . 0.82999999999999996 109.183 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.86 131.44 34.52 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 113.614 -1.63 . . . . 0.47999999999999998 109.446 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -120.71 109.47 15.23 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.987 -1.085 . . . . 0.37 113.364 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.74 134.06 24.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 106.819 -1.548 . . . . 1.48 106.819 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.31 155.02 0.11 Allowed 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 120.512 0.808 . . . . 0.45000000000000001 112.586 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.4 mt-30 -149.56 2.95 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.786 -1.097 . . . . 3.5 108.387 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' CG ' ' OE2' ' A' ' 18' ' ' GLU . 11.2 mm-40 -125.76 -179.09 4.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.454 -1.248 . . . . 1.8400000000000001 109.635 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.15 80.82 5.04 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.014 -1.075 . . . . 4.0800000000000001 110.975 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 18' ' ' GLU . . . 124.74 -9.44 8.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.254 -1.138 . . . . 1.0900000000000001 110.254 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.6 tt0 -41.38 177.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.343 1.544 . . . . 2.3100000000000001 115.087 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 tp -97.69 157.04 16.27 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 111.397 -2.638 . . . . 0.87 110.544 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -143.71 112.89 0.72 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.261 -1.447 . . . . 0.48999999999999999 111.142 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.5 p90 -135.5 -179.25 5.52 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.266 -0.973 . . . . 0.44 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 23' ' ' ARG . 2.9 mmt85 -137.29 124.32 21.52 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.537 -0.865 . . . . 3.6699999999999999 112.22 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -10.08 128.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.283 0.989 . . . . 3.9700000000000002 113.281 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.48 -20.08 50.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.287 -1.525 . . . . 0.19 109.287 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.0 126.02 28.42 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.856 -1.138 . . . . 1.7 108.234 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 2.3 m-85 -78.39 108.39 11.71 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.92000000000000004 113.38 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.504 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.12 142.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 105.765 -1.939 . . . . 0.29999999999999999 105.765 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.481 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 9.9 t-160 -101.55 97.78 8.18 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.173 -1.411 . . . . 0.33000000000000002 107.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.524 ' C ' ' HG1' ' A' ' 3' ' ' THR . 6.0 t -63.55 84.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.546 -1.207 . . . . 0.39000000000000001 110.842 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 28' ' ' HIS . 3.7 ttm -69.14 -30.79 69.11 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.112 -1.403 . . . . 0.93000000000000005 111.547 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -169.3 90.99 0.22 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.707 -1.597 . . . . 1.6399999999999999 111.983 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.2 104.35 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.075 -1.45 . . . . 2.6099999999999999 108.386 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 m -94.6 -37.16 11.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.168 -1.013 . . . . 2.2400000000000002 113.534 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -124.58 160.43 53.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.373 -0.931 . . . . 1.1799999999999999 111.471 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.65 -68.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.736 1.624 . . . . 0.55000000000000004 111.604 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.1 t30 -91.25 12.94 18.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.539 -0.864 . . . . 2.6400000000000001 111.094 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.5 m95 -145.46 144.79 30.8 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.773 -0.825 . . . . 0.46999999999999997 108.773 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 20.5 m0 -144.62 172.86 12.39 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.4 -0.92 . . . . 0.27000000000000002 111.82 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -115.09 123.82 49.97 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.559 -1.645 . . . . 1.3400000000000001 106.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.94 -148.03 4.67 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 118.241 -1.933 . . . . 0.17000000000000001 108.831 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.52 20.62 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.117 -1.433 . . . . 0.23999999999999999 111.95 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 23.4 t -161.14 -108.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 116.597 -2.041 . . . . 0.28000000000000003 114.471 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 2.2 p80 -26.96 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.348 -0.842 . . . . 3.0800000000000001 113.213 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 161.98 18.08 0.03 OUTLIER Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.046 -1.549 . . . . 2.1499999999999999 109.991 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.5 162.21 37.44 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.153 -1.019 . . . . 4.1600000000000001 110.221 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -95.66 -171.17 2.3 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.195 -1.002 . . . . 1.5700000000000001 111.393 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.42 -170.89 28.91 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.657 -1.156 . . . . 0.22 110.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.3 mtp -105.25 143.35 33.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.827 -0.749 . . . . 0.70999999999999996 110.746 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.9 p90 -147.65 146.02 23.2 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 119.705 -0.798 . . . . 0.25 108.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.99 126.9 23.06 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 N-CA-C 110.458 -0.632 . . . . 0.22 110.458 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.415 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -60.77 -36.16 78.25 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.462 -0.79 . . . . 4.4400000000000004 111.045 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -74.25 -0.73 17.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.058 -1.057 . . . . 4.1100000000000003 112.692 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -93.45 6.39 48.35 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 118.719 -1.192 . . . . 1.6000000000000001 110.092 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.44 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.3 m -134.27 171.39 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 115.457 -0.792 . . . . 0.26000000000000001 109.827 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -146.3 149.17 37.12 Favored Pre-proline 0 C--N 1.303 -1.424 0 C-N-CA 119.338 -0.945 . . . . 1.3899999999999999 109.132 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.96 154.61 31.9 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.882 1.055 . . . . 0.47999999999999998 111.885 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.92 153.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.982 -0.687 . . . . 1.5 111.62 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -79.25 161.33 26.41 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.38 -0.928 . . . . 9.7100000000000009 110.224 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 116.354 -1.784 . . . . 8.9100000000000001 111.106 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.974 -1.25 . . . . 4.7199999999999998 109.974 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 69.98 145.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.271 -0.972 . . . . 4.54 111.012 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -125.6 26.72 6.66 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.969 -0.693 . . . . 0.67000000000000004 110.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.576 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 79.7 m-85 -88.15 160.76 17.62 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.308 -1.357 . . . . 0.77000000000000002 112.84 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.61 -170.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.821 -1.536 . . . . 0.23000000000000001 108.275 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -138.78 102.7 4.64 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.936 -1.135 . . . . 0.39000000000000001 107.936 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.27 110.61 0.06 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.326 -0.852 . . . . 0.20000000000000001 112.396 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -64.2 -37.14 86.41 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.132 -0.692 . . . . 0.89000000000000001 109.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -174.4 4.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.146 0.974 . . . . 1.5900000000000001 109.74 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -83.33 127.62 33.82 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.496 -1.684 . . . . 0.38 110.815 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -115.84 106.42 13.81 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.633 -0.827 . . . . 0.28000000000000003 111.905 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.86 127.5 53.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 117.724 -1.591 . . . . 3.8799999999999999 109.439 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -40.87 117.17 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.138 1.226 . . . . 1.1000000000000001 114.215 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -102.65 6.69 39.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.333 -1.729 . . . . 3.6299999999999999 106.333 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -134.43 -174.63 3.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.019 -1.9 . . . . 1.6499999999999999 110.415 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -122.76 1.22 9.37 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.324 -0.853 . . . . 3.04 109.123 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.42 12.71 5.19 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.703 -1.359 . . . . 2.3999999999999999 109.703 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -113.93 -174.13 2.41 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.567 -0.853 . . . . 1.8100000000000001 112.102 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.555 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -84.08 172.41 12.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 116.026 1.861 . . . . 0.47999999999999998 116.026 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.08 120.97 1.01 Allowed Glycine 0 N--CA 1.497 2.743 0 CA-C-N 113.645 -1.616 . . . . 0.16 110.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.1 p90 -145.78 -170.94 3.59 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.319 -1.352 . . . . 0.28999999999999998 112.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.0 mmt-85 -138.72 129.8 26.83 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.4 -0.818 . . . . 5.2999999999999998 112.222 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -16.61 137.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.194 0.934 . . . . 3.5600000000000001 113.239 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -21.65 10.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.816 -1.714 . . . . 0.26000000000000001 108.816 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' ARG . 20.8 m-20 -65.64 118.88 10.18 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.94 -1.104 . . . . 1.1100000000000001 108.055 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -76.55 112.92 13.61 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.662 -1.215 . . . . 1.05 112.482 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.472 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.26 147.62 7.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.702 -1.222 . . . . 0.23999999999999999 107.702 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.7 t-80 -103.9 101.61 11.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.761 -1.175 . . . . 0.34000000000000002 107.83 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 3' ' ' THR . 4.1 t -69.39 98.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.5 -1.227 . . . . 0.26000000000000001 111.505 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -30.22 41.42 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.09 -1.414 . . . . 3.0800000000000001 110.959 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.24 114.48 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.334 -1.346 . . . . 2.29 111.014 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 19.6 p30 -56.72 109.82 0.69 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.223 -1.391 . . . . 1.8100000000000001 109.69 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 p -91.75 -38.58 12.3 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.04 -1.064 . . . . 3.6699999999999999 112.049 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -138.63 161.91 56.02 Favored Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.496 -0.881 . . . . 1.1599999999999999 110.747 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.27 -64.43 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.224 1.283 . . . . 0.69999999999999996 111.254 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.8 t-20 -90.49 4.07 52.14 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.244 -0.982 . . . . 0.39000000000000001 111.191 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 26.5 m95 -138.73 140.87 38.85 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 108.801 -0.815 . . . . 0.45000000000000001 108.801 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -138.59 -177.72 4.99 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.68 -0.808 . . . . 1.04 111.928 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -124.2 124.74 43.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.578 -1.267 . . . . 1.02 107.578 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -155.86 -144.97 4.06 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 108.724 -1.751 . . . . 0.10000000000000001 108.724 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.7 173.74 11.53 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.375 -1.33 . . . . 0.17999999999999999 111.735 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 13.8 t -166.06 -103.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 116.871 -1.932 . . . . 1.0 114.407 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.605 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.9 p80 -29.92 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.403 -0.817 . . . . 2.8199999999999998 112.943 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 152.51 13.7 0.07 OUTLIER Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.278 -1.529 . . . . 2.1299999999999999 109.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.73 164.21 35.87 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.714 -0.794 . . . . 5.3700000000000001 110.382 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 p -97.52 -175.03 3.08 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.116 -1.034 . . . . 0.73999999999999999 111.556 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.59 -174.58 29.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.112 -1.195 . . . . 0.14000000000000001 110.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 mtp -102.59 146.56 27.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.705 -0.798 . . . . 1.27 110.748 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.472 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.3 p90 -151.39 147.24 19.99 Favored Pre-proline 0 C--N 1.303 -1.439 0 C-N-CA 119.441 -0.903 . . . . 0.37 109.892 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.38 124.77 15.83 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.051 -0.788 . . . . 0.32000000000000001 110.051 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -17.87 63.89 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.632 -0.827 . . . . 4.4900000000000002 111.526 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.97 -1.3 54.38 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.583 -1.247 . . . . 3.3300000000000001 111.552 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -96.61 7.57 46.23 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.314 -0.955 . . . . 1.05 108.894 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.8 m -137.32 169.58 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.935 -1.029 . . . . 0.29999999999999999 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.94 144.41 21.9 Favored Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 119.118 -1.033 . . . . 0.70999999999999996 109.646 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -61.48 142.15 94.25 Favored 'Trans proline' 0 C--N 1.322 -0.854 0 C-N-CA 121.074 1.182 . . . . 0.69999999999999996 112.444 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.16 -168.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.384 -0.826 . . . . 2.6099999999999999 109.838 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -79.94 -109.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.278 -0.969 . . . . 8.6400000000000006 109.567 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 116.253 -1.832 . . . . 9.7799999999999994 110.94 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 110.073 -1.211 . . . . 5.29 110.073 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t 57.93 65.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.298 -0.561 . . . . 3.8999999999999999 111.628 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.6 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -168.83 24.47 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.906 -0.718 . . . . 0.97999999999999998 110.333 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.62 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 54.1 m-85 -99.15 149.27 23.23 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.63 -1.228 . . . . 2.6099999999999999 113.218 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.14 -167.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.921 -1.491 . . . . 0.19 108.741 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -142.78 97.81 3.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.895 -1.15 . . . . 0.32000000000000001 107.895 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.69 110.93 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.496 -1.229 . . . . 0.27000000000000002 113.915 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 2.9 tp -56.46 -50.04 72.88 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.573 -0.74 . . . . 2.27 109.634 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -174.52 4.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.987 -1.006 . . . . 1.79 108.451 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 126.53 31.18 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.086 -1.416 . . . . 0.64000000000000001 110.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -111.77 102.42 10.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.428 -0.909 . . . . 0.34000000000000002 111.892 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.82 126.98 64.31 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 117.312 -1.755 . . . . 3.7999999999999998 109.052 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -40.51 115.03 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.195 1.264 . . . . 1.01 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -93.74 3.42 55.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.676 -1.972 . . . . 2.96 105.676 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -134.35 -173.33 3.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.542 -2.117 . . . . 3.52 109.943 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.64 0.27 7.49 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.676 -0.861 . . . . 4.6100000000000003 108.676 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.66 3.22 7.56 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.48 -1.448 . . . . 1.9399999999999999 109.48 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.97 -172.44 2.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.756 -0.778 . . . . 1.5900000000000001 111.775 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.536 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -82.09 168.07 18.13 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 116.053 1.871 . . . . 1.8999999999999999 116.053 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -156.94 123.19 1.26 Allowed Glycine 0 N--CA 1.496 2.69 0 CA-C-N 113.819 -1.537 . . . . 0.13 109.751 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.4 p90 -148.82 -175.68 5.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.369 -1.332 . . . . 0.28999999999999998 112.377 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 23' ' ' ARG . 19.7 mmt180 -132.19 129.85 40.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.414 -0.812 . . . . 4.3899999999999997 111.742 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -19.72 138.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 124.184 0.928 . . . . 4.3099999999999996 113.256 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.73 39.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.528 -1.429 . . . . 0.12 109.528 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -73.71 120.36 19.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.356 -1.35 . . . . 0.52000000000000002 107.356 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -74.23 112.99 10.92 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.711 -1.196 . . . . 1.3500000000000001 113.195 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.464 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.74 141.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.517 -1.66 . . . . 0.23000000000000001 106.517 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.62 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 12.2 t-160 -100.5 95.82 6.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.388 -1.325 . . . . 0.34999999999999998 108.307 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.483 ' O ' ' OG1' ' A' ' 3' ' ' THR . 5.2 t -60.63 97.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 114.465 -1.243 . . . . 0.28000000000000003 111.115 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.495 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 2.8 mmt -72.77 -32.14 65.41 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.209 -1.359 . . . . 3.2799999999999998 110.983 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 101.2 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.053 -1.459 . . . . 3.21 111.213 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 7.4 p-10 -51.34 100.88 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.541 -1.264 . . . . 2.7000000000000002 109.553 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.22 -77.34 0.46 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.953 -1.099 . . . . 1.6799999999999999 110.674 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -78.22 159.09 76.06 Favored Pre-proline 0 C--N 1.296 -1.752 0 C-N-CA 119.255 -0.978 . . . . 0.98999999999999999 110.696 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.47 -64.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.659 1.573 . . . . 0.65000000000000002 111.399 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.1 t-20 -86.16 -1.81 57.77 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.711 -0.796 . . . . 0.57999999999999996 111.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 16.2 m95 -132.01 153.49 50.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.022 -1.103 . . . . 0.53000000000000003 108.022 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.5 m0 -148.34 176.12 10.53 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.256 -0.978 . . . . 0.68000000000000005 111.728 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.4 131.1 55.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.466 -1.309 . . . . 1.2 107.466 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.495 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.01 -145.87 4.3 Favored Glycine 0 C--N 1.302 -1.31 0 C-N-CA 118.123 -1.989 . . . . 0.32000000000000001 109.608 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.45 154.99 12.57 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 118.517 -1.273 . . . . 0.70999999999999996 111.847 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.4 t -152.31 -94.62 0.05 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.875 -1.13 . . . . 0.53000000000000003 111.33 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.625 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.6 p80 -59.96 77.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.509 -0.876 . . . . 0.33000000000000002 110.878 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 24.53 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.177 -1.011 . . . . 0.20000000000000001 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' HIS . 59.8 mt-30 -147.44 144.98 29.02 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.781 -1.167 . . . . 1.8600000000000001 111.49 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -95.96 -177.06 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.811 -0.756 . . . . 0.76000000000000001 110.335 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -174.91 27.66 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.45 -1.357 . . . . 0.16 110.62 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 mtp -102.18 146.79 27.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.854 -0.738 . . . . 0.97999999999999998 111.477 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 7.5 p90 -149.32 143.94 17.43 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.137 -0.938 . . . . 0.25 108.958 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.81 126.62 22.84 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 N-CA-C 110.705 -0.537 . . . . 0.35999999999999999 110.705 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -27.68 68.59 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.454 -0.794 . . . . 2.5600000000000001 112.055 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 2.46 33.59 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.31 -1.356 . . . . 1.8200000000000001 112.175 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.03 6.33 49.1 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.248 -0.981 . . . . 0.70999999999999996 109.213 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.6 m -135.32 176.26 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.582 -1.19 . . . . 0.26000000000000001 108.997 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -149.68 133.0 8.46 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 119.236 -0.985 . . . . 1.6899999999999999 109.205 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.88 149.58 60.05 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 120.413 0.742 . . . . 1.4299999999999999 111.834 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.3 t -79.05 72.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.67 -0.812 . . . . 2.8799999999999999 111.015 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -90.64 128.58 36.66 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.271 -0.972 . . . . 8.1099999999999994 110.646 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 116.32 -1.8 . . . . 13.77 110.627 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 110.159 -1.176 . . . . 6.1500000000000004 110.159 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.19 6.1 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.457 -0.897 . . . . 2.9900000000000002 110.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.574 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -97.95 33.27 2.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.796 -0.762 . . . . 1.1000000000000001 110.27 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.5 m-85 -97.1 155.16 16.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.056 -1.058 . . . . 2.02 113.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 m -136.1 -170.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.087 -1.415 . . . . 0.91000000000000003 108.684 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -140.83 97.14 3.13 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.428 -0.952 . . . . 0.17000000000000001 108.428 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -22.25 110.69 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.899 -1.501 . . . . 0.14999999999999999 113.269 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.479 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 tp -64.52 -50.59 66.78 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.454 -0.794 . . . . 2.3100000000000001 109.852 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -131.93 -178.81 5.05 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.279 -1.008 . . . . 1.4199999999999999 108.279 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 131.62 35.21 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.159 -1.382 . . . . 0.22 108.325 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -118.51 107.14 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.194 -1.002 . . . . 0.41999999999999998 112.746 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.57 129.29 45.46 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 117.725 -1.59 . . . . 3.9199999999999999 109.307 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -43.94 106.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 121.121 1.214 . . . . 1.4299999999999999 114.048 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.52 5.51 47.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.089 -2.189 . . . . 4.4299999999999997 105.089 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -127.95 178.51 6.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 112.392 -2.186 . . . . 2.3199999999999998 110.077 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -122.24 15.86 10.62 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.761 -0.776 . . . . 3.6200000000000001 109.099 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.6 9.69 1.23 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.463 -1.455 . . . . 1.8899999999999999 109.463 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.3 -174.44 2.47 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.849 -0.741 . . . . 1.52 111.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.562 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -79.18 169.64 17.84 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 115.647 1.721 . . . . 0.5 115.647 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.08 121.42 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-N 113.848 -1.524 . . . . 0.17000000000000001 110.743 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.6 p90 -147.61 -172.86 4.13 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.515 -1.274 . . . . 0.14999999999999999 112.007 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.6 mmm180 -136.35 130.06 32.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.614 -0.721 . . . . 3.2400000000000002 111.61 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 22' ' ' ARG . 4.3 ttp180 -19.11 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.126 0.891 . . . . 5.2999999999999998 112.922 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.8 62.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.25 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.93 117.79 20.34 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.801 -1.185 . . . . 0.40000000000000002 107.801 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -73.72 111.73 9.14 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.809 -1.156 . . . . 0.80000000000000004 112.722 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.27 146.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.009 -1.478 . . . . 0.16 107.009 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 10.4 t-80 -103.43 100.21 10.07 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.463 -1.31 . . . . 0.46999999999999997 107.463 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.9 t -65.46 89.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.771 -1.104 . . . . 0.23999999999999999 110.949 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.446 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 7.7 tpp -78.55 -28.07 45.98 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 113.889 -1.505 . . . . 3.0699999999999998 111.874 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 33' ' ' SER . 1.6 t70 -161.28 82.29 0.62 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 117.771 -1.572 . . . . 1.3300000000000001 111.663 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 10.1 p-10 -54.1 96.62 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.689 -1.205 . . . . 0.81999999999999995 109.038 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' ASP . 45.9 m -96.94 -84.96 0.36 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.225 -0.99 . . . . 1.1899999999999999 111.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -65.45 158.88 71.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 C-N-CA 119.299 -0.96 . . . . 0.53000000000000003 111.575 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.39 -65.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.616 1.544 . . . . 0.48999999999999999 111.22 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 6.3 t-20 -82.23 -0.07 43.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.411 -0.813 . . . . 0.63 111.348 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.8 m95 -137.19 148.99 46.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.657 -0.868 . . . . 0.33000000000000002 108.657 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 7.7 m0 -144.51 169.57 17.71 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.141 -1.023 . . . . 0.69999999999999996 112.378 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.96 123.65 50.01 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 106.854 -1.536 . . . . 3.1699999999999999 106.854 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -154.09 -150.26 5.44 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.296 -1.907 . . . . 0.17000000000000001 109.188 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.36 172.97 12.76 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 117.983 -1.487 . . . . 0.28000000000000003 112.448 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' GLY . 13.1 t -169.96 -96.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.826 -1.15 . . . . 0.77000000000000002 111.478 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.569 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.1 p80 -57.85 77.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.762 -0.775 . . . . 0.48999999999999999 111.378 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.6 22.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.318 -0.944 . . . . 0.28000000000000003 111.765 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.9 mt-30 -146.6 136.24 23.08 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.927 -1.109 . . . . 2.8500000000000001 111.121 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -88.93 -179.49 5.96 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.655 -0.818 . . . . 0.34000000000000002 109.593 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.72 -172.97 31.79 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.623 -1.751 . . . . 0.14999999999999999 111.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtp -103.98 141.04 36.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.311 -0.556 . . . . 1.24 110.716 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 5.3 p90 -145.76 145.89 27.06 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.558 -0.857 . . . . 0.17000000000000001 109.835 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.43 128.89 31.96 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 N-CA-C 110.098 -0.77 . . . . 0.20999999999999999 110.098 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.44 -30.97 71.83 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.392 -0.923 . . . . 3.75 111.672 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -77.34 4.38 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.79 -1.164 . . . . 2.8500000000000001 112.018 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.48 11.09 39.69 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.405 -0.918 . . . . 0.71999999999999997 109.431 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.6 m -139.98 173.65 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.835 -1.075 . . . . 0.17000000000000001 109.076 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 146.83 18.25 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 118.57 -1.252 . . . . 1.8400000000000001 109.368 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.91 154.44 44.39 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 120.503 0.802 . . . . 0.28999999999999998 111.013 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.8 t -75.44 89.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.241 -0.983 . . . . 1.8 110.298 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.23 -175.76 4.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.383 -0.927 . . . . 9.8499999999999996 111.072 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 116.46 -1.733 . . . . 10.17 111.099 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 3.4700000000000002 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -82.49 98.28 8.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.495 -0.882 . . . . 4.5300000000000002 110.801 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.631 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.6 OUTLIER -135.11 38.17 2.98 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.045 0.926 . . . . 1.0 109.879 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.643 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 63.6 m-85 -126.89 130.67 50.61 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.082 -0.963 . . . . 2.1000000000000001 110.373 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 54' ' ' VAL . 11.4 m -123.29 -165.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.928 -1.033 . . . . 0.44 110.354 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 26' ' ' PHE . 3.0 mt-30 -143.92 100.08 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.169 -1.419 . . . . 0.81000000000000005 107.169 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -25.5 111.76 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.366 -1.288 . . . . 0.12 113.279 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.0 tp -66.51 -47.74 72.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.58 -0.736 . . . . 2.4700000000000002 109.671 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -131.06 -179.28 5.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.617 -1.253 . . . . 1.1000000000000001 107.617 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.05 135.55 35.85 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 106.758 -1.571 . . . . 0.29999999999999999 106.758 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -122.48 112.68 18.33 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.405 -1.318 . . . . 0.17999999999999999 114.31 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER -94.15 142.81 25.43 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 106.783 -1.562 . . . . 4.5499999999999998 106.783 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 12' ' ' ASP . 82.9 Cg_exo -49.63 -160.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 120.527 0.818 . . . . 1.23 113.568 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.599 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 158.34 -16.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.651 -1.159 . . . . 5.4100000000000001 107.934 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -106.71 156.07 19.02 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.436 -1.256 . . . . 4.6200000000000001 109.306 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -65.03 115.05 5.03 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.694 -1.202 . . . . 4.8499999999999996 111.487 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.11 95.85 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 119.644 -1.265 . . . . 0.76000000000000001 110.632 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.599 ' OE2' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -92.21 171.76 8.87 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.946 -1.102 . . . . 0.83999999999999997 109.482 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.596 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 7.2 tp -77.91 158.35 29.42 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.549 0.944 . . . . 1.3999999999999999 113.549 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -149.96 123.51 1.59 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.531 -1.428 . . . . 0.40000000000000002 109.531 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.9 p90 -147.78 -168.39 3.05 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.783 -1.167 . . . . 0.28999999999999998 111.91 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.8 mmm-85 -139.08 133.94 32.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.907 -0.717 . . . . 3.27 111.599 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -18.83 139.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.15 0.907 . . . . 4.5 113.224 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -19.37 31.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.291 -1.524 . . . . 0.17000000000000001 109.291 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.74 121.66 15.92 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.871 -1.132 . . . . 0.56000000000000005 108.947 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m-85 -77.13 104.65 7.74 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.687 -1.205 . . . . 1.0 112.175 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.466 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -74.31 147.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.412 -1.329 . . . . 0.13 107.412 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.643 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.6 t-160 -107.76 96.73 6.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.865 -1.134 . . . . 0.65000000000000002 108.425 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.4 t -60.04 90.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.777 -1.101 . . . . 0.64000000000000001 113.336 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.462 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -61.62 -33.86 74.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.033 -1.067 . . . . 2.2400000000000002 109.984 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -178.56 111.74 0.06 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.676 -1.21 . . . . 2.2999999999999998 111.105 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -57.29 99.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.232 -1.387 . . . . 3.21 109.272 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -94.19 -68.16 0.82 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.143 -1.023 . . . . 2.9100000000000001 111.434 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.512 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -86.61 160.07 51.28 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 118.851 -1.139 . . . . 0.81000000000000005 110.888 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.08 -68.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.428 1.419 . . . . 0.53000000000000003 111.021 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.5 t-20 -81.85 -2.61 51.66 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.391 -0.822 . . . . 0.76000000000000001 111.43 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 28.9 m95 -133.1 153.94 51.04 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 108.738 -0.838 . . . . 0.40000000000000002 108.738 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.1 m0 -149.04 168.04 24.22 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.957 -0.697 . . . . 0.5 111.129 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -108.03 130.52 55.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.41 -1.33 . . . . 0.76000000000000001 107.41 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.71 -152.19 6.34 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 117.71 -2.186 . . . . 0.19 110.106 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.54 27.18 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 117.921 -1.511 . . . . 0.40000000000000002 112.425 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 41.7 t -158.39 -89.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.895 -1.122 . . . . 1.96 111.853 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.2 p80 -60.73 73.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.849 -0.74 . . . . 0.46000000000000002 111.039 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.47 19.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.026 -1.083 . . . . 0.37 111.006 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' HIS . 9.1 mm100 -144.08 135.1 25.37 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.021 -1.071 . . . . 4.1299999999999999 111.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 ' H ' ' HG1' ' A' ' 46' ' ' THR . 5.1 p -84.24 -174.78 5.47 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.724 -0.79 . . . . 1.5700000000000001 110.727 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.96 -167.62 27.73 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.56 -1.305 . . . . 0.31 111.013 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.9 mtp -109.3 144.28 37.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.168 -0.613 . . . . 0.90000000000000002 111.517 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 9.5 p90 -145.54 144.3 22.38 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 115.384 -0.826 . . . . 0.40999999999999998 109.567 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.71 126.2 21.65 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.303 0.668 . . . . 0.32000000000000001 110.386 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -61.91 -30.77 71.11 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.428 -0.806 . . . . 4.0199999999999996 111.543 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.79 1.93 18.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.848 -1.141 . . . . 3.2799999999999998 112.595 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.92 12.8 36.94 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.301 -0.96 . . . . 0.58999999999999997 109.635 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -139.93 174.74 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.265 -0.879 . . . . 0.14999999999999999 110.347 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 139.65 12.52 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.035 -1.066 . . . . 0.22 109.679 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.82 152.31 64.67 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.125 1.217 . . . . 0.75 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.46 42.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.582 -0.735 . . . . 1.8400000000000001 109.826 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -77.85 109.79 12.18 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.569 -0.852 . . . . 5.2800000000000002 111.145 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 116.394 -1.765 . . . . 6.7699999999999996 111.054 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 110.052 -1.219 . . . . 3.8300000000000001 110.052 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 103.56 16.26 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.314 -0.954 . . . . 4.3600000000000003 110.587 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.636 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.5 OUTLIER -133.8 37.62 3.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.849 0.833 . . . . 0.94999999999999996 110.535 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 58.7 m-85 -126.31 126.28 43.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.442 -0.903 . . . . 1.6499999999999999 110.916 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.57 -165.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 114.821 -1.081 . . . . 0.93000000000000005 109.555 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.517 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -145.46 94.52 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.818 -1.179 . . . . 0.33000000000000002 107.818 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.46 110.97 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.251 -1.341 . . . . 0.14999999999999999 113.211 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.462 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.52 -46.16 80.7 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.045 -0.525 . . . . 1.78 109.944 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.25 -179.32 5.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.028 -1.101 . . . . 1.03 108.028 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.72 136.3 36.74 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.278 -1.328 . . . . 0.67000000000000004 108.225 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -127.61 109.37 11.63 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.755 -1.178 . . . . 0.25 114.002 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.94 143.19 27.34 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 117.722 -1.591 . . . . 1.8 106.744 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 163.12 1.63 Allowed 'Trans proline' 0 C--N 1.295 -2.252 0 CA-C-O 121.536 0.557 . . . . 0.46000000000000002 112.708 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.558 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 25.9 mt-30 -154.42 -11.62 0.13 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.546 -1.206 . . . . 2.3599999999999999 108.44 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.21 174.2 6.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.486 -1.234 . . . . 4.0099999999999998 110.33 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.14 4.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.887 -1.125 . . . . 5.8899999999999997 110.936 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.37 32.89 31.0 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.48 -1.343 . . . . 1.22 110.777 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -74.27 173.63 9.92 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.891 -1.152 . . . . 0.28000000000000003 107.891 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.581 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -69.64 164.05 24.22 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 119.941 -0.704 . . . . 0.28000000000000003 112.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.92 121.81 1.1 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.545 -1.022 . . . . 0.12 110.545 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 6.3 p90 -147.01 -170.49 3.55 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.465 -1.294 . . . . 0.17999999999999999 112.516 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.5 mmt180 -136.51 130.74 32.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.181 -0.918 . . . . 4.2400000000000002 111.435 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' ARG . 3.3 ttp85 -16.42 138.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.03 1.122 . . . . 3.48 114.03 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.32 -22.38 13.12 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.412 -1.475 . . . . 0.40999999999999998 109.412 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.84 121.53 13.71 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.957 -1.097 . . . . 1.3300000000000001 108.261 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -77.36 106.83 9.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.439 -1.304 . . . . 1.21 112.174 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.461 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.77 143.82 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.356 -1.349 . . . . 0.20000000000000001 107.356 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.633 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.1 t-160 -103.56 94.01 5.24 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.6 -1.24 . . . . 0.35999999999999999 108.796 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.521 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.4 t -59.24 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 114.56 -1.2 . . . . 0.76000000000000001 112.783 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.488 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 30.7 mtt -72.5 -30.66 64.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.999 -1.0 . . . . 2.7799999999999998 111.052 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -159.21 93.58 1.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.283 -1.367 . . . . 1.1499999999999999 111.404 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.644 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -68.71 94.11 0.57 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.868 -1.133 . . . . 3.8100000000000001 109.333 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t -98.16 -74.34 0.58 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.326 -0.95 . . . . 3.6699999999999999 112.209 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -69.24 157.27 89.78 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.763 -1.175 . . . . 0.46000000000000002 111.48 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.54 -65.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.176 1.918 . . . . 0.58999999999999997 111.961 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 5.7 t30 -87.53 5.78 37.48 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.768 -0.773 . . . . 2.98 111.396 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 14.9 m95 -139.73 147.64 41.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.259 -1.015 . . . . 0.39000000000000001 108.259 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.3 m0 -147.29 172.11 14.37 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.36 -0.936 . . . . 0.51000000000000001 111.383 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -112.75 129.4 56.43 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.639 -1.245 . . . . 0.89000000000000001 107.639 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.43 -144.71 4.06 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 118.261 -1.923 . . . . 0.13 109.335 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.09 174.96 9.82 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 117.824 -1.55 . . . . 0.089999999999999997 112.704 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' GLY . 38.9 t -170.52 -95.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.147 -1.021 . . . . 1.5800000000000001 112.071 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 6.5 p80 -58.61 78.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.458 -0.897 . . . . 0.70999999999999996 111.415 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.75 25.64 0.22 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.101 -1.047 . . . . 0.42999999999999999 111.956 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.48 149.24 25.31 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 117.941 -1.503 . . . . 4.7800000000000002 111.902 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -95.68 -175.75 3.53 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.799 -0.76 . . . . 1.6399999999999999 110.839 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.51 -164.73 29.08 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.237 -1.459 . . . . 0.14000000000000001 111.392 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.4 mtp -109.39 145.66 35.74 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.466 -0.494 . . . . 0.35999999999999999 111.258 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 8.2 p90 -148.82 142.49 16.2 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.369 -0.932 . . . . 0.22 109.408 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.46 123.81 14.75 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.712 -0.919 . . . . 0.27000000000000002 109.712 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -29.82 70.44 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.078 -1.049 . . . . 4.2999999999999998 111.354 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -73.26 -5.0 36.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.839 -1.144 . . . . 3.8500000000000001 112.176 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.82 10.4 35.41 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.052 -1.059 . . . . 0.28000000000000003 109.778 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.8 m -136.85 172.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.335 -0.848 . . . . 0.19 109.859 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -142.65 122.95 8.1 Favored Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.554 -0.859 . . . . 0.80000000000000004 109.142 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.06 145.19 98.5 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.345 0.697 . . . . 2.2799999999999998 112.241 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.59 78.3 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 115.353 -0.84 . . . . 3.4399999999999999 111.154 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -149.57 164.53 34.84 Favored 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 119.678 -0.809 . . . . 6.2800000000000002 110.313 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 116.262 -1.827 . . . . 9.0999999999999996 110.878 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 110.01 -1.236 . . . . 6.0300000000000002 110.01 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.04 142.79 18.98 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.565 -0.854 . . . . 7.2800000000000002 111.033 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 1.5 p -64.48 162.0 16.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.611 -0.836 . . . . 2.4100000000000001 110.869 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 178.84 154.73 0.42 Allowed 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.323 -1.351 . . . . 1.9099999999999999 113.192 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 m -141.75 -170.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.788 -1.097 . . . . 0.75 108.557 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.499 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -141.8 100.63 3.79 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.762 -1.199 . . . . 0.5 107.762 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -26.49 113.45 0.05 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.582 -1.19 . . . . 0.16 112.913 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.428 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.6 -39.55 91.67 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.565 0.698 . . . . 2.1600000000000001 109.753 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.62 -174.72 4.68 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.895 -1.048 . . . . 1.9299999999999999 108.827 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.2 122.4 26.8 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.218 -1.355 . . . . 0.82999999999999996 109.363 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -111.28 99.23 8.08 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.897 -1.121 . . . . 0.40000000000000002 113.578 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -77.17 148.77 78.6 Favored Pre-proline 0 C--N 1.294 -1.819 0 C-N-CA 115.916 -2.314 . . . . 1.51 104.805 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 12' ' ' ASP . 84.0 Cg_exo -50.54 -147.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 120.7 0.933 . . . . 1.72 112.915 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 1.6 mt-30 159.25 -30.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.557 -0.905 . . . . 2.1200000000000001 108.557 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.49 176.1 6.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.8 -1.091 . . . . 0.75 110.136 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 110.68 16.42 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.78 -1.168 . . . . 5.4000000000000004 110.59 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.39 32.41 79.27 Favored Glycine 0 N--CA 1.483 1.809 0 C-N-CA 119.023 -1.56 . . . . 0.57999999999999996 109.931 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -87.16 171.77 10.43 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.386 -0.968 . . . . 0.35999999999999999 108.386 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.8 tp -71.93 164.21 26.48 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.75 0.786 . . . . 0.28999999999999998 112.757 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.42 117.89 0.8 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.395 -1.882 . . . . 0.28999999999999998 108.395 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.7 p90 -140.62 -168.94 2.68 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.66 -1.216 . . . . 0.23000000000000001 113.029 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' ARG . 9.6 mmm-85 -137.07 129.58 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.75 . . . . 3.3100000000000001 112.775 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -13.68 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.458 1.098 . . . . 4.0599999999999996 113.633 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.28 -22.73 5.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.802 -1.719 . . . . 0.48999999999999999 108.802 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' ARG . 4.4 m-20 -61.46 121.51 12.86 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 118.607 -1.237 . . . . 0.66000000000000003 107.968 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -77.81 112.24 14.47 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.874 -1.13 . . . . 1.3999999999999999 112.703 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.51 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -79.04 142.15 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.733 -1.21 . . . . 0.29999999999999999 107.733 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.454 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 20.4 t-80 -99.44 99.66 10.6 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.244 -1.382 . . . . 1.3400000000000001 107.87 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.33 92.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 C-N-CA 118.7 -1.2 . . . . 0.89000000000000001 110.35 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.426 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 5.1 mmt -71.9 -28.96 63.85 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.159 -1.382 . . . . 3.6200000000000001 111.729 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.48 104.81 0.21 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.1 -1.44 . . . . 1.6799999999999999 111.462 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -58.4 104.55 0.22 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.587 -1.245 . . . . 2.3900000000000001 109.173 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -66.94 0.87 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.094 -1.042 . . . . 3.4399999999999999 111.478 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -98.65 159.49 30.29 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 119.404 -0.919 . . . . 0.62 111.266 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.95 -60.88 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.965 1.777 . . . . 0.56999999999999995 110.963 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -89.47 4.25 49.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.348 -0.842 . . . . 0.45000000000000001 111.408 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' ASP . 21.9 m95 -142.0 141.72 32.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.881 -0.785 . . . . 0.16 108.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.6 m0 -141.92 169.72 17.06 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.651 -0.82 . . . . 0.67000000000000004 111.805 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -108.41 134.12 51.64 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.07 -1.085 . . . . 2.5299999999999998 108.07 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -163.87 -148.7 5.5 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 117.812 -2.137 . . . . 0.29999999999999999 109.7 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.01 172.81 13.36 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.222 -1.391 . . . . 0.20000000000000001 112.114 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -172.01 -94.0 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.733 -1.187 . . . . 0.72999999999999998 112.005 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.554 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.9 p80 -58.42 77.64 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.539 -0.864 . . . . 0.72999999999999998 111.397 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.32 27.36 0.25 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.115 -1.041 . . . . 0.78000000000000003 111.499 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -156.61 151.83 26.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.162 -1.415 . . . . 1.04 111.757 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.516 ' H ' ' HG1' ' A' ' 46' ' ' THR . 3.1 p -97.51 -176.48 3.51 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.669 -0.812 . . . . 1.8400000000000001 110.473 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.69 -176.83 24.46 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.337 -1.411 . . . . 0.39000000000000001 111.628 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.9 mtp -100.45 150.63 22.44 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.327 0.584 . . . . 0.54000000000000004 111.378 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.7 p90 -151.7 146.2 18.55 Favored Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.311 -0.858 . . . . 0.14999999999999999 109.607 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.29 123.17 12.84 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 110.367 -0.666 . . . . 0.17999999999999999 110.367 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.05 -18.45 60.67 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.396 -0.922 . . . . 3.8199999999999998 111.078 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -86.64 0.4 54.6 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.737 -1.185 . . . . 3.46 111.733 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -100.27 9.64 42.42 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.365 -0.934 . . . . 0.85999999999999999 109.407 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -136.2 171.6 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 114.886 -1.052 . . . . 0.28000000000000003 108.989 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 144.55 19.68 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 119.231 -0.988 . . . . 0.5 108.759 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.97 156.7 18.91 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 120.519 0.813 . . . . 0.66000000000000003 111.607 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.67 -54.47 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 1.3999999999999999 111.773 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -147.95 -176.59 5.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.136 -1.026 . . . . 8.0800000000000001 111.028 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 116.348 -1.786 . . . . 5.5999999999999996 110.629 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.782 -1.327 . . . . 1.76 109.782 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.1 t 165.65 -70.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.928 -0.709 . . . . 4.1299999999999999 109.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER 37.92 90.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.29 -0.868 . . . . 2.9399999999999999 112.287 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -176.27 150.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.578 -1.249 . . . . 1.97 111.996 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.22 -164.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.16 -0.927 . . . . 0.87 109.88 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.87 101.45 3.65 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.304 -1.369 . . . . 0.41999999999999998 107.304 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -28.13 115.66 0.09 Allowed 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.938 1.088 . . . . 0.29999999999999999 113.938 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.81 -34.33 69.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -174.62 4.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.639 -1.164 . . . . 1.1899999999999999 109.292 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 127.94 35.61 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.757 -1.565 . . . . 0.39000000000000001 109.453 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.58 108.23 16.88 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.332 -0.947 . . . . 0.34000000000000002 113.458 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.24 128.24 54.15 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 117.773 -1.571 . . . . 1.05 108.631 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.75 108.73 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 120.707 0.938 . . . . 1.47 113.851 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.539 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -90.03 -10.79 43.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.294 -1.002 . . . . 5.3200000000000003 108.294 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.12 179.19 5.36 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.727 -1.124 . . . . 1.0700000000000001 109.472 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -85.4 -57.62 3.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.814 -1.154 . . . . 3.4399999999999999 111.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.94 -7.65 66.86 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.81 -1.662 . . . . 2.7999999999999998 110.214 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 1.8 tt0 -54.4 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 115.633 1.716 . . . . 2.4199999999999999 115.633 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.33 170.06 8.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 110.747 -2.933 . . . . 2.02 110.528 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.69 113.94 0.59 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.851 -1.166 . . . . 0.37 110.21 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 p90 -138.49 -162.05 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.937 -1.105 . . . . 0.31 112.196 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -147.82 133.14 18.49 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.961 -1.096 . . . . 7.4100000000000001 113.307 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.56 127.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.641 1.213 . . . . 3.7400000000000002 112.259 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 7' ' ' ALA . . . 91.16 -32.62 5.09 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 119.715 -1.231 . . . . 0.84999999999999998 110.484 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.59 125.99 24.66 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.393 -1.323 . . . . 2.04 108.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.94 113.66 14.88 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.024 -1.07 . . . . 0.91000000000000003 113.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.481 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -77.53 140.85 16.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.668 -1.213 . . . . 0.28000000000000003 108.062 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.6 t-80 -96.0 96.84 9.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.189 -1.404 . . . . 1.52 108.53 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 3' ' ' THR . 10.8 t -64.8 100.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 119.018 -1.073 . . . . 0.52000000000000002 111.293 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.436 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mtt -67.08 -39.22 86.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.004 -1.078 . . . . 1.5900000000000001 108.547 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -179.23 116.29 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.98 -1.009 . . . . 1.46 109.654 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -47.17 111.64 0.43 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.297 -1.361 . . . . 3.29 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -42.43 11.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.138 -1.025 . . . . 1.3200000000000001 112.208 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.94 162.12 58.67 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 119.906 -0.718 . . . . 1.4099999999999999 111.015 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 -61.05 0.48 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.894 1.729 . . . . 1.0 111.985 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -99.65 17.83 19.57 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.604 -0.839 . . . . 0.95999999999999996 110.667 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 23.4 m95 -151.47 139.46 20.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.414 -0.958 . . . . 0.54000000000000004 108.414 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 26.4 m0 -138.79 175.9 9.16 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.334 -0.947 . . . . 0.28000000000000003 112.128 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 129.91 56.53 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.784 -1.561 . . . . 0.90000000000000002 106.784 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.24 -152.92 6.56 Favored Glycine 0 C--N 1.298 -1.573 0 C-N-CA 117.888 -2.101 . . . . 0.23999999999999999 109.834 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.44 168.28 18.65 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 118.225 -1.39 . . . . 0.35999999999999999 111.763 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 36.4 t -163.89 -91.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.689 -1.205 . . . . 1.55 111.522 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.634 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 2.9 p80 -59.98 77.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.63 -0.828 . . . . 0.53000000000000003 111.429 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.93 23.74 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.098 -1.048 . . . . 0.5 111.93 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -152.96 153.44 32.96 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.071 -1.452 . . . . 4.4500000000000002 111.201 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 p -99.44 -174.89 2.84 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.652 -0.819 . . . . 1.99 111.37 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.23 -172.09 28.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.356 -1.098 . . . . 0.22 110.356 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.3 mtp -105.03 157.99 16.86 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.747 -0.781 . . . . 1.5700000000000001 110.387 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.7 p90 -159.21 142.72 10.76 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.134 -1.061 . . . . 0.34000000000000002 108.134 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -54.76 127.0 24.33 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 CA-C-N 118.613 0.541 . . . . 0.40000000000000002 111.239 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.535 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -40.22 85.84 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.574 -0.851 . . . . 3.1800000000000002 109.578 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.5 2.39 1.8 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.529 -0.868 . . . . 3.0499999999999998 112.867 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.79 10.39 41.2 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.101 -1.039 . . . . 1.22 109.328 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.2 m -141.58 175.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.25 109.463 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.401 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -147.21 128.09 7.06 Favored Pre-proline 0 C--N 1.3 -1.545 0 C-N-CA 119.23 -0.988 . . . . 0.87 109.324 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.69 145.83 94.3 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.633 0.889 . . . . 1.9299999999999999 112.47 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.25 -170.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.393 -0.821 . . . . 3.6000000000000001 110.794 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.88 172.36 8.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.327 -0.949 . . . . 7.7800000000000002 110.776 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 . . . . . 0 C--N 1.304 -1.403 0 CA-C-O 116.34 -1.791 . . . . 10.49 111.035 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 110.066 -1.214 . . . . 7.6799999999999997 110.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -112.28 -163.52 0.86 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.897 -0.721 . . . . 2.6000000000000001 111.215 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 95.3 2.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.857 -0.737 . . . . 3.4199999999999999 110.706 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -171.08 153.19 3.67 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.357 -1.337 . . . . 1.8200000000000001 112.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 m -143.81 -170.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.078 -0.964 . . . . 0.35999999999999999 110.011 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.512 ' NE2' ' CE2' ' A' ' 26' ' ' PHE . 1.9 mt-30 -141.72 101.13 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.678 -1.23 . . . . 0.45000000000000001 107.678 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.26 110.55 0.06 Allowed 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.188 -0.915 . . . . 0.19 113.116 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.53 -42.04 87.82 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.469 0.652 . . . . 1.8400000000000001 109.978 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.56 -178.24 4.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.741 -1.118 . . . . 2.0499999999999998 108.758 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 140.59 32.44 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 113.435 -1.711 . . . . 1.01 106.995 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.57 106.99 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.031 1.493 . . . . 0.48999999999999999 115.031 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.13 137.72 29.31 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 105.925 -1.88 . . . . 2.0099999999999998 105.925 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.62 162.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.348 0 CA-C-O 121.794 0.664 . . . . 0.53000000000000003 112.969 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.54 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 91.0 mt-30 -151.61 -12.18 0.2 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.966 -1.47 . . . . 1.6299999999999999 108.1 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.7 mt-10 -114.9 166.97 11.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.335 -1.302 . . . . 4.2300000000000004 109.651 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -64.5 123.72 19.96 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.259 -1.376 . . . . 5.9500000000000002 110.202 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 47.03 37.96 10.26 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 119.349 -1.405 . . . . 1.1699999999999999 111.161 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.78 172.2 12.43 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.941 -1.104 . . . . 1.28 108.089 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.598 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.4 tp -69.0 154.61 41.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 112.858 0.688 . . . . 1.0800000000000001 112.858 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.15 123.13 1.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.659 -1.377 . . . . 0.28999999999999998 109.659 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 p90 -146.44 -176.11 5.05 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.582 -1.247 . . . . 0.17999999999999999 112.03 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.9 mmt85 -135.73 127.72 29.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.498 -0.774 . . . . 4.0899999999999999 111.305 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -13.56 135.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.03 1.122 . . . . 1.5600000000000001 114.03 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.39 -21.82 30.11 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.23000000000000001 109.402 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -69.09 117.52 10.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.731 -1.211 . . . . 0.93999999999999995 107.731 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 67.3 m-85 -73.28 108.3 6.08 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.978 -1.089 . . . . 1.1499999999999999 112.174 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.472 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.38 142.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.068 -1.456 . . . . 0.19 107.068 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 31.8 t-80 -101.45 99.17 9.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.861 -1.536 . . . . 1.8600000000000001 108.125 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.4 t -64.74 102.43 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 C-N-CA 118.731 -1.187 . . . . 0.76000000000000001 110.12 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.41 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.6 ttp -93.32 -21.96 19.26 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.825 -1.08 . . . . 1.9299999999999999 111.216 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.01 87.82 0.94 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.092 -1.443 . . . . 1.97 111.734 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.15 82.78 0.23 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.78 -1.168 . . . . 2.3700000000000001 108.755 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -95.7 -83.14 0.37 Allowed 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.191 -1.003 . . . . 2.9100000000000001 111.855 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.1 m-20 -57.85 156.15 19.93 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 118.675 -1.21 . . . . 0.84999999999999998 111.352 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.17 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.896 1.731 . . . . 0.40999999999999998 111.833 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.88 -3.26 53.72 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.225 -0.898 . . . . 0.38 111.556 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 32.8 m95 -129.67 151.8 49.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.18 -1.044 . . . . 0.94999999999999996 108.18 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.2 m0 -151.81 164.85 36.17 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.04 -0.664 . . . . 0.76000000000000001 110.905 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -108.16 137.79 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.579 -1.267 . . . . 1.27 107.579 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -160.52 -148.71 5.35 Favored Glycine 0 C--O 1.214 -1.145 0 C-N-CA 118.078 -2.01 . . . . 0.38 109.54 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.17 154.39 10.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.403 -1.319 . . . . 0.76000000000000001 112.185 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 44' ' ' GLY . 35.1 t -155.25 -100.93 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.956 -1.098 . . . . 1.4399999999999999 111.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.558 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.4 p80 -53.65 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.571 -0.74 . . . . 0.51000000000000001 111.715 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 26.66 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.139 -1.029 . . . . 0.46000000000000002 112.268 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -156.73 149.9 24.11 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.408 -1.317 . . . . 5.0800000000000001 111.982 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.476 ' N ' ' NE2' ' A' ' 45' ' ' GLN . 7.1 p -97.27 -172.9 2.53 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.604 -0.726 . . . . 0.93000000000000005 110.855 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.52 -171.15 26.65 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.374 -1.393 . . . . 0.20000000000000001 111.422 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 18.7 mtp -104.9 145.46 30.38 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.241 -0.584 . . . . 0.84999999999999998 111.489 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.472 ' CE2' HG23 ' A' ' 27' ' ' ILE . 7.4 p90 -149.42 141.17 14.81 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 119.516 -0.874 . . . . 0.20000000000000001 109.94 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.31 128.31 29.91 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 N-CA-C 110.067 -0.782 . . . . 0.29999999999999999 110.067 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -23.01 64.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.411 -0.916 . . . . 3.48 111.56 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -84.38 10.18 11.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.712 -1.195 . . . . 5.7800000000000002 111.383 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.01 6.85 29.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.814 -0.755 . . . . 1.1399999999999999 109.112 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.442 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.0 m -134.7 175.07 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.553 -1.203 . . . . 0.26000000000000001 109.603 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -140.88 135.03 15.13 Favored Pre-proline 0 C--N 1.305 -1.344 0 C-N-CA 119.414 -0.914 . . . . 0.54000000000000004 108.949 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -66.11 144.19 74.59 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 120.576 0.851 . . . . 1.55 113.114 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.18 -1.77 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.502 -0.925 . . . . 2.27 108.502 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 59' ' ' ARG . 21.4 t-20 -143.51 -105.1 0.12 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.723 -1.126 . . . . 5.0199999999999996 110.106 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 58' ' ' ASN . 16.3 ttm180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 116.446 -1.74 . . . . 14.609999999999999 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.832 -1.307 . . . . 4.7999999999999998 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -162.01 152.79 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.124 -1.03 . . . . 7.2000000000000002 111.513 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.56 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -131.75 172.43 12.29 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.233 -0.894 . . . . 2.5699999999999998 109.554 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 175.21 148.79 0.09 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.135 -1.426 . . . . 3.2000000000000002 113.24 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.87 -164.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 115.174 -0.921 . . . . 1.03 109.218 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.511 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -145.26 97.48 3.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.286 -1.005 . . . . 0.55000000000000004 108.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.4 115.25 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.729 -1.123 . . . . 0.16 113.282 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 17.2 tp -64.95 -41.27 95.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.666 -0.697 . . . . 3.4500000000000002 109.425 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.68 -174.92 4.6 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.962 -1.017 . . . . 1.6499999999999999 109.489 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.57 127.63 33.56 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 113.903 -1.499 . . . . 0.59999999999999998 107.456 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -114.44 103.89 11.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.453 1.279 . . . . 0.42999999999999999 114.453 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 13' ' ' PRO . 5.0 m-20 -86.06 142.11 35.9 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 105.687 -1.968 . . . . 1.8200000000000001 105.687 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 12' ' ' ASP . 80.4 Cg_exo -47.55 -158.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 120.8 1.0 . . . . 1.6000000000000001 114.066 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 1.2 mm-40 165.67 -23.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.44 -1.254 . . . . 3.21 107.635 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -102.57 148.64 25.3 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.379 -1.282 . . . . 5.4100000000000001 109.007 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.29 105.52 1.14 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.494 -1.282 . . . . 4.1600000000000001 111.211 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 32.15 29.73 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.712 -1.233 . . . . 0.45000000000000001 110.666 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' OE2' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -93.63 170.75 9.35 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.195 -1.002 . . . . 0.88 109.545 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.563 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 11.3 tp -72.16 155.99 39.65 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.003 -0.999 . . . . 2.0299999999999998 113.291 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.48 117.2 0.86 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 107.999 -2.04 . . . . 0.42999999999999999 107.999 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 7.9 p90 -139.52 -169.3 2.66 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.889 -1.124 . . . . 0.39000000000000001 113.064 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -133.97 130.14 37.23 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.463 -0.79 . . . . 4.1500000000000004 112.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -18.71 137.92 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.829 0.706 . . . . 4.0599999999999996 112.879 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 -21.5 15.23 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.916 -1.674 . . . . 0.33000000000000002 108.916 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -64.85 121.73 15.29 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.935 -1.106 . . . . 0.34000000000000002 108.308 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 110.2 11.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.986 -1.086 . . . . 1.0700000000000001 112.763 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.463 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -76.18 146.85 8.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.784 -1.191 . . . . 0.20000000000000001 107.784 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -103.49 89.78 3.47 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.277 -1.369 . . . . 1.24 109.408 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.403 ' O ' ' OG1' ' A' ' 3' ' ' THR . 2.3 t -59.83 94.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 118.677 -1.209 . . . . 0.90000000000000002 110.285 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.415 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 15.4 mtp -74.88 -29.57 61.05 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.655 -1.157 . . . . 2.8399999999999999 110.482 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.25 99.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 117.946 -1.502 . . . . 2.3199999999999998 111.805 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -54.56 101.53 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.103 -1.439 . . . . 2.0699999999999998 108.326 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -94.04 -72.89 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.007 -1.077 . . . . 1.9299999999999999 111.735 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.1 m-20 -80.34 160.55 67.53 Favored Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.049 -1.06 . . . . 0.64000000000000001 111.0 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.34 -68.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.577 1.518 . . . . 0.53000000000000003 111.127 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.5 t-20 -87.13 4.13 43.54 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.712 -0.795 . . . . 0.32000000000000001 111.577 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.2 m95 -136.66 148.62 47.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.465 -0.939 . . . . 0.14999999999999999 108.465 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 22.8 m0 -142.37 175.55 9.68 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.616 -0.834 . . . . 0.20000000000000001 111.5 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 133.03 56.32 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.965 -1.494 . . . . 1.29 106.965 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.71 -150.68 5.91 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 117.918 -2.086 . . . . 0.20000000000000001 109.261 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.68 159.66 19.1 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 118.226 -1.389 . . . . 0.53000000000000003 111.662 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' GLY . 40.6 t -155.37 -100.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.553 -1.259 . . . . 0.33000000000000002 112.097 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.481 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 5.7 p80 -52.77 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.584 -0.735 . . . . 0.87 111.899 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.2 24.05 0.1 OUTLIER Glycine 0 N--CA 1.489 2.216 0 CA-C-N 115.167 -0.924 . . . . 0.51000000000000001 112.252 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 tp60 -156.16 163.71 39.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.814 -1.554 . . . . 5.7699999999999996 111.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 p -99.82 -177.26 3.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.341 -0.845 . . . . 2.1800000000000002 111.313 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.99 171.39 18.36 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.01 -1.567 . . . . 0.76000000000000001 111.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 mtp -95.92 146.28 24.72 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 120.218 -0.593 . . . . 1.24 110.394 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 10.1 p90 -148.78 145.54 20.06 Favored Pre-proline 0 C--N 1.296 -1.743 0 C-N-CA 119.403 -0.919 . . . . 0.32000000000000001 108.859 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.93 128.04 27.43 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.008 0.472 . . . . 0.20999999999999999 110.973 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -59.16 -36.56 75.5 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 4.4900000000000002 110.253 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 26.7 t-20 -75.13 3.32 8.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.473 -0.891 . . . . 3.6899999999999999 112.787 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.12 9.16 43.25 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.905 -1.118 . . . . 0.97999999999999998 109.598 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.5 m -138.42 177.94 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.943 -1.026 . . . . 0.20000000000000001 109.03 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -148.8 133.18 8.86 Favored Pre-proline 0 C--N 1.297 -1.689 0 C-N-CA 119.18 -1.008 . . . . 1.6699999999999999 109.259 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.09 149.8 60.69 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 120.363 0.709 . . . . 1.3500000000000001 111.632 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.54 -15.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.268 -0.973 . . . . 1.9299999999999999 110.702 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.03 -175.57 4.61 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.48 -0.888 . . . . 4.5199999999999996 110.452 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.388 0 CA-C-O 116.216 -1.85 . . . . 8.8499999999999996 110.739 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 109.954 -1.258 . . . . 9.7200000000000006 109.954 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m 46.45 -105.1 0.11 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.497 -0.881 . . . . 4.1600000000000001 110.77 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.1 94.34 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.718 -0.674 . . . . 3.21 110.448 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 3' ' ' THR . 1.8 m-85 -172.17 159.52 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.681 -1.608 . . . . 1.6100000000000001 113.091 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.45 -167.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 115.062 -0.972 . . . . 0.78000000000000003 109.9 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.88 97.08 2.96 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.588 -1.264 . . . . 0.38 107.588 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.22 115.54 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.359 -1.291 . . . . 0.22 113.663 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -70.77 -42.09 70.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.809 -0.632 . . . . 1.0700000000000001 109.888 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 -179.94 5.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.478 1.132 . . . . 1.3500000000000001 109.155 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -85.31 124.76 32.3 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.107 -1.86 . . . . 0.71999999999999997 107.412 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -111.96 104.54 12.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.262 -0.975 . . . . 0.52000000000000002 112.798 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.4 p-10 -86.23 128.51 57.24 Favored Pre-proline 0 C--N 1.304 -1.37 0 C-N-CA 117.514 -1.675 . . . . 3.3500000000000001 108.765 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -39.84 149.23 0.13 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.146 1.23 . . . . 0.56000000000000005 114.095 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -137.97 4.72 2.53 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.87 -1.9 . . . . 2.8900000000000001 105.87 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -141.55 139.48 33.2 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.707 -2.042 . . . . 1.74 109.657 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -89.03 42.88 1.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.282 -1.367 . . . . 4.4900000000000002 109.134 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -162.15 -9.05 0.04 OUTLIER Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.646 -1.381 . . . . 1.5900000000000001 109.646 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.2 pt-20 -99.75 -170.76 1.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.313 -0.955 . . . . 1.8400000000000001 111.732 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -84.82 170.22 13.39 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 116.138 1.903 . . . . 0.40000000000000002 116.138 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -158.93 119.66 0.91 Allowed Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.168 -1.833 . . . . 0.17000000000000001 109.209 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.5 p90 -144.97 -170.81 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.367 -1.333 . . . . 0.16 112.455 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 23' ' ' ARG . 5.1 mmt85 -136.88 126.91 25.98 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.544 -0.753 . . . . 3.0800000000000001 111.743 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.3 ttp85 -12.8 135.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.398 1.259 . . . . 4.0199999999999996 114.398 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.11 -23.81 10.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.52000000000000002 109.6 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -61.26 117.07 5.14 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.388 -1.325 . . . . 0.84999999999999998 107.891 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -71.89 107.57 4.72 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.48 -1.288 . . . . 1.1499999999999999 112.376 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.495 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.85 136.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.362 -1.347 . . . . 0.38 107.362 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.409 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 25.5 t-80 -94.36 94.12 8.09 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.454 -1.699 . . . . 1.7 108.29 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.01 100.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 C-N-CA 118.967 -1.093 . . . . 0.64000000000000001 111.388 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.6 tpp -61.51 -36.0 79.29 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.062 -1.055 . . . . 2.2400000000000002 108.931 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 p30 171.58 126.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.026 -0.988 . . . . 3.5899999999999999 109.39 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.559 ' ND2' ' N ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -49.97 109.78 0.32 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.914 -1.514 . . . . 3.54 109.716 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -92.51 -65.69 0.98 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.422 -0.911 . . . . 3.1000000000000001 110.162 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -102.57 160.75 25.36 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.021 -0.99 . . . . 0.84999999999999998 110.315 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -59.47 -60.57 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.309 1.34 . . . . 0.67000000000000004 111.087 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -92.53 -3.58 54.87 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.666 -0.813 . . . . 0.54000000000000004 111.708 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 17.0 m95 -131.01 152.85 49.88 Favored 'General case' 0 C--O 1.204 -1.327 0 N-CA-C 108.343 -0.984 . . . . 0.42999999999999999 108.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.677 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 15.2 m0 -145.24 177.91 8.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.69 -0.804 . . . . 0.44 111.825 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -118.02 135.95 53.85 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.943 -1.132 . . . . 4.3700000000000001 107.943 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.409 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -165.89 -150.36 6.26 Favored Glycine 0 C--N 1.3 -1.451 0 C-N-CA 118.031 -2.033 . . . . 0.20999999999999999 109.268 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.44 174.27 12.95 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 118.264 -1.374 . . . . 0.17999999999999999 111.877 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -170.33 -93.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.832 -1.147 . . . . 1.0 112.156 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 7.7 p80 -59.69 78.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.259 -0.977 . . . . 1.0600000000000001 111.049 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.76 20.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.132 -0.94 . . . . 0.65000000000000002 111.688 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' HIS . 54.8 mt-30 -148.3 151.79 35.99 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.393 -1.323 . . . . 1.76 111.745 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -96.14 -179.46 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.629 -0.828 . . . . 1.8200000000000001 110.239 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -179.06 28.21 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.019 -1.562 . . . . 0.37 111.092 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.6 mtp -102.79 147.04 27.36 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.398 0.618 . . . . 0.53000000000000003 110.81 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 5.0 p90 -149.16 149.7 30.2 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.359 -0.837 . . . . 0.28000000000000003 108.799 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.11 131.16 37.6 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 N-CA-C 110.564 -0.591 . . . . 0.42999999999999999 110.564 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.677 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.39 -51.41 68.91 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.204 -0.998 . . . . 4.7000000000000002 109.755 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -61.1 9.12 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.522 0.934 . . . . 4.5099999999999998 113.522 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -104.39 3.75 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.112 -1.035 . . . . 0.5 109.26 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.9 m -134.06 175.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.29999999999999999 108.875 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.21 130.47 10.8 Favored Pre-proline 0 C--N 1.299 -1.599 0 C-N-CA 119.305 -0.958 . . . . 0.46000000000000002 108.693 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.4 ' HD3' HH12 ' A' ' 51' ' ' ARG . 6.0 Cg_exo -54.47 147.17 48.83 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 CA-C-N 118.756 0.591 . . . . 1.26 111.426 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.3 t -70.23 -58.54 5.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.765 -1.198 . . . . 1.23 107.765 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.63 -170.98 1.78 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.936 -1.135 . . . . 6.3399999999999999 107.936 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 116.326 -1.797 . . . . 6.5 111.093 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.825 -1.31 . . . . 6.71 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 p -170.54 16.66 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.703 -0.799 . . . . 5.8399999999999999 110.374 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.553 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -76.13 164.68 25.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.789 -0.764 . . . . 2.52 111.359 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.6 OUTLIER 175.84 151.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.264 -0.975 . . . . 2.7400000000000002 112.068 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.75 -168.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.556 -0.747 . . . . 0.85999999999999999 109.52 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.6 mt-30 -143.05 89.67 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.828 -0.749 . . . . 0.28000000000000003 109.031 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -14.55 111.69 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.023 -1.444 . . . . 0.23999999999999999 114.139 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.46 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 6.1 tp -63.75 -52.98 57.97 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.639 -0.71 . . . . 2.6400000000000001 109.537 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.23 -178.92 5.05 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.865 -1.161 . . . . 0.75 107.865 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.85 136.48 36.7 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 114.328 -1.305 . . . . 0.31 109.088 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -123.69 109.55 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.958 -1.097 . . . . 0.28999999999999998 113.391 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.4 133.81 32.33 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 117.816 -1.554 . . . . 1.27 108.452 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.515 ' C ' ' H ' ' A' ' 15' ' ' GLU . 95.3 Cg_exo -43.64 106.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 120.703 0.935 . . . . 1.3799999999999999 112.986 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -86.02 12.19 10.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 106.271 -1.751 . . . . 3.0299999999999998 106.271 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 13' ' ' PRO . 4.9 mm-40 -141.01 -178.56 5.62 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.947 -1.933 . . . . 1.8999999999999999 110.251 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -120.46 26.54 9.11 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.684 0.754 . . . . 3.8900000000000001 109.28 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -158.6 1.02 0.1 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.209 -1.556 . . . . 1.6100000000000001 109.209 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -100.95 -174.21 2.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.29 -0.964 . . . . 1.5800000000000001 112.049 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.536 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.6 tp -76.71 166.06 23.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 115.492 1.664 . . . . 1.8 115.492 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.08 120.9 1.05 Allowed Glycine 0 N--CA 1.499 2.88 0 CA-C-N 114.237 -1.347 . . . . 0.20999999999999999 110.437 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.05 -175.54 5.0 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.073 -1.451 . . . . 0.26000000000000001 112.861 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' ARG . 31.3 mmt-85 -135.6 130.55 34.62 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.189 -0.914 . . . . 7.1100000000000003 111.603 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.98 140.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.456 1.28 . . . . 2.0600000000000001 114.456 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.11 -15.07 29.67 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 114.067 -1.424 . . . . 0.23000000000000001 109.594 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -72.68 118.81 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.555 -1.276 . . . . 0.40999999999999998 107.555 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.69 107.21 5.8 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.687 -1.205 . . . . 0.90000000000000002 113.276 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.454 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -73.04 142.84 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.819 -1.548 . . . . 0.26000000000000001 106.819 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -100.6 93.92 5.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.17 -1.412 . . . . 1.27 108.887 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.07 96.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 118.135 -1.426 . . . . 0.90000000000000002 110.5 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.6 ttm -82.48 -25.87 33.12 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.51 -1.223 . . . . 0.83999999999999997 110.706 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.9 85.06 0.95 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.15 -1.42 . . . . 2.0600000000000001 111.766 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.676 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.18 91.78 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.027 -1.069 . . . . 3.8300000000000001 109.0 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.2 m -103.1 -85.86 0.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.285 -0.966 . . . . 2.0600000000000001 111.936 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 8.4 m-20 -55.58 154.52 12.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 118.488 -1.285 . . . . 1.1299999999999999 110.753 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.05 -71.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.876 1.717 . . . . 0.44 112.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.47 7.82 13.28 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.721 -0.792 . . . . 2.7400000000000002 111.387 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.3 m95 -139.85 146.19 39.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.617 -0.882 . . . . 0.52000000000000002 108.617 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.8 m0 -145.59 167.34 23.28 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.378 -0.929 . . . . 0.47999999999999998 111.447 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -108.21 132.1 54.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.241 -1.022 . . . . 0.27000000000000002 108.241 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.09 -146.66 4.62 Favored Glycine 0 C--N 1.3 -1.443 0 C-N-CA 117.883 -2.103 . . . . 0.16 109.116 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.76 159.21 21.11 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.173 -1.811 . . . . 0.41999999999999998 113.495 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 8.2 t -175.61 -179.72 1.28 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 2.9100000000000001 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.609 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 10.8 p80 40.78 26.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.802 -0.636 . . . . 1.8700000000000001 111.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 81.27 31.04 35.38 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.732 -1.223 . . . . 0.85999999999999999 112.778 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.6 tt0 -164.91 155.23 13.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.832 -1.547 . . . . 1.97 112.19 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -95.04 -179.5 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.399 -0.921 . . . . 0.88 110.814 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 -159.2 28.27 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.14 -1.505 . . . . 0.32000000000000001 111.255 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.5 mtp -120.03 148.37 43.66 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.167 0.508 . . . . 0.47999999999999998 110.759 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 8.5 p90 -151.08 143.9 16.64 Favored Pre-proline 0 C--N 1.297 -1.712 0 C-N-CA 119.563 -0.855 . . . . 0.32000000000000001 109.146 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.91 126.92 24.02 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 109.864 -0.86 . . . . 0.28000000000000003 109.864 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.88 -32.59 72.03 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.149 -1.02 . . . . 4.21 111.58 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 -74.54 0.12 15.86 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.494 -1.283 . . . . 2.23 112.349 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.39 12.56 32.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.93 -1.108 . . . . 1.76 109.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.6 m -139.38 171.0 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.983 -1.008 . . . . 0.27000000000000002 109.741 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -135.76 122.54 14.43 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.576 -0.898 . . . . 1.28 108.576 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -64.05 144.47 87.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 CA-C-N 118.948 0.66 . . . . 2.0099999999999998 112.04 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.14 99.11 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.435 -0.802 . . . . 4.0800000000000001 109.042 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -138.14 76.59 1.58 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.749 -0.78 . . . . 6.4800000000000004 111.773 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 116.298 -1.81 . . . . 8.8599999999999994 110.753 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 110.345 -1.102 . . . . 2.02 110.345 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m -149.15 34.59 0.73 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.574 -0.851 . . . . 2.8900000000000001 110.926 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.456 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -64.54 94.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.87 -0.732 . . . . 3.2200000000000002 111.091 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -173.26 138.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.224 -1.391 . . . . 1.55 112.66 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.42 -167.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.266 -0.879 . . . . 1.1499999999999999 110.098 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 7' ' ' ALA . 4.4 mt-30 -141.83 109.34 5.64 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.673 -1.603 . . . . 0.41999999999999998 106.673 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -34.79 115.73 0.29 Allowed 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.927 -1.109 . . . . 0.40999999999999998 111.79 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 1.4 tt -73.71 -39.82 64.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.018 -0.992 . . . . 1.8400000000000001 109.837 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.99 -179.9 5.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.781 -1.1 . . . . 1.24 108.582 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.61 135.47 36.06 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.294 -1.775 . . . . 0.55000000000000004 107.702 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -131.07 111.93 12.44 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.475 -1.29 . . . . 0.55000000000000004 113.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -94.26 131.58 31.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 118.023 -1.471 . . . . 3.79 107.928 179.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -42.55 110.97 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 120.616 0.878 . . . . 1.1899999999999999 112.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.559 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 14.5 mm-40 -111.82 15.75 20.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.921 -1.036 . . . . 3.7799999999999998 109.881 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 17.4 mm-40 -138.7 -178.16 5.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.814 -0.754 . . . . 3.1099999999999999 110.012 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 17' ' ' GLY . 5.5 p30 -73.21 129.21 37.55 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.509 -0.877 . . . . 6.7400000000000002 112.029 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 16' ' ' ASP . . . 34.42 38.37 0.11 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.975 -0.85 . . . . 1.0700000000000001 110.975 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.638 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -84.43 177.42 8.14 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.689 -0.804 . . . . 1.22 110.147 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.638 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -73.74 167.35 21.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.107 -0.951 . . . . 0.38 112.109 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.76 130.12 2.68 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.598 -1.001 . . . . 0.23999999999999999 110.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -156.75 -172.05 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.682 -1.607 . . . . 0.40999999999999998 113.075 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . 10.8 mmm180 -138.77 128.57 24.98 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.278 -0.874 . . . . 5.9100000000000001 112.153 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -12.7 135.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.295 1.22 . . . . 4.1399999999999997 114.295 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.63 -19.51 32.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.095 -1.602 . . . . 0.16 109.095 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -65.39 118.81 9.92 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.166 -1.014 . . . . 0.81000000000000005 108.777 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.78 107.79 7.1 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.068 -1.053 . . . . 1.75 112.696 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -77.92 143.4 12.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.139 -1.43 . . . . 0.39000000000000001 107.139 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -100.82 95.24 6.5 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.739 -1.585 . . . . 1.79 108.767 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 3' ' ' THR . 3.8 t -64.83 106.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 118.114 -1.434 . . . . 0.91000000000000003 109.613 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.3 tpp -88.75 -26.34 21.8 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.122 -0.944 . . . . 2.3500000000000001 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -172.06 108.52 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.691 -1.604 . . . . 1.6000000000000001 111.595 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.42 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 3.7 p30 -62.33 100.01 0.16 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.381 -1.328 . . . . 1.76 109.249 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -91.25 -66.55 0.92 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.782 -1.167 . . . . 1.3500000000000001 111.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 4.3 m-20 -90.19 159.9 41.2 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 119.226 -0.99 . . . . 2.3500000000000001 110.726 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.54 -65.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.443 1.429 . . . . 0.41999999999999998 111.066 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -83.14 -8.93 59.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.489 -0.778 . . . . 0.92000000000000004 111.559 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 18.9 m95 -126.57 155.94 41.65 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.768 -0.827 . . . . 0.46999999999999997 108.768 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.6 m0 -149.84 -179.31 7.03 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.507 -0.877 . . . . 0.71999999999999997 112.151 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -122.43 128.13 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.879 -1.156 . . . . 1.1699999999999999 107.879 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.87 -148.43 4.99 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.587 -1.805 . . . . 0.19 108.587 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.91 159.05 17.82 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 117.303 -1.759 . . . . 0.57999999999999996 113.763 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' GLY . 43.2 t -172.7 -178.85 1.99 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.543 -1.208 . . . . 2.5299999999999998 111.041 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 4.0 p80 39.6 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.874 -0.603 . . . . 2.21 111.616 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 85.9 30.47 23.31 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.718 -1.229 . . . . 0.53000000000000003 112.907 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 46' ' ' THR . 1.3 tm0? -164.37 151.72 11.81 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.119 -1.433 . . . . 5.5800000000000001 111.814 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.517 ' N ' ' OE1' ' A' ' 45' ' ' GLN . 6.1 p -94.28 -175.69 3.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.55 -0.86 . . . . 0.57999999999999996 110.689 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.15 -170.07 29.49 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.462 -1.351 . . . . 0.20000000000000001 110.933 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.0 mtp -107.76 143.91 35.63 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.975 -0.69 . . . . 1.0900000000000001 111.095 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 3.5 p90 -148.52 145.59 20.55 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 119.701 -0.8 . . . . 0.28999999999999998 110.093 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.43 125.64 19.46 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 N-CA-C 109.966 -0.821 . . . . 0.34999999999999998 109.966 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.31 -25.22 67.53 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.626 -0.829 . . . . 2.6099999999999999 112.211 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.25 7.44 16.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.367 -1.333 . . . . 3.9300000000000002 111.876 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.96 7.37 39.17 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.506 -0.878 . . . . 0.93000000000000005 109.547 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.475 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 11.6 m -135.18 179.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.767 -1.106 . . . . 0.37 109.033 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.72 121.63 4.18 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 118.745 -1.182 . . . . 0.38 110.818 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.13 149.67 78.62 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 120.576 0.851 . . . . 2.4300000000000002 111.747 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.474 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 0.8 OUTLIER -97.35 124.96 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.649 -0.82 . . . . 3.73 110.617 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 57' ' ' VAL . 1.6 m120 -138.49 -13.13 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.358 -0.937 . . . . 7.0700000000000003 110.46 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 C--N 1.298 -1.643 0 CA-C-O 116.197 -1.859 . . . . 8.0899999999999999 110.491 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 110.186 -1.166 . . . . 3.2999999999999998 110.186 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 p -142.67 146.6 34.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.739 -0.784 . . . . 3.7599999999999998 110.628 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -127.39 22.88 6.45 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.694 -0.802 . . . . 0.93999999999999995 111.181 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.466 ' CE2' ' CD2' ' A' ' 28' ' ' HIS . 82.9 m-85 -87.94 155.17 19.98 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.329 -1.348 . . . . 3.3100000000000001 112.666 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -130.93 -166.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.308 -1.315 . . . . 1.0700000000000001 108.708 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.1 mt-30 -144.45 95.41 2.71 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.928 -1.138 . . . . 0.19 107.928 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.54 111.15 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.481 -1.236 . . . . 0.14999999999999999 113.186 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.484 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 14.0 tp -61.98 -45.72 92.39 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.514 0.673 . . . . 2.9700000000000002 109.682 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.09 -174.44 3.85 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.709 -1.132 . . . . 1.3100000000000001 108.252 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.84 148.31 30.02 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 114.168 -1.378 . . . . 0.27000000000000002 107.805 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -139.21 119.35 13.56 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.125 -1.43 . . . . 0.68999999999999995 113.704 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -101.1 132.42 22.0 Favored Pre-proline 0 C--N 1.311 -1.066 0 C-N-CA 118.643 -1.223 . . . . 1.73 108.64 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.39 119.3 2.54 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 120.82 1.013 . . . . 1.1599999999999999 114.191 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 5.1 mt-30 -116.56 8.7 13.99 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.756 -1.111 . . . . 2.6000000000000001 108.375 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 4.4 mm-40 -130.37 170.11 14.6 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.913 -1.039 . . . . 3.6699999999999999 109.146 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 127.06 31.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.736 -1.186 . . . . 1.75 111.481 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.91 55.05 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.976 -1.107 . . . . 0.81999999999999995 111.179 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.636 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -99.19 175.63 5.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.667 -0.813 . . . . 1.1200000000000001 110.103 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.636 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -74.88 161.62 29.38 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.674 0.99 . . . . 2.6000000000000001 113.674 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -153.2 120.92 1.09 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.072 -1.211 . . . . 0.23999999999999999 110.072 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.7 p90 -144.16 -169.61 3.16 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.778 -1.169 . . . . 0.26000000000000001 111.796 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.1 mmm-85 -138.7 125.05 20.4 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.937 -0.705 . . . . 3.4100000000000001 112.0 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.63 130.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.143 0.902 . . . . 3.8599999999999999 113.282 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.52 -19.61 53.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.23000000000000001 109.381 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' OD1' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -72.84 120.73 18.87 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.961 -1.096 . . . . 1.8400000000000001 108.925 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -76.01 109.46 9.67 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.96 -1.096 . . . . 0.55000000000000004 112.65 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.454 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -74.58 142.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.677 -1.231 . . . . 0.31 107.677 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 12.2 t-80 -100.74 97.99 8.57 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 118.29 -1.364 . . . . 0.87 108.032 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.459 ' O ' ' OG1' ' A' ' 3' ' ' THR . 4.8 t -67.12 94.81 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.908 -1.042 . . . . 0.62 110.884 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 ttm -82.28 -27.21 32.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.56 -1.2 . . . . 1.3700000000000001 111.343 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' SER . 11.8 t70 -160.46 83.44 0.69 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 117.701 -1.6 . . . . 1.8700000000000001 111.903 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 1.6 p-10 -52.93 99.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.456 -1.297 . . . . 2.71 108.904 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 1.1 t -95.17 -78.06 0.46 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.126 -1.03 . . . . 2.23 111.554 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -72.63 158.48 87.27 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.064 -1.054 . . . . 0.62 111.498 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.49 -65.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.783 1.655 . . . . 0.23000000000000001 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 6.67 35.33 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.689 -0.804 . . . . 2.7999999999999998 111.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' ASP . 15.8 m95 -139.65 147.53 41.15 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.704 -1.221 . . . . 0.25 107.704 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -145.8 174.83 10.88 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.254 -0.978 . . . . 0.52000000000000002 112.024 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.31 135.94 53.44 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.621 -1.251 . . . . 2.6499999999999999 107.621 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -162.31 -145.11 4.22 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 117.895 -2.097 . . . . 0.42999999999999999 109.643 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.12 155.58 11.8 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.543 -1.263 . . . . 0.73999999999999999 112.237 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 44' ' ' GLY . 28.7 t -155.81 -98.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.012 -1.075 . . . . 0.55000000000000004 111.751 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.609 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.9 p80 -55.47 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.563 -0.855 . . . . 0.59999999999999998 111.029 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.56 26.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.327 -0.94 . . . . 0.47999999999999998 111.866 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -154.78 153.01 30.54 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.15 -1.42 . . . . 3.8399999999999999 111.792 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.528 ' H ' ' HG1' ' A' ' 46' ' ' THR . 3.0 p -98.15 -174.25 2.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.638 -0.71 . . . . 1.95 110.692 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.45 -169.55 27.0 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.371 -1.395 . . . . 0.31 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.5 mtp -110.2 151.41 27.35 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.355 0.598 . . . . 0.47999999999999998 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.9 p90 -152.53 147.99 20.19 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.165 -0.925 . . . . 0.34000000000000002 109.067 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.56 128.39 27.0 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 110.006 -0.805 . . . . 0.23000000000000001 110.006 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -39.1 90.89 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.877 -1.129 . . . . 2.5800000000000001 110.674 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.03 2.43 2.71 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.017 -1.073 . . . . 3.0600000000000001 112.694 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.29 9.23 41.94 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.275 -0.97 . . . . 0.28999999999999998 109.342 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.484 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.7 m -138.28 176.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.972 -1.013 . . . . 0.22 109.451 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.83 142.28 13.23 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.555 -1.258 . . . . 0.46999999999999997 109.627 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.78 145.93 88.04 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 120.628 0.885 . . . . 0.72999999999999998 111.481 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.19 -11.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.328 -0.949 . . . . 0.60999999999999999 110.292 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -154.1 126.44 7.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.395 -0.922 . . . . 2.6299999999999999 110.502 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 116.42 -1.753 . . . . 6.9800000000000004 110.84 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 110.033 -1.227 . . . . 6.8700000000000001 110.033 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.3 p 72.66 24.71 2.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.873 -0.731 . . . . 5.0199999999999996 110.939 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.591 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -156.25 30.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.289 -0.965 . . . . 0.85999999999999999 110.909 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.67 160.63 14.91 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 118.654 -1.218 . . . . 2.1299999999999999 112.546 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.8 -171.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 114.738 -1.119 . . . . 0.20000000000000001 109.328 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.5 mt-30 -140.66 93.63 2.63 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.821 -0.752 . . . . 0.39000000000000001 109.341 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -19.92 110.57 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.864 -1.516 . . . . 0.17999999999999999 114.739 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' ' NE ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -71.67 -44.35 64.42 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.102 -0.954 . . . . 2.02 109.291 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.85 -179.98 5.24 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.128 -1.064 . . . . 2.0499999999999998 108.128 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.37 143.32 26.87 Favored 'General case' 0 C--N 1.268 -2.941 0 N-CA-C 106.848 -1.538 . . . . 0.64000000000000001 106.848 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -131.41 115.09 15.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.205 -1.398 . . . . 0.46999999999999997 114.415 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.34 129.75 32.67 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 118.638 -1.225 . . . . 4.0899999999999999 107.915 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -43.66 159.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 120.502 0.802 . . . . 0.64000000000000001 112.767 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 40.4 mt-30 -146.55 -4.5 0.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.261 -1.385 . . . . 2.1400000000000001 107.261 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' CG ' ' OE2' ' A' ' 18' ' ' GLU . 17.4 mm-40 -129.33 150.75 50.56 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.679 -1.6 . . . . 1.8799999999999999 109.351 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.02 55.4 2.12 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.164 -1.414 . . . . 2.2999999999999998 110.036 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.34 -18.78 0.03 OUTLIER Glycine 0 C--N 1.296 -1.668 0 N-CA-C 107.994 -2.042 . . . . 1.3899999999999999 107.994 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.4 mt-10 -49.97 -179.3 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 123.113 1.435 . . . . 2.3900000000000001 113.697 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -104.06 160.11 15.12 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 111.385 -2.643 . . . . 1.0 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.77 105.23 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.933 -1.603 . . . . 0.5 110.767 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.2 p90 -132.03 -170.19 2.36 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.38 -0.928 . . . . 0.33000000000000002 111.178 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 23' ' ' ARG . 1.3 mmm180 -144.04 124.9 14.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.398 -0.921 . . . . 4.4299999999999997 112.046 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.5 ttt-85 -11.68 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 124.351 1.032 . . . . 2.3199999999999998 113.542 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.7 -17.78 55.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.262 -1.535 . . . . 0.33000000000000002 109.262 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.93 126.17 29.86 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.578 -1.249 . . . . 1.25 108.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -77.36 111.5 13.09 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.601 -1.24 . . . . 0.55000000000000004 112.816 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.451 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.46 144.19 11.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 118.618 -1.233 . . . . 0.17000000000000001 107.965 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 13.0 t-80 -101.16 101.24 11.93 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 106.658 -1.608 . . . . 0.68999999999999995 106.658 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.491 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.3 t -70.26 91.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 115.106 -0.952 . . . . 0.64000000000000001 112.781 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.456 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 4.4 mtt -57.68 -39.35 76.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.538 -1.21 . . . . 1.78 109.529 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.7 OUTLIER 179.8 119.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.591 -1.244 . . . . 3.23 110.594 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.46 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 6.4 p-10 -49.13 108.55 0.19 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.372 -1.331 . . . . 3.2799999999999998 110.154 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.7 t -92.28 -47.78 7.02 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.186 -1.006 . . . . 1.9299999999999999 111.481 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -125.73 161.19 52.36 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.397 -0.82 . . . . 1.4399999999999999 110.181 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -58.27 -67.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.505 1.47 . . . . 0.66000000000000003 111.648 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -87.9 7.05 32.65 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.65000000000000002 111.348 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASP . 24.4 m95 -141.42 145.08 34.87 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.815 . . . . 0.41999999999999998 108.801 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.549 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -143.93 173.05 12.04 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.402 -0.919 . . . . 0.66000000000000003 112.218 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -116.15 132.44 56.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.936 -1.135 . . . . 1.0800000000000001 107.936 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -157.08 -144.16 3.86 Favored Glycine 0 C--N 1.297 -1.594 0 C-N-CA 118.004 -2.046 . . . . 0.16 109.163 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.82 161.58 15.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.397 -1.321 . . . . 0.40000000000000002 111.419 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 44' ' ' GLY . 47.1 t -161.29 -112.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.039 -1.865 . . . . 0.56000000000000005 113.771 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.536 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 p80 -21.93 -42.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.413 1.071 . . . . 2.75 113.052 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 164.39 18.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.137 -1.506 . . . . 2.5600000000000001 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -157.12 161.96 39.4 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.452 -0.899 . . . . 2.1899999999999999 110.749 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 p -96.79 -174.11 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.313 -0.955 . . . . 0.57999999999999996 110.475 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.19 -172.3 30.04 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.584 -1.293 . . . . 0.5 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtp -104.83 138.82 40.51 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.002 -0.679 . . . . 1.52 110.333 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.4 p90 -142.19 146.06 38.2 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 119.777 -0.769 . . . . 0.28000000000000003 109.32 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.78 127.06 24.53 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 110.141 -0.754 . . . . 0.39000000000000001 110.141 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -29.53 70.69 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.282 -0.967 . . . . 4.4699999999999998 111.747 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -76.51 -8.37 57.05 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.58 -1.248 . . . . 4.1799999999999997 111.736 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.91 15.56 7.02 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.962 -1.095 . . . . 1.1599999999999999 109.947 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.5 m -144.16 174.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 110.322 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -148.06 135.04 10.28 Favored Pre-proline 0 C--N 1.3 -1.551 0 C-N-CA 119.673 -0.811 . . . . 0.64000000000000001 109.121 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -65.67 155.58 68.32 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 121.077 1.185 . . . . 1.48 113.554 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -94.25 -144.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.769 -1.105 . . . . 3.5499999999999998 108.918 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.436 ' N ' ' ND2' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -157.51 8.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.058 -1.457 . . . . 6.4900000000000002 112.722 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp85 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 116.405 -1.759 . . . . 11.51 111.049 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 110.094 -1.203 . . . . 3.6400000000000001 110.094 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.69 36.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.243 -0.983 . . . . 5.3399999999999999 110.978 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.558 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -44.05 158.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.571 -0.852 . . . . 2.5499999999999998 111.124 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.4 m-85 179.22 156.77 0.53 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.395 -0.922 . . . . 1.54 111.968 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 m -143.81 -169.16 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 0.81999999999999995 109.851 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.512 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.5 mt-30 -143.57 105.36 4.34 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.228 -1.397 . . . . 0.45000000000000001 107.228 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -33.84 111.69 0.11 Allowed 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.01 -1.076 . . . . 0.40000000000000002 112.162 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.03 -37.21 86.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.934 -0.706 . . . . 1.8200000000000001 109.376 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.29 -173.55 4.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.891 -1.049 . . . . 2.0600000000000001 109.522 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 129.13 34.19 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.383 -1.735 . . . . 0.53000000000000003 109.731 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.28 109.56 17.0 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.85 -1.14 . . . . 0.34999999999999998 113.133 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' PRO . 22.7 m-20 -81.6 133.77 52.1 Favored Pre-proline 0 C--N 1.295 -1.781 0 C-N-CA 117.234 -1.786 . . . . 1.5800000000000001 106.848 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.612 ' C ' ' H ' ' A' ' 15' ' ' GLU . 28.3 Cg_exo -34.46 -45.73 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.211 1.274 . . . . 3.3999999999999999 113.605 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 58.79 2.76 0.26 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.158 -1.417 . . . . 2.7000000000000002 108.896 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.612 ' H ' ' C ' ' A' ' 13' ' ' PRO . 42.2 mm-40 -150.87 137.74 19.03 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.733 -1.121 . . . . 2.04 109.748 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -86.89 30.84 0.72 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.22 -1.392 . . . . 4.5800000000000001 109.394 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 15' ' ' GLU . . . -155.68 10.43 0.34 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 119.389 -1.386 . . . . 2.27 110.673 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.618 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -120.08 -177.26 3.38 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.463 -0.895 . . . . 2.71 111.861 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.618 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -77.33 161.65 27.9 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 115.187 1.551 . . . . 1.25 115.187 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -150.58 131.57 3.61 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.138 -1.185 . . . . 0.34999999999999998 110.138 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 8.2 p90 -152.57 -168.43 3.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.432 -1.307 . . . . 0.34000000000000002 112.029 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 23' ' ' ARG . 8.5 mmm180 -140.38 131.28 26.03 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.618 -0.833 . . . . 6.0800000000000001 112.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -13.13 135.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.016 1.117 . . . . 3.1499999999999999 114.016 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.13 14.01 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.367 -1.493 . . . . 0.37 109.367 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.26 119.23 7.52 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.841 -1.144 . . . . 0.65000000000000002 108.435 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.458 ' CZ ' ' NE2' ' A' ' 6' ' ' GLN . 26.9 m-85 -77.07 105.36 8.1 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.568 -1.253 . . . . 2.9100000000000001 112.569 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.487 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -75.54 144.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.017 -1.475 . . . . 0.26000000000000001 107.017 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -104.1 98.88 8.63 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.772 -1.171 . . . . 1.1299999999999999 108.149 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.16 92.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 118.346 -1.342 . . . . 0.80000000000000004 111.311 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.466 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -68.62 -36.09 78.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.803 -1.544 . . . . 2.8900000000000001 110.372 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -164.23 92.53 0.65 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.582 -1.247 . . . . 2.2200000000000002 111.106 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.75 99.24 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.346 -1.342 . . . . 2.1299999999999999 109.282 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -96.47 -82.64 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.314 -0.954 . . . . 2.5899999999999999 111.636 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.3 m-20 -64.27 158.23 66.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.052 -1.059 . . . . 0.63 110.86 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.06 -68.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.54 1.493 . . . . 0.29999999999999999 111.539 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.6 t30 -84.13 3.71 33.68 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.577 -0.849 . . . . 3.1400000000000001 111.332 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.447 ' O ' ' O ' ' A' ' 34' ' ' ASP . 22.9 m95 -136.47 144.4 44.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.541 -0.911 . . . . 0.56999999999999995 108.541 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.6 m0 -143.01 171.63 13.79 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.679 -0.808 . . . . 0.42999999999999999 111.692 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.08 130.33 55.55 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.533 -1.654 . . . . 0.98999999999999999 106.533 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.48 -154.56 7.14 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 117.952 -2.071 . . . . 0.20000000000000001 109.535 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.67 155.36 21.6 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 117.458 -1.697 . . . . 0.55000000000000004 112.926 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 44' ' ' GLY . 5.7 t -167.55 178.8 5.21 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.658 -1.156 . . . . 2.3399999999999999 110.777 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 42' ' ' CYS . 10.8 p80 41.01 23.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.096 -0.641 . . . . 2.3900000000000001 110.75 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 79.13 35.59 29.99 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.804 -1.189 . . . . 0.81999999999999995 111.812 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.7 mt-30 -160.23 144.16 14.14 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.895 -1.122 . . . . 1.8600000000000001 111.352 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 p -93.6 -177.91 4.54 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.272 -0.971 . . . . 0.84999999999999998 111.684 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.98 -163.88 28.6 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.642 -1.266 . . . . 0.38 111.066 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.2 mtp -113.89 147.98 37.52 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.263 -0.575 . . . . 0.91000000000000003 111.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 4.0 p90 -151.25 145.74 18.32 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.527 -0.869 . . . . 0.31 109.317 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.23 128.32 29.17 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 N-CA-C 109.884 -0.852 . . . . 0.41999999999999998 109.884 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -34.89 77.07 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.898 -0.721 . . . . 1.6499999999999999 112.565 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.457 ' OD1' ' OD1' ' A' ' 36' ' ' ASN . 18.4 m120 -75.05 12.15 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.148 -1.021 . . . . 2.73 113.253 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.92 7.09 27.84 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.505 -0.878 . . . . 0.63 109.089 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.443 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -136.86 173.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 114.57 -1.196 . . . . 0.28000000000000003 109.578 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -136.29 125.09 15.47 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.392 -0.966 . . . . 0.84999999999999998 108.392 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.3 140.94 88.98 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 120.445 0.763 . . . . 2.0600000000000001 113.186 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.8 132.38 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.099 -0.955 . . . . 4.9000000000000004 109.971 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.612 HD21 ' H ' ' A' ' 59' ' ' ARG . 6.6 p-10 -157.12 -135.01 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.955 -1.098 . . . . 4.6699999999999999 111.063 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.612 ' H ' HD21 ' A' ' 58' ' ' ASN . 48.1 ttt180 . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 116.388 -1.767 . . . . 13.52 110.565 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' O ' ' OG1' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 110.094 -1.202 . . . . 6.4800000000000004 110.094 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.13 6.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.299 -0.96 . . . . 4.9900000000000002 111.108 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' CG ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -135.94 107.67 7.03 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.716 -0.674 . . . . 3.3399999999999999 110.45 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 3' ' ' THR . 2.5 m-85 -169.15 155.39 6.51 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 117.584 -1.646 . . . . 2.2400000000000002 113.003 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.05 -166.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.823 -1.08 . . . . 0.81000000000000005 109.36 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 7' ' ' ALA . 4.6 mt-30 -145.37 105.07 3.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.975 -1.011 . . . . 0.84999999999999998 108.438 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.05 116.63 0.11 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.793 -1.094 . . . . 0.20999999999999999 113.681 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.42 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.38 -52.89 22.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.233 -1.025 . . . . 0.66000000000000003 108.233 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -132.04 177.64 7.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.77 -1.196 . . . . 0.92000000000000004 107.77 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -75.38 134.36 40.97 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.284 -1.325 . . . . 1.1399999999999999 108.953 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -121.53 109.87 15.34 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.021 -1.072 . . . . 0.31 113.073 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -93.26 131.76 32.11 Favored Pre-proline 0 C--N 1.307 -1.265 0 C-N-CA 118.167 -1.413 . . . . 1.1000000000000001 108.387 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -43.95 157.27 0.15 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 120.575 0.85 . . . . 0.28000000000000003 112.746 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.576 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 89.7 mt-30 -145.3 -3.53 0.74 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.324 -1.362 . . . . 0.57999999999999996 107.324 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.86 151.1 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.432 -1.713 . . . . 3.7799999999999998 108.171 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.74 -5.51 30.51 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.236 -1.385 . . . . 2.3799999999999999 111.308 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.12 -5.47 13.25 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.411 -1.475 . . . . 2.8900000000000001 109.411 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.4 mt-10 -61.7 176.74 0.48 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 123.328 1.537 . . . . 2.52 114.412 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.4 161.29 14.95 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.043 -2.799 . . . . 1.0800000000000001 109.4 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -145.11 115.19 0.82 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.364 -1.398 . . . . 0.34000000000000002 110.768 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.3 p90 -138.95 -174.49 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.984 -1.086 . . . . 0.31 111.65 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -139.77 125.92 19.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.595 -0.842 . . . . 3.3799999999999999 112.322 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.1 ttt180 -4.01 135.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.13 1.53 . . . . 2.1400000000000001 115.13 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 -21.68 3.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.289 -1.524 . . . . 0.60999999999999999 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -59.19 119.38 7.24 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.705 -1.198 . . . . 0.46000000000000002 108.399 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 48.1 m-85 -75.32 107.51 7.48 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.971 -1.092 . . . . 1.1399999999999999 113.525 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.494 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.17 143.92 12.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.029 -1.471 . . . . 0.28999999999999998 107.029 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 39.2 t-80 -101.0 102.39 13.38 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 117.79 -1.564 . . . . 1.95 107.773 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.0 101.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 C-N-CA 118.444 -1.303 . . . . 0.68000000000000005 110.751 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.7 ttm -77.6 -32.42 53.55 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.029 -0.987 . . . . 1.27 110.591 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.21 108.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.447 -1.301 . . . . 3.5699999999999998 110.975 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 12.4 p-10 -58.03 107.6 0.49 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.985 -1.486 . . . . 1.0900000000000001 108.695 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -93.46 -57.08 2.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.85 -1.14 . . . . 2.2799999999999998 111.804 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -107.05 161.1 24.02 Favored Pre-proline 0 C--N 1.299 -1.615 0 C-N-CA 119.625 -0.83 . . . . 0.75 111.461 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.33 -58.25 0.82 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.063 1.842 . . . . 0.39000000000000001 111.606 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 8.0 t-20 -98.96 13.35 32.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.725 -0.79 . . . . 0.40999999999999998 111.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 34.6 m95 -147.51 136.62 22.31 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.543 -0.863 . . . . 0.38 109.478 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.659 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 34.4 m0 -139.44 168.35 20.01 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.889 -0.724 . . . . 0.42999999999999999 111.27 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -106.85 135.5 48.29 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.942 -1.503 . . . . 1.8300000000000001 106.942 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -161.34 -152.0 6.48 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 117.839 -2.124 . . . . 0.28000000000000003 109.519 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.12 160.08 18.36 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 117.772 -1.571 . . . . 0.56999999999999995 113.138 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.1 t -158.79 -86.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.127 -1.029 . . . . 0.62 112.104 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 6.4 p80 -62.95 74.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.325 -0.95 . . . . 0.72999999999999998 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.29 23.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.715 -1.231 . . . . 0.60999999999999999 111.095 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' HIS . 12.7 mt-30 -149.41 139.7 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.372 -1.331 . . . . 2.5099999999999998 111.499 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -91.39 -172.46 3.27 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.665 -0.814 . . . . 0.59999999999999998 110.849 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.84 -167.91 27.61 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.288 -1.434 . . . . 0.20000000000000001 111.956 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 31.1 mtp -107.35 143.55 35.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.235 -0.586 . . . . 0.78000000000000003 110.753 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.0 p90 -147.4 147.06 27.04 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.622 -0.831 . . . . 0.13 109.049 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.05 124.72 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 120.189 0.592 . . . . 0.25 111.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.659 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.36 -27.36 55.77 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.309 -0.86 . . . . 2.6899999999999999 110.227 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -1.1 52.34 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.17 -1.012 . . . . 5.4900000000000002 113.091 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.7 12.68 31.02 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.811 -1.156 . . . . 1.77 109.931 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -141.45 172.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.404 -1.271 . . . . 0.25 108.157 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -143.93 141.63 18.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 118.963 -1.095 . . . . 0.97999999999999998 108.853 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 2.4 Cg_endo -55.29 158.27 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 120.119 0.546 . . . . 0.91000000000000003 110.764 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.77 111.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.394 -0.922 . . . . 3.0299999999999998 111.57 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -136.04 130.82 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.846 -0.742 . . . . 8.5199999999999996 110.69 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 116.235 -1.84 . . . . 9.4900000000000002 110.724 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 110.177 -1.169 . . . . 6.3300000000000001 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 75.96 0.97 3.42 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.176 -0.61 . . . . 4.5800000000000001 111.292 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -161.61 87.84 0.69 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.542 -0.863 . . . . 3.7799999999999998 110.252 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.5 m-85 -170.79 154.69 4.43 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.493 -1.283 . . . . 1.97 111.645 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -146.14 174.69 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.835 -1.075 . . . . 0.65000000000000002 109.453 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.498 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.9 mt-30 -123.48 109.12 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.389 -1.337 . . . . 0.48999999999999999 107.389 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -32.2 116.13 0.19 Allowed 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.552 -0.859 . . . . 0.28000000000000003 112.371 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.482 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 11.8 tp -74.52 -42.26 59.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.435 -0.802 . . . . 3.1899999999999999 109.836 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.67 176.42 8.2 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.758 -1.11 . . . . 1.98 108.129 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.37 125.46 32.98 Favored 'General case' 0 C--N 1.265 -3.107 0 N-CA-C 105.909 -1.886 . . . . 0.82999999999999996 105.909 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.29 106.56 17.06 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.869 -1.132 . . . . 0.23000000000000001 113.658 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.56 126.7 61.1 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 118.298 -1.361 . . . . 0.95999999999999996 107.856 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -40.39 128.35 2.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 120.805 1.004 . . . . 0.55000000000000004 114.073 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -114.49 2.36 14.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.439 -1.689 . . . . 2.4700000000000002 106.439 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.91 158.65 43.73 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.172 -1.831 . . . . 2.0499999999999998 109.89 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -96.56 3.58 52.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.131 -1.028 . . . . 3.1899999999999999 109.276 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.35 14.93 6.46 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.264 -1.134 . . . . 2.52 110.264 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.9 pt-20 -121.61 -176.41 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.711 1.004 . . . . 2.02 113.711 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.513 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -78.52 170.12 17.15 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 116.414 2.005 . . . . 0.55000000000000004 116.414 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.34 122.0 1.1 Allowed Glycine 0 N--CA 1.499 2.889 0 CA-C-N 113.286 -1.779 . . . . 0.23999999999999999 109.292 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.14 -169.99 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.705 -1.198 . . . . 0.23000000000000001 112.393 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' A' ' 23' ' ' ARG . 6.2 mmm180 -135.45 134.57 39.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.52 -0.763 . . . . 5.0499999999999998 112.361 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.4 ttp180 -20.53 141.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.229 0.956 . . . . 3.7200000000000002 113.146 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.41 -27.1 4.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.643 -1.383 . . . . 0.38 109.643 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' ARG . 13.6 m-20 -60.49 125.8 25.05 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.589 -1.245 . . . . 1.0600000000000001 108.127 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.58 111.62 14.83 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.302 -1.359 . . . . 1.1799999999999999 113.585 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.89 141.88 14.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.872 -1.529 . . . . 0.22 106.872 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -100.07 97.18 8.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 117.598 -1.641 . . . . 1.5800000000000001 108.026 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.13 99.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 C-N-CA 118.624 -1.231 . . . . 0.35999999999999999 111.021 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.4 mtt -82.75 -26.22 32.1 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.274 -0.875 . . . . 2.1299999999999999 110.44 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -163.81 80.34 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 118.223 -1.391 . . . . 1.5900000000000001 111.656 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.597 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.04 87.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.46 -1.296 . . . . 3.5800000000000001 108.521 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 31' ' ' ASP . 6.4 t -103.76 -72.59 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.755 -0.778 . . . . 3.3799999999999999 112.705 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 3.0 m-20 -60.59 153.96 58.73 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 118.859 -1.136 . . . . 1.77 111.021 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.26 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.106 1.871 . . . . 0.60999999999999999 112.87 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.39 14.38 3.69 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.599 -0.728 . . . . 0.84999999999999998 110.681 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 55.4 m95 -147.47 149.38 32.57 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.276 -0.875 . . . . 1.25 109.227 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.8 m0 -148.75 161.6 41.45 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.484 -0.886 . . . . 0.48999999999999999 111.302 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 132.33 48.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.929 -1.137 . . . . 1.8400000000000001 107.929 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 -152.58 6.98 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 118.255 -1.926 . . . . 0.31 109.731 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.35 175.38 11.63 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.595 -1.242 . . . . 0.17000000000000001 111.202 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.565 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.8 t -168.81 -79.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.001 -1.88 . . . . 1.51 114.679 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 2.4 p80 -65.07 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.85 -0.614 . . . . 1.47 112.622 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 89.77 6.12 70.41 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.048 -1.549 . . . . 0.97999999999999998 109.75 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.04 151.22 47.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.656 -0.818 . . . . 5.8799999999999999 109.868 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -92.41 -175.71 4.09 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.871 -1.131 . . . . 1.3999999999999999 110.823 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.49 179.05 25.02 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.777 -1.202 . . . . 0.46999999999999997 110.13 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.3 mtp -100.87 147.16 26.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 1.03 110.886 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 7.0 p90 -147.57 147.02 26.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.702 -0.799 . . . . 0.32000000000000001 109.345 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.11 126.53 22.46 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.786 0.991 . . . . 0.13 111.484 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -34.34 72.31 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.426 -0.806 . . . . 4.3499999999999996 111.223 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.53 3.03 14.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.918 -1.113 . . . . 3.5299999999999998 112.763 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.54 8.45 44.88 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.085 -1.046 . . . . 1.71 109.774 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.9 m -136.28 171.65 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 114.853 -1.067 . . . . 0.17000000000000001 109.113 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -142.88 139.13 16.61 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 119.102 -1.039 . . . . 1.1299999999999999 110.286 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.29 127.5 25.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.596 0.864 . . . . 1.05 110.872 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 3.1 p -87.1 7.4 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.751 -0.78 . . . . 4.21 111.457 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -105.84 37.54 2.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.709 -0.796 . . . . 4.2199999999999998 111.277 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 116.28 -1.819 . . . . 12.5 111.063 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.972 -1.251 . . . . 5.6799999999999997 109.972 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 t -99.88 170.35 8.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.575 -0.85 . . . . 4.3099999999999996 110.847 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.676 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.6 OUTLIER -132.04 46.2 2.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.78000000000000003 110.013 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.41 135.19 47.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.366 -0.934 . . . . 2.5699999999999998 111.053 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.94 -162.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.442 -1.253 . . . . 0.84999999999999998 109.781 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.2 mt-30 -146.9 100.27 3.29 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.841 -1.17 . . . . 1.24 107.841 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.09 111.52 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.58 -1.191 . . . . 0.28000000000000003 113.11 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.81 -41.53 91.77 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.62 -0.718 . . . . 0.44 109.104 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -173.09 3.59 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.602 -1.181 . . . . 1.3600000000000001 108.453 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.47 120.48 27.84 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.705 -1.589 . . . . 0.68000000000000005 109.583 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -104.68 103.15 12.74 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.228 -0.989 . . . . 0.28999999999999998 111.724 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.08 127.38 67.04 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 117.243 -1.783 . . . . 4.5899999999999999 109.838 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -41.18 113.85 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 120.925 1.084 . . . . 0.93999999999999995 114.153 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -94.46 8.4 42.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 105.427 -2.064 . . . . 5.2699999999999996 105.427 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -155.6 161.6 40.8 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.75 -2.023 . . . . 3.3599999999999999 109.695 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -7.38 27.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.137 -1.025 . . . . 4.9800000000000004 108.876 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.26 -7.1 41.08 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.907 -1.277 . . . . 1.9299999999999999 109.907 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.3 pt-20 -101.85 -168.72 1.58 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.607 -0.837 . . . . 1.8999999999999999 112.01 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.541 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -87.04 175.73 7.97 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 115.454 1.65 . . . . 2.0099999999999998 115.454 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -162.19 128.61 1.91 Allowed Glycine 0 N--CA 1.502 3.045 0 CA-C-N 114.319 -1.309 . . . . 0.26000000000000001 110.072 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 7.9 p90 -158.11 -174.8 5.0 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.081 -1.448 . . . . 0.27000000000000002 112.095 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' ARG . 23.4 mmt-85 -133.96 133.65 41.61 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.796 -0.762 . . . . 5.0800000000000001 112.698 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.42 138.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.418 1.074 . . . . 5.9500000000000002 113.731 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.6 5.98 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.469 -1.452 . . . . 0.46999999999999997 109.469 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.17 122.35 13.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.993 -1.083 . . . . 0.63 109.242 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 73.5 m-85 -78.74 108.91 12.5 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.054 -1.058 . . . . 1.3600000000000001 113.114 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -78.42 148.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.338 -0.986 . . . . 0.23000000000000001 108.338 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.629 ' CD2' ' HG1' ' A' ' 3' ' ' THR . 11.7 t-160 -106.26 94.07 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.045 -1.062 . . . . 0.85999999999999999 108.857 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' O ' ' OG1' ' A' ' 3' ' ' THR . 5.3 t -57.64 85.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 C-N-CA 119.297 -0.961 . . . . 0.56999999999999995 112.43 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.512 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mmt -59.23 -35.89 74.47 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.893 -1.048 . . . . 3.0099999999999998 110.402 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 33' ' ' SER . 67.6 t0 -170.56 99.75 0.25 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.176 -1.409 . . . . 1.54 111.749 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.18 97.78 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.095 -1.442 . . . . 2.9700000000000002 108.784 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 31' ' ' ASP . 65.8 m -96.26 -71.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.307 -0.957 . . . . 1.3799999999999999 111.832 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.4 m-20 -81.93 161.17 61.63 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 119.249 -0.98 . . . . 0.68999999999999995 111.679 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.53 -69.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.743 1.629 . . . . 0.39000000000000001 110.92 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 4.9 t-20 -80.2 -5.01 55.37 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 110.949 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' ASP . 28.4 m95 -131.99 150.59 52.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.092 -0.643 . . . . 0.38 109.625 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 9.8 m0 -145.9 162.56 37.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.381 -0.827 . . . . 0.68000000000000005 111.722 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.05 129.46 46.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.867 -1.531 . . . . 0.42999999999999999 106.867 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.26 -156.79 7.99 Favored Glycine 0 C--N 1.304 -1.224 0 C-N-CA 117.835 -2.126 . . . . 0.26000000000000001 110.349 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.8 162.81 32.44 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 118.452 -1.299 . . . . 0.54000000000000004 111.46 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 43.7 t -160.58 -114.55 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.295 -1.762 . . . . 1.1000000000000001 113.853 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.556 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.1 p80 -20.95 -45.11 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.277 0.985 . . . . 2.8900000000000001 113.044 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 167.1 18.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.338 -1.411 . . . . 2.4399999999999999 109.884 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -150.34 161.19 42.95 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.637 -0.825 . . . . 2.54 110.049 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.4 p -100.33 -175.94 3.07 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.424 -0.911 . . . . 0.79000000000000004 109.812 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.69 -169.14 29.89 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.132 -1.508 . . . . 0.31 111.225 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 mtp -108.28 136.66 47.56 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.071 -0.652 . . . . 1.01 110.963 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 6.0 p90 -139.11 146.48 49.49 Favored Pre-proline 0 C--N 1.304 -1.387 0 C-N-CA 119.714 -0.795 . . . . 0.19 110.143 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.38 122.86 12.21 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 120.292 0.661 . . . . 0.19 110.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -11.45 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.397 -0.921 . . . . 4.79 110.983 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -88.01 -9.1 54.48 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.041 -1.064 . . . . 2.3399999999999999 111.655 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -94.13 14.28 20.5 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.187 -1.005 . . . . 1.5800000000000001 109.415 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.7 m -139.62 166.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.986 -1.006 . . . . 0.32000000000000001 109.439 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -136.84 99.86 10.09 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 119.738 -0.785 . . . . 0.82999999999999996 109.565 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -48.0 141.66 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.685 0.923 . . . . 3.73 111.929 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.52 -22.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.127 -0.942 . . . . 3.54 111.782 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -141.4 122.19 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.117 -1.033 . . . . 4.7599999999999998 111.623 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.283 -1.818 . . . . 14.57 109.946 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 113.98 1.104 . . . . 1.7 113.98 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 27' ' ' ILE . 17.6 m -138.39 -168.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 113.391 -1.731 . . . . 0.059999999999999998 108.298 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 55' ' ' THR . 7.3 mt-30 -140.29 104.12 4.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.336 -1.357 . . . . 0.70999999999999996 107.336 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.71 114.21 0.11 Allowed 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 113.666 0.987 . . . . 0.10000000000000001 113.666 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.429 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 9.7 tp -69.39 -34.1 74.02 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.388 -0.824 . . . . 1.78 108.917 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.63 -174.2 4.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.943 -1.026 . . . . 0.53000000000000003 109.669 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -86.4 126.48 34.41 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 113.434 -1.712 . . . . 0.44 110.336 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.11 106.32 13.6 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.307 -0.957 . . . . 0.27000000000000002 112.804 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--N 1.304 -1.391 0 C-N-CA 117.734 -1.586 . . . . 3.3399999999999999 108.336 179.592 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.504 -0.798 0 CA-C-O 123.231 1.491 . . . . 1.03 114.253 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tp -101.54 158.19 16.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 111.797 -2.456 . . . . 0.47999999999999998 110.407 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.36 113.07 0.65 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.606 -1.283 . . . . 0.40999999999999998 110.726 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -139.94 -172.7 3.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.841 -1.144 . . . . 0.26000000000000001 112.192 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' ARG . 5.0 mmm-85 -139.61 126.08 20.34 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.574 -0.85 . . . . 2.4900000000000002 113.187 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -7.65 132.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.493 1.121 . . . . 1.8200000000000001 113.887 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -19.27 20.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.218 -1.553 . . . . 0.56999999999999995 109.218 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.79 123.7 19.12 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.791 -1.164 . . . . 0.57999999999999996 108.52 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.92 107.66 10.62 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.647 -1.221 . . . . 0.28999999999999998 112.657 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -77.32 147.62 7.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.84 -1.17 . . . . 0.23000000000000001 107.84 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -105.65 96.21 6.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.687 -1.227 . . . . 0.17999999999999999 107.687 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 t -63.29 91.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 114.584 -1.189 . . . . 0.39000000000000001 110.219 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.525 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.3 ttm -78.31 -27.32 47.21 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.945 -1.479 . . . . 0.45000000000000001 112.011 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.11 96.65 0.6 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.43 -1.708 . . . . 1.75 111.794 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.433 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -55.47 104.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.113 -1.435 . . . . 2.1200000000000001 107.914 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m -90.86 -64.9 1.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.649 -1.22 . . . . 1.0700000000000001 111.761 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -103.89 161.71 22.12 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 115.189 -0.914 . . . . 0.65000000000000002 111.812 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' O ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 Cg_endo -57.95 -63.34 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.737 1.625 . . . . 0.56999999999999995 111.478 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.2 t30 -92.15 6.8 45.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.558 -0.857 . . . . 2.9199999999999999 111.392 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 20.0 m95 -139.23 139.32 37.43 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.75 -1.204 . . . . 0.32000000000000001 107.75 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -141.86 169.38 17.7 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.281 -0.968 . . . . 0.66000000000000003 112.939 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -101.78 146.53 27.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.332 -1.729 . . . . 0.68000000000000005 106.332 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.1 -158.42 9.75 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 116.784 -2.627 . . . . 0.27000000000000002 110.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.33 137.94 4.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.031 -1.067 . . . . 1.1799999999999999 111.278 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' GLY . 32.9 t -145.03 -94.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.114 -1.035 . . . . 0.42999999999999999 111.807 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.626 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.5 p80 -60.69 75.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.434 -0.907 . . . . 0.54000000000000004 111.3 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.45 21.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.333 -0.937 . . . . 0.60999999999999999 111.575 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' HIS . 70.2 mt-30 -144.49 134.95 24.56 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.011 -1.076 . . . . 2.23 111.096 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -90.97 -178.33 5.18 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.73 -0.788 . . . . 0.55000000000000004 111.056 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.4 -172.77 27.72 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.377 -1.392 . . . . 0.35999999999999999 110.884 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mtp -101.22 157.39 16.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.824 -0.751 . . . . 0.27000000000000002 111.268 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.1 p90 -159.36 144.25 11.45 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 115.124 -0.944 . . . . 0.28999999999999998 109.06 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.2 125.96 20.57 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 120.264 0.643 . . . . 0.33000000000000002 110.801 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -64.53 -20.44 66.22 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.562 -0.855 . . . . 2.3599999999999999 110.968 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.99 1.59 49.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.915 -1.114 . . . . 1.03 111.082 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.74 13.5 33.45 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.616 -0.834 . . . . 0.14999999999999999 109.006 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.429 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 31.5 m -140.98 171.54 12.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.646 -1.161 . . . . 0.34999999999999998 109.905 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 C-N-CA 119.441 -0.904 . . . . 0.26000000000000001 109.242 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.039 0.923 . . . . 1.3200000000000001 113.118 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 27' ' ' ILE . 25.1 m -140.22 -172.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 113.823 -1.535 . . . . 0.23999999999999999 108.057 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' ALA . 11.5 mt-30 -142.07 98.17 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.058 -1.089 . . . . 0.72999999999999998 108.058 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -20.93 111.97 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.916 -1.493 . . . . 0.080000000000000002 113.487 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.472 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -67.38 -36.42 81.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.167 -0.679 . . . . 0.52000000000000002 109.167 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.16 -174.73 4.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.844 -1.071 . . . . 0.65000000000000002 109.183 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.86 131.44 34.52 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 113.614 -1.63 . . . . 0.47999999999999998 109.446 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -120.71 109.47 15.23 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.987 -1.085 . . . . 0.34999999999999998 113.364 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 . . . . . 0 C--N 1.302 -1.474 0 N-CA-C 106.819 -1.548 . . . . 1.48 106.819 179.442 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.213 -0.839 0 CA-C-O 123.343 1.544 . . . . 1.24 115.087 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 tp -97.69 157.04 16.27 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 111.397 -2.638 . . . . 0.5 110.544 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -143.71 112.89 0.72 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.261 -1.447 . . . . 0.42999999999999999 111.142 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.5 p90 -135.5 -179.25 5.52 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.266 -0.973 . . . . 0.31 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 23' ' ' ARG . 2.9 mmt85 -137.29 124.32 21.52 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.537 -0.865 . . . . 3.0499999999999998 112.22 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -10.08 128.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.283 0.989 . . . . 2.3700000000000001 113.281 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.48 -20.08 50.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.287 -1.525 . . . . 0.19 109.287 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.0 126.02 28.42 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.856 -1.138 . . . . 1.7 108.234 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 2.3 m-85 -78.39 108.39 11.71 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.78000000000000003 113.38 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.12 142.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 105.765 -1.939 . . . . 0.28000000000000003 105.765 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 30' ' ' MET . 12.4 t60 -101.55 97.78 8.18 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.173 -1.411 . . . . 0.31 107.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.55 84.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.546 -1.207 . . . . 0.28999999999999998 110.842 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.7 ttm -69.14 -30.79 69.11 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.112 -1.403 . . . . 0.79000000000000004 111.547 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -169.3 90.99 0.22 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.707 -1.597 . . . . 1.6399999999999999 111.983 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.436 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -50.2 104.35 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.075 -1.45 . . . . 1.5900000000000001 108.386 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 m -94.6 -37.16 11.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.168 -1.013 . . . . 1.72 113.534 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -124.58 160.43 53.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.373 -0.931 . . . . 1.1799999999999999 111.471 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.65 -68.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.736 1.624 . . . . 0.46000000000000002 111.604 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.1 t30 -91.25 12.94 18.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.539 -0.864 . . . . 2.6400000000000001 111.094 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.5 m95 -145.46 144.79 30.8 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.773 -0.825 . . . . 0.40000000000000002 108.773 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 20.5 m0 -144.62 172.86 12.39 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.4 -0.92 . . . . 0.20999999999999999 111.82 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -115.09 123.82 49.97 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.559 -1.645 . . . . 0.39000000000000001 106.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -149.94 -148.03 4.67 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 118.241 -1.933 . . . . 0.11 108.831 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.828 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.77 165.52 20.62 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.117 -1.433 . . . . 0.23999999999999999 111.95 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 23.4 t -161.14 -108.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 116.597 -2.041 . . . . 0.28000000000000003 114.471 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 2.2 p80 -26.96 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.348 -0.842 . . . . 3.0800000000000001 113.213 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 161.98 18.08 0.03 OUTLIER Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.046 -1.549 . . . . 0.88 109.991 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.5 162.21 37.44 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.153 -1.019 . . . . 4.1600000000000001 110.221 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 ' HB2' ' A' ' 41' ' ' ALA . 18.7 p -95.66 -171.17 2.3 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.195 -1.002 . . . . 0.38 111.393 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.42 -170.89 28.91 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.657 -1.156 . . . . 0.22 110.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.3 mtp -105.25 143.35 33.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.827 -0.749 . . . . 0.35999999999999999 110.746 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.9 p90 -147.65 146.02 23.2 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 119.705 -0.798 . . . . 0.23000000000000001 108.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.99 126.9 23.06 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 N-CA-C 110.458 -0.632 . . . . 0.19 110.458 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.77 -36.16 78.25 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.462 -0.79 . . . . 2.54 111.045 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -74.25 -0.73 17.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.058 -1.057 . . . . 4.1100000000000003 112.692 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -93.45 6.39 48.35 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 118.719 -1.192 . . . . 0.20000000000000001 110.092 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.3 m -134.27 171.39 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 115.457 -0.792 . . . . 0.10000000000000001 109.827 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 119.338 -0.945 . . . . 0.29999999999999999 109.132 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.928 0.87 . . . . 0.70999999999999996 112.84 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 27' ' ' ILE . 16.4 m -136.61 -170.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.821 -1.536 . . . . 0.17000000000000001 108.275 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 7' ' ' ALA . 11.1 mt-30 -138.78 102.7 4.64 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.936 -1.135 . . . . 0.39000000000000001 107.936 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.27 110.61 0.06 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.326 -0.852 . . . . 0.14000000000000001 112.396 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -64.2 -37.14 86.41 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.132 -0.692 . . . . 0.56999999999999995 109.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -174.4 4.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.146 0.974 . . . . 1.26 109.74 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -83.33 127.62 33.82 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.496 -1.684 . . . . 0.38 110.815 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -115.84 106.42 13.81 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.633 -0.827 . . . . 0.23000000000000001 111.905 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.313 0 C-N-CA 117.724 -1.591 . . . . 3.8799999999999999 109.439 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.374 0.607 . . . . 1.1799999999999999 112.102 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.58 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -84.08 172.41 12.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 116.026 1.861 . . . . 0.40000000000000002 116.026 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.08 120.97 1.01 Allowed Glycine 0 N--CA 1.497 2.743 0 CA-C-N 113.645 -1.616 . . . . 0.14000000000000001 110.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.1 p90 -145.78 -170.94 3.59 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.319 -1.352 . . . . 0.25 112.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.0 mmt-85 -138.72 129.8 26.83 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.4 -0.818 . . . . 4.5700000000000003 112.222 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -16.61 137.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.194 0.934 . . . . 2.8799999999999999 113.239 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -21.65 10.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.816 -1.714 . . . . 0.26000000000000001 108.816 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.64 118.88 10.18 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.94 -1.104 . . . . 1.1100000000000001 108.055 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -76.55 112.92 13.61 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.662 -1.215 . . . . 0.83999999999999997 112.482 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.26 147.62 7.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.702 -1.222 . . . . 0.14999999999999999 107.702 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.469 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 30.8 t60 -103.9 101.61 11.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.761 -1.175 . . . . 0.20999999999999999 107.83 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.39 98.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.5 -1.227 . . . . 0.26000000000000001 111.505 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.438 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.0 OUTLIER -79.6 -30.22 41.42 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.09 -1.414 . . . . 1.6200000000000001 110.959 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.24 114.48 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.334 -1.346 . . . . 2.29 111.014 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 19.6 p30 -56.72 109.82 0.69 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.223 -1.391 . . . . 1.5600000000000001 109.69 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 p -91.75 -38.58 12.3 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.04 -1.064 . . . . 3.1600000000000001 112.049 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -138.63 161.91 56.02 Favored Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.496 -0.881 . . . . 0.73999999999999999 110.747 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.27 -64.43 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.224 1.283 . . . . 0.56000000000000005 111.254 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -90.49 4.07 52.14 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.244 -0.982 . . . . 0.39000000000000001 111.191 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 26.5 m95 -138.73 140.87 38.85 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 108.801 -0.815 . . . . 0.40000000000000002 108.801 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -138.59 -177.72 4.99 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.68 -0.808 . . . . 0.83999999999999997 111.928 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -124.2 124.74 43.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.578 -1.267 . . . . 0.31 107.578 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -155.86 -144.97 4.06 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 108.724 -1.751 . . . . 0.10000000000000001 108.724 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.7 173.74 11.53 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.375 -1.33 . . . . 0.13 111.735 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 13.8 t -166.06 -103.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 116.871 -1.932 . . . . 0.40999999999999998 114.407 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.605 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.9 p80 -29.92 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.403 -0.817 . . . . 2.8199999999999998 112.943 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 152.51 13.7 0.07 OUTLIER Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.278 -1.529 . . . . 0.89000000000000001 109.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' H ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -149.73 164.21 35.87 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.714 -0.794 . . . . 5.3700000000000001 110.382 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 41' ' ' ALA . 12.3 p -97.52 -175.03 3.08 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.116 -1.034 . . . . 0.32000000000000001 111.556 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.59 -174.58 29.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.112 -1.195 . . . . 0.13 110.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 mtp -102.59 146.56 27.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.705 -0.798 . . . . 0.40999999999999998 110.748 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -151.39 147.24 19.99 Favored Pre-proline 0 C--N 1.303 -1.439 0 C-N-CA 119.441 -0.903 . . . . 0.31 109.892 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.38 124.77 15.83 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.051 -0.788 . . . . 0.28000000000000003 110.051 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -17.87 63.89 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.632 -0.827 . . . . 2.75 111.526 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.97 -1.3 54.38 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.583 -1.247 . . . . 1.98 111.552 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -96.61 7.57 46.23 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.314 -0.955 . . . . 0.48999999999999999 108.894 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.8 m -137.32 169.58 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.935 -1.029 . . . . 0.22 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 119.118 -1.033 . . . . 0.14999999999999999 109.646 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.42 ' CE1' ' ND1' ' A' ' 28' ' ' HIS . 54.1 m-85 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.993 0.902 . . . . 2.6099999999999999 113.218 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 27' ' ' ILE . 15.8 m -129.14 -167.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.921 -1.491 . . . . 0.16 108.741 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 7' ' ' ALA . 10.6 mt-30 -142.78 97.81 3.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.895 -1.15 . . . . 0.32000000000000001 107.895 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.69 110.93 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.496 -1.229 . . . . 0.27000000000000002 113.915 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.507 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 2.9 tp -56.46 -50.04 72.88 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.573 -0.74 . . . . 1.75 109.634 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -174.52 4.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.987 -1.006 . . . . 1.53 108.451 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 126.53 31.18 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.086 -1.416 . . . . 0.64000000000000001 110.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -111.77 102.42 10.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.428 -0.909 . . . . 0.28999999999999998 111.892 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 117.312 -1.755 . . . . 3.7999999999999998 109.052 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.373 0.606 . . . . 1.0 111.775 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.568 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -82.09 168.07 18.13 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 116.053 1.871 . . . . 0.20000000000000001 116.053 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -156.94 123.19 1.26 Allowed Glycine 0 N--CA 1.496 2.69 0 CA-C-N 113.819 -1.537 . . . . 0.12 109.751 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.555 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -148.82 -175.68 5.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.369 -1.332 . . . . 0.22 112.377 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 23' ' ' ARG . 19.7 mmt180 -132.19 129.85 40.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.414 -0.812 . . . . 2.96 111.742 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -19.72 138.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 124.184 0.928 . . . . 3.6200000000000001 113.256 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.73 39.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.528 -1.429 . . . . 0.10000000000000001 109.528 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -73.71 120.36 19.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.356 -1.35 . . . . 0.52000000000000002 107.356 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -74.23 112.99 10.92 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.711 -1.196 . . . . 1.1000000000000001 113.195 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.559 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.74 141.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.517 -1.66 . . . . 0.23000000000000001 106.517 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.42 ' ND1' ' CE1' ' A' ' 4' ' ' TYR . 7.5 t60 -100.5 95.82 6.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.388 -1.325 . . . . 0.20999999999999999 108.307 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.63 97.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 114.465 -1.243 . . . . 0.17999999999999999 111.115 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.589 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 2.8 mmt -72.77 -32.14 65.41 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.209 -1.359 . . . . 1.6799999999999999 110.983 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 101.2 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.053 -1.459 . . . . 3.21 111.213 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 7.4 p-10 -51.34 100.88 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.541 -1.264 . . . . 1.8300000000000001 109.553 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.22 -77.34 0.46 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.953 -1.099 . . . . 0.77000000000000002 110.674 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -78.22 159.09 76.06 Favored Pre-proline 0 C--N 1.296 -1.752 0 C-N-CA 119.255 -0.978 . . . . 0.98999999999999999 110.696 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.47 -64.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.659 1.573 . . . . 0.59999999999999998 111.399 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -86.16 -1.81 57.77 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.711 -0.796 . . . . 0.51000000000000001 111.583 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 16.2 m95 -132.01 153.49 50.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.022 -1.103 . . . . 0.47999999999999998 108.022 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.5 m0 -148.34 176.12 10.53 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.256 -0.978 . . . . 0.48999999999999999 111.728 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.4 131.1 55.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.466 -1.309 . . . . 0.55000000000000004 107.466 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.589 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.01 -145.87 4.3 Favored Glycine 0 C--N 1.302 -1.31 0 C-N-CA 118.123 -1.989 . . . . 0.32000000000000001 109.608 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.45 154.99 12.57 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 118.517 -1.273 . . . . 0.57999999999999996 111.847 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.4 t -152.31 -94.62 0.05 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.875 -1.13 . . . . 0.37 111.33 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.703 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.6 p80 -59.96 77.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.509 -0.876 . . . . 0.25 110.878 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 24.53 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.177 -1.011 . . . . 0.20000000000000001 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' HIS . 59.8 mt-30 -147.44 144.98 29.02 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.781 -1.167 . . . . 1.1399999999999999 111.49 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.757 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.5 p -95.96 -177.06 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.811 -0.756 . . . . 0.19 110.335 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -174.91 27.66 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.45 -1.357 . . . . 0.16 110.62 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 mtp -102.18 146.79 27.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.854 -0.738 . . . . 0.67000000000000004 111.477 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.5 p90 -149.32 143.94 17.43 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.137 -0.938 . . . . 0.22 108.958 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.81 126.62 22.84 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 N-CA-C 110.705 -0.537 . . . . 0.33000000000000002 110.705 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.18 -27.68 68.59 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.454 -0.794 . . . . 1.95 112.055 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 2.46 33.59 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.31 -1.356 . . . . 1.04 112.175 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.03 6.33 49.1 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.248 -0.981 . . . . 0.70999999999999996 109.213 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.507 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.6 m -135.32 176.26 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.582 -1.19 . . . . 0.26000000000000001 108.997 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.878 0 C-N-CA 119.236 -0.985 . . . . 0.31 109.205 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.5 m-85 . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 121.923 0.868 . . . . 0.25 113.197 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 HG22 HG22 ' A' ' 27' ' ' ILE . 21.8 m -136.1 -170.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.087 -1.415 . . . . 0.14999999999999999 108.684 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 7' ' ' ALA . 14.1 mt-30 -140.83 97.14 3.13 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.428 -0.952 . . . . 0.13 108.428 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -22.25 110.69 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.899 -1.501 . . . . 0.14999999999999999 113.269 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 tp -64.52 -50.59 66.78 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.454 -0.794 . . . . 1.6699999999999999 109.852 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -131.93 -178.81 5.05 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.279 -1.008 . . . . 0.90000000000000002 108.279 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 131.62 35.21 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.159 -1.382 . . . . 0.22 108.325 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -118.51 107.14 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.194 -1.002 . . . . 0.34999999999999998 112.746 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 117.725 -1.59 . . . . 3.9199999999999999 109.307 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.456 0.646 . . . . 0.93999999999999995 111.943 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.587 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -79.18 169.64 17.84 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 115.647 1.721 . . . . 0.25 115.647 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.08 121.42 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-N 113.848 -1.524 . . . . 0.16 110.743 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.6 p90 -147.61 -172.86 4.13 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.515 -1.274 . . . . 0.14999999999999999 112.007 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.6 mmm180 -136.35 130.06 32.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.614 -0.721 . . . . 2.1299999999999999 111.61 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 22' ' ' ARG . 4.3 ttp180 -19.11 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.126 0.891 . . . . 4.0899999999999999 112.922 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.8 62.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.25 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.93 117.79 20.34 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.801 -1.185 . . . . 0.40000000000000002 107.801 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -73.72 111.73 9.14 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.809 -1.156 . . . . 0.66000000000000003 112.722 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.553 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.27 146.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.009 -1.478 . . . . 0.16 107.009 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 10.4 t-80 -103.43 100.21 10.07 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.463 -1.31 . . . . 0.38 107.463 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.46 89.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.771 -1.104 . . . . 0.17000000000000001 110.949 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 7.7 tpp -78.55 -28.07 45.98 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 113.889 -1.505 . . . . 3.0699999999999998 111.874 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 33' ' ' SER . 1.6 t70 -161.28 82.29 0.62 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 117.771 -1.572 . . . . 1.3300000000000001 111.663 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 10.1 p-10 -54.1 96.62 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.689 -1.205 . . . . 0.76000000000000001 109.038 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' ASP . 45.9 m -96.94 -84.96 0.36 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.225 -0.99 . . . . 1.0 111.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -65.45 158.88 71.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 C-N-CA 119.299 -0.96 . . . . 0.51000000000000001 111.575 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.39 -65.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.616 1.544 . . . . 0.45000000000000001 111.22 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 6.3 t-20 -82.23 -0.07 43.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.411 -0.813 . . . . 0.63 111.348 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.8 m95 -137.19 148.99 46.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.657 -0.868 . . . . 0.33000000000000002 108.657 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 7.7 m0 -144.51 169.57 17.71 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.141 -1.023 . . . . 0.52000000000000002 112.378 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -109.96 123.65 50.01 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 106.854 -1.536 . . . . 1.71 106.854 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -154.09 -150.26 5.44 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.296 -1.907 . . . . 0.16 109.188 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.36 172.97 12.76 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 117.983 -1.487 . . . . 0.20999999999999999 112.448 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' GLY . 13.1 t -169.96 -96.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.826 -1.15 . . . . 0.31 111.478 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.646 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.1 p80 -57.85 77.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.762 -0.775 . . . . 0.37 111.378 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.6 22.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.318 -0.944 . . . . 0.28000000000000003 111.765 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.9 mt-30 -146.6 136.24 23.08 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.927 -1.109 . . . . 2.6800000000000002 111.121 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.0 p -88.93 -179.49 5.96 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.655 -0.818 . . . . 0.17000000000000001 109.593 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.72 -172.97 31.79 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.623 -1.751 . . . . 0.13 111.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtp -103.98 141.04 36.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.311 -0.556 . . . . 0.35999999999999999 110.716 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -145.76 145.89 27.06 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.558 -0.857 . . . . 0.14000000000000001 109.835 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.43 128.89 31.96 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 N-CA-C 110.098 -0.77 . . . . 0.20999999999999999 110.098 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 38' ' ' TRP . 2.1 tmt_? -65.44 -30.97 71.83 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.392 -0.923 . . . . 2.5499999999999998 111.672 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -77.34 4.38 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.79 -1.164 . . . . 2.0 112.018 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.48 11.09 39.69 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.405 -0.918 . . . . 0.46000000000000002 109.431 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.6 m -139.98 173.65 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.835 -1.075 . . . . 0.089999999999999997 109.076 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.292 -1.911 0 C-N-CA 118.57 -1.252 . . . . 0.17000000000000001 109.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.443 ' CZ ' ' ND1' ' A' ' 28' ' ' HIS . 63.6 m-85 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.399 0.618 . . . . 1.73 110.373 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 27' ' ' ILE . 11.4 m -123.29 -165.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.928 -1.033 . . . . 0.23000000000000001 110.354 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 7' ' ' ALA . 9.1 mt-30 -143.92 100.08 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.169 -1.419 . . . . 0.60999999999999999 107.169 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -25.5 111.76 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.366 -1.288 . . . . 0.12 113.279 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.0 tp -66.51 -47.74 72.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.58 -0.736 . . . . 1.5600000000000001 109.671 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -131.06 -179.28 5.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.617 -1.253 . . . . 0.90000000000000002 107.617 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.05 135.55 35.85 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 106.758 -1.571 . . . . 0.29999999999999999 106.758 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -122.48 112.68 18.33 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.405 -1.318 . . . . 0.16 114.31 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 106.783 -1.562 . . . . 4.5499999999999998 106.783 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.213 -0.826 0 N-CA-C 109.482 -0.562 . . . . 0.83999999999999997 109.482 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.646 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 7.2 tp -77.91 158.35 29.42 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.549 0.944 . . . . 0.84999999999999998 113.549 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -149.96 123.51 1.59 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.531 -1.428 . . . . 0.27000000000000002 109.531 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.9 p90 -147.78 -168.39 3.05 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.783 -1.167 . . . . 0.26000000000000001 111.91 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.8 mmm-85 -139.08 133.94 32.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.907 -0.717 . . . . 2.6600000000000001 111.599 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -18.83 139.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.15 0.907 . . . . 3.3799999999999999 113.224 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -19.37 31.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.291 -1.524 . . . . 0.17000000000000001 109.291 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.74 121.66 15.92 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.871 -1.132 . . . . 0.56000000000000005 108.947 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.13 104.65 7.74 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.687 -1.205 . . . . 0.77000000000000002 112.175 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.556 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -74.31 147.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.412 -1.329 . . . . 0.12 107.412 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.443 ' ND1' ' CZ ' ' A' ' 4' ' ' TYR . 17.5 t60 -107.76 96.73 6.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.865 -1.134 . . . . 0.65000000000000002 108.425 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.04 90.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.777 -1.101 . . . . 0.39000000000000001 113.336 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -61.62 -33.86 74.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.033 -1.067 . . . . 1.9299999999999999 109.984 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -178.56 111.74 0.06 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.676 -1.21 . . . . 2.2999999999999998 111.105 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -57.29 99.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.232 -1.387 . . . . 2.2400000000000002 109.272 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -94.19 -68.16 0.82 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.143 -1.023 . . . . 2.0 111.434 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.512 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -86.61 160.07 51.28 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 118.851 -1.139 . . . . 0.81000000000000005 110.888 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.08 -68.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.428 1.419 . . . . 0.47999999999999998 111.021 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -81.85 -2.61 51.66 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.391 -0.822 . . . . 0.76000000000000001 111.43 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 28.9 m95 -133.1 153.94 51.04 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 108.738 -0.838 . . . . 0.34000000000000002 108.738 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.1 m0 -149.04 168.04 24.22 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.957 -0.697 . . . . 0.39000000000000001 111.129 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -108.03 130.52 55.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.41 -1.33 . . . . 0.5 107.41 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.71 -152.19 6.34 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 117.71 -2.186 . . . . 0.16 110.106 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.758 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.46 161.54 27.18 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 117.921 -1.511 . . . . 0.40000000000000002 112.425 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 41.7 t -158.39 -89.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.895 -1.122 . . . . 0.27000000000000002 111.853 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.642 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.2 p80 -60.73 73.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.849 -0.74 . . . . 0.40999999999999998 111.039 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.47 19.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.026 -1.083 . . . . 0.34999999999999998 111.006 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' HIS . 9.1 mm100 -144.08 135.1 25.37 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.021 -1.071 . . . . 4.1299999999999999 111.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.1 p -84.24 -174.78 5.47 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.724 -0.79 . . . . 0.34999999999999998 110.727 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.96 -167.62 27.73 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.56 -1.305 . . . . 0.29999999999999999 111.013 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.9 mtp -109.3 144.28 37.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.168 -0.613 . . . . 0.40000000000000002 111.517 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 27' ' ' ILE . 9.5 p90 -145.54 144.3 22.38 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 115.384 -0.826 . . . . 0.29999999999999999 109.567 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.71 126.2 21.65 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.303 0.668 . . . . 0.28000000000000003 110.386 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -61.91 -30.77 71.11 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.428 -0.806 . . . . 3.04 111.543 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.79 1.93 18.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.848 -1.141 . . . . 3.2799999999999998 112.595 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.92 12.8 36.94 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.301 -0.96 . . . . 0.20000000000000001 109.635 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -139.93 174.74 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.265 -0.879 . . . . 0.089999999999999997 110.347 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 C-N-CA 119.035 -1.066 . . . . 0.14999999999999999 109.679 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.438 ' CZ ' ' CE1' ' A' ' 28' ' ' HIS . 58.7 m-85 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.485 0.66 . . . . 1.5 110.916 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 27' ' ' ILE . 6.3 m -117.57 -165.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 114.821 -1.081 . . . . 0.23999999999999999 109.555 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.517 ' O ' ' C ' ' A' ' 7' ' ' ALA . 14.9 mt-30 -145.46 94.52 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.818 -1.179 . . . . 0.29999999999999999 107.818 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.46 110.97 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.251 -1.341 . . . . 0.11 113.211 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.52 -46.16 80.7 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.045 -0.525 . . . . 0.92000000000000004 109.944 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.25 -179.32 5.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.028 -1.101 . . . . 0.65000000000000002 108.028 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.72 136.3 36.74 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.278 -1.328 . . . . 0.67000000000000004 108.225 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -127.61 109.37 11.63 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.755 -1.178 . . . . 0.17000000000000001 114.002 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.306 -1.293 0 C-N-CA 117.722 -1.591 . . . . 1.8 106.744 179.469 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.733 0 N-CA-C 107.891 -1.152 . . . . 0.27000000000000002 107.891 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -69.64 164.05 24.22 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 119.941 -0.704 . . . . 0.20999999999999999 112.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.92 121.81 1.1 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.545 -1.022 . . . . 0.12 110.545 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 6.3 p90 -147.01 -170.49 3.55 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.465 -1.294 . . . . 0.14999999999999999 112.516 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.5 mmt180 -136.51 130.74 32.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.181 -0.918 . . . . 3.5299999999999998 111.435 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' ARG . 3.3 ttp85 -16.42 138.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.03 1.122 . . . . 1.8400000000000001 114.03 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.32 -22.38 13.12 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.412 -1.475 . . . . 0.40999999999999998 109.412 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.84 121.53 13.71 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.957 -1.097 . . . . 1.3300000000000001 108.261 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -77.36 106.83 9.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.439 -1.304 . . . . 0.96999999999999997 112.174 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -73.77 143.82 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.356 -1.349 . . . . 0.20000000000000001 107.356 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CE1' ' CZ ' ' A' ' 4' ' ' TYR . 7.3 t60 -103.56 94.01 5.24 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.6 -1.24 . . . . 0.23000000000000001 108.796 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.24 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 114.56 -1.2 . . . . 0.31 112.783 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.603 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 30.7 mtt -72.5 -30.66 64.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.999 -1.0 . . . . 1.75 111.052 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -159.21 93.58 1.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.283 -1.367 . . . . 1.1499999999999999 111.404 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 94.11 0.57 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.868 -1.133 . . . . 2.73 109.333 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t -98.16 -74.34 0.58 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.326 -0.95 . . . . 1.9099999999999999 112.209 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -69.24 157.27 89.78 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.763 -1.175 . . . . 0.45000000000000001 111.48 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.54 -65.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.176 1.918 . . . . 0.55000000000000004 111.961 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 5.7 t30 -87.53 5.78 37.48 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.768 -0.773 . . . . 2.3199999999999998 111.396 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 14.9 m95 -139.73 147.64 41.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.259 -1.015 . . . . 0.39000000000000001 108.259 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.3 m0 -147.29 172.11 14.37 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.36 -0.936 . . . . 0.35999999999999999 111.383 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -112.75 129.4 56.43 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.639 -1.245 . . . . 0.14999999999999999 107.639 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.43 -144.71 4.06 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 118.261 -1.923 . . . . 0.12 109.335 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.09 174.96 9.82 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 117.824 -1.55 . . . . 0.080000000000000002 112.704 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' GLY . 38.9 t -170.52 -95.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.147 -1.021 . . . . 0.22 112.071 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 6.5 p80 -58.61 78.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.458 -0.897 . . . . 0.55000000000000004 111.415 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.75 25.64 0.22 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.101 -1.047 . . . . 0.42999999999999999 111.956 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.48 149.24 25.31 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 117.941 -1.503 . . . . 4.7800000000000002 111.902 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.9 p -95.68 -175.75 3.53 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.799 -0.76 . . . . 0.14999999999999999 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.51 -164.73 29.08 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.237 -1.459 . . . . 0.13 111.392 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.4 mtp -109.39 145.66 35.74 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.466 -0.494 . . . . 0.23000000000000001 111.258 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.2 p90 -148.82 142.49 16.2 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.369 -0.932 . . . . 0.14999999999999999 109.408 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.46 123.81 14.75 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.712 -0.919 . . . . 0.27000000000000002 109.712 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -61.85 -29.82 70.44 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.078 -1.049 . . . . 2.4399999999999999 111.354 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.26 -5.0 36.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.839 -1.144 . . . . 2.98 112.176 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.82 10.4 35.41 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.052 -1.059 . . . . 0.25 109.778 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.504 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.8 m -136.85 172.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.335 -0.848 . . . . 0.19 109.859 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.466 0 C-N-CA 119.554 -0.859 . . . . 0.42999999999999999 109.142 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 113.192 0.812 . . . . 1.9099999999999999 113.192 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 27' ' ' ILE . 17.9 m -141.75 -170.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.788 -1.097 . . . . 0.25 108.557 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.499 ' O ' ' C ' ' A' ' 7' ' ' ALA . 24.6 mt-30 -141.8 100.63 3.79 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.762 -1.199 . . . . 0.47999999999999998 107.762 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -26.49 113.45 0.05 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.582 -1.19 . . . . 0.16 112.913 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.465 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.6 -39.55 91.67 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.565 0.698 . . . . 0.70999999999999996 109.753 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.62 -174.72 4.68 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.895 -1.048 . . . . 1.6000000000000001 108.827 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.2 122.4 26.8 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.218 -1.355 . . . . 0.82999999999999996 109.363 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -111.28 99.23 8.08 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.897 -1.121 . . . . 0.34000000000000002 113.578 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.294 -1.819 0 C-N-CA 115.916 -2.314 . . . . 1.51 104.805 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.216 -0.708 0 N-CA-C 108.386 -0.968 . . . . 0.35999999999999999 108.386 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.601 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.8 tp -71.93 164.21 26.48 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.75 0.786 . . . . 0.14999999999999999 112.757 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.42 117.89 0.8 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.395 -1.882 . . . . 0.23999999999999999 108.395 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.7 p90 -140.62 -168.94 2.68 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.66 -1.216 . . . . 0.16 113.029 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' ARG . 9.6 mmm-85 -137.07 129.58 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.75 . . . . 2.5 112.775 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -13.68 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.458 1.098 . . . . 2.77 113.633 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.28 -22.73 5.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.802 -1.719 . . . . 0.48999999999999999 108.802 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' ARG . 4.4 m-20 -61.46 121.51 12.86 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 118.607 -1.237 . . . . 0.66000000000000003 107.968 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -77.81 112.24 14.47 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.874 -1.13 . . . . 1.1200000000000001 112.703 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -79.04 142.15 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.733 -1.21 . . . . 0.29999999999999999 107.733 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.454 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 20.4 t-80 -99.44 99.66 10.6 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.244 -1.382 . . . . 1.01 107.87 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 29' ' ' VAL . 3.1 t -66.33 92.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 C-N-CA 118.7 -1.2 . . . . 0.45000000000000001 110.35 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.511 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 5.1 mmt -71.9 -28.96 63.85 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.159 -1.382 . . . . 2.2999999999999998 111.729 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.48 104.81 0.21 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.1 -1.44 . . . . 1.6799999999999999 111.462 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -58.4 104.55 0.22 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.587 -1.245 . . . . 1.53 109.173 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -66.94 0.87 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.094 -1.042 . . . . 2.3799999999999999 111.478 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -98.65 159.49 30.29 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 119.404 -0.919 . . . . 0.62 111.266 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.95 -60.88 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.965 1.777 . . . . 0.48999999999999999 110.963 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -89.47 4.25 49.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.348 -0.842 . . . . 0.45000000000000001 111.408 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' ASP . 21.9 m95 -142.0 141.72 32.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.881 -0.785 . . . . 0.14999999999999999 108.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.6 m0 -141.92 169.72 17.06 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.651 -0.82 . . . . 0.52000000000000002 111.805 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -108.41 134.12 51.64 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.07 -1.085 . . . . 1.47 108.07 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.87 -148.7 5.5 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 117.812 -2.137 . . . . 0.20999999999999999 109.7 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.01 172.81 13.36 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.222 -1.391 . . . . 0.14999999999999999 112.114 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -172.01 -94.0 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.733 -1.187 . . . . 0.23000000000000001 112.005 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.627 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.9 p80 -58.42 77.64 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.539 -0.864 . . . . 0.56999999999999995 111.397 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.32 27.36 0.25 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.115 -1.041 . . . . 0.78000000000000003 111.499 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -156.61 151.83 26.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.162 -1.415 . . . . 1.04 111.757 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.1 p -97.51 -176.48 3.51 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.669 -0.812 . . . . 0.39000000000000001 110.473 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.69 -176.83 24.46 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.337 -1.411 . . . . 0.39000000000000001 111.628 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.9 mtp -100.45 150.63 22.44 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.327 0.584 . . . . 0.26000000000000001 111.378 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.596 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.7 p90 -151.7 146.2 18.55 Favored Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.311 -0.858 . . . . 0.14999999999999999 109.607 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.29 123.17 12.84 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 110.367 -0.666 . . . . 0.17999999999999999 110.367 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.05 -18.45 60.67 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.396 -0.922 . . . . 2.0899999999999999 111.078 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -86.64 0.4 54.6 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.737 -1.185 . . . . 2.77 111.733 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -100.27 9.64 42.42 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.365 -0.934 . . . . 0.39000000000000001 109.407 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -136.2 171.6 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 114.886 -1.052 . . . . 0.28000000000000003 108.989 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 C-N-CA 119.231 -0.988 . . . . 0.34999999999999998 108.759 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.274 0.559 . . . . 1.97 111.996 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 27' ' ' ILE . 16.6 m -141.22 -164.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.16 -0.927 . . . . 0.17999999999999999 109.88 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' ALA . 10.7 mt-30 -144.87 101.45 3.65 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.304 -1.369 . . . . 0.27000000000000002 107.304 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -28.13 115.66 0.09 Allowed 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.938 1.088 . . . . 0.16 113.938 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.81 -34.33 69.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.53 -0.915 . . . . 0.73999999999999999 108.53 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -174.62 4.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.639 -1.164 . . . . 0.72999999999999998 109.292 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 127.94 35.61 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.757 -1.565 . . . . 0.39000000000000001 109.453 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.58 108.23 16.88 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.332 -0.947 . . . . 0.32000000000000001 113.458 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.31 -1.145 0 C-N-CA 117.773 -1.571 . . . . 1.05 108.631 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.214 -0.775 0 N-CA-C 115.633 1.716 . . . . 1.1000000000000001 115.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.33 170.06 8.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 110.747 -2.933 . . . . 0.40000000000000002 110.528 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.69 113.94 0.59 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.851 -1.166 . . . . 0.37 110.21 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.1 p90 -138.49 -162.05 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.937 -1.105 . . . . 0.31 112.196 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -147.82 133.14 18.49 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.961 -1.096 . . . . 6.0800000000000001 113.307 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.56 127.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.641 1.213 . . . . 2.3199999999999998 112.259 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 7' ' ' ALA . . . 91.16 -32.62 5.09 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 119.715 -1.231 . . . . 0.84999999999999998 110.484 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.59 125.99 24.66 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.393 -1.323 . . . . 2.04 108.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.94 113.66 14.88 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.024 -1.07 . . . . 0.72999999999999998 113.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.53 140.85 16.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.668 -1.213 . . . . 0.28000000000000003 108.062 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.6 t-80 -96.0 96.84 9.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.189 -1.404 . . . . 1.1100000000000001 108.53 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -64.8 100.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 119.018 -1.073 . . . . 0.41999999999999998 111.293 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.514 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mtt -67.08 -39.22 86.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.004 -1.078 . . . . 1.1100000000000001 108.547 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -179.23 116.29 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.98 -1.009 . . . . 1.46 109.654 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 9.0 p-10 -47.17 111.64 0.43 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.297 -1.361 . . . . 2.3700000000000001 109.346 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -42.43 11.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.138 -1.025 . . . . 1.23 112.208 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.94 162.12 58.67 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 119.906 -0.718 . . . . 1.0700000000000001 111.015 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 -61.05 0.48 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.894 1.729 . . . . 0.81000000000000005 111.985 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 48.8 t30 -99.65 17.83 19.57 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.604 -0.839 . . . . 0.95999999999999996 110.667 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 23.4 m95 -151.47 139.46 20.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.414 -0.958 . . . . 0.39000000000000001 108.414 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 26.4 m0 -138.79 175.9 9.16 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.334 -0.947 . . . . 0.23000000000000001 112.128 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 129.91 56.53 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.784 -1.561 . . . . 0.72999999999999998 106.784 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.24 -152.92 6.56 Favored Glycine 0 C--N 1.298 -1.573 0 C-N-CA 117.888 -2.101 . . . . 0.20000000000000001 109.834 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.44 168.28 18.65 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 118.225 -1.39 . . . . 0.35999999999999999 111.763 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 36.4 t -163.89 -91.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.689 -1.205 . . . . 0.52000000000000002 111.522 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.705 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 2.9 p80 -59.98 77.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.63 -0.828 . . . . 0.40000000000000002 111.429 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.93 23.74 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.098 -1.048 . . . . 0.46000000000000002 111.93 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -152.96 153.44 32.96 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.071 -1.452 . . . . 4.4500000000000002 111.201 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 41' ' ' ALA . 8.9 p -99.44 -174.89 2.84 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.652 -0.819 . . . . 0.34999999999999998 111.37 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.23 -172.09 28.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.356 -1.098 . . . . 0.22 110.356 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.3 mtp -105.03 157.99 16.86 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.747 -0.781 . . . . 0.58999999999999997 110.387 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.7 p90 -159.21 142.72 10.76 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.134 -1.061 . . . . 0.26000000000000001 108.134 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -54.76 127.0 24.33 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 CA-C-N 118.613 0.541 . . . . 0.32000000000000001 111.239 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.535 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -40.22 85.84 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.574 -0.851 . . . . 2.23 109.578 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.5 2.39 1.8 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.529 -0.868 . . . . 2.2799999999999998 112.867 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.79 10.39 41.2 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.101 -1.039 . . . . 0.17000000000000001 109.328 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 51' ' ' ARG . 14.2 m -141.58 175.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.13 109.463 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.545 0 C-N-CA 119.23 -0.988 . . . . 0.29999999999999999 109.324 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.318 0.58 . . . . 0.89000000000000001 112.553 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 27' ' ' ILE . 6.2 m -143.81 -170.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.078 -0.964 . . . . 0.28999999999999998 110.011 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 55' ' ' THR . 8.4 mt-30 -141.72 101.13 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.678 -1.23 . . . . 0.35999999999999999 107.678 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.26 110.55 0.06 Allowed 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.188 -0.915 . . . . 0.19 113.116 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.53 -42.04 87.82 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.469 0.652 . . . . 1.1699999999999999 109.978 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.56 -178.24 4.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.741 -1.118 . . . . 1.3999999999999999 108.758 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 140.59 32.44 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 113.435 -1.711 . . . . 1.01 106.995 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.57 106.99 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.031 1.493 . . . . 0.37 115.031 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.305 -1.343 0 N-CA-C 105.925 -1.88 . . . . 2.0099999999999998 105.925 179.385 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 108.089 -1.078 . . . . 1.28 108.089 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.4 tp -69.0 154.61 41.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 112.858 0.688 . . . . 0.54000000000000004 112.858 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.15 123.13 1.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.659 -1.377 . . . . 0.14999999999999999 109.659 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.6 p90 -146.44 -176.11 5.05 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.582 -1.247 . . . . 0.13 112.03 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.5 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.9 mmt85 -135.73 127.72 29.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.498 -0.774 . . . . 2.3500000000000001 111.305 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.5 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -13.56 135.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.03 1.122 . . . . 1.1299999999999999 114.03 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.39 -21.82 30.11 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.20999999999999999 109.402 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -69.09 117.52 10.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.731 -1.211 . . . . 0.93999999999999995 107.731 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -73.28 108.3 6.08 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.978 -1.089 . . . . 0.93000000000000005 112.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -73.38 142.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.068 -1.456 . . . . 0.19 107.068 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 62.9 t60 -101.45 99.17 9.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.861 -1.536 . . . . 1.3100000000000001 108.125 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 29' ' ' VAL . 6.4 t -64.74 102.43 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 C-N-CA 118.731 -1.187 . . . . 0.27000000000000002 110.12 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.492 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.6 ttp -93.32 -21.96 19.26 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.825 -1.08 . . . . 1.7 111.216 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.01 87.82 0.94 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.092 -1.443 . . . . 1.97 111.734 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.15 82.78 0.23 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.78 -1.168 . . . . 2.0800000000000001 108.755 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -95.7 -83.14 0.37 Allowed 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.191 -1.003 . . . . 1.51 111.855 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.1 m-20 -57.85 156.15 19.93 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 118.675 -1.21 . . . . 0.84999999999999998 111.352 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.17 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.896 1.731 . . . . 0.35999999999999999 111.833 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -81.88 -3.26 53.72 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.225 -0.898 . . . . 0.31 111.556 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 32.8 m95 -129.67 151.8 49.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.18 -1.044 . . . . 0.80000000000000004 108.18 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.2 m0 -151.81 164.85 36.17 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.04 -0.664 . . . . 0.59999999999999998 110.905 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -108.16 137.79 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.579 -1.267 . . . . 0.59999999999999998 107.579 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.492 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.52 -148.71 5.35 Favored Glycine 0 C--O 1.214 -1.145 0 C-N-CA 118.078 -2.01 . . . . 0.38 109.54 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.17 154.39 10.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.403 -1.319 . . . . 0.76000000000000001 112.185 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 44' ' ' GLY . 35.1 t -155.25 -100.93 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.956 -1.098 . . . . 0.38 111.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.63 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.4 p80 -53.65 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.571 -0.74 . . . . 0.46999999999999997 111.715 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 26.66 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.139 -1.029 . . . . 0.46000000000000002 112.268 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 mm-40 -156.73 149.9 24.11 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.408 -1.317 . . . . 4.5199999999999996 111.982 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.1 p -97.27 -172.9 2.53 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.604 -0.726 . . . . 0.20999999999999999 110.855 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.52 -171.15 26.65 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.374 -1.393 . . . . 0.20000000000000001 111.422 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 18.7 mtp -104.9 145.46 30.38 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.241 -0.584 . . . . 0.62 111.489 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.4 p90 -149.42 141.17 14.81 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 119.516 -0.874 . . . . 0.16 109.94 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.31 128.31 29.91 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 N-CA-C 110.067 -0.782 . . . . 0.28999999999999998 110.067 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -23.01 64.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.411 -0.916 . . . . 2.7999999999999998 111.56 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -84.38 10.18 11.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.712 -1.195 . . . . 4.6699999999999999 111.383 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.01 6.85 29.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.814 -0.755 . . . . 0.33000000000000002 109.112 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.0 m -134.7 175.07 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.553 -1.203 . . . . 0.26000000000000001 109.603 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.344 0 C-N-CA 119.414 -0.914 . . . . 0.39000000000000001 108.949 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 113.24 0.83 . . . . 1.9099999999999999 113.24 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 27' ' ' ILE . 16.9 m -137.87 -164.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 115.174 -0.921 . . . . 0.20999999999999999 109.218 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.511 ' O ' ' C ' ' A' ' 7' ' ' ALA . 28.2 mt-30 -145.26 97.48 3.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.286 -1.005 . . . . 0.41999999999999998 108.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.4 115.25 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.729 -1.123 . . . . 0.14999999999999999 113.282 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 17.2 tp -64.95 -41.27 95.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.666 -0.697 . . . . 1.9399999999999999 109.425 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.68 -174.92 4.6 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.962 -1.017 . . . . 1.45 109.489 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.57 127.63 33.56 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 113.903 -1.499 . . . . 0.59999999999999998 107.456 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -114.44 103.89 11.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.453 1.279 . . . . 0.38 114.453 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 105.687 -1.968 . . . . 1.8200000000000001 105.687 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.606 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.739 0 CA-C-O 121.429 0.633 . . . . 0.88 109.545 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.606 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 11.3 tp -72.16 155.99 39.65 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.003 -0.999 . . . . 1.0800000000000001 113.291 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.48 117.2 0.86 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 107.999 -2.04 . . . . 0.41999999999999998 107.999 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -139.52 -169.3 2.66 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.889 -1.124 . . . . 0.32000000000000001 113.064 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -133.97 130.14 37.23 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.463 -0.79 . . . . 3.3300000000000001 112.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -18.71 137.92 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.829 0.706 . . . . 2.6299999999999999 112.879 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 -21.5 15.23 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.916 -1.674 . . . . 0.33000000000000002 108.916 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -64.85 121.73 15.29 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.935 -1.106 . . . . 0.34000000000000002 108.308 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 110.2 11.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.986 -1.086 . . . . 0.84999999999999998 112.763 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.559 HG22 HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -76.18 146.85 8.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.784 -1.191 . . . . 0.20000000000000001 107.784 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -103.49 89.78 3.47 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.277 -1.369 . . . . 1.01 109.408 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.83 94.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 118.677 -1.209 . . . . 0.66000000000000003 110.285 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.507 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 15.4 mtp -74.88 -29.57 61.05 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.655 -1.157 . . . . 1.98 110.482 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.25 99.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 117.946 -1.502 . . . . 2.3199999999999998 111.805 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 0.7 OUTLIER -54.56 101.53 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.103 -1.439 . . . . 1.45 108.326 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -94.04 -72.89 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.007 -1.077 . . . . 1.05 111.735 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.1 m-20 -80.34 160.55 67.53 Favored Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.049 -1.06 . . . . 0.64000000000000001 111.0 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.34 -68.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.577 1.518 . . . . 0.46000000000000002 111.127 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -87.13 4.13 43.54 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.712 -0.795 . . . . 0.26000000000000001 111.577 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.2 m95 -136.66 148.62 47.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.465 -0.939 . . . . 0.11 108.465 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 22.8 m0 -142.37 175.55 9.68 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.616 -0.834 . . . . 0.17999999999999999 111.5 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 133.03 56.32 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.965 -1.494 . . . . 0.56000000000000005 106.965 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.71 -150.68 5.91 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 117.918 -2.086 . . . . 0.14999999999999999 109.261 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.68 159.66 19.1 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 118.226 -1.389 . . . . 0.53000000000000003 111.662 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' GLY . 40.6 t -155.37 -100.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.553 -1.259 . . . . 0.32000000000000001 112.097 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.517 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.7 p80 -52.77 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.584 -0.735 . . . . 0.69999999999999996 111.899 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.2 24.05 0.1 OUTLIER Glycine 0 N--CA 1.489 2.216 0 CA-C-N 115.167 -0.924 . . . . 0.46999999999999997 112.252 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 tp60 -156.16 163.71 39.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.814 -1.554 . . . . 4.2800000000000002 111.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.719 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.8 p -99.82 -177.26 3.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.341 -0.845 . . . . 0.48999999999999999 111.313 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.99 171.39 18.36 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.01 -1.567 . . . . 0.76000000000000001 111.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 mtp -95.92 146.28 24.72 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 120.218 -0.593 . . . . 0.59999999999999998 110.394 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 10.1 p90 -148.78 145.54 20.06 Favored Pre-proline 0 C--N 1.296 -1.743 0 C-N-CA 119.403 -0.919 . . . . 0.23000000000000001 108.859 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.93 128.04 27.43 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.008 0.472 . . . . 0.14999999999999999 110.973 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -59.16 -36.56 75.5 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 3.6200000000000001 110.253 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 26.7 t-20 -75.13 3.32 8.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.473 -0.891 . . . . 3.6899999999999999 112.787 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.12 9.16 43.25 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.905 -1.118 . . . . 0.19 109.598 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.5 m -138.42 177.94 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.943 -1.026 . . . . 0.20000000000000001 109.03 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 C-N-CA 119.18 -1.008 . . . . 0.20000000000000001 109.259 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 113.091 0.775 . . . . 0.73999999999999999 113.091 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 27' ' ' ILE . 16.0 m -147.45 -167.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 115.062 -0.972 . . . . 0.23999999999999999 109.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 7' ' ' ALA . 14.9 mt-30 -144.88 97.08 2.96 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.588 -1.264 . . . . 0.32000000000000001 107.588 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HA ' HG12 ' A' ' 54' ' ' VAL . . . -24.22 115.54 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.359 -1.291 . . . . 0.16 113.663 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -70.77 -42.09 70.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.809 -0.632 . . . . 0.88 109.888 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 -179.94 5.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.478 1.132 . . . . 1.1299999999999999 109.155 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -85.31 124.76 32.3 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.107 -1.86 . . . . 0.71999999999999997 107.412 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -111.96 104.54 12.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.262 -0.975 . . . . 0.41999999999999998 112.798 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.4 p-10 . . . . . 0 C--N 1.304 -1.37 0 C-N-CA 117.514 -1.675 . . . . 3.3500000000000001 108.765 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.576 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.2 pt-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.327 0.584 . . . . 1.1599999999999999 111.732 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.576 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -84.82 170.22 13.39 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 116.138 1.903 . . . . 0.23999999999999999 116.138 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -158.93 119.66 0.91 Allowed Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.168 -1.833 . . . . 0.17000000000000001 109.209 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.567 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.5 p90 -144.97 -170.81 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.367 -1.333 . . . . 0.11 112.455 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 23' ' ' ARG . 5.1 mmt85 -136.88 126.91 25.98 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.544 -0.753 . . . . 1.9399999999999999 111.743 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.3 ttp85 -12.8 135.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.398 1.259 . . . . 2.8399999999999999 114.398 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.11 -23.81 10.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.52000000000000002 109.6 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -61.26 117.07 5.14 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.388 -1.325 . . . . 0.84999999999999998 107.891 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -71.89 107.57 4.72 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.48 -1.288 . . . . 0.93999999999999995 112.376 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.85 136.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.362 -1.347 . . . . 0.38 107.362 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.409 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 53.0 t60 -94.36 94.12 8.09 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.454 -1.699 . . . . 1.22 108.29 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 29' ' ' VAL . 7.7 t -61.01 100.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 C-N-CA 118.967 -1.093 . . . . 0.27000000000000002 111.388 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.42 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 8.6 tpp -61.51 -36.0 79.29 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.062 -1.055 . . . . 1.8200000000000001 108.931 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 p30 171.58 126.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.026 -0.988 . . . . 2.8399999999999999 109.39 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.405 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 5.2 p30 -49.97 109.78 0.32 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.914 -1.514 . . . . 2.75 109.716 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -92.51 -65.69 0.98 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.422 -0.911 . . . . 2.0800000000000001 110.162 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -102.57 160.75 25.36 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.021 -0.99 . . . . 0.63 110.315 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -59.47 -60.57 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.309 1.34 . . . . 0.58999999999999997 111.087 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -92.53 -3.58 54.87 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.666 -0.813 . . . . 0.47999999999999998 111.708 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 17.0 m95 -131.01 152.85 49.88 Favored 'General case' 0 C--O 1.204 -1.327 0 N-CA-C 108.343 -0.984 . . . . 0.38 108.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.677 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 15.2 m0 -145.24 177.91 8.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.69 -0.804 . . . . 0.33000000000000002 111.825 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -118.02 135.95 53.85 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.943 -1.132 . . . . 3.3199999999999998 107.943 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -165.89 -150.36 6.26 Favored Glycine 0 C--N 1.3 -1.451 0 C-N-CA 118.031 -2.033 . . . . 0.11 109.268 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.44 174.27 12.95 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 118.264 -1.374 . . . . 0.17999999999999999 111.877 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -170.33 -93.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.832 -1.147 . . . . 0.40000000000000002 112.156 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 7.7 p80 -59.69 78.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.259 -0.977 . . . . 0.81000000000000005 111.049 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.76 20.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.132 -0.94 . . . . 0.57999999999999996 111.688 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' HIS . 54.8 mt-30 -148.3 151.79 35.99 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.393 -1.323 . . . . 1.1399999999999999 111.745 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.2 p -96.14 -179.46 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.629 -0.828 . . . . 0.34999999999999998 110.239 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -179.06 28.21 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.019 -1.562 . . . . 0.37 111.092 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.6 mtp -102.79 147.04 27.36 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.398 0.618 . . . . 0.44 110.81 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -149.16 149.7 30.2 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.359 -0.837 . . . . 0.23000000000000001 108.799 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.11 131.16 37.6 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 N-CA-C 110.564 -0.591 . . . . 0.34999999999999998 110.564 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.677 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.39 -51.41 68.91 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.204 -0.998 . . . . 4.1699999999999999 109.755 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -61.1 9.12 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.522 0.934 . . . . 3.1400000000000001 113.522 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -104.39 3.75 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.112 -1.035 . . . . 0.46000000000000002 109.26 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ARG . 12.9 m -134.06 175.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.14000000000000001 108.875 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.305 -0.958 . . . . 0.32000000000000001 108.693 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.12 0.486 . . . . 1.3200000000000001 112.068 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 27' ' ' ILE . 10.0 m -140.75 -168.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.556 -0.747 . . . . 0.14999999999999999 109.52 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 7' ' ' ALA . 13.8 mt-30 -143.05 89.67 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.828 -0.749 . . . . 0.28000000000000003 109.031 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -14.55 111.69 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.023 -1.444 . . . . 0.14999999999999999 114.139 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 6.1 tp -63.75 -52.98 57.97 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.639 -0.71 . . . . 1.76 109.537 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.23 -178.92 5.05 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.865 -1.161 . . . . 0.54000000000000004 107.865 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.85 136.48 36.7 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 114.328 -1.305 . . . . 0.31 109.088 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -123.69 109.55 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.958 -1.097 . . . . 0.25 113.391 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.306 -1.297 0 C-N-CA 117.816 -1.554 . . . . 1.27 108.452 179.595 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.519 0.676 . . . . 0.97999999999999998 112.049 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.563 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.6 tp -76.71 166.06 23.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 115.492 1.664 . . . . 0.25 115.492 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.08 120.9 1.05 Allowed Glycine 0 N--CA 1.499 2.88 0 CA-C-N 114.237 -1.347 . . . . 0.17000000000000001 110.437 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.05 -175.54 5.0 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.073 -1.451 . . . . 0.20000000000000001 112.861 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' ARG . 31.3 mmt-85 -135.6 130.55 34.62 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.189 -0.914 . . . . 5.9500000000000002 111.603 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.98 140.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.456 1.28 . . . . 1.45 114.456 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.11 -15.07 29.67 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 114.067 -1.424 . . . . 0.17000000000000001 109.594 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -72.68 118.81 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.555 -1.276 . . . . 0.40999999999999998 107.555 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.69 107.21 5.8 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.687 -1.205 . . . . 0.73999999999999999 113.276 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -73.04 142.84 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.819 -1.548 . . . . 0.26000000000000001 106.819 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 15.8 t-80 -100.6 93.92 5.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.17 -1.412 . . . . 0.96999999999999997 108.887 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 29' ' ' VAL . 2.0 t -63.07 96.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 118.135 -1.426 . . . . 0.59999999999999998 110.5 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.469 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 57.6 ttm -82.48 -25.87 33.12 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.51 -1.223 . . . . 0.56999999999999995 110.706 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.9 85.06 0.95 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.15 -1.42 . . . . 2.0600000000000001 111.766 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.18 91.78 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.027 -1.069 . . . . 2.8799999999999999 109.0 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.2 m -103.1 -85.86 0.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.285 -0.966 . . . . 1.6899999999999999 111.936 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 8.4 m-20 -55.58 154.52 12.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 118.488 -1.285 . . . . 1.1299999999999999 110.753 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.05 -71.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.876 1.717 . . . . 0.39000000000000001 112.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.47 7.82 13.28 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.721 -0.792 . . . . 2.7400000000000002 111.387 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.3 m95 -139.85 146.19 39.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.617 -0.882 . . . . 0.42999999999999999 108.617 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.8 m0 -145.59 167.34 23.28 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.378 -0.929 . . . . 0.45000000000000001 111.447 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -108.21 132.1 54.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.241 -1.022 . . . . 0.23999999999999999 108.241 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.09 -146.66 4.62 Favored Glycine 0 C--N 1.3 -1.443 0 C-N-CA 117.883 -2.103 . . . . 0.16 109.116 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -163.76 159.21 21.11 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.173 -1.811 . . . . 0.41999999999999998 113.495 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 8.2 t -175.61 -179.72 1.28 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 2.9100000000000001 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.609 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 10.8 p80 40.78 26.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.802 -0.636 . . . . 1.3500000000000001 111.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 81.27 31.04 35.38 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.732 -1.223 . . . . 0.77000000000000002 112.778 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.6 tt0 -164.91 155.23 13.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.832 -1.547 . . . . 1.73 112.19 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.4 p -95.04 -179.5 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.399 -0.921 . . . . 0.20000000000000001 110.814 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 -159.2 28.27 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.14 -1.505 . . . . 0.32000000000000001 111.255 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.5 mtp -120.03 148.37 43.66 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.167 0.508 . . . . 0.28000000000000003 110.759 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.5 p90 -151.08 143.9 16.64 Favored Pre-proline 0 C--N 1.297 -1.712 0 C-N-CA 119.563 -0.855 . . . . 0.22 109.146 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.91 126.92 24.02 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 109.864 -0.86 . . . . 0.23000000000000001 109.864 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -60.88 -32.59 72.03 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.149 -1.02 . . . . 3.46 111.58 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 -74.54 0.12 15.86 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.494 -1.283 . . . . 1.7 112.349 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.39 12.56 32.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.93 -1.108 . . . . 0.19 109.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.6 m -139.38 171.0 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.983 -1.008 . . . . 0.14000000000000001 109.741 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.576 -0.898 . . . . 0.55000000000000004 108.576 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 112.66 0.615 . . . . 0.82999999999999996 112.66 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' ILE . 14.7 m -128.42 -167.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.266 -0.879 . . . . 0.27000000000000002 110.098 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.533 ' O ' HG22 ' A' ' 55' ' ' THR . 21.6 mt-30 -141.83 109.34 5.64 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.673 -1.603 . . . . 0.41999999999999998 106.673 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -34.79 115.73 0.29 Allowed 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.927 -1.109 . . . . 0.31 111.79 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.531 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 1.4 tt -73.71 -39.82 64.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.018 -0.992 . . . . 0.73999999999999999 109.837 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.99 -179.9 5.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.781 -1.1 . . . . 0.85999999999999999 108.582 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.61 135.47 36.06 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.294 -1.775 . . . . 0.53000000000000003 107.702 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -131.07 111.93 12.44 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.475 -1.29 . . . . 0.40999999999999998 113.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.311 -1.077 0 C-N-CA 118.023 -1.471 . . . . 3.79 107.928 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.75 0 CA-C-O 121.28 0.562 . . . . 1.22 110.147 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.688 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -73.74 167.35 21.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.107 -0.951 . . . . 0.34999999999999998 112.109 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.76 130.12 2.68 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.598 -1.001 . . . . 0.23999999999999999 110.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 27' ' ' ILE . 9.4 p90 -156.75 -172.05 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.682 -1.607 . . . . 0.26000000000000001 113.075 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . 10.8 mmm180 -138.77 128.57 24.98 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.278 -0.874 . . . . 4.2999999999999998 112.153 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -12.7 135.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.295 1.22 . . . . 3.1000000000000001 114.295 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.63 -19.51 32.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.095 -1.602 . . . . 0.16 109.095 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -65.39 118.81 9.92 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.166 -1.014 . . . . 0.81000000000000005 108.777 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.78 107.79 7.1 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.068 -1.053 . . . . 1.3300000000000001 112.696 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.92 143.4 12.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.139 -1.43 . . . . 0.28999999999999998 107.139 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -100.82 95.24 6.5 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.739 -1.585 . . . . 1.26 108.767 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 29' ' ' VAL . 3.8 t -64.83 106.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 118.114 -1.434 . . . . 0.44 109.613 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.3 tpp -88.75 -26.34 21.8 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.122 -0.944 . . . . 2.3500000000000001 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -172.06 108.52 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.691 -1.604 . . . . 1.6000000000000001 111.595 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.557 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 0.7 OUTLIER -62.33 100.01 0.16 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.381 -1.328 . . . . 1.72 109.249 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -91.25 -66.55 0.92 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.782 -1.167 . . . . 1.1299999999999999 111.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 4.3 m-20 -90.19 159.9 41.2 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 119.226 -0.99 . . . . 2.3500000000000001 110.726 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.54 -65.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.443 1.429 . . . . 0.38 111.066 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -83.14 -8.93 59.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.489 -0.778 . . . . 0.92000000000000004 111.559 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 18.9 m95 -126.57 155.94 41.65 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.768 -0.827 . . . . 0.39000000000000001 108.768 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.6 m0 -149.84 -179.31 7.03 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.507 -0.877 . . . . 0.57999999999999996 112.151 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -122.43 128.13 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.879 -1.156 . . . . 0.65000000000000002 107.879 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.87 -148.43 4.99 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.587 -1.805 . . . . 0.19 108.587 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.739 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.91 159.05 17.82 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 117.303 -1.759 . . . . 0.57999999999999996 113.763 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' GLY . 43.2 t -172.7 -178.85 1.99 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.543 -1.208 . . . . 2.5299999999999998 111.041 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 4.0 p80 39.6 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.874 -0.603 . . . . 1.55 111.616 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 85.9 30.47 23.31 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.718 -1.229 . . . . 0.40999999999999998 112.907 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 46' ' ' THR . 1.3 tm0? -164.37 151.72 11.81 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.119 -1.433 . . . . 4.4199999999999999 111.814 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.739 HG22 ' HB2' ' A' ' 41' ' ' ALA . 6.1 p -94.28 -175.69 3.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.55 -0.86 . . . . 0.28000000000000003 110.689 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.15 -170.07 29.49 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.462 -1.351 . . . . 0.17000000000000001 110.933 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.0 mtp -107.76 143.91 35.63 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.975 -0.69 . . . . 0.27000000000000002 111.095 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.5 p90 -148.52 145.59 20.55 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 119.701 -0.8 . . . . 0.25 110.093 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.43 125.64 19.46 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 N-CA-C 109.966 -0.821 . . . . 0.34999999999999998 109.966 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.31 -25.22 67.53 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.626 -0.829 . . . . 2.04 112.211 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.25 7.44 16.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.367 -1.333 . . . . 2.2599999999999998 111.876 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.96 7.37 39.17 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.506 -0.878 . . . . 0.23000000000000001 109.547 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 11.6 m -135.18 179.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.767 -1.106 . . . . 0.29999999999999999 109.033 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 118.745 -1.182 . . . . 0.38 110.818 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.765 0.793 . . . . 2.1600000000000001 112.666 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 19.4 m -130.93 -166.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.308 -1.315 . . . . 0.20999999999999999 108.708 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 7' ' ' ALA . 13.8 mt-30 -144.45 95.41 2.71 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.928 -1.138 . . . . 0.19 107.928 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.54 111.15 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.481 -1.236 . . . . 0.14999999999999999 113.186 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.523 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 14.0 tp -61.98 -45.72 92.39 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.514 0.673 . . . . 1.8700000000000001 109.682 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.09 -174.44 3.85 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.709 -1.132 . . . . 0.85999999999999999 108.252 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.84 148.31 30.02 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 114.168 -1.378 . . . . 0.27000000000000002 107.805 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -139.21 119.35 13.56 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.125 -1.43 . . . . 0.45000000000000001 113.704 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--N 1.311 -1.066 0 C-N-CA 118.643 -1.223 . . . . 1.73 108.64 179.571 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.76 0 CA-C-O 121.399 0.619 . . . . 1.1200000000000001 110.103 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.69 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -74.88 161.62 29.38 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.674 0.99 . . . . 0.60999999999999999 113.674 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -153.2 120.92 1.09 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.072 -1.211 . . . . 0.20999999999999999 110.072 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.7 p90 -144.16 -169.61 3.16 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.778 -1.169 . . . . 0.22 111.796 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.1 mmm-85 -138.7 125.05 20.4 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.937 -0.705 . . . . 2.29 112.0 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.63 130.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.143 0.902 . . . . 2.21 113.282 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.52 -19.61 53.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.17999999999999999 109.381 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' OD1' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -72.84 120.73 18.87 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.961 -1.096 . . . . 1.8400000000000001 108.925 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -76.01 109.46 9.67 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.96 -1.096 . . . . 0.48999999999999999 112.65 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -74.58 142.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.677 -1.231 . . . . 0.31 107.677 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.462 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.1 t60 -100.74 97.99 8.57 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 118.29 -1.364 . . . . 0.71999999999999997 108.032 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 29' ' ' VAL . 4.8 t -67.12 94.81 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.908 -1.042 . . . . 0.40999999999999998 110.884 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.452 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 39.7 ttm -82.28 -27.21 32.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.56 -1.2 . . . . 0.89000000000000001 111.343 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' SER . 11.8 t70 -160.46 83.44 0.69 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 117.701 -1.6 . . . . 1.8700000000000001 111.903 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 1.6 p-10 -52.93 99.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.456 -1.297 . . . . 1.5800000000000001 108.904 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 1.1 t -95.17 -78.06 0.46 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.126 -1.03 . . . . 2.0600000000000001 111.554 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -72.63 158.48 87.27 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.064 -1.054 . . . . 0.62 111.498 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.49 -65.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.783 1.655 . . . . 0.23000000000000001 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 6.67 35.33 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.689 -0.804 . . . . 2.7999999999999998 111.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' ASP . 15.8 m95 -139.65 147.53 41.15 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.704 -1.221 . . . . 0.25 107.704 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -145.8 174.83 10.88 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.254 -0.978 . . . . 0.35999999999999999 112.024 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.31 135.94 53.44 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.621 -1.251 . . . . 1.5600000000000001 107.621 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -162.31 -145.11 4.22 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 117.895 -2.097 . . . . 0.42999999999999999 109.643 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.12 155.58 11.8 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.543 -1.263 . . . . 0.73999999999999999 112.237 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 44' ' ' GLY . 28.7 t -155.81 -98.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.012 -1.075 . . . . 0.20000000000000001 111.751 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.686 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.9 p80 -55.47 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.563 -0.855 . . . . 0.53000000000000003 111.029 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.56 26.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.327 -0.94 . . . . 0.47999999999999998 111.866 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 43' ' ' HIS . 3.0 tt0 -154.78 153.01 30.54 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.15 -1.42 . . . . 2.5499999999999998 111.792 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.0 p -98.15 -174.25 2.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.638 -0.71 . . . . 0.35999999999999999 110.692 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.45 -169.55 27.0 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.371 -1.395 . . . . 0.28000000000000003 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.5 mtp -110.2 151.41 27.35 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.355 0.598 . . . . 0.31 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.9 p90 -152.53 147.99 20.19 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.165 -0.925 . . . . 0.27000000000000002 109.067 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.56 128.39 27.0 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 110.006 -0.805 . . . . 0.23000000000000001 110.006 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.93 -39.1 90.89 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.877 -1.129 . . . . 1.99 110.674 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.03 2.43 2.71 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.017 -1.073 . . . . 2.2599999999999998 112.694 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.29 9.23 41.94 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.275 -0.97 . . . . 0.17000000000000001 109.342 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.7 m -138.28 176.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.972 -1.013 . . . . 0.19 109.451 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.292 -1.913 0 C-N-CA 118.555 -1.258 . . . . 0.28000000000000003 109.627 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.529 0.681 . . . . 0.78000000000000003 112.546 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 13.8 m -142.8 -171.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 109.328 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 7' ' ' ALA . 13.3 mt-30 -140.66 93.63 2.63 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.821 -0.752 . . . . 0.39000000000000001 109.341 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -19.92 110.57 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.864 -1.516 . . . . 0.14999999999999999 114.739 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' ' NE ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -71.67 -44.35 64.42 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.102 -0.954 . . . . 1.3200000000000001 109.291 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.85 -179.98 5.24 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.128 -1.064 . . . . 1.72 108.128 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.37 143.32 26.87 Favored 'General case' 0 C--N 1.268 -2.941 0 N-CA-C 106.848 -1.538 . . . . 0.64000000000000001 106.848 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -131.41 115.09 15.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.205 -1.398 . . . . 0.41999999999999998 114.415 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.307 -1.28 0 C-N-CA 118.638 -1.225 . . . . 4.0899999999999999 107.915 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.499 -0.998 0 CA-C-O 123.113 1.435 . . . . 1.8 113.697 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -104.06 160.11 15.12 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 111.385 -2.643 . . . . 0.48999999999999999 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.77 105.23 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.933 -1.603 . . . . 0.5 110.767 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.2 p90 -132.03 -170.19 2.36 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.38 -0.928 . . . . 0.23000000000000001 111.178 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 23' ' ' ARG . 1.3 mmm180 -144.04 124.9 14.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.398 -0.921 . . . . 3.2599999999999998 112.046 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.5 ttt-85 -11.68 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 124.351 1.032 . . . . 1.8700000000000001 113.542 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.7 -17.78 55.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.262 -1.535 . . . . 0.29999999999999999 109.262 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.93 126.17 29.86 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.578 -1.249 . . . . 1.25 108.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -77.36 111.5 13.09 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.601 -1.24 . . . . 0.45000000000000001 112.816 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.46 144.19 11.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 118.618 -1.233 . . . . 0.17000000000000001 107.965 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 33.0 t60 -101.16 101.24 11.93 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 106.658 -1.608 . . . . 0.51000000000000001 106.658 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.26 91.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 115.106 -0.952 . . . . 0.45000000000000001 112.781 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.551 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 4.4 mtt -57.68 -39.35 76.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.538 -1.21 . . . . 1.0700000000000001 109.529 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.7 OUTLIER 179.8 119.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.591 -1.244 . . . . 3.23 110.594 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 6.4 p-10 -49.13 108.55 0.19 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.372 -1.331 . . . . 2.3199999999999998 110.154 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.7 t -92.28 -47.78 7.02 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.186 -1.006 . . . . 1.54 111.481 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -125.73 161.19 52.36 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.397 -0.82 . . . . 1.4399999999999999 110.181 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -58.27 -67.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.505 1.47 . . . . 0.54000000000000004 111.648 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -87.9 7.05 32.65 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.56999999999999995 111.348 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASP . 24.4 m95 -141.42 145.08 34.87 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.815 . . . . 0.38 108.801 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.549 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -143.93 173.05 12.04 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.402 -0.919 . . . . 0.46000000000000002 112.218 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -116.15 132.44 56.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.936 -1.135 . . . . 0.96999999999999997 107.936 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.551 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.08 -144.16 3.86 Favored Glycine 0 C--N 1.297 -1.594 0 C-N-CA 118.004 -2.046 . . . . 0.16 109.163 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.82 161.58 15.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.397 -1.321 . . . . 0.40000000000000002 111.419 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 44' ' ' GLY . 47.1 t -161.29 -112.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.039 -1.865 . . . . 0.56000000000000005 113.771 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.536 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 p80 -21.93 -42.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.413 1.071 . . . . 2.75 113.052 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 164.39 18.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.137 -1.506 . . . . 1.25 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -157.12 161.96 39.4 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.452 -0.899 . . . . 1.78 110.749 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -96.79 -174.11 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.313 -0.955 . . . . 0.57999999999999996 110.475 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.19 -172.3 30.04 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.584 -1.293 . . . . 0.46999999999999997 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtp -104.83 138.82 40.51 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.002 -0.679 . . . . 0.63 110.333 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.4 p90 -142.19 146.06 38.2 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 119.777 -0.769 . . . . 0.26000000000000001 109.32 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.78 127.06 24.53 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 110.141 -0.754 . . . . 0.31 110.141 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.92 -29.53 70.69 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.282 -0.967 . . . . 3.4399999999999999 111.747 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -8.37 57.05 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.58 -1.248 . . . . 4.1799999999999997 111.736 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.91 15.56 7.02 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.962 -1.095 . . . . 0.35999999999999999 109.947 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.5 m -144.16 174.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 115.601 -0.727 . . . . 0.23000000000000001 110.322 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.551 0 C-N-CA 119.673 -0.811 . . . . 0.57999999999999996 109.121 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.353 0.597 . . . . 0.82999999999999996 111.968 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 27' ' ' ILE . 3.9 m -143.81 -169.16 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 0.28999999999999998 109.851 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' THR . 11.4 mt-30 -143.57 105.36 4.34 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.228 -1.397 . . . . 0.39000000000000001 107.228 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -33.84 111.69 0.11 Allowed 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.01 -1.076 . . . . 0.34000000000000002 112.162 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.03 -37.21 86.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.934 -0.706 . . . . 1.3100000000000001 109.376 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.29 -173.55 4.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.891 -1.049 . . . . 1.54 109.522 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 129.13 34.19 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.383 -1.735 . . . . 0.46000000000000002 109.731 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.28 109.56 17.0 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.85 -1.14 . . . . 0.34999999999999998 113.133 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 . . . . . 0 C--N 1.295 -1.781 0 C-N-CA 117.234 -1.786 . . . . 1.5800000000000001 106.848 179.451 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.661 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.561 0.696 . . . . 2.71 111.861 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.661 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -77.33 161.65 27.9 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 115.187 1.551 . . . . 0.71999999999999997 115.187 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -150.58 131.57 3.61 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.138 -1.185 . . . . 0.23999999999999999 110.138 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 27' ' ' ILE . 8.2 p90 -152.57 -168.43 3.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.432 -1.307 . . . . 0.23999999999999999 112.029 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 23' ' ' ARG . 8.5 mmm180 -140.38 131.28 26.03 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.618 -0.833 . . . . 4.4800000000000004 112.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -13.13 135.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.016 1.117 . . . . 2.2200000000000002 114.016 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.13 14.01 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.367 -1.493 . . . . 0.37 109.367 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.26 119.23 7.52 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.841 -1.144 . . . . 0.65000000000000002 108.435 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.07 105.36 8.1 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.568 -1.253 . . . . 2.29 112.569 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.577 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -75.54 144.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.017 -1.475 . . . . 0.23000000000000001 107.017 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 16.0 t-80 -104.1 98.88 8.63 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.772 -1.171 . . . . 0.87 108.149 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.16 92.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 118.346 -1.342 . . . . 0.54000000000000004 111.311 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.555 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -68.62 -36.09 78.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.803 -1.544 . . . . 1.6200000000000001 110.372 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -164.23 92.53 0.65 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.582 -1.247 . . . . 2.2200000000000002 111.106 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.75 99.24 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.346 -1.342 . . . . 1.74 109.282 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -96.47 -82.64 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.314 -0.954 . . . . 1.1599999999999999 111.636 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.3 m-20 -64.27 158.23 66.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.052 -1.059 . . . . 0.58999999999999997 110.86 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.06 -68.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.54 1.493 . . . . 0.29999999999999999 111.539 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' ND2' ' A' ' 52' ' ' ASN . 2.6 t30 -84.13 3.71 33.68 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.577 -0.849 . . . . 1.9099999999999999 111.332 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.447 ' O ' ' O ' ' A' ' 34' ' ' ASP . 22.9 m95 -136.47 144.4 44.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.541 -0.911 . . . . 0.52000000000000002 108.541 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CZ2' ' HG3' ' A' ' 51' ' ' ARG . 12.6 m0 -143.01 171.63 13.79 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.679 -0.808 . . . . 0.32000000000000001 111.692 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.08 130.33 55.55 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.533 -1.654 . . . . 0.35999999999999999 106.533 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.555 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.48 -154.56 7.14 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 117.952 -2.071 . . . . 0.14000000000000001 109.535 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -161.67 155.36 21.6 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 117.458 -1.697 . . . . 0.55000000000000004 112.926 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 44' ' ' GLY . 5.7 t -167.55 178.8 5.21 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.658 -1.156 . . . . 2.3399999999999999 110.777 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 42' ' ' CYS . 10.8 p80 41.01 23.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.096 -0.641 . . . . 1.6899999999999999 110.75 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 79.13 35.59 29.99 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.804 -1.189 . . . . 0.68999999999999995 111.812 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.7 mt-30 -160.23 144.16 14.14 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.895 -1.122 . . . . 1.22 111.352 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -93.6 -177.91 4.54 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.272 -0.971 . . . . 0.38 111.684 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.98 -163.88 28.6 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.642 -1.266 . . . . 0.34999999999999998 111.066 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.2 mtp -113.89 147.98 37.52 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.263 -0.575 . . . . 0.54000000000000004 111.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 27' ' ' ILE . 4.0 p90 -151.25 145.74 18.32 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.527 -0.869 . . . . 0.23000000000000001 109.317 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.23 128.32 29.17 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 N-CA-C 109.884 -0.852 . . . . 0.35999999999999999 109.884 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -62.03 -34.89 77.07 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.898 -0.721 . . . . 1.28 112.565 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.598 ' ND2' ' OD1' ' A' ' 36' ' ' ASN . 56.5 m-80 -75.05 12.15 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.148 -1.021 . . . . 1.95 113.253 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.92 7.09 27.84 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.505 -0.878 . . . . 0.57999999999999996 109.089 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -136.86 173.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 114.57 -1.196 . . . . 0.20000000000000001 109.578 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 108.392 -0.966 . . . . 0.51000000000000001 108.392 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 113.003 0.742 . . . . 0.72999999999999998 113.003 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 27' ' ' ILE . 15.9 m -141.05 -166.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.823 -1.08 . . . . 0.20000000000000001 109.36 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 7' ' ' ALA . 23.5 mt-30 -145.37 105.07 3.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.975 -1.011 . . . . 0.64000000000000001 108.438 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.05 116.63 0.11 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.793 -1.094 . . . . 0.16 113.681 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.38 -52.89 22.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.233 -1.025 . . . . 0.53000000000000003 108.233 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -132.04 177.64 7.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.77 -1.196 . . . . 0.71999999999999997 107.77 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -75.38 134.36 40.97 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.284 -1.325 . . . . 1.1399999999999999 108.953 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -121.53 109.87 15.34 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.021 -1.072 . . . . 0.26000000000000001 113.073 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 . . . . . 0 C--N 1.307 -1.265 0 C-N-CA 118.167 -1.413 . . . . 1.1000000000000001 108.387 179.692 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 123.328 1.537 . . . . 1.74 114.412 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.4 161.29 14.95 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.043 -2.799 . . . . 0.58999999999999997 109.4 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -145.11 115.19 0.82 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.364 -1.398 . . . . 0.29999999999999999 110.768 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.3 p90 -138.95 -174.49 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.984 -1.086 . . . . 0.23999999999999999 111.65 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -139.77 125.92 19.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.595 -0.842 . . . . 2.75 112.322 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.1 ttt180 -4.01 135.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.13 1.53 . . . . 1.6000000000000001 115.13 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 -21.68 3.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.289 -1.524 . . . . 0.60999999999999999 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -59.19 119.38 7.24 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.705 -1.198 . . . . 0.46000000000000002 108.399 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 48.1 m-85 -75.32 107.51 7.48 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.971 -1.092 . . . . 0.91000000000000003 113.525 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -75.17 143.92 12.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.029 -1.471 . . . . 0.16 107.029 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 71.0 t60 -101.0 102.39 13.38 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 117.79 -1.564 . . . . 1.3500000000000001 107.773 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.0 101.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 C-N-CA 118.444 -1.303 . . . . 0.32000000000000001 110.751 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.7 ttm -77.6 -32.42 53.55 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.591 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.21 108.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.447 -1.301 . . . . 3.5699999999999998 110.975 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 12.4 p-10 -58.03 107.6 0.49 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.985 -1.486 . . . . 0.93999999999999995 108.695 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -93.46 -57.08 2.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.85 -1.14 . . . . 1.5800000000000001 111.804 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -107.05 161.1 24.02 Favored Pre-proline 0 C--N 1.299 -1.615 0 C-N-CA 119.625 -0.83 . . . . 0.75 111.461 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.33 -58.25 0.82 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.063 1.842 . . . . 0.29999999999999999 111.606 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 41.2 t30 -98.96 13.35 32.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.725 -0.79 . . . . 0.40999999999999998 111.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 34.6 m95 -147.51 136.62 22.31 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.543 -0.863 . . . . 0.34000000000000002 109.478 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.659 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 34.4 m0 -139.44 168.35 20.01 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.889 -0.724 . . . . 0.42999999999999999 111.27 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -106.85 135.5 48.29 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.942 -1.503 . . . . 1.21 106.942 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -161.34 -152.0 6.48 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 117.839 -2.124 . . . . 0.25 109.519 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.12 160.08 18.36 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 117.772 -1.571 . . . . 0.56999999999999995 113.138 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.1 t -158.79 -86.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.127 -1.029 . . . . 0.25 112.104 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.649 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 6.4 p80 -62.95 74.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.325 -0.95 . . . . 0.52000000000000002 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.29 23.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.715 -1.231 . . . . 0.60999999999999999 111.095 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' HIS . 12.7 mt-30 -149.41 139.7 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.372 -1.331 . . . . 1.6000000000000001 111.499 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 41' ' ' ALA . 19.3 p -91.39 -172.46 3.27 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.665 -0.814 . . . . 0.45000000000000001 110.849 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.84 -167.91 27.61 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.288 -1.434 . . . . 0.20000000000000001 111.956 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 31.1 mtp -107.35 143.55 35.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.235 -0.586 . . . . 0.31 110.753 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -147.4 147.06 27.04 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.622 -0.831 . . . . 0.10000000000000001 109.049 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.05 124.72 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 120.189 0.592 . . . . 0.20000000000000001 111.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.659 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.36 -27.36 55.77 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.309 -0.86 . . . . 2.4100000000000001 110.227 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -83.27 -1.1 52.34 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.17 -1.012 . . . . 4.5800000000000001 113.091 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.7 12.68 31.02 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.811 -1.156 . . . . 0.29999999999999999 109.931 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -141.45 172.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.404 -1.271 . . . . 0.25 108.157 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.847 0 C-N-CA 118.963 -1.095 . . . . 0.31 108.853 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.81000000000000005 111.645 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 27' ' ' ILE . 15.7 m -146.14 174.69 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.835 -1.075 . . . . 0.65000000000000002 109.453 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.498 ' O ' ' C ' ' A' ' 7' ' ' ALA . 16.4 mt-30 -123.48 109.12 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.389 -1.337 . . . . 0.40999999999999998 107.389 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -32.2 116.13 0.19 Allowed 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.552 -0.859 . . . . 0.23999999999999999 112.371 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.535 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 11.8 tp -74.52 -42.26 59.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.435 -0.802 . . . . 1.8799999999999999 109.836 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.67 176.42 8.2 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.758 -1.11 . . . . 1.6200000000000001 108.129 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.37 125.46 32.98 Favored 'General case' 0 C--N 1.265 -3.107 0 N-CA-C 105.909 -1.886 . . . . 0.82999999999999996 105.909 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.29 106.56 17.06 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.869 -1.132 . . . . 0.23000000000000001 113.658 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.306 -1.293 0 C-N-CA 118.298 -1.361 . . . . 0.95999999999999996 107.856 179.56 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.9 pt-20 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 113.711 1.004 . . . . 1.22 113.711 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -78.52 170.12 17.15 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 116.414 2.005 . . . . 0.41999999999999998 116.414 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.34 122.0 1.1 Allowed Glycine 0 N--CA 1.499 2.889 0 CA-C-N 113.286 -1.779 . . . . 0.22 109.292 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.14 -169.99 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.705 -1.198 . . . . 0.17000000000000001 112.393 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' A' ' 23' ' ' ARG . 6.2 mmm180 -135.45 134.57 39.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.52 -0.763 . . . . 3.5600000000000001 112.361 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.4 ttp180 -20.53 141.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.229 0.956 . . . . 1.95 113.146 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.41 -27.1 4.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.643 -1.383 . . . . 0.38 109.643 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.49 125.8 25.05 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.589 -1.245 . . . . 1.0600000000000001 108.127 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.58 111.62 14.83 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.302 -1.359 . . . . 0.92000000000000004 113.585 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -77.89 141.88 14.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.872 -1.529 . . . . 0.20999999999999999 106.872 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -100.07 97.18 8.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 117.598 -1.641 . . . . 1.1100000000000001 108.026 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.13 99.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 C-N-CA 118.624 -1.231 . . . . 0.27000000000000002 111.021 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.455 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 21.4 mtt -82.75 -26.22 32.1 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.274 -0.875 . . . . 1.3500000000000001 110.44 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -163.81 80.34 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 118.223 -1.391 . . . . 1.5900000000000001 111.656 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -61.04 87.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.46 -1.296 . . . . 3.5800000000000001 108.521 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 31' ' ' ASP . 6.4 t -103.76 -72.59 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.755 -0.778 . . . . 2.52 112.705 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 3.0 m-20 -60.59 153.96 58.73 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 118.859 -1.136 . . . . 1.77 111.021 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.26 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.106 1.871 . . . . 0.60999999999999999 112.87 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -83.39 14.38 3.69 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.599 -0.728 . . . . 0.84999999999999998 110.681 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 55.4 m95 -147.47 149.38 32.57 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.276 -0.875 . . . . 1.01 109.227 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.8 m0 -148.75 161.6 41.45 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.484 -0.886 . . . . 0.47999999999999998 111.302 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 132.33 48.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.929 -1.137 . . . . 1.1799999999999999 107.929 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.92 -152.58 6.98 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 118.255 -1.926 . . . . 0.17999999999999999 109.731 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.35 175.38 11.63 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.595 -1.242 . . . . 0.16 111.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.8 t -168.81 -79.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.001 -1.88 . . . . 0.52000000000000002 114.679 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.647 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 2.4 p80 -65.07 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.85 -0.614 . . . . 1.47 112.622 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 89.77 6.12 70.41 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.048 -1.549 . . . . 0.55000000000000004 109.75 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.04 151.22 47.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.656 -0.818 . . . . 4.3600000000000003 109.868 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.6 p -92.41 -175.71 4.09 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.871 -1.131 . . . . 0.26000000000000001 110.823 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.49 179.05 25.02 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.777 -1.202 . . . . 0.46999999999999997 110.13 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.3 mtp -100.87 147.16 26.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.41999999999999998 110.886 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 27' ' ' ILE . 7.0 p90 -147.57 147.02 26.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.702 -0.799 . . . . 0.23999999999999999 109.345 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.11 126.53 22.46 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.786 0.991 . . . . 0.13 111.484 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HD3' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -34.34 72.31 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.426 -0.806 . . . . 2.54 111.223 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.53 3.03 14.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.918 -1.113 . . . . 2.3700000000000001 112.763 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.54 8.45 44.88 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.085 -1.046 . . . . 0.14000000000000001 109.774 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.9 m -136.28 171.65 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 114.853 -1.067 . . . . 0.17000000000000001 109.113 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 119.102 -1.039 . . . . 0.28999999999999998 110.286 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.725 0.774 . . . . 1.3100000000000001 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 27' ' ' ILE . 5.9 m -125.94 -162.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.442 -1.253 . . . . 0.23000000000000001 109.781 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 7' ' ' ALA . 15.4 mt-30 -146.9 100.27 3.29 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.841 -1.17 . . . . 0.85999999999999999 107.841 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.09 111.52 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.58 -1.191 . . . . 0.25 113.11 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.517 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.81 -41.53 91.77 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.62 -0.718 . . . . 0.33000000000000002 109.104 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -173.09 3.59 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.602 -1.181 . . . . 0.80000000000000004 108.453 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.47 120.48 27.84 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.705 -1.589 . . . . 0.68000000000000005 109.583 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -104.68 103.15 12.74 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.228 -0.989 . . . . 0.26000000000000001 111.724 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 C-N-CA 117.243 -1.783 . . . . 4.5899999999999999 109.838 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.3 pt-20 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.263 0.554 . . . . 1.22 112.01 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -87.04 175.73 7.97 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 115.454 1.65 . . . . 0.29999999999999999 115.454 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -162.19 128.61 1.91 Allowed Glycine 0 N--CA 1.502 3.045 0 CA-C-N 114.319 -1.309 . . . . 0.26000000000000001 110.072 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -158.11 -174.8 5.0 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.081 -1.448 . . . . 0.25 112.095 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' ARG . 23.4 mmt-85 -133.96 133.65 41.61 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.796 -0.762 . . . . 4.2199999999999998 112.698 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.42 138.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.418 1.074 . . . . 4.9699999999999998 113.731 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.6 5.98 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.469 -1.452 . . . . 0.46999999999999997 109.469 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.17 122.35 13.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.993 -1.083 . . . . 0.63 109.242 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 73.5 m-85 -78.74 108.91 12.5 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.054 -1.058 . . . . 1.03 113.114 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -78.42 148.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.338 -0.986 . . . . 0.20000000000000001 108.338 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 30' ' ' MET . 11.7 t-160 -106.26 94.07 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.045 -1.062 . . . . 0.83999999999999997 108.857 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.64 85.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 C-N-CA 119.297 -0.961 . . . . 0.34000000000000002 112.43 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.621 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mmt -59.23 -35.89 74.47 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.893 -1.048 . . . . 1.4299999999999999 110.402 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 33' ' ' SER . 67.6 t0 -170.56 99.75 0.25 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.176 -1.409 . . . . 1.54 111.749 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -53.18 97.78 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.095 -1.442 . . . . 2.5699999999999998 108.784 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 31' ' ' ASP . 65.8 m -96.26 -71.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.307 -0.957 . . . . 1.3799999999999999 111.832 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.4 m-20 -81.93 161.17 61.63 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 119.249 -0.98 . . . . 0.68999999999999995 111.679 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.53 -69.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.743 1.629 . . . . 0.35999999999999999 110.92 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 4.9 t-20 -80.2 -5.01 55.37 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 110.949 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' ASP . 28.4 m95 -131.99 150.59 52.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.092 -0.643 . . . . 0.38 109.625 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 9.8 m0 -145.9 162.56 37.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.381 -0.827 . . . . 0.5 111.722 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.05 129.46 46.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.867 -1.531 . . . . 0.29999999999999999 106.867 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.26 -156.79 7.99 Favored Glycine 0 C--N 1.304 -1.224 0 C-N-CA 117.835 -2.126 . . . . 0.20999999999999999 110.349 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.769 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -160.8 162.81 32.44 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 118.452 -1.299 . . . . 0.44 111.46 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 43.7 t -160.58 -114.55 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.295 -1.762 . . . . 0.56000000000000005 113.853 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.556 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.1 p80 -20.95 -45.11 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.277 0.985 . . . . 2.8900000000000001 113.044 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 167.1 18.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.338 -1.411 . . . . 1.01 109.884 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -150.34 161.19 42.95 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.637 -0.825 . . . . 2.54 110.049 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -100.33 -175.94 3.07 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.424 -0.911 . . . . 0.38 109.812 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.69 -169.14 29.89 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.132 -1.508 . . . . 0.28999999999999998 111.225 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 mtp -108.28 136.66 47.56 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.071 -0.652 . . . . 0.71999999999999997 110.963 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.0 p90 -139.11 146.48 49.49 Favored Pre-proline 0 C--N 1.304 -1.387 0 C-N-CA 119.714 -0.795 . . . . 0.14999999999999999 110.143 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.38 122.86 12.21 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 120.292 0.661 . . . . 0.19 110.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -11.45 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.397 -0.921 . . . . 2.9900000000000002 110.983 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -88.01 -9.1 54.48 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.041 -1.064 . . . . 1.8500000000000001 111.655 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 8' ' ' LEU . 4.8 m-85 -94.13 14.28 20.5 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.187 -1.005 . . . . 0.44 109.415 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.7 m -139.62 166.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.986 -1.006 . . . . 0.27000000000000002 109.439 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 119.738 -0.785 . . . . 0.82999999999999996 109.565 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 110.308 -1.117 . . . . 2.02 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t -155.68 106.37 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.608 -0.837 . . . . 2.23 110.629 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -135.07 30.66 3.31 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.842 -0.743 . . . . 0.66000000000000003 110.685 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -88.62 160.07 17.58 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.658 -1.217 . . . . 1.7 113.98 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 27' ' ' ILE . 17.6 m -138.39 -168.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 113.391 -1.731 . . . . 0.059999999999999998 108.298 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 55' ' ' THR . 2.2 mt-30 -140.29 104.12 4.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.336 -1.357 . . . . 0.70999999999999996 107.336 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.71 114.21 0.11 Allowed 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 113.666 0.987 . . . . 0.10000000000000001 113.666 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.429 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 9.7 tp -69.39 -34.1 74.02 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.388 -0.824 . . . . 1.78 108.917 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.63 -174.2 4.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.943 -1.026 . . . . 0.53000000000000003 109.669 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -86.4 126.48 34.41 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 113.434 -1.712 . . . . 0.44 110.336 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.11 106.32 13.6 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.307 -0.957 . . . . 0.27000000000000002 112.804 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.0 133.73 33.15 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 117.734 -1.586 . . . . 3.3399999999999999 108.336 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -43.91 152.85 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 120.532 0.821 . . . . 0.53000000000000003 112.105 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 35.2 mt-30 -150.84 7.98 0.56 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.084 -1.08 . . . . 2.1400000000000001 108.084 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -141.13 162.01 36.49 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.284 -1.325 . . . . 3.6299999999999999 110.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.13 100.1 5.62 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.007 -1.077 . . . . 1.6699999999999999 110.572 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' GLU . . . 113.14 -18.38 21.32 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.92 -1.134 . . . . 1.1499999999999999 110.268 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.1 tt0 -42.34 177.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.231 1.491 . . . . 1.03 114.253 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tp -101.54 158.19 16.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 111.797 -2.456 . . . . 0.47999999999999998 110.407 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.36 113.07 0.65 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.606 -1.283 . . . . 0.40999999999999998 110.726 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -139.94 -172.7 3.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.841 -1.144 . . . . 0.26000000000000001 112.192 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' ARG . 5.0 mmm-85 -139.61 126.08 20.34 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.574 -0.85 . . . . 2.4900000000000002 113.187 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -7.65 132.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.493 1.121 . . . . 1.8200000000000001 113.887 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -19.27 20.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.218 -1.553 . . . . 0.56999999999999995 109.218 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.79 123.7 19.12 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.791 -1.164 . . . . 0.57999999999999996 108.52 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.92 107.66 10.62 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.647 -1.221 . . . . 0.28999999999999998 112.657 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -77.32 147.62 7.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.84 -1.17 . . . . 0.23000000000000001 107.84 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -105.65 96.21 6.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.687 -1.227 . . . . 0.17999999999999999 107.687 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 3' ' ' THR . 4.1 t -63.29 91.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 114.584 -1.189 . . . . 0.39000000000000001 110.219 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.525 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.3 ttm -78.31 -27.32 47.21 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.945 -1.479 . . . . 0.45000000000000001 112.011 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.11 96.65 0.6 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.43 -1.708 . . . . 1.75 111.794 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.433 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -55.47 104.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.113 -1.435 . . . . 2.1200000000000001 107.914 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m -90.86 -64.9 1.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.649 -1.22 . . . . 1.0700000000000001 111.761 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -103.89 161.71 22.12 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 115.189 -0.914 . . . . 0.65000000000000002 111.812 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' O ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 Cg_endo -57.95 -63.34 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.737 1.625 . . . . 0.56999999999999995 111.478 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.2 t30 -92.15 6.8 45.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.558 -0.857 . . . . 2.9199999999999999 111.392 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 20.0 m95 -139.23 139.32 37.43 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.75 -1.204 . . . . 0.32000000000000001 107.75 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -141.86 169.38 17.7 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.281 -0.968 . . . . 0.66000000000000003 112.939 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -101.78 146.53 27.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.332 -1.729 . . . . 0.68000000000000005 106.332 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.1 -158.42 9.75 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 116.784 -2.627 . . . . 0.27000000000000002 110.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.33 137.94 4.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.031 -1.067 . . . . 1.1799999999999999 111.278 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' GLY . 32.9 t -145.03 -94.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.114 -1.035 . . . . 0.42999999999999999 111.807 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.626 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.5 p80 -60.69 75.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.434 -0.907 . . . . 0.54000000000000004 111.3 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.45 21.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.333 -0.937 . . . . 0.60999999999999999 111.575 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' HIS . 70.2 mt-30 -144.49 134.95 24.56 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.011 -1.076 . . . . 2.23 111.096 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -90.97 -178.33 5.18 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.73 -0.788 . . . . 0.55000000000000004 111.056 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.4 -172.77 27.72 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.377 -1.392 . . . . 0.35999999999999999 110.884 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mtp -101.22 157.39 16.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.824 -0.751 . . . . 0.27000000000000002 111.268 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.1 p90 -159.36 144.25 11.45 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 115.124 -0.944 . . . . 0.28999999999999998 109.06 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.2 125.96 20.57 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 120.264 0.643 . . . . 0.33000000000000002 110.801 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -64.53 -20.44 66.22 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.562 -0.855 . . . . 2.3599999999999999 110.968 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.99 1.59 49.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.915 -1.114 . . . . 1.03 111.082 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.74 13.5 33.45 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.616 -0.834 . . . . 0.14999999999999999 109.006 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.429 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 31.5 m -140.98 171.54 12.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.646 -1.161 . . . . 0.34999999999999998 109.905 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -143.07 139.79 17.16 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 119.441 -0.904 . . . . 0.26000000000000001 109.242 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.15 148.17 93.69 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 120.854 1.036 . . . . 0.77000000000000002 112.44 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG22 ' CG ' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -105.83 -29.24 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.445 -0.798 . . . . 1.6100000000000001 109.911 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 2.7 p-10 -94.29 79.5 3.96 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.713 -0.795 . . . . 3.46 110.248 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 116.221 -1.847 . . . . 7.2800000000000002 110.681 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.943 -1.263 . . . . 5.5599999999999996 109.943 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.12 169.29 14.61 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.39 -0.924 . . . . 2.9300000000000002 111.088 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.62 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -143.12 36.07 1.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.879 -0.728 . . . . 0.41999999999999998 110.063 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -104.97 153.96 20.74 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.966 -1.094 . . . . 1.3200000000000001 113.118 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 27' ' ' ILE . 25.1 m -140.22 -172.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 113.823 -1.535 . . . . 0.23999999999999999 108.057 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' ALA . 11.5 mt-30 -142.07 98.17 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.058 -1.089 . . . . 0.72999999999999998 108.058 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -20.93 111.97 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.916 -1.493 . . . . 0.080000000000000002 113.487 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.472 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -67.38 -36.42 81.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.167 -0.679 . . . . 0.52000000000000002 109.167 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.16 -174.73 4.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.844 -1.071 . . . . 0.65000000000000002 109.183 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.86 131.44 34.52 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 113.614 -1.63 . . . . 0.47999999999999998 109.446 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -120.71 109.47 15.23 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.987 -1.085 . . . . 0.34999999999999998 113.364 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.74 134.06 24.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 106.819 -1.548 . . . . 1.48 106.819 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.31 155.02 0.11 Allowed 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 120.512 0.808 . . . . 0.40999999999999998 112.586 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 69.3 mt-30 -149.56 2.95 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.786 -1.097 . . . . 2.54 108.387 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' CG ' ' OE2' ' A' ' 18' ' ' GLU . 11.2 mm-40 -125.76 -179.09 4.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.454 -1.248 . . . . 1.8400000000000001 109.635 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.15 80.82 5.04 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.014 -1.075 . . . . 4.0800000000000001 110.975 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 18' ' ' GLU . . . 124.74 -9.44 8.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.254 -1.138 . . . . 1.0900000000000001 110.254 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.6 tt0 -41.38 177.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.343 1.544 . . . . 1.24 115.087 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 tp -97.69 157.04 16.27 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 111.397 -2.638 . . . . 0.5 110.544 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -143.71 112.89 0.72 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.261 -1.447 . . . . 0.42999999999999999 111.142 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.5 p90 -135.5 -179.25 5.52 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.266 -0.973 . . . . 0.31 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 23' ' ' ARG . 2.9 mmt85 -137.29 124.32 21.52 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.537 -0.865 . . . . 3.0499999999999998 112.22 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -10.08 128.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.283 0.989 . . . . 2.3700000000000001 113.281 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.48 -20.08 50.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.287 -1.525 . . . . 0.19 109.287 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.0 126.02 28.42 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.856 -1.138 . . . . 1.7 108.234 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 2.3 m-85 -78.39 108.39 11.71 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.78000000000000003 113.38 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.12 142.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 105.765 -1.939 . . . . 0.28000000000000003 105.765 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' A' ' 30' ' ' MET . 12.4 t60 -101.55 97.78 8.18 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.173 -1.411 . . . . 0.31 107.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 3' ' ' THR . 6.0 t -63.55 84.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.546 -1.207 . . . . 0.28999999999999998 110.842 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.7 ttm -69.14 -30.79 69.11 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.112 -1.403 . . . . 0.79000000000000004 111.547 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -169.3 90.99 0.22 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.707 -1.597 . . . . 1.6399999999999999 111.983 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.436 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -50.2 104.35 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.075 -1.45 . . . . 1.5900000000000001 108.386 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 m -94.6 -37.16 11.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.168 -1.013 . . . . 1.72 113.534 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -124.58 160.43 53.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.373 -0.931 . . . . 1.1799999999999999 111.471 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.65 -68.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.736 1.624 . . . . 0.46000000000000002 111.604 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.1 t30 -91.25 12.94 18.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.539 -0.864 . . . . 2.6400000000000001 111.094 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.5 m95 -145.46 144.79 30.8 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.773 -0.825 . . . . 0.40000000000000002 108.773 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 20.5 m0 -144.62 172.86 12.39 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.4 -0.92 . . . . 0.20999999999999999 111.82 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -115.09 123.82 49.97 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.559 -1.645 . . . . 0.39000000000000001 106.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -149.94 -148.03 4.67 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 118.241 -1.933 . . . . 0.11 108.831 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.828 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.77 165.52 20.62 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.117 -1.433 . . . . 0.23999999999999999 111.95 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 23.4 t -161.14 -108.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 116.597 -2.041 . . . . 0.28000000000000003 114.471 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 2.2 p80 -26.96 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.348 -0.842 . . . . 3.0800000000000001 113.213 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 161.98 18.08 0.03 OUTLIER Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.046 -1.549 . . . . 0.88 109.991 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.5 162.21 37.44 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.153 -1.019 . . . . 4.1600000000000001 110.221 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 ' HB2' ' A' ' 41' ' ' ALA . 18.7 p -95.66 -171.17 2.3 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.195 -1.002 . . . . 0.38 111.393 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.42 -170.89 28.91 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.657 -1.156 . . . . 0.22 110.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.3 mtp -105.25 143.35 33.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.827 -0.749 . . . . 0.35999999999999999 110.746 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.9 p90 -147.65 146.02 23.2 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 119.705 -0.798 . . . . 0.23000000000000001 108.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.99 126.9 23.06 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 N-CA-C 110.458 -0.632 . . . . 0.19 110.458 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.77 -36.16 78.25 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.462 -0.79 . . . . 2.54 111.045 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -74.25 -0.73 17.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.058 -1.057 . . . . 4.1100000000000003 112.692 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -93.45 6.39 48.35 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 118.719 -1.192 . . . . 0.20000000000000001 110.092 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.3 m -134.27 171.39 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 115.457 -0.792 . . . . 0.10000000000000001 109.827 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -146.3 149.17 37.12 Favored Pre-proline 0 C--N 1.303 -1.424 0 C-N-CA 119.338 -0.945 . . . . 0.29999999999999999 109.132 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.96 154.61 31.9 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.882 1.055 . . . . 0.42999999999999999 111.885 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.92 153.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.982 -0.687 . . . . 1.5 111.62 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.25 161.33 26.41 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.38 -0.928 . . . . 9.0899999999999999 110.224 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 116.354 -1.784 . . . . 8.9100000000000001 111.106 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.974 -1.25 . . . . 3.8399999999999999 109.974 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 69.98 145.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.271 -0.972 . . . . 4.3700000000000001 111.012 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.6 26.72 6.66 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.969 -0.693 . . . . 0.58999999999999997 110.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -88.15 160.76 17.62 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.308 -1.357 . . . . 0.70999999999999996 112.84 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 27' ' ' ILE . 16.4 m -136.61 -170.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.821 -1.536 . . . . 0.17000000000000001 108.275 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.536 ' OE1' HG13 ' A' ' 57' ' ' VAL . 2.9 mt-30 -138.78 102.7 4.64 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.936 -1.135 . . . . 0.39000000000000001 107.936 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.27 110.61 0.06 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.326 -0.852 . . . . 0.14000000000000001 112.396 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -64.2 -37.14 86.41 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.132 -0.692 . . . . 0.56999999999999995 109.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -174.4 4.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.146 0.974 . . . . 1.26 109.74 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -83.33 127.62 33.82 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.496 -1.684 . . . . 0.38 110.815 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -115.84 106.42 13.81 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.633 -0.827 . . . . 0.23000000000000001 111.905 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.86 127.5 53.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 117.724 -1.591 . . . . 3.8799999999999999 109.439 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -40.87 117.17 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.138 1.226 . . . . 1.1000000000000001 114.215 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -102.65 6.69 39.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.333 -1.729 . . . . 2.1600000000000001 106.333 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -134.43 -174.63 3.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.019 -1.9 . . . . 1.6499999999999999 110.415 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -122.76 1.22 9.37 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.324 -0.853 . . . . 3.04 109.123 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.42 12.71 5.19 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.703 -1.359 . . . . 1.6000000000000001 109.703 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -113.93 -174.13 2.41 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.567 -0.853 . . . . 1.1799999999999999 112.102 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.58 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -84.08 172.41 12.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 116.026 1.861 . . . . 0.40000000000000002 116.026 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.08 120.97 1.01 Allowed Glycine 0 N--CA 1.497 2.743 0 CA-C-N 113.645 -1.616 . . . . 0.14000000000000001 110.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.1 p90 -145.78 -170.94 3.59 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.319 -1.352 . . . . 0.25 112.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.0 mmt-85 -138.72 129.8 26.83 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.4 -0.818 . . . . 4.5700000000000003 112.222 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -16.61 137.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.194 0.934 . . . . 2.8799999999999999 113.239 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -21.65 10.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.816 -1.714 . . . . 0.26000000000000001 108.816 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.64 118.88 10.18 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.94 -1.104 . . . . 1.1100000000000001 108.055 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -76.55 112.92 13.61 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.662 -1.215 . . . . 0.83999999999999997 112.482 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.26 147.62 7.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.702 -1.222 . . . . 0.14999999999999999 107.702 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.469 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 30.8 t60 -103.9 101.61 11.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.761 -1.175 . . . . 0.20999999999999999 107.83 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 3' ' ' THR . 4.1 t -69.39 98.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.5 -1.227 . . . . 0.26000000000000001 111.505 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.438 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.0 OUTLIER -79.6 -30.22 41.42 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.09 -1.414 . . . . 1.6200000000000001 110.959 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.24 114.48 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.334 -1.346 . . . . 2.29 111.014 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 19.6 p30 -56.72 109.82 0.69 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.223 -1.391 . . . . 1.5600000000000001 109.69 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 p -91.75 -38.58 12.3 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.04 -1.064 . . . . 3.1600000000000001 112.049 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -138.63 161.91 56.02 Favored Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.496 -0.881 . . . . 0.73999999999999999 110.747 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.27 -64.43 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.224 1.283 . . . . 0.56000000000000005 111.254 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -90.49 4.07 52.14 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.244 -0.982 . . . . 0.39000000000000001 111.191 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 26.5 m95 -138.73 140.87 38.85 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 108.801 -0.815 . . . . 0.40000000000000002 108.801 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -138.59 -177.72 4.99 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.68 -0.808 . . . . 0.83999999999999997 111.928 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -124.2 124.74 43.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.578 -1.267 . . . . 0.31 107.578 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -155.86 -144.97 4.06 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 108.724 -1.751 . . . . 0.10000000000000001 108.724 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.7 173.74 11.53 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.375 -1.33 . . . . 0.13 111.735 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 13.8 t -166.06 -103.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 116.871 -1.932 . . . . 0.40999999999999998 114.407 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.605 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.9 p80 -29.92 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.403 -0.817 . . . . 2.8199999999999998 112.943 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 152.51 13.7 0.07 OUTLIER Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.278 -1.529 . . . . 0.89000000000000001 109.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' H ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -149.73 164.21 35.87 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.714 -0.794 . . . . 5.3700000000000001 110.382 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 41' ' ' ALA . 12.3 p -97.52 -175.03 3.08 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.116 -1.034 . . . . 0.32000000000000001 111.556 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.59 -174.58 29.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.112 -1.195 . . . . 0.13 110.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 mtp -102.59 146.56 27.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.705 -0.798 . . . . 0.40999999999999998 110.748 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -151.39 147.24 19.99 Favored Pre-proline 0 C--N 1.303 -1.439 0 C-N-CA 119.441 -0.903 . . . . 0.31 109.892 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.38 124.77 15.83 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.051 -0.788 . . . . 0.28000000000000003 110.051 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -17.87 63.89 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.632 -0.827 . . . . 2.75 111.526 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.97 -1.3 54.38 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.583 -1.247 . . . . 1.98 111.552 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -96.61 7.57 46.23 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.314 -0.955 . . . . 0.48999999999999999 108.894 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.8 m -137.32 169.58 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.935 -1.029 . . . . 0.22 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.94 144.41 21.9 Favored Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 119.118 -1.033 . . . . 0.14999999999999999 109.646 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -61.48 142.15 94.25 Favored 'Trans proline' 0 C--N 1.322 -0.854 0 C-N-CA 121.074 1.182 . . . . 0.69999999999999996 112.444 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER -91.16 -168.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.384 -0.826 . . . . 2.6099999999999999 109.838 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.602 ' H ' HG12 ' A' ' 57' ' ' VAL . 15.7 m120 -79.94 -109.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.278 -0.969 . . . . 7.4500000000000002 109.567 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 116.253 -1.832 . . . . 9.7799999999999994 110.94 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 110.073 -1.211 . . . . 3.6400000000000001 110.073 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.504 ' C ' HG22 ' A' ' 3' ' ' THR . 32.3 t 57.93 65.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.298 -0.561 . . . . 2.3199999999999998 111.628 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.6 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -168.83 24.47 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.906 -0.718 . . . . 0.39000000000000001 110.333 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.42 ' CE1' ' ND1' ' A' ' 28' ' ' HIS . 54.1 m-85 -99.15 149.27 23.23 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.63 -1.228 . . . . 2.6099999999999999 113.218 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 27' ' ' ILE . 15.8 m -129.14 -167.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.921 -1.491 . . . . 0.16 108.741 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 7' ' ' ALA . 10.6 mt-30 -142.78 97.81 3.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.895 -1.15 . . . . 0.32000000000000001 107.895 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.69 110.93 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.496 -1.229 . . . . 0.27000000000000002 113.915 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.507 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 2.9 tp -56.46 -50.04 72.88 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.573 -0.74 . . . . 1.75 109.634 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -174.52 4.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.987 -1.006 . . . . 1.53 108.451 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 126.53 31.18 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.086 -1.416 . . . . 0.64000000000000001 110.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -111.77 102.42 10.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.428 -0.909 . . . . 0.28999999999999998 111.892 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.82 126.98 64.31 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 117.312 -1.755 . . . . 3.7999999999999998 109.052 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -40.51 115.03 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.195 1.264 . . . . 1.01 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -93.74 3.42 55.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.676 -1.972 . . . . 2.96 105.676 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -134.35 -173.33 3.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.542 -2.117 . . . . 3.52 109.943 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.64 0.27 7.49 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.676 -0.861 . . . . 3.3700000000000001 108.676 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.66 3.22 7.56 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.48 -1.448 . . . . 1.1200000000000001 109.48 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.97 -172.44 2.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.756 -0.778 . . . . 1.0 111.775 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.568 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -82.09 168.07 18.13 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 116.053 1.871 . . . . 0.20000000000000001 116.053 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -156.94 123.19 1.26 Allowed Glycine 0 N--CA 1.496 2.69 0 CA-C-N 113.819 -1.537 . . . . 0.12 109.751 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.555 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -148.82 -175.68 5.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.369 -1.332 . . . . 0.22 112.377 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 23' ' ' ARG . 19.7 mmt180 -132.19 129.85 40.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.414 -0.812 . . . . 2.96 111.742 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -19.72 138.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 124.184 0.928 . . . . 3.6200000000000001 113.256 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.73 39.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.528 -1.429 . . . . 0.10000000000000001 109.528 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -73.71 120.36 19.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.356 -1.35 . . . . 0.52000000000000002 107.356 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -74.23 112.99 10.92 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.711 -1.196 . . . . 1.1000000000000001 113.195 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.559 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.74 141.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.517 -1.66 . . . . 0.23000000000000001 106.517 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.42 ' ND1' ' CE1' ' A' ' 4' ' ' TYR . 7.5 t60 -100.5 95.82 6.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.388 -1.325 . . . . 0.20999999999999999 108.307 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 3' ' ' THR . 5.2 t -60.63 97.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 114.465 -1.243 . . . . 0.17999999999999999 111.115 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.589 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 2.8 mmt -72.77 -32.14 65.41 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.209 -1.359 . . . . 1.6799999999999999 110.983 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 101.2 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.053 -1.459 . . . . 3.21 111.213 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 7.4 p-10 -51.34 100.88 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.541 -1.264 . . . . 1.8300000000000001 109.553 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.22 -77.34 0.46 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.953 -1.099 . . . . 0.77000000000000002 110.674 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -78.22 159.09 76.06 Favored Pre-proline 0 C--N 1.296 -1.752 0 C-N-CA 119.255 -0.978 . . . . 0.98999999999999999 110.696 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.47 -64.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.659 1.573 . . . . 0.59999999999999998 111.399 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -86.16 -1.81 57.77 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.711 -0.796 . . . . 0.51000000000000001 111.583 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 16.2 m95 -132.01 153.49 50.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.022 -1.103 . . . . 0.47999999999999998 108.022 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.5 m0 -148.34 176.12 10.53 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.256 -0.978 . . . . 0.48999999999999999 111.728 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.4 131.1 55.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.466 -1.309 . . . . 0.55000000000000004 107.466 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.589 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.01 -145.87 4.3 Favored Glycine 0 C--N 1.302 -1.31 0 C-N-CA 118.123 -1.989 . . . . 0.32000000000000001 109.608 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.45 154.99 12.57 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 118.517 -1.273 . . . . 0.57999999999999996 111.847 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.4 t -152.31 -94.62 0.05 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.875 -1.13 . . . . 0.37 111.33 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.703 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.6 p80 -59.96 77.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.509 -0.876 . . . . 0.25 110.878 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 24.53 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.177 -1.011 . . . . 0.20000000000000001 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' HIS . 59.8 mt-30 -147.44 144.98 29.02 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.781 -1.167 . . . . 1.1399999999999999 111.49 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.757 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.5 p -95.96 -177.06 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.811 -0.756 . . . . 0.19 110.335 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -174.91 27.66 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.45 -1.357 . . . . 0.16 110.62 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 mtp -102.18 146.79 27.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.854 -0.738 . . . . 0.67000000000000004 111.477 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.5 p90 -149.32 143.94 17.43 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.137 -0.938 . . . . 0.22 108.958 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.81 126.62 22.84 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 N-CA-C 110.705 -0.537 . . . . 0.33000000000000002 110.705 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.18 -27.68 68.59 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.454 -0.794 . . . . 1.95 112.055 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 2.46 33.59 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.31 -1.356 . . . . 1.04 112.175 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.03 6.33 49.1 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.248 -0.981 . . . . 0.70999999999999996 109.213 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.507 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.6 m -135.32 176.26 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.582 -1.19 . . . . 0.26000000000000001 108.997 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -149.68 133.0 8.46 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 119.236 -0.985 . . . . 0.31 109.205 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.88 149.58 60.05 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 120.413 0.742 . . . . 1.1699999999999999 111.834 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.594 ' O ' HG12 ' A' ' 57' ' ' VAL . 95.3 t -79.05 72.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.67 -0.812 . . . . 2.1000000000000001 111.015 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -90.64 128.58 36.66 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.271 -0.972 . . . . 7.3200000000000003 110.646 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 116.32 -1.8 . . . . 12.41 110.627 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 110.159 -1.176 . . . . 5.2699999999999996 110.159 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.19 6.1 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.457 -0.897 . . . . 2.1099999999999999 110.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -97.95 33.27 2.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.796 -0.762 . . . . 0.5 110.27 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.5 m-85 -97.1 155.16 16.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.056 -1.058 . . . . 0.25 113.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG22 HG22 ' A' ' 27' ' ' ILE . 21.8 m -136.1 -170.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.087 -1.415 . . . . 0.14999999999999999 108.684 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 7' ' ' ALA . 14.1 mt-30 -140.83 97.14 3.13 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.428 -0.952 . . . . 0.13 108.428 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -22.25 110.69 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.899 -1.501 . . . . 0.14999999999999999 113.269 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 tp -64.52 -50.59 66.78 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.454 -0.794 . . . . 1.6699999999999999 109.852 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -131.93 -178.81 5.05 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.279 -1.008 . . . . 0.90000000000000002 108.279 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 131.62 35.21 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.159 -1.382 . . . . 0.22 108.325 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -118.51 107.14 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.194 -1.002 . . . . 0.34999999999999998 112.746 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.57 129.29 45.46 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 117.725 -1.59 . . . . 3.9199999999999999 109.307 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -43.94 106.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 121.121 1.214 . . . . 1.4299999999999999 114.048 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.52 5.51 47.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.089 -2.189 . . . . 4.0300000000000002 105.089 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -127.95 178.51 6.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 112.392 -2.186 . . . . 2.3199999999999998 110.077 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -122.24 15.86 10.62 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.761 -0.776 . . . . 3.6200000000000001 109.099 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.6 9.69 1.23 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.463 -1.455 . . . . 1.1699999999999999 109.463 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.3 -174.44 2.47 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.849 -0.741 . . . . 0.93999999999999995 111.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.587 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -79.18 169.64 17.84 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 115.647 1.721 . . . . 0.25 115.647 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.08 121.42 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-N 113.848 -1.524 . . . . 0.16 110.743 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.6 p90 -147.61 -172.86 4.13 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.515 -1.274 . . . . 0.14999999999999999 112.007 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.6 mmm180 -136.35 130.06 32.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.614 -0.721 . . . . 2.1299999999999999 111.61 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 22' ' ' ARG . 4.3 ttp180 -19.11 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.126 0.891 . . . . 4.0899999999999999 112.922 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.8 62.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.25 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.93 117.79 20.34 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.801 -1.185 . . . . 0.40000000000000002 107.801 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -73.72 111.73 9.14 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.809 -1.156 . . . . 0.66000000000000003 112.722 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.553 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.27 146.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.009 -1.478 . . . . 0.16 107.009 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 10.4 t-80 -103.43 100.21 10.07 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.463 -1.31 . . . . 0.38 107.463 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 3' ' ' THR . 3.9 t -65.46 89.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.771 -1.104 . . . . 0.17000000000000001 110.949 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 7.7 tpp -78.55 -28.07 45.98 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 113.889 -1.505 . . . . 3.0699999999999998 111.874 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 33' ' ' SER . 1.6 t70 -161.28 82.29 0.62 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 117.771 -1.572 . . . . 1.3300000000000001 111.663 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 10.1 p-10 -54.1 96.62 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.689 -1.205 . . . . 0.76000000000000001 109.038 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' ASP . 45.9 m -96.94 -84.96 0.36 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.225 -0.99 . . . . 1.0 111.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -65.45 158.88 71.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 C-N-CA 119.299 -0.96 . . . . 0.51000000000000001 111.575 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.39 -65.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.616 1.544 . . . . 0.45000000000000001 111.22 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 6.3 t-20 -82.23 -0.07 43.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.411 -0.813 . . . . 0.63 111.348 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.8 m95 -137.19 148.99 46.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.657 -0.868 . . . . 0.33000000000000002 108.657 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 7.7 m0 -144.51 169.57 17.71 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.141 -1.023 . . . . 0.52000000000000002 112.378 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -109.96 123.65 50.01 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 106.854 -1.536 . . . . 1.71 106.854 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -154.09 -150.26 5.44 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.296 -1.907 . . . . 0.16 109.188 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.36 172.97 12.76 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 117.983 -1.487 . . . . 0.20999999999999999 112.448 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' GLY . 13.1 t -169.96 -96.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.826 -1.15 . . . . 0.31 111.478 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.646 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.1 p80 -57.85 77.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.762 -0.775 . . . . 0.37 111.378 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.6 22.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.318 -0.944 . . . . 0.28000000000000003 111.765 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.9 mt-30 -146.6 136.24 23.08 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.927 -1.109 . . . . 2.6800000000000002 111.121 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.0 p -88.93 -179.49 5.96 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.655 -0.818 . . . . 0.17000000000000001 109.593 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.72 -172.97 31.79 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.623 -1.751 . . . . 0.13 111.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtp -103.98 141.04 36.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.311 -0.556 . . . . 0.35999999999999999 110.716 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -145.76 145.89 27.06 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.558 -0.857 . . . . 0.14000000000000001 109.835 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.43 128.89 31.96 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 N-CA-C 110.098 -0.77 . . . . 0.20999999999999999 110.098 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 38' ' ' TRP . 2.1 tmt_? -65.44 -30.97 71.83 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.392 -0.923 . . . . 2.5499999999999998 111.672 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -77.34 4.38 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.79 -1.164 . . . . 2.0 112.018 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.48 11.09 39.69 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.405 -0.918 . . . . 0.46000000000000002 109.431 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.6 m -139.98 173.65 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.835 -1.075 . . . . 0.089999999999999997 109.076 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 146.83 18.25 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 118.57 -1.252 . . . . 0.17000000000000001 109.368 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.91 154.44 44.39 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 120.503 0.802 . . . . 0.28999999999999998 111.013 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.8 t -75.44 89.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.241 -0.983 . . . . 1.27 110.298 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.23 -175.76 4.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.383 -0.927 . . . . 9.8499999999999996 111.072 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 116.46 -1.733 . . . . 10.17 111.099 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 2.4700000000000002 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -82.49 98.28 8.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.495 -0.882 . . . . 2.6200000000000001 110.801 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.631 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.6 OUTLIER -135.11 38.17 2.98 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.045 0.926 . . . . 0.96999999999999997 109.879 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.443 ' CZ ' ' ND1' ' A' ' 28' ' ' HIS . 63.6 m-85 -126.89 130.67 50.61 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.082 -0.963 . . . . 1.73 110.373 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 27' ' ' ILE . 11.4 m -123.29 -165.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.928 -1.033 . . . . 0.23000000000000001 110.354 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.489 ' O ' ' C ' ' A' ' 7' ' ' ALA . 9.1 mt-30 -143.92 100.08 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.169 -1.419 . . . . 0.60999999999999999 107.169 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -25.5 111.76 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.366 -1.288 . . . . 0.12 113.279 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.0 tp -66.51 -47.74 72.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.58 -0.736 . . . . 1.5600000000000001 109.671 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -131.06 -179.28 5.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.617 -1.253 . . . . 0.90000000000000002 107.617 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.05 135.55 35.85 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 106.758 -1.571 . . . . 0.29999999999999999 106.758 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -122.48 112.68 18.33 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.405 -1.318 . . . . 0.16 114.31 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER -94.15 142.81 25.43 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 106.783 -1.562 . . . . 4.5499999999999998 106.783 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 12' ' ' ASP . 82.9 Cg_exo -49.63 -160.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 120.527 0.818 . . . . 1.23 113.568 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.599 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 158.34 -16.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.651 -1.159 . . . . 4.3799999999999999 107.934 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -106.71 156.07 19.02 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.436 -1.256 . . . . 4.6200000000000001 109.306 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -65.03 115.05 5.03 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.694 -1.202 . . . . 4.8499999999999996 111.487 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.11 95.85 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 119.644 -1.265 . . . . 0.46000000000000002 110.632 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.21 171.76 8.87 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.946 -1.102 . . . . 0.83999999999999997 109.482 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.646 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 7.2 tp -77.91 158.35 29.42 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.549 0.944 . . . . 0.84999999999999998 113.549 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -149.96 123.51 1.59 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.531 -1.428 . . . . 0.27000000000000002 109.531 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.9 p90 -147.78 -168.39 3.05 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.783 -1.167 . . . . 0.26000000000000001 111.91 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.8 mmm-85 -139.08 133.94 32.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.907 -0.717 . . . . 2.6600000000000001 111.599 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -18.83 139.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.15 0.907 . . . . 3.3799999999999999 113.224 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -19.37 31.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.291 -1.524 . . . . 0.17000000000000001 109.291 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.74 121.66 15.92 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.871 -1.132 . . . . 0.56000000000000005 108.947 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.13 104.65 7.74 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.687 -1.205 . . . . 0.77000000000000002 112.175 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.556 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -74.31 147.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.412 -1.329 . . . . 0.12 107.412 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.443 ' ND1' ' CZ ' ' A' ' 4' ' ' TYR . 17.5 t60 -107.76 96.73 6.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.865 -1.134 . . . . 0.65000000000000002 108.425 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.518 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.4 t -60.04 90.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.777 -1.101 . . . . 0.39000000000000001 113.336 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -61.62 -33.86 74.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.033 -1.067 . . . . 1.9299999999999999 109.984 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -178.56 111.74 0.06 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.676 -1.21 . . . . 2.2999999999999998 111.105 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -57.29 99.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.232 -1.387 . . . . 2.2400000000000002 109.272 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -94.19 -68.16 0.82 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.143 -1.023 . . . . 2.0 111.434 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.512 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -86.61 160.07 51.28 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 118.851 -1.139 . . . . 0.81000000000000005 110.888 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.08 -68.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.428 1.419 . . . . 0.47999999999999998 111.021 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -81.85 -2.61 51.66 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.391 -0.822 . . . . 0.76000000000000001 111.43 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 28.9 m95 -133.1 153.94 51.04 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 108.738 -0.838 . . . . 0.34000000000000002 108.738 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.1 m0 -149.04 168.04 24.22 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.957 -0.697 . . . . 0.39000000000000001 111.129 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -108.03 130.52 55.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.41 -1.33 . . . . 0.5 107.41 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.71 -152.19 6.34 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 117.71 -2.186 . . . . 0.16 110.106 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.758 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.46 161.54 27.18 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 117.921 -1.511 . . . . 0.40000000000000002 112.425 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 41.7 t -158.39 -89.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.895 -1.122 . . . . 0.27000000000000002 111.853 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.642 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.2 p80 -60.73 73.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.849 -0.74 . . . . 0.40999999999999998 111.039 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.47 19.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.026 -1.083 . . . . 0.34999999999999998 111.006 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' HIS . 9.1 mm100 -144.08 135.1 25.37 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.021 -1.071 . . . . 4.1299999999999999 111.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.1 p -84.24 -174.78 5.47 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.724 -0.79 . . . . 0.34999999999999998 110.727 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.96 -167.62 27.73 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.56 -1.305 . . . . 0.29999999999999999 111.013 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.9 mtp -109.3 144.28 37.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.168 -0.613 . . . . 0.40000000000000002 111.517 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 27' ' ' ILE . 9.5 p90 -145.54 144.3 22.38 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 115.384 -0.826 . . . . 0.29999999999999999 109.567 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.71 126.2 21.65 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.303 0.668 . . . . 0.28000000000000003 110.386 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -61.91 -30.77 71.11 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.428 -0.806 . . . . 3.04 111.543 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.79 1.93 18.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.848 -1.141 . . . . 3.2799999999999998 112.595 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.92 12.8 36.94 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.301 -0.96 . . . . 0.20000000000000001 109.635 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -139.93 174.74 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.265 -0.879 . . . . 0.089999999999999997 110.347 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 139.65 12.52 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.035 -1.066 . . . . 0.14999999999999999 109.679 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.82 152.31 64.67 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.125 1.217 . . . . 0.64000000000000001 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG13 ' NE2' ' A' ' 6' ' ' GLN . 1.9 t -95.46 42.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.582 -0.735 . . . . 1.8400000000000001 109.826 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -77.85 109.79 12.18 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.569 -0.852 . . . . 5.2800000000000002 111.145 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 116.394 -1.765 . . . . 6.7699999999999996 111.054 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 110.052 -1.219 . . . . 2.9500000000000002 110.052 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 103.56 16.26 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.314 -0.954 . . . . 3.0899999999999999 110.587 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.636 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.5 OUTLIER -133.8 37.62 3.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.849 0.833 . . . . 0.84999999999999998 110.535 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.438 ' CZ ' ' CE1' ' A' ' 28' ' ' HIS . 58.7 m-85 -126.31 126.28 43.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.442 -0.903 . . . . 1.5 110.916 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 27' ' ' ILE . 6.3 m -117.57 -165.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 114.821 -1.081 . . . . 0.23999999999999999 109.555 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.517 ' O ' ' C ' ' A' ' 7' ' ' ALA . 14.9 mt-30 -145.46 94.52 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.818 -1.179 . . . . 0.29999999999999999 107.818 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.46 110.97 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.251 -1.341 . . . . 0.11 113.211 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.52 -46.16 80.7 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.045 -0.525 . . . . 0.92000000000000004 109.944 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.25 -179.32 5.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.028 -1.101 . . . . 0.65000000000000002 108.028 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.72 136.3 36.74 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.278 -1.328 . . . . 0.67000000000000004 108.225 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -127.61 109.37 11.63 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.755 -1.178 . . . . 0.17000000000000001 114.002 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.94 143.19 27.34 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 117.722 -1.591 . . . . 1.8 106.744 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 163.12 1.63 Allowed 'Trans proline' 0 C--N 1.295 -2.252 0 CA-C-O 121.536 0.557 . . . . 0.31 112.708 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.558 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 25.9 mt-30 -154.42 -11.62 0.13 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.546 -1.206 . . . . 1.3 108.44 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.21 174.2 6.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.486 -1.234 . . . . 4.0099999999999998 110.33 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.14 4.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.887 -1.125 . . . . 5.8899999999999997 110.936 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.37 32.89 31.0 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.48 -1.343 . . . . 1.0600000000000001 110.777 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -74.27 173.63 9.92 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.891 -1.152 . . . . 0.27000000000000002 107.891 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -69.64 164.05 24.22 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 119.941 -0.704 . . . . 0.20999999999999999 112.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.92 121.81 1.1 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.545 -1.022 . . . . 0.12 110.545 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 6.3 p90 -147.01 -170.49 3.55 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.465 -1.294 . . . . 0.14999999999999999 112.516 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.5 mmt180 -136.51 130.74 32.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.181 -0.918 . . . . 3.5299999999999998 111.435 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' ARG . 3.3 ttp85 -16.42 138.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.03 1.122 . . . . 1.8400000000000001 114.03 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.32 -22.38 13.12 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.412 -1.475 . . . . 0.40999999999999998 109.412 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.84 121.53 13.71 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.957 -1.097 . . . . 1.3300000000000001 108.261 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -77.36 106.83 9.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.439 -1.304 . . . . 0.96999999999999997 112.174 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -73.77 143.82 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.356 -1.349 . . . . 0.20000000000000001 107.356 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' CE1' ' CZ ' ' A' ' 4' ' ' TYR . 7.3 t60 -103.56 94.01 5.24 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.6 -1.24 . . . . 0.23000000000000001 108.796 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.521 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.4 t -59.24 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 114.56 -1.2 . . . . 0.31 112.783 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.603 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 30.7 mtt -72.5 -30.66 64.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.999 -1.0 . . . . 1.75 111.052 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -159.21 93.58 1.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.283 -1.367 . . . . 1.1499999999999999 111.404 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 94.11 0.57 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.868 -1.133 . . . . 2.73 109.333 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t -98.16 -74.34 0.58 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.326 -0.95 . . . . 1.9099999999999999 112.209 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -69.24 157.27 89.78 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.763 -1.175 . . . . 0.45000000000000001 111.48 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.54 -65.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.176 1.918 . . . . 0.55000000000000004 111.961 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 5.7 t30 -87.53 5.78 37.48 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.768 -0.773 . . . . 2.3199999999999998 111.396 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 14.9 m95 -139.73 147.64 41.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.259 -1.015 . . . . 0.39000000000000001 108.259 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.3 m0 -147.29 172.11 14.37 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.36 -0.936 . . . . 0.35999999999999999 111.383 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -112.75 129.4 56.43 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.639 -1.245 . . . . 0.14999999999999999 107.639 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.43 -144.71 4.06 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 118.261 -1.923 . . . . 0.12 109.335 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.09 174.96 9.82 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 117.824 -1.55 . . . . 0.080000000000000002 112.704 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' GLY . 38.9 t -170.52 -95.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.147 -1.021 . . . . 0.22 112.071 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 6.5 p80 -58.61 78.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.458 -0.897 . . . . 0.55000000000000004 111.415 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.75 25.64 0.22 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.101 -1.047 . . . . 0.42999999999999999 111.956 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.48 149.24 25.31 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 117.941 -1.503 . . . . 4.7800000000000002 111.902 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.9 p -95.68 -175.75 3.53 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.799 -0.76 . . . . 0.14999999999999999 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.51 -164.73 29.08 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.237 -1.459 . . . . 0.13 111.392 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.4 mtp -109.39 145.66 35.74 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.466 -0.494 . . . . 0.23000000000000001 111.258 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.2 p90 -148.82 142.49 16.2 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.369 -0.932 . . . . 0.14999999999999999 109.408 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.46 123.81 14.75 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.712 -0.919 . . . . 0.27000000000000002 109.712 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -61.85 -29.82 70.44 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.078 -1.049 . . . . 2.4399999999999999 111.354 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -73.26 -5.0 36.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.839 -1.144 . . . . 2.98 112.176 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.82 10.4 35.41 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.052 -1.059 . . . . 0.25 109.778 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.8 m -136.85 172.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.335 -0.848 . . . . 0.19 109.859 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -142.65 122.95 8.1 Favored Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.554 -0.859 . . . . 0.42999999999999999 109.142 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.06 145.19 98.5 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.345 0.697 . . . . 1.8700000000000001 112.241 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.59 78.3 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 115.353 -0.84 . . . . 3.2999999999999998 111.154 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -149.57 164.53 34.84 Favored 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 119.678 -0.809 . . . . 4.5099999999999998 110.313 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 116.262 -1.827 . . . . 8.0899999999999999 110.878 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 110.01 -1.236 . . . . 4.5 110.01 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.04 142.79 18.98 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.565 -0.854 . . . . 6.5700000000000003 111.033 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 1.5 p -64.48 162.0 16.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.611 -0.836 . . . . 2.4100000000000001 110.869 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 178.84 154.73 0.42 Allowed 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.323 -1.351 . . . . 1.9099999999999999 113.192 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 27' ' ' ILE . 17.9 m -141.75 -170.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.788 -1.097 . . . . 0.25 108.557 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.499 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -141.8 100.63 3.79 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.762 -1.199 . . . . 0.47999999999999998 107.762 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -26.49 113.45 0.05 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.582 -1.19 . . . . 0.16 112.913 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.465 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.6 -39.55 91.67 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.565 0.698 . . . . 0.70999999999999996 109.753 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.62 -174.72 4.68 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.895 -1.048 . . . . 1.6000000000000001 108.827 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.2 122.4 26.8 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.218 -1.355 . . . . 0.82999999999999996 109.363 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -111.28 99.23 8.08 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.897 -1.121 . . . . 0.34000000000000002 113.578 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -77.17 148.77 78.6 Favored Pre-proline 0 C--N 1.294 -1.819 0 C-N-CA 115.916 -2.314 . . . . 1.51 104.805 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 12' ' ' ASP . 84.0 Cg_exo -50.54 -147.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 120.7 0.933 . . . . 1.72 112.915 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 1.6 mt-30 159.25 -30.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.557 -0.905 . . . . 1.5700000000000001 108.557 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.49 176.1 6.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.8 -1.091 . . . . 0.73999999999999999 110.136 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 110.68 16.42 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.78 -1.168 . . . . 5.4000000000000004 110.59 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.39 32.41 79.27 Favored Glycine 0 N--CA 1.483 1.809 0 C-N-CA 119.023 -1.56 . . . . 0.46000000000000002 109.931 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -87.16 171.77 10.43 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.386 -0.968 . . . . 0.35999999999999999 108.386 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.601 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.8 tp -71.93 164.21 26.48 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.75 0.786 . . . . 0.14999999999999999 112.757 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.42 117.89 0.8 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.395 -1.882 . . . . 0.23999999999999999 108.395 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.7 p90 -140.62 -168.94 2.68 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.66 -1.216 . . . . 0.16 113.029 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' ARG . 9.6 mmm-85 -137.07 129.58 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.75 . . . . 2.5 112.775 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -13.68 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.458 1.098 . . . . 2.77 113.633 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.28 -22.73 5.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.802 -1.719 . . . . 0.48999999999999999 108.802 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' ARG . 4.4 m-20 -61.46 121.51 12.86 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 118.607 -1.237 . . . . 0.66000000000000003 107.968 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -77.81 112.24 14.47 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.874 -1.13 . . . . 1.1200000000000001 112.703 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -79.04 142.15 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.733 -1.21 . . . . 0.29999999999999999 107.733 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.454 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 20.4 t-80 -99.44 99.66 10.6 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.244 -1.382 . . . . 1.01 107.87 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 29' ' ' VAL . 3.1 t -66.33 92.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 C-N-CA 118.7 -1.2 . . . . 0.45000000000000001 110.35 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.511 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 5.1 mmt -71.9 -28.96 63.85 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.159 -1.382 . . . . 2.2999999999999998 111.729 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.48 104.81 0.21 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.1 -1.44 . . . . 1.6799999999999999 111.462 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -58.4 104.55 0.22 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.587 -1.245 . . . . 1.53 109.173 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -66.94 0.87 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.094 -1.042 . . . . 2.3799999999999999 111.478 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -98.65 159.49 30.29 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 119.404 -0.919 . . . . 0.62 111.266 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.95 -60.88 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.965 1.777 . . . . 0.48999999999999999 110.963 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -89.47 4.25 49.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.348 -0.842 . . . . 0.45000000000000001 111.408 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' ASP . 21.9 m95 -142.0 141.72 32.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.881 -0.785 . . . . 0.14999999999999999 108.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.6 m0 -141.92 169.72 17.06 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.651 -0.82 . . . . 0.52000000000000002 111.805 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -108.41 134.12 51.64 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.07 -1.085 . . . . 1.47 108.07 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.87 -148.7 5.5 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 117.812 -2.137 . . . . 0.20999999999999999 109.7 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.01 172.81 13.36 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.222 -1.391 . . . . 0.14999999999999999 112.114 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -172.01 -94.0 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.733 -1.187 . . . . 0.23000000000000001 112.005 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.627 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.9 p80 -58.42 77.64 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.539 -0.864 . . . . 0.56999999999999995 111.397 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.32 27.36 0.25 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.115 -1.041 . . . . 0.78000000000000003 111.499 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -156.61 151.83 26.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.162 -1.415 . . . . 1.04 111.757 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.1 p -97.51 -176.48 3.51 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.669 -0.812 . . . . 0.39000000000000001 110.473 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.69 -176.83 24.46 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.337 -1.411 . . . . 0.39000000000000001 111.628 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.9 mtp -100.45 150.63 22.44 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.327 0.584 . . . . 0.26000000000000001 111.378 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.596 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.7 p90 -151.7 146.2 18.55 Favored Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.311 -0.858 . . . . 0.14999999999999999 109.607 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.29 123.17 12.84 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 110.367 -0.666 . . . . 0.17999999999999999 110.367 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.05 -18.45 60.67 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.396 -0.922 . . . . 2.0899999999999999 111.078 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -86.64 0.4 54.6 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.737 -1.185 . . . . 2.77 111.733 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -100.27 9.64 42.42 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.365 -0.934 . . . . 0.39000000000000001 109.407 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -136.2 171.6 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 114.886 -1.052 . . . . 0.28000000000000003 108.989 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 144.55 19.68 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 119.231 -0.988 . . . . 0.34999999999999998 108.759 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.97 156.7 18.91 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 120.519 0.813 . . . . 0.60999999999999999 111.607 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.67 -54.47 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 1.0700000000000001 111.773 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -147.95 -176.59 5.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.136 -1.026 . . . . 6.7400000000000002 111.028 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 116.348 -1.786 . . . . 4.8099999999999996 110.629 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.782 -1.327 . . . . 1.76 109.782 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.1 t 165.65 -70.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.928 -0.709 . . . . 4.1299999999999999 109.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER 37.92 90.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.29 -0.868 . . . . 2.7999999999999998 112.287 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -176.27 150.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.578 -1.249 . . . . 1.97 111.996 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 27' ' ' ILE . 16.6 m -141.22 -164.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.16 -0.927 . . . . 0.17999999999999999 109.88 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.87 101.45 3.65 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.304 -1.369 . . . . 0.27000000000000002 107.304 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -28.13 115.66 0.09 Allowed 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.938 1.088 . . . . 0.16 113.938 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.81 -34.33 69.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.53 -0.915 . . . . 0.73999999999999999 108.53 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -174.62 4.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.639 -1.164 . . . . 0.72999999999999998 109.292 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 127.94 35.61 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.757 -1.565 . . . . 0.39000000000000001 109.453 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.58 108.23 16.88 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.332 -0.947 . . . . 0.32000000000000001 113.458 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.24 128.24 54.15 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 117.773 -1.571 . . . . 1.05 108.631 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.75 108.73 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 120.707 0.938 . . . . 1.47 113.851 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.539 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -90.03 -10.79 43.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.294 -1.002 . . . . 4.4000000000000004 108.294 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.12 179.19 5.36 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.727 -1.124 . . . . 1.0700000000000001 109.472 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -85.4 -57.62 3.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.814 -1.154 . . . . 3.4399999999999999 111.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.94 -7.65 66.86 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.81 -1.662 . . . . 1.3799999999999999 110.214 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 1.8 tt0 -54.4 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 115.633 1.716 . . . . 1.1000000000000001 115.633 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.33 170.06 8.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 110.747 -2.933 . . . . 0.40000000000000002 110.528 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.69 113.94 0.59 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.851 -1.166 . . . . 0.37 110.21 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.1 p90 -138.49 -162.05 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.937 -1.105 . . . . 0.31 112.196 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -147.82 133.14 18.49 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.961 -1.096 . . . . 6.0800000000000001 113.307 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.56 127.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.641 1.213 . . . . 2.3199999999999998 112.259 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 7' ' ' ALA . . . 91.16 -32.62 5.09 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 119.715 -1.231 . . . . 0.84999999999999998 110.484 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.59 125.99 24.66 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.393 -1.323 . . . . 2.04 108.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.94 113.66 14.88 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.024 -1.07 . . . . 0.72999999999999998 113.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.53 140.85 16.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.668 -1.213 . . . . 0.28000000000000003 108.062 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.6 t-80 -96.0 96.84 9.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.189 -1.404 . . . . 1.1100000000000001 108.53 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 3' ' ' THR . 10.8 t -64.8 100.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 119.018 -1.073 . . . . 0.41999999999999998 111.293 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.514 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mtt -67.08 -39.22 86.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.004 -1.078 . . . . 1.1100000000000001 108.547 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -179.23 116.29 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.98 -1.009 . . . . 1.46 109.654 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 9.0 p-10 -47.17 111.64 0.43 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.297 -1.361 . . . . 2.3700000000000001 109.346 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -42.43 11.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.138 -1.025 . . . . 1.23 112.208 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.94 162.12 58.67 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 119.906 -0.718 . . . . 1.0700000000000001 111.015 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 -61.05 0.48 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.894 1.729 . . . . 0.81000000000000005 111.985 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 48.8 t30 -99.65 17.83 19.57 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.604 -0.839 . . . . 0.95999999999999996 110.667 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 23.4 m95 -151.47 139.46 20.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.414 -0.958 . . . . 0.39000000000000001 108.414 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 26.4 m0 -138.79 175.9 9.16 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.334 -0.947 . . . . 0.23000000000000001 112.128 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 129.91 56.53 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.784 -1.561 . . . . 0.72999999999999998 106.784 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.24 -152.92 6.56 Favored Glycine 0 C--N 1.298 -1.573 0 C-N-CA 117.888 -2.101 . . . . 0.20000000000000001 109.834 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.44 168.28 18.65 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 118.225 -1.39 . . . . 0.35999999999999999 111.763 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 36.4 t -163.89 -91.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.689 -1.205 . . . . 0.52000000000000002 111.522 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.705 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 2.9 p80 -59.98 77.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.63 -0.828 . . . . 0.40000000000000002 111.429 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.93 23.74 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.098 -1.048 . . . . 0.46000000000000002 111.93 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -152.96 153.44 32.96 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.071 -1.452 . . . . 4.4500000000000002 111.201 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 41' ' ' ALA . 8.9 p -99.44 -174.89 2.84 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.652 -0.819 . . . . 0.34999999999999998 111.37 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.23 -172.09 28.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.356 -1.098 . . . . 0.22 110.356 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.3 mtp -105.03 157.99 16.86 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.747 -0.781 . . . . 0.58999999999999997 110.387 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.7 p90 -159.21 142.72 10.76 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.134 -1.061 . . . . 0.26000000000000001 108.134 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -54.76 127.0 24.33 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 CA-C-N 118.613 0.541 . . . . 0.32000000000000001 111.239 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.535 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -40.22 85.84 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.574 -0.851 . . . . 2.23 109.578 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.5 2.39 1.8 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.529 -0.868 . . . . 2.2799999999999998 112.867 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.79 10.39 41.2 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.101 -1.039 . . . . 0.17000000000000001 109.328 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 51' ' ' ARG . 14.2 m -141.58 175.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.13 109.463 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -147.21 128.09 7.06 Favored Pre-proline 0 C--N 1.3 -1.545 0 C-N-CA 119.23 -0.988 . . . . 0.29999999999999999 109.324 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.69 145.83 94.3 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.633 0.889 . . . . 1.5800000000000001 112.47 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -92.25 -170.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.393 -0.821 . . . . 3.6000000000000001 110.794 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.41 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -92.88 172.36 8.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.327 -0.949 . . . . 6.3300000000000001 110.776 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 . . . . . 0 C--N 1.304 -1.403 0 CA-C-O 116.34 -1.791 . . . . 8.6899999999999995 111.035 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 110.066 -1.214 . . . . 6.7000000000000002 110.066 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -112.28 -163.52 0.86 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.897 -0.721 . . . . 2.27 111.215 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 95.3 2.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.857 -0.737 . . . . 2.77 110.706 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -171.08 153.19 3.67 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.357 -1.337 . . . . 0.89000000000000001 112.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 27' ' ' ILE . 6.2 m -143.81 -170.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.078 -0.964 . . . . 0.28999999999999998 110.011 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 55' ' ' THR . 8.4 mt-30 -141.72 101.13 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.678 -1.23 . . . . 0.35999999999999999 107.678 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.26 110.55 0.06 Allowed 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.188 -0.915 . . . . 0.19 113.116 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.53 -42.04 87.82 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.469 0.652 . . . . 1.1699999999999999 109.978 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.56 -178.24 4.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.741 -1.118 . . . . 1.3999999999999999 108.758 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 140.59 32.44 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 113.435 -1.711 . . . . 1.01 106.995 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.57 106.99 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.031 1.493 . . . . 0.37 115.031 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.13 137.72 29.31 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 105.925 -1.88 . . . . 2.0099999999999998 105.925 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.62 162.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.348 0 CA-C-O 121.794 0.664 . . . . 0.40999999999999998 112.969 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.54 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 91.0 mt-30 -151.61 -12.18 0.2 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.966 -1.47 . . . . 1.6299999999999999 108.1 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.7 mt-10 -114.9 166.97 11.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.335 -1.302 . . . . 4.2300000000000004 109.651 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -64.5 123.72 19.96 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.259 -1.376 . . . . 5.9500000000000002 110.202 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 47.03 37.96 10.26 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 119.349 -1.405 . . . . 0.75 111.161 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.78 172.2 12.43 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.941 -1.104 . . . . 1.28 108.089 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.4 tp -69.0 154.61 41.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 112.858 0.688 . . . . 0.54000000000000004 112.858 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.15 123.13 1.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.659 -1.377 . . . . 0.14999999999999999 109.659 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.6 p90 -146.44 -176.11 5.05 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.582 -1.247 . . . . 0.13 112.03 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.9 mmt85 -135.73 127.72 29.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.498 -0.774 . . . . 2.3500000000000001 111.305 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -13.56 135.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.03 1.122 . . . . 1.1299999999999999 114.03 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.39 -21.82 30.11 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.20999999999999999 109.402 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -69.09 117.52 10.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.731 -1.211 . . . . 0.93999999999999995 107.731 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -73.28 108.3 6.08 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.978 -1.089 . . . . 0.93000000000000005 112.174 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -73.38 142.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.068 -1.456 . . . . 0.19 107.068 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 62.9 t60 -101.45 99.17 9.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.861 -1.536 . . . . 1.3100000000000001 108.125 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 29' ' ' VAL . 6.4 t -64.74 102.43 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 C-N-CA 118.731 -1.187 . . . . 0.27000000000000002 110.12 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.492 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.6 ttp -93.32 -21.96 19.26 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.825 -1.08 . . . . 1.7 111.216 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.01 87.82 0.94 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.092 -1.443 . . . . 1.97 111.734 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.15 82.78 0.23 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.78 -1.168 . . . . 2.0800000000000001 108.755 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -95.7 -83.14 0.37 Allowed 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.191 -1.003 . . . . 1.51 111.855 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.1 m-20 -57.85 156.15 19.93 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 118.675 -1.21 . . . . 0.84999999999999998 111.352 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.17 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.896 1.731 . . . . 0.35999999999999999 111.833 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -81.88 -3.26 53.72 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.225 -0.898 . . . . 0.31 111.556 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 32.8 m95 -129.67 151.8 49.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.18 -1.044 . . . . 0.80000000000000004 108.18 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.2 m0 -151.81 164.85 36.17 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.04 -0.664 . . . . 0.59999999999999998 110.905 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -108.16 137.79 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.579 -1.267 . . . . 0.59999999999999998 107.579 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.492 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.52 -148.71 5.35 Favored Glycine 0 C--O 1.214 -1.145 0 C-N-CA 118.078 -2.01 . . . . 0.38 109.54 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.17 154.39 10.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.403 -1.319 . . . . 0.76000000000000001 112.185 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 44' ' ' GLY . 35.1 t -155.25 -100.93 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.956 -1.098 . . . . 0.38 111.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.63 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.4 p80 -53.65 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.571 -0.74 . . . . 0.46999999999999997 111.715 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 26.66 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.139 -1.029 . . . . 0.46000000000000002 112.268 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 mm-40 -156.73 149.9 24.11 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.408 -1.317 . . . . 4.5199999999999996 111.982 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.1 p -97.27 -172.9 2.53 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.604 -0.726 . . . . 0.20999999999999999 110.855 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.52 -171.15 26.65 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.374 -1.393 . . . . 0.20000000000000001 111.422 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 18.7 mtp -104.9 145.46 30.38 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.241 -0.584 . . . . 0.62 111.489 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.4 p90 -149.42 141.17 14.81 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 119.516 -0.874 . . . . 0.16 109.94 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.31 128.31 29.91 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 N-CA-C 110.067 -0.782 . . . . 0.28999999999999998 110.067 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -23.01 64.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.411 -0.916 . . . . 2.7999999999999998 111.56 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -84.38 10.18 11.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.712 -1.195 . . . . 4.6699999999999999 111.383 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.01 6.85 29.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.814 -0.755 . . . . 0.33000000000000002 109.112 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.0 m -134.7 175.07 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.553 -1.203 . . . . 0.26000000000000001 109.603 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -140.88 135.03 15.13 Favored Pre-proline 0 C--N 1.305 -1.344 0 C-N-CA 119.414 -0.914 . . . . 0.39000000000000001 108.949 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -66.11 144.19 74.59 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 120.576 0.851 . . . . 1.3600000000000001 113.114 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.18 -1.77 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.502 -0.925 . . . . 2.27 108.502 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 59' ' ' ARG . 21.4 t-20 -143.51 -105.1 0.12 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.723 -1.126 . . . . 4.4500000000000002 110.106 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 58' ' ' ASN . 16.3 ttm180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 116.446 -1.74 . . . . 13.68 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.832 -1.307 . . . . 4.7999999999999998 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -162.01 152.79 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.124 -1.03 . . . . 5.3200000000000003 111.513 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.56 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -131.75 172.43 12.29 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.233 -0.894 . . . . 2.5699999999999998 109.554 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 175.21 148.79 0.09 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.135 -1.426 . . . . 1.9099999999999999 113.24 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 27' ' ' ILE . 16.9 m -137.87 -164.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 115.174 -0.921 . . . . 0.20999999999999999 109.218 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.511 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -145.26 97.48 3.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.286 -1.005 . . . . 0.41999999999999998 108.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.4 115.25 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.729 -1.123 . . . . 0.14999999999999999 113.282 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 17.2 tp -64.95 -41.27 95.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.666 -0.697 . . . . 1.9399999999999999 109.425 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.68 -174.92 4.6 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.962 -1.017 . . . . 1.45 109.489 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.57 127.63 33.56 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 113.903 -1.499 . . . . 0.59999999999999998 107.456 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -114.44 103.89 11.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.453 1.279 . . . . 0.38 114.453 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 13' ' ' PRO . 5.0 m-20 -86.06 142.11 35.9 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 105.687 -1.968 . . . . 1.8200000000000001 105.687 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 12' ' ' ASP . 80.4 Cg_exo -47.55 -158.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 120.8 1.0 . . . . 1.6000000000000001 114.066 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 1.2 mm-40 165.67 -23.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.44 -1.254 . . . . 2.6000000000000001 107.635 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -102.57 148.64 25.3 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.379 -1.282 . . . . 5.4100000000000001 109.007 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.29 105.52 1.14 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.494 -1.282 . . . . 4.1600000000000001 111.211 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 32.15 29.73 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.712 -1.233 . . . . 0.34999999999999998 110.666 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' OE2' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -93.63 170.75 9.35 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.195 -1.002 . . . . 0.88 109.545 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.606 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 11.3 tp -72.16 155.99 39.65 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.003 -0.999 . . . . 1.0800000000000001 113.291 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.48 117.2 0.86 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 107.999 -2.04 . . . . 0.41999999999999998 107.999 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -139.52 -169.3 2.66 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.889 -1.124 . . . . 0.32000000000000001 113.064 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -133.97 130.14 37.23 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.463 -0.79 . . . . 3.3300000000000001 112.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -18.71 137.92 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.829 0.706 . . . . 2.6299999999999999 112.879 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 -21.5 15.23 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.916 -1.674 . . . . 0.33000000000000002 108.916 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -64.85 121.73 15.29 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.935 -1.106 . . . . 0.34000000000000002 108.308 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 110.2 11.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.986 -1.086 . . . . 0.84999999999999998 112.763 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.559 HG22 HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -76.18 146.85 8.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.784 -1.191 . . . . 0.20000000000000001 107.784 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -103.49 89.78 3.47 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.277 -1.369 . . . . 1.01 109.408 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 3' ' ' THR . 2.3 t -59.83 94.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 118.677 -1.209 . . . . 0.66000000000000003 110.285 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.507 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 15.4 mtp -74.88 -29.57 61.05 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.655 -1.157 . . . . 1.98 110.482 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.25 99.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 117.946 -1.502 . . . . 2.3199999999999998 111.805 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 0.7 OUTLIER -54.56 101.53 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.103 -1.439 . . . . 1.45 108.326 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -94.04 -72.89 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.007 -1.077 . . . . 1.05 111.735 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.1 m-20 -80.34 160.55 67.53 Favored Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.049 -1.06 . . . . 0.64000000000000001 111.0 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.34 -68.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.577 1.518 . . . . 0.46000000000000002 111.127 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -87.13 4.13 43.54 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.712 -0.795 . . . . 0.26000000000000001 111.577 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.2 m95 -136.66 148.62 47.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.465 -0.939 . . . . 0.11 108.465 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 22.8 m0 -142.37 175.55 9.68 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.616 -0.834 . . . . 0.17999999999999999 111.5 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 133.03 56.32 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.965 -1.494 . . . . 0.56000000000000005 106.965 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.71 -150.68 5.91 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 117.918 -2.086 . . . . 0.14999999999999999 109.261 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.68 159.66 19.1 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 118.226 -1.389 . . . . 0.53000000000000003 111.662 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' GLY . 40.6 t -155.37 -100.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.553 -1.259 . . . . 0.32000000000000001 112.097 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.517 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 5.7 p80 -52.77 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.584 -0.735 . . . . 0.69999999999999996 111.899 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.2 24.05 0.1 OUTLIER Glycine 0 N--CA 1.489 2.216 0 CA-C-N 115.167 -0.924 . . . . 0.46999999999999997 112.252 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 tp60 -156.16 163.71 39.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.814 -1.554 . . . . 4.2800000000000002 111.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.719 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.8 p -99.82 -177.26 3.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.341 -0.845 . . . . 0.48999999999999999 111.313 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.99 171.39 18.36 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.01 -1.567 . . . . 0.76000000000000001 111.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 mtp -95.92 146.28 24.72 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 120.218 -0.593 . . . . 0.59999999999999998 110.394 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 10.1 p90 -148.78 145.54 20.06 Favored Pre-proline 0 C--N 1.296 -1.743 0 C-N-CA 119.403 -0.919 . . . . 0.23000000000000001 108.859 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.93 128.04 27.43 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.008 0.472 . . . . 0.14999999999999999 110.973 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -59.16 -36.56 75.5 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 3.6200000000000001 110.253 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 26.7 t-20 -75.13 3.32 8.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.473 -0.891 . . . . 3.6899999999999999 112.787 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.12 9.16 43.25 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.905 -1.118 . . . . 0.19 109.598 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.5 m -138.42 177.94 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.943 -1.026 . . . . 0.20000000000000001 109.03 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -148.8 133.18 8.86 Favored Pre-proline 0 C--N 1.297 -1.689 0 C-N-CA 119.18 -1.008 . . . . 0.20000000000000001 109.259 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.09 149.8 60.69 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 120.363 0.709 . . . . 1.1200000000000001 111.632 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.54 -15.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.268 -0.973 . . . . 1.3100000000000001 110.702 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.03 -175.57 4.61 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.48 -0.888 . . . . 2.96 110.452 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.388 0 CA-C-O 116.216 -1.85 . . . . 7.6600000000000001 110.739 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 109.954 -1.258 . . . . 8.8399999999999999 109.954 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m 46.45 -105.1 0.11 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.497 -0.881 . . . . 2.6099999999999999 110.77 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.1 94.34 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.718 -0.674 . . . . 2.8999999999999999 110.448 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 3' ' ' THR . 1.8 m-85 -172.17 159.52 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.681 -1.608 . . . . 0.73999999999999999 113.091 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 27' ' ' ILE . 16.0 m -147.45 -167.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 115.062 -0.972 . . . . 0.23999999999999999 109.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 7' ' ' ALA . 14.9 mt-30 -144.88 97.08 2.96 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.588 -1.264 . . . . 0.32000000000000001 107.588 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HA ' HG12 ' A' ' 54' ' ' VAL . . . -24.22 115.54 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.359 -1.291 . . . . 0.16 113.663 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -70.77 -42.09 70.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.809 -0.632 . . . . 0.88 109.888 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 -179.94 5.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.478 1.132 . . . . 1.1299999999999999 109.155 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -85.31 124.76 32.3 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.107 -1.86 . . . . 0.71999999999999997 107.412 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -111.96 104.54 12.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.262 -0.975 . . . . 0.41999999999999998 112.798 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.4 p-10 -86.23 128.51 57.24 Favored Pre-proline 0 C--N 1.304 -1.37 0 C-N-CA 117.514 -1.675 . . . . 3.3500000000000001 108.765 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -39.84 149.23 0.13 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.146 1.23 . . . . 0.52000000000000002 114.095 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -137.97 4.72 2.53 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.87 -1.9 . . . . 2.1099999999999999 105.87 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -141.55 139.48 33.2 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.707 -2.042 . . . . 1.3500000000000001 109.657 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -89.03 42.88 1.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.282 -1.367 . . . . 4.4900000000000002 109.134 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -162.15 -9.05 0.04 OUTLIER Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.646 -1.381 . . . . 1.0800000000000001 109.646 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.576 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.2 pt-20 -99.75 -170.76 1.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.313 -0.955 . . . . 1.1599999999999999 111.732 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.576 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -84.82 170.22 13.39 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 116.138 1.903 . . . . 0.23999999999999999 116.138 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -158.93 119.66 0.91 Allowed Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.168 -1.833 . . . . 0.17000000000000001 109.209 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.567 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.5 p90 -144.97 -170.81 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.367 -1.333 . . . . 0.11 112.455 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 23' ' ' ARG . 5.1 mmt85 -136.88 126.91 25.98 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.544 -0.753 . . . . 1.9399999999999999 111.743 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.3 ttp85 -12.8 135.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.398 1.259 . . . . 2.8399999999999999 114.398 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.11 -23.81 10.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.52000000000000002 109.6 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -61.26 117.07 5.14 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.388 -1.325 . . . . 0.84999999999999998 107.891 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -71.89 107.57 4.72 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.48 -1.288 . . . . 0.93999999999999995 112.376 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.85 136.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.362 -1.347 . . . . 0.38 107.362 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.409 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 53.0 t60 -94.36 94.12 8.09 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.454 -1.699 . . . . 1.22 108.29 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 29' ' ' VAL . 7.7 t -61.01 100.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 C-N-CA 118.967 -1.093 . . . . 0.27000000000000002 111.388 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.42 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 8.6 tpp -61.51 -36.0 79.29 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.062 -1.055 . . . . 1.8200000000000001 108.931 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 p30 171.58 126.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.026 -0.988 . . . . 2.8399999999999999 109.39 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.405 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 5.2 p30 -49.97 109.78 0.32 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.914 -1.514 . . . . 2.75 109.716 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -92.51 -65.69 0.98 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.422 -0.911 . . . . 2.0800000000000001 110.162 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -102.57 160.75 25.36 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.021 -0.99 . . . . 0.63 110.315 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -59.47 -60.57 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.309 1.34 . . . . 0.58999999999999997 111.087 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -92.53 -3.58 54.87 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.666 -0.813 . . . . 0.47999999999999998 111.708 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 17.0 m95 -131.01 152.85 49.88 Favored 'General case' 0 C--O 1.204 -1.327 0 N-CA-C 108.343 -0.984 . . . . 0.38 108.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.677 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 15.2 m0 -145.24 177.91 8.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.69 -0.804 . . . . 0.33000000000000002 111.825 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -118.02 135.95 53.85 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.943 -1.132 . . . . 3.3199999999999998 107.943 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -165.89 -150.36 6.26 Favored Glycine 0 C--N 1.3 -1.451 0 C-N-CA 118.031 -2.033 . . . . 0.11 109.268 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.44 174.27 12.95 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 118.264 -1.374 . . . . 0.17999999999999999 111.877 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -170.33 -93.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.832 -1.147 . . . . 0.40000000000000002 112.156 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 7.7 p80 -59.69 78.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.259 -0.977 . . . . 0.81000000000000005 111.049 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.76 20.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.132 -0.94 . . . . 0.57999999999999996 111.688 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' HIS . 54.8 mt-30 -148.3 151.79 35.99 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.393 -1.323 . . . . 1.1399999999999999 111.745 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.2 p -96.14 -179.46 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.629 -0.828 . . . . 0.34999999999999998 110.239 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -179.06 28.21 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.019 -1.562 . . . . 0.37 111.092 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.6 mtp -102.79 147.04 27.36 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.398 0.618 . . . . 0.44 110.81 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -149.16 149.7 30.2 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.359 -0.837 . . . . 0.23000000000000001 108.799 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.11 131.16 37.6 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 N-CA-C 110.564 -0.591 . . . . 0.34999999999999998 110.564 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.677 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.39 -51.41 68.91 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.204 -0.998 . . . . 4.1699999999999999 109.755 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -61.1 9.12 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.522 0.934 . . . . 3.1400000000000001 113.522 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -104.39 3.75 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.112 -1.035 . . . . 0.46000000000000002 109.26 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ARG . 12.9 m -134.06 175.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.14000000000000001 108.875 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.21 130.47 10.8 Favored Pre-proline 0 C--N 1.299 -1.599 0 C-N-CA 119.305 -0.958 . . . . 0.32000000000000001 108.693 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.406 ' HD3' HH12 ' A' ' 51' ' ' ARG . 6.0 Cg_exo -54.47 147.17 48.83 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 CA-C-N 118.756 0.591 . . . . 1.01 111.426 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' H ' HG23 ' A' ' 57' ' ' VAL . 1.3 t -70.23 -58.54 5.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.765 -1.198 . . . . 1.23 107.765 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.63 -170.98 1.78 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.936 -1.135 . . . . 4.6799999999999997 107.936 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 116.326 -1.797 . . . . 5.1500000000000004 111.093 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.825 -1.31 . . . . 4.9299999999999997 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 p -170.54 16.66 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.703 -0.799 . . . . 3.9100000000000001 110.374 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.553 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -76.13 164.68 25.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.789 -0.764 . . . . 2.52 111.359 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.6 OUTLIER 175.84 151.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.264 -0.975 . . . . 1.3200000000000001 112.068 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 27' ' ' ILE . 10.0 m -140.75 -168.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.556 -0.747 . . . . 0.14999999999999999 109.52 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.6 mt-30 -143.05 89.67 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.828 -0.749 . . . . 0.28000000000000003 109.031 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -14.55 111.69 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.023 -1.444 . . . . 0.14999999999999999 114.139 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 6.1 tp -63.75 -52.98 57.97 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.639 -0.71 . . . . 1.76 109.537 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.23 -178.92 5.05 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.865 -1.161 . . . . 0.54000000000000004 107.865 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.85 136.48 36.7 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 114.328 -1.305 . . . . 0.31 109.088 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -123.69 109.55 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.958 -1.097 . . . . 0.25 113.391 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.4 133.81 32.33 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 117.816 -1.554 . . . . 1.27 108.452 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 15' ' ' GLU . 95.3 Cg_exo -43.64 106.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 120.703 0.935 . . . . 1.3799999999999999 112.986 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -86.02 12.19 10.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 106.271 -1.751 . . . . 2.5600000000000001 106.271 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' PRO . 4.9 mm-40 -141.01 -178.56 5.62 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.947 -1.933 . . . . 1.8999999999999999 110.251 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -120.46 26.54 9.11 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.684 0.754 . . . . 3.8900000000000001 109.28 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -158.6 1.02 0.1 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.209 -1.556 . . . . 0.83999999999999997 109.209 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -100.95 -174.21 2.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.29 -0.964 . . . . 0.97999999999999998 112.049 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.563 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.6 tp -76.71 166.06 23.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 115.492 1.664 . . . . 0.25 115.492 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.08 120.9 1.05 Allowed Glycine 0 N--CA 1.499 2.88 0 CA-C-N 114.237 -1.347 . . . . 0.17000000000000001 110.437 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.05 -175.54 5.0 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.073 -1.451 . . . . 0.20000000000000001 112.861 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' ARG . 31.3 mmt-85 -135.6 130.55 34.62 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.189 -0.914 . . . . 5.9500000000000002 111.603 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.98 140.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.456 1.28 . . . . 1.45 114.456 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.11 -15.07 29.67 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 114.067 -1.424 . . . . 0.17000000000000001 109.594 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -72.68 118.81 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.555 -1.276 . . . . 0.40999999999999998 107.555 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.69 107.21 5.8 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.687 -1.205 . . . . 0.73999999999999999 113.276 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -73.04 142.84 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.819 -1.548 . . . . 0.26000000000000001 106.819 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 15.8 t-80 -100.6 93.92 5.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.17 -1.412 . . . . 0.96999999999999997 108.887 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 29' ' ' VAL . 2.0 t -63.07 96.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 118.135 -1.426 . . . . 0.59999999999999998 110.5 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.469 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 57.6 ttm -82.48 -25.87 33.12 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.51 -1.223 . . . . 0.56999999999999995 110.706 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.9 85.06 0.95 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.15 -1.42 . . . . 2.0600000000000001 111.766 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.18 91.78 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.027 -1.069 . . . . 2.8799999999999999 109.0 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.2 m -103.1 -85.86 0.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.285 -0.966 . . . . 1.6899999999999999 111.936 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 8.4 m-20 -55.58 154.52 12.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 118.488 -1.285 . . . . 1.1299999999999999 110.753 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.05 -71.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.876 1.717 . . . . 0.39000000000000001 112.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.47 7.82 13.28 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.721 -0.792 . . . . 2.7400000000000002 111.387 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.3 m95 -139.85 146.19 39.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.617 -0.882 . . . . 0.42999999999999999 108.617 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.8 m0 -145.59 167.34 23.28 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.378 -0.929 . . . . 0.45000000000000001 111.447 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -108.21 132.1 54.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.241 -1.022 . . . . 0.23999999999999999 108.241 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.09 -146.66 4.62 Favored Glycine 0 C--N 1.3 -1.443 0 C-N-CA 117.883 -2.103 . . . . 0.16 109.116 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -163.76 159.21 21.11 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.173 -1.811 . . . . 0.41999999999999998 113.495 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 8.2 t -175.61 -179.72 1.28 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 2.9100000000000001 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.609 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 10.8 p80 40.78 26.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.802 -0.636 . . . . 1.3500000000000001 111.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 81.27 31.04 35.38 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.732 -1.223 . . . . 0.77000000000000002 112.778 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.6 tt0 -164.91 155.23 13.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.832 -1.547 . . . . 1.73 112.19 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.4 p -95.04 -179.5 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.399 -0.921 . . . . 0.20000000000000001 110.814 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 -159.2 28.27 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.14 -1.505 . . . . 0.32000000000000001 111.255 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.5 mtp -120.03 148.37 43.66 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.167 0.508 . . . . 0.28000000000000003 110.759 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.5 p90 -151.08 143.9 16.64 Favored Pre-proline 0 C--N 1.297 -1.712 0 C-N-CA 119.563 -0.855 . . . . 0.22 109.146 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.91 126.92 24.02 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 109.864 -0.86 . . . . 0.23000000000000001 109.864 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -60.88 -32.59 72.03 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.149 -1.02 . . . . 3.46 111.58 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 -74.54 0.12 15.86 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.494 -1.283 . . . . 1.7 112.349 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.39 12.56 32.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.93 -1.108 . . . . 0.19 109.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.6 m -139.38 171.0 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.983 -1.008 . . . . 0.14000000000000001 109.741 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -135.76 122.54 14.43 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.576 -0.898 . . . . 0.55000000000000004 108.576 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -64.05 144.47 87.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 CA-C-N 118.948 0.66 . . . . 1.7 112.04 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.14 99.11 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.435 -0.802 . . . . 4.0800000000000001 109.042 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -138.14 76.59 1.58 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.749 -0.78 . . . . 6.4800000000000004 111.773 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 116.298 -1.81 . . . . 7.4699999999999998 110.753 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 110.345 -1.102 . . . . 1.5 110.345 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m -149.15 34.59 0.73 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.574 -0.851 . . . . 1.71 110.926 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.456 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -64.54 94.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.87 -0.732 . . . . 2.8799999999999999 111.091 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -173.26 138.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.224 -1.391 . . . . 0.82999999999999996 112.66 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' ILE . 14.7 m -128.42 -167.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.266 -0.879 . . . . 0.27000000000000002 110.098 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.533 ' O ' HG22 ' A' ' 55' ' ' THR . 4.4 mt-30 -141.83 109.34 5.64 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.673 -1.603 . . . . 0.41999999999999998 106.673 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -34.79 115.73 0.29 Allowed 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.927 -1.109 . . . . 0.31 111.79 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.531 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 1.4 tt -73.71 -39.82 64.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.018 -0.992 . . . . 0.73999999999999999 109.837 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.99 -179.9 5.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.781 -1.1 . . . . 0.85999999999999999 108.582 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.61 135.47 36.06 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.294 -1.775 . . . . 0.53000000000000003 107.702 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -131.07 111.93 12.44 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.475 -1.29 . . . . 0.40999999999999998 113.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -94.26 131.58 31.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 118.023 -1.471 . . . . 3.79 107.928 179.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -42.55 110.97 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 120.616 0.878 . . . . 1.1899999999999999 112.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.559 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 14.5 mm-40 -111.82 15.75 20.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.921 -1.036 . . . . 2.6499999999999999 109.881 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 17.4 mm-40 -138.7 -178.16 5.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.814 -0.754 . . . . 3.1099999999999999 110.012 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 17' ' ' GLY . 5.5 p30 -73.21 129.21 37.55 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.509 -0.877 . . . . 6.7400000000000002 112.029 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 16' ' ' ASP . . . 34.42 38.37 0.11 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.975 -0.85 . . . . 0.56999999999999995 110.975 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -84.43 177.42 8.14 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.689 -0.804 . . . . 1.22 110.147 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.688 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -73.74 167.35 21.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.107 -0.951 . . . . 0.34999999999999998 112.109 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.76 130.12 2.68 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.598 -1.001 . . . . 0.23999999999999999 110.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 27' ' ' ILE . 9.4 p90 -156.75 -172.05 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.682 -1.607 . . . . 0.26000000000000001 113.075 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . 10.8 mmm180 -138.77 128.57 24.98 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.278 -0.874 . . . . 4.2999999999999998 112.153 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -12.7 135.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.295 1.22 . . . . 3.1000000000000001 114.295 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.63 -19.51 32.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.095 -1.602 . . . . 0.16 109.095 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -65.39 118.81 9.92 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.166 -1.014 . . . . 0.81000000000000005 108.777 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.78 107.79 7.1 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.068 -1.053 . . . . 1.3300000000000001 112.696 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.92 143.4 12.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.139 -1.43 . . . . 0.28999999999999998 107.139 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -100.82 95.24 6.5 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.739 -1.585 . . . . 1.26 108.767 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 3' ' ' THR . 3.8 t -64.83 106.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 118.114 -1.434 . . . . 0.44 109.613 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.3 tpp -88.75 -26.34 21.8 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.122 -0.944 . . . . 2.3500000000000001 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -172.06 108.52 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.691 -1.604 . . . . 1.6000000000000001 111.595 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.557 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 0.7 OUTLIER -62.33 100.01 0.16 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.381 -1.328 . . . . 1.72 109.249 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -91.25 -66.55 0.92 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.782 -1.167 . . . . 1.1299999999999999 111.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 4.3 m-20 -90.19 159.9 41.2 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 119.226 -0.99 . . . . 2.3500000000000001 110.726 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.54 -65.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.443 1.429 . . . . 0.38 111.066 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -83.14 -8.93 59.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.489 -0.778 . . . . 0.92000000000000004 111.559 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 18.9 m95 -126.57 155.94 41.65 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.768 -0.827 . . . . 0.39000000000000001 108.768 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.6 m0 -149.84 -179.31 7.03 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.507 -0.877 . . . . 0.57999999999999996 112.151 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -122.43 128.13 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.879 -1.156 . . . . 0.65000000000000002 107.879 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.87 -148.43 4.99 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.587 -1.805 . . . . 0.19 108.587 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.739 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.91 159.05 17.82 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 117.303 -1.759 . . . . 0.57999999999999996 113.763 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' GLY . 43.2 t -172.7 -178.85 1.99 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.543 -1.208 . . . . 2.5299999999999998 111.041 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 4.0 p80 39.6 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.874 -0.603 . . . . 1.55 111.616 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 85.9 30.47 23.31 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.718 -1.229 . . . . 0.40999999999999998 112.907 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 46' ' ' THR . 1.3 tm0? -164.37 151.72 11.81 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.119 -1.433 . . . . 4.4199999999999999 111.814 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.739 HG22 ' HB2' ' A' ' 41' ' ' ALA . 6.1 p -94.28 -175.69 3.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.55 -0.86 . . . . 0.28000000000000003 110.689 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.15 -170.07 29.49 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.462 -1.351 . . . . 0.17000000000000001 110.933 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.0 mtp -107.76 143.91 35.63 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.975 -0.69 . . . . 0.27000000000000002 111.095 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.5 p90 -148.52 145.59 20.55 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 119.701 -0.8 . . . . 0.25 110.093 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.43 125.64 19.46 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 N-CA-C 109.966 -0.821 . . . . 0.34999999999999998 109.966 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.31 -25.22 67.53 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.626 -0.829 . . . . 2.04 112.211 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.25 7.44 16.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.367 -1.333 . . . . 2.2599999999999998 111.876 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.96 7.37 39.17 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.506 -0.878 . . . . 0.23000000000000001 109.547 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 11.6 m -135.18 179.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.767 -1.106 . . . . 0.29999999999999999 109.033 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -149.72 121.63 4.18 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 118.745 -1.182 . . . . 0.38 110.818 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.13 149.67 78.62 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 120.576 0.851 . . . . 1.96 111.747 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.35 124.96 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.649 -0.82 . . . . 3.73 110.617 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -138.49 -13.13 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.358 -0.937 . . . . 7.0700000000000003 110.46 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 C--N 1.298 -1.643 0 CA-C-O 116.197 -1.859 . . . . 8.0899999999999999 110.491 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 110.186 -1.166 . . . . 2.6499999999999999 110.186 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 p -142.67 146.6 34.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.739 -0.784 . . . . 2.3500000000000001 110.628 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -127.39 22.88 6.45 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.694 -0.802 . . . . 0.89000000000000001 111.181 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -87.94 155.17 19.98 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.329 -1.348 . . . . 2.1600000000000001 112.666 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 19.4 m -130.93 -166.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.308 -1.315 . . . . 0.20999999999999999 108.708 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.526 ' OE1' HG13 ' A' ' 57' ' ' VAL . 3.1 mt-30 -144.45 95.41 2.71 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.928 -1.138 . . . . 0.19 107.928 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.54 111.15 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.481 -1.236 . . . . 0.14999999999999999 113.186 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.523 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 14.0 tp -61.98 -45.72 92.39 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.514 0.673 . . . . 1.8700000000000001 109.682 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.09 -174.44 3.85 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.709 -1.132 . . . . 0.85999999999999999 108.252 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.84 148.31 30.02 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 114.168 -1.378 . . . . 0.27000000000000002 107.805 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -139.21 119.35 13.56 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.125 -1.43 . . . . 0.45000000000000001 113.704 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -101.1 132.42 22.0 Favored Pre-proline 0 C--N 1.311 -1.066 0 C-N-CA 118.643 -1.223 . . . . 1.73 108.64 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.39 119.3 2.54 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 120.82 1.013 . . . . 1.1599999999999999 114.191 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 5.1 mt-30 -116.56 8.7 13.99 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.756 -1.111 . . . . 2.6000000000000001 108.375 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 4.4 mm-40 -130.37 170.11 14.6 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.913 -1.039 . . . . 3.6699999999999999 109.146 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 127.06 31.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.736 -1.186 . . . . 1.75 111.481 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.91 55.05 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.976 -1.107 . . . . 0.47999999999999998 111.179 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -99.19 175.63 5.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.667 -0.813 . . . . 1.1200000000000001 110.103 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.69 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -74.88 161.62 29.38 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.674 0.99 . . . . 0.60999999999999999 113.674 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -153.2 120.92 1.09 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.072 -1.211 . . . . 0.20999999999999999 110.072 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.7 p90 -144.16 -169.61 3.16 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.778 -1.169 . . . . 0.22 111.796 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.1 mmm-85 -138.7 125.05 20.4 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.937 -0.705 . . . . 2.29 112.0 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.63 130.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.143 0.902 . . . . 2.21 113.282 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.52 -19.61 53.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.17999999999999999 109.381 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' OD1' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -72.84 120.73 18.87 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.961 -1.096 . . . . 1.8400000000000001 108.925 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -76.01 109.46 9.67 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.96 -1.096 . . . . 0.48999999999999999 112.65 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -74.58 142.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.677 -1.231 . . . . 0.31 107.677 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.462 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.1 t60 -100.74 97.99 8.57 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 118.29 -1.364 . . . . 0.71999999999999997 108.032 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 3' ' ' THR . 4.8 t -67.12 94.81 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.908 -1.042 . . . . 0.40999999999999998 110.884 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.452 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 39.7 ttm -82.28 -27.21 32.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.56 -1.2 . . . . 0.89000000000000001 111.343 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' SER . 11.8 t70 -160.46 83.44 0.69 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 117.701 -1.6 . . . . 1.8700000000000001 111.903 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 1.6 p-10 -52.93 99.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.456 -1.297 . . . . 1.5800000000000001 108.904 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 1.1 t -95.17 -78.06 0.46 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.126 -1.03 . . . . 2.0600000000000001 111.554 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -72.63 158.48 87.27 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.064 -1.054 . . . . 0.62 111.498 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.49 -65.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.783 1.655 . . . . 0.23000000000000001 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 6.67 35.33 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.689 -0.804 . . . . 2.7999999999999998 111.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' ASP . 15.8 m95 -139.65 147.53 41.15 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.704 -1.221 . . . . 0.25 107.704 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -145.8 174.83 10.88 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.254 -0.978 . . . . 0.35999999999999999 112.024 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.31 135.94 53.44 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.621 -1.251 . . . . 1.5600000000000001 107.621 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -162.31 -145.11 4.22 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 117.895 -2.097 . . . . 0.42999999999999999 109.643 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.12 155.58 11.8 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.543 -1.263 . . . . 0.73999999999999999 112.237 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 44' ' ' GLY . 28.7 t -155.81 -98.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.012 -1.075 . . . . 0.20000000000000001 111.751 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.686 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 3.9 p80 -55.47 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.563 -0.855 . . . . 0.53000000000000003 111.029 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.56 26.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.327 -0.94 . . . . 0.47999999999999998 111.866 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 43' ' ' HIS . 3.0 tt0 -154.78 153.01 30.54 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.15 -1.42 . . . . 2.5499999999999998 111.792 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.0 p -98.15 -174.25 2.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.638 -0.71 . . . . 0.35999999999999999 110.692 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.45 -169.55 27.0 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.371 -1.395 . . . . 0.28000000000000003 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.5 mtp -110.2 151.41 27.35 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.355 0.598 . . . . 0.31 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.9 p90 -152.53 147.99 20.19 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.165 -0.925 . . . . 0.27000000000000002 109.067 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.56 128.39 27.0 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 110.006 -0.805 . . . . 0.23000000000000001 110.006 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.93 -39.1 90.89 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.877 -1.129 . . . . 1.99 110.674 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.03 2.43 2.71 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.017 -1.073 . . . . 2.2599999999999998 112.694 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.29 9.23 41.94 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.275 -0.97 . . . . 0.17000000000000001 109.342 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.7 m -138.28 176.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.972 -1.013 . . . . 0.19 109.451 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.83 142.28 13.23 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.555 -1.258 . . . . 0.28000000000000003 109.627 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.78 145.93 88.04 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 120.628 0.885 . . . . 0.64000000000000001 111.481 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.526 HG13 ' OE1' ' A' ' 6' ' ' GLN . 1.8 t -79.19 -11.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.328 -0.949 . . . . 0.60999999999999999 110.292 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -154.1 126.44 7.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.395 -0.922 . . . . 1.78 110.502 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 116.42 -1.753 . . . . 6.9800000000000004 110.84 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 110.033 -1.227 . . . . 5.5099999999999998 110.033 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.3 p 72.66 24.71 2.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.873 -0.731 . . . . 4.3700000000000001 110.939 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -156.25 30.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.289 -0.965 . . . . 0.65000000000000002 110.909 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.67 160.63 14.91 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 118.654 -1.218 . . . . 0.78000000000000003 112.546 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 13.8 m -142.8 -171.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 109.328 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 7' ' ' ALA . 13.3 mt-30 -140.66 93.63 2.63 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.821 -0.752 . . . . 0.39000000000000001 109.341 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -19.92 110.57 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.864 -1.516 . . . . 0.14999999999999999 114.739 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' ' NE ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -71.67 -44.35 64.42 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.102 -0.954 . . . . 1.3200000000000001 109.291 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.85 -179.98 5.24 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.128 -1.064 . . . . 1.72 108.128 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.37 143.32 26.87 Favored 'General case' 0 C--N 1.268 -2.941 0 N-CA-C 106.848 -1.538 . . . . 0.64000000000000001 106.848 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -131.41 115.09 15.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.205 -1.398 . . . . 0.41999999999999998 114.415 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.34 129.75 32.67 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 118.638 -1.225 . . . . 4.0899999999999999 107.915 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -43.66 159.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 120.502 0.802 . . . . 0.64000000000000001 112.767 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 40.4 mt-30 -146.55 -4.5 0.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.261 -1.385 . . . . 1.51 107.261 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' CG ' ' OE2' ' A' ' 18' ' ' GLU . 17.4 mm-40 -129.33 150.75 50.56 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.679 -1.6 . . . . 1.8799999999999999 109.351 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.02 55.4 2.12 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.164 -1.414 . . . . 1.8899999999999999 110.036 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.34 -18.78 0.03 OUTLIER Glycine 0 C--N 1.296 -1.668 0 N-CA-C 107.994 -2.042 . . . . 0.97999999999999998 107.994 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.4 mt-10 -49.97 -179.3 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 123.113 1.435 . . . . 1.8 113.697 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -104.06 160.11 15.12 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 111.385 -2.643 . . . . 0.48999999999999999 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.77 105.23 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.933 -1.603 . . . . 0.5 110.767 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.2 p90 -132.03 -170.19 2.36 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.38 -0.928 . . . . 0.23000000000000001 111.178 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 23' ' ' ARG . 1.3 mmm180 -144.04 124.9 14.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.398 -0.921 . . . . 3.2599999999999998 112.046 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.5 ttt-85 -11.68 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 124.351 1.032 . . . . 1.8700000000000001 113.542 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.7 -17.78 55.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.262 -1.535 . . . . 0.29999999999999999 109.262 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.93 126.17 29.86 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.578 -1.249 . . . . 1.25 108.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -77.36 111.5 13.09 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.601 -1.24 . . . . 0.45000000000000001 112.816 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.46 144.19 11.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 118.618 -1.233 . . . . 0.17000000000000001 107.965 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 33.0 t60 -101.16 101.24 11.93 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 106.658 -1.608 . . . . 0.51000000000000001 106.658 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 3' ' ' THR . 3.3 t -70.26 91.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 115.106 -0.952 . . . . 0.45000000000000001 112.781 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.551 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 4.4 mtt -57.68 -39.35 76.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.538 -1.21 . . . . 1.0700000000000001 109.529 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.7 OUTLIER 179.8 119.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.591 -1.244 . . . . 3.23 110.594 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 6.4 p-10 -49.13 108.55 0.19 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.372 -1.331 . . . . 2.3199999999999998 110.154 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.7 t -92.28 -47.78 7.02 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.186 -1.006 . . . . 1.54 111.481 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -125.73 161.19 52.36 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.397 -0.82 . . . . 1.4399999999999999 110.181 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -58.27 -67.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.505 1.47 . . . . 0.54000000000000004 111.648 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -87.9 7.05 32.65 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.56999999999999995 111.348 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASP . 24.4 m95 -141.42 145.08 34.87 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.815 . . . . 0.38 108.801 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.549 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -143.93 173.05 12.04 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.402 -0.919 . . . . 0.46000000000000002 112.218 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -116.15 132.44 56.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.936 -1.135 . . . . 0.96999999999999997 107.936 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.551 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.08 -144.16 3.86 Favored Glycine 0 C--N 1.297 -1.594 0 C-N-CA 118.004 -2.046 . . . . 0.16 109.163 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.82 161.58 15.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.397 -1.321 . . . . 0.40000000000000002 111.419 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 44' ' ' GLY . 47.1 t -161.29 -112.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.039 -1.865 . . . . 0.56000000000000005 113.771 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.536 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 p80 -21.93 -42.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.413 1.071 . . . . 2.75 113.052 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 164.39 18.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.137 -1.506 . . . . 1.25 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -157.12 161.96 39.4 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.452 -0.899 . . . . 1.78 110.749 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -96.79 -174.11 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.313 -0.955 . . . . 0.57999999999999996 110.475 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.19 -172.3 30.04 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.584 -1.293 . . . . 0.46999999999999997 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtp -104.83 138.82 40.51 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.002 -0.679 . . . . 0.63 110.333 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.4 p90 -142.19 146.06 38.2 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 119.777 -0.769 . . . . 0.26000000000000001 109.32 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.78 127.06 24.53 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 110.141 -0.754 . . . . 0.31 110.141 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.92 -29.53 70.69 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.282 -0.967 . . . . 3.4399999999999999 111.747 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -8.37 57.05 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.58 -1.248 . . . . 4.1799999999999997 111.736 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.91 15.56 7.02 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.962 -1.095 . . . . 0.35999999999999999 109.947 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.5 m -144.16 174.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 115.601 -0.727 . . . . 0.23000000000000001 110.322 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -148.06 135.04 10.28 Favored Pre-proline 0 C--N 1.3 -1.551 0 C-N-CA 119.673 -0.811 . . . . 0.57999999999999996 109.121 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -65.67 155.58 68.32 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 121.077 1.185 . . . . 1.1699999999999999 113.554 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.25 -144.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.769 -1.105 . . . . 3.5499999999999998 108.918 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 59' ' ' ARG . 5.7 p-10 -157.51 8.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.058 -1.457 . . . . 5.8300000000000001 112.722 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HG3' ' ND2' ' A' ' 58' ' ' ASN . 34.4 mtp85 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 116.405 -1.759 . . . . 11.1 111.049 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 110.094 -1.203 . . . . 2.75 110.094 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.69 36.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.243 -0.983 . . . . 5.3399999999999999 110.978 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.558 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -44.05 158.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.571 -0.852 . . . . 2.5499999999999998 111.124 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.4 m-85 179.22 156.77 0.53 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.395 -0.922 . . . . 0.82999999999999996 111.968 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 27' ' ' ILE . 3.9 m -143.81 -169.16 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 0.28999999999999998 109.851 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' THR . 11.4 mt-30 -143.57 105.36 4.34 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.228 -1.397 . . . . 0.39000000000000001 107.228 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -33.84 111.69 0.11 Allowed 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.01 -1.076 . . . . 0.34000000000000002 112.162 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.03 -37.21 86.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.934 -0.706 . . . . 1.3100000000000001 109.376 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.29 -173.55 4.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.891 -1.049 . . . . 1.54 109.522 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 129.13 34.19 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.383 -1.735 . . . . 0.46000000000000002 109.731 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.28 109.56 17.0 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.85 -1.14 . . . . 0.34999999999999998 113.133 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' PRO . 22.7 m-20 -81.6 133.77 52.1 Favored Pre-proline 0 C--N 1.295 -1.781 0 C-N-CA 117.234 -1.786 . . . . 1.5800000000000001 106.848 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.594 ' C ' ' H ' ' A' ' 15' ' ' GLU . 28.3 Cg_exo -34.46 -45.73 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.211 1.274 . . . . 3.3999999999999999 113.605 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 58.79 2.76 0.26 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.158 -1.417 . . . . 1.96 108.896 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.594 ' H ' ' C ' ' A' ' 13' ' ' PRO . 42.2 mm-40 -150.87 137.74 19.03 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.733 -1.121 . . . . 2.04 109.748 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -86.89 30.84 0.72 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.22 -1.392 . . . . 4.5800000000000001 109.394 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -155.68 10.43 0.34 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 119.389 -1.386 . . . . 1.6399999999999999 110.673 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.661 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -120.08 -177.26 3.38 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.463 -0.895 . . . . 2.71 111.861 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.661 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -77.33 161.65 27.9 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 115.187 1.551 . . . . 0.71999999999999997 115.187 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -150.58 131.57 3.61 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.138 -1.185 . . . . 0.23999999999999999 110.138 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 27' ' ' ILE . 8.2 p90 -152.57 -168.43 3.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.432 -1.307 . . . . 0.23999999999999999 112.029 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 23' ' ' ARG . 8.5 mmm180 -140.38 131.28 26.03 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.618 -0.833 . . . . 4.4800000000000004 112.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -13.13 135.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.016 1.117 . . . . 2.2200000000000002 114.016 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.13 14.01 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.367 -1.493 . . . . 0.37 109.367 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.26 119.23 7.52 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.841 -1.144 . . . . 0.65000000000000002 108.435 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.07 105.36 8.1 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.568 -1.253 . . . . 2.29 112.569 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.577 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -75.54 144.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.017 -1.475 . . . . 0.23000000000000001 107.017 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 16.0 t-80 -104.1 98.88 8.63 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.772 -1.171 . . . . 0.87 108.149 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.16 92.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 118.346 -1.342 . . . . 0.54000000000000004 111.311 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.555 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -68.62 -36.09 78.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.803 -1.544 . . . . 1.6200000000000001 110.372 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -164.23 92.53 0.65 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.582 -1.247 . . . . 2.2200000000000002 111.106 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.75 99.24 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.346 -1.342 . . . . 1.74 109.282 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -96.47 -82.64 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.314 -0.954 . . . . 1.1599999999999999 111.636 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.3 m-20 -64.27 158.23 66.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.052 -1.059 . . . . 0.58999999999999997 110.86 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.06 -68.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.54 1.493 . . . . 0.29999999999999999 111.539 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' ND2' ' A' ' 52' ' ' ASN . 2.6 t30 -84.13 3.71 33.68 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.577 -0.849 . . . . 1.9099999999999999 111.332 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.447 ' O ' ' O ' ' A' ' 34' ' ' ASP . 22.9 m95 -136.47 144.4 44.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.541 -0.911 . . . . 0.52000000000000002 108.541 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CZ2' ' HG3' ' A' ' 51' ' ' ARG . 12.6 m0 -143.01 171.63 13.79 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.679 -0.808 . . . . 0.32000000000000001 111.692 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.08 130.33 55.55 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.533 -1.654 . . . . 0.35999999999999999 106.533 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.555 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.48 -154.56 7.14 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 117.952 -2.071 . . . . 0.14000000000000001 109.535 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -161.67 155.36 21.6 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 117.458 -1.697 . . . . 0.55000000000000004 112.926 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 44' ' ' GLY . 5.7 t -167.55 178.8 5.21 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.658 -1.156 . . . . 2.3399999999999999 110.777 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 42' ' ' CYS . 10.8 p80 41.01 23.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.096 -0.641 . . . . 1.6899999999999999 110.75 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 79.13 35.59 29.99 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.804 -1.189 . . . . 0.68999999999999995 111.812 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.7 mt-30 -160.23 144.16 14.14 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.895 -1.122 . . . . 1.22 111.352 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -93.6 -177.91 4.54 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.272 -0.971 . . . . 0.38 111.684 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.98 -163.88 28.6 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.642 -1.266 . . . . 0.34999999999999998 111.066 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.2 mtp -113.89 147.98 37.52 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.263 -0.575 . . . . 0.54000000000000004 111.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 27' ' ' ILE . 4.0 p90 -151.25 145.74 18.32 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.527 -0.869 . . . . 0.23000000000000001 109.317 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.23 128.32 29.17 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 N-CA-C 109.884 -0.852 . . . . 0.35999999999999999 109.884 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -62.03 -34.89 77.07 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.898 -0.721 . . . . 1.28 112.565 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.598 ' ND2' ' OD1' ' A' ' 36' ' ' ASN . 56.5 m-80 -75.05 12.15 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.148 -1.021 . . . . 1.95 113.253 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.92 7.09 27.84 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.505 -0.878 . . . . 0.57999999999999996 109.089 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -136.86 173.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 114.57 -1.196 . . . . 0.20000000000000001 109.578 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -136.29 125.09 15.47 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.392 -0.966 . . . . 0.51000000000000001 108.392 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.3 140.94 88.98 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 120.445 0.763 . . . . 1.73 113.186 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.2 p -137.8 132.38 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.099 -0.955 . . . . 4.9000000000000004 109.971 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 59' ' ' ARG . 5.2 p30 -157.12 -135.01 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.955 -1.098 . . . . 4.6699999999999999 111.063 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' N ' ' OD1' ' A' ' 58' ' ' ASN . 48.1 ttt180 . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 116.388 -1.767 . . . . 12.33 110.565 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' O ' ' OG1' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 110.094 -1.202 . . . . 5.3700000000000001 110.094 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.13 6.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.299 -0.96 . . . . 3.6800000000000002 111.108 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' CG ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -135.94 107.67 7.03 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.716 -0.674 . . . . 2.6400000000000001 110.45 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 3' ' ' THR . 2.5 m-85 -169.15 155.39 6.51 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 117.584 -1.646 . . . . 0.72999999999999998 113.003 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 27' ' ' ILE . 15.9 m -141.05 -166.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.823 -1.08 . . . . 0.20000000000000001 109.36 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 7' ' ' ALA . 4.6 mt-30 -145.37 105.07 3.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.975 -1.011 . . . . 0.64000000000000001 108.438 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.05 116.63 0.11 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.793 -1.094 . . . . 0.16 113.681 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.38 -52.89 22.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.233 -1.025 . . . . 0.53000000000000003 108.233 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -132.04 177.64 7.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.77 -1.196 . . . . 0.71999999999999997 107.77 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -75.38 134.36 40.97 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.284 -1.325 . . . . 1.1399999999999999 108.953 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -121.53 109.87 15.34 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.021 -1.072 . . . . 0.26000000000000001 113.073 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -93.26 131.76 32.11 Favored Pre-proline 0 C--N 1.307 -1.265 0 C-N-CA 118.167 -1.413 . . . . 1.1000000000000001 108.387 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -43.95 157.27 0.15 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 120.575 0.85 . . . . 0.28000000000000003 112.746 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.576 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 89.7 mt-30 -145.3 -3.53 0.74 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.324 -1.362 . . . . 0.57999999999999996 107.324 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' H ' ' H ' ' A' ' 14' ' ' GLN . 28.1 mt-10 -131.86 151.1 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.432 -1.713 . . . . 3.7799999999999998 108.171 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.74 -5.51 30.51 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.236 -1.385 . . . . 2.3799999999999999 111.308 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.12 -5.47 13.25 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.411 -1.475 . . . . 1.8999999999999999 109.411 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.4 mt-10 -61.7 176.74 0.48 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 123.328 1.537 . . . . 1.74 114.412 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.4 161.29 14.95 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.043 -2.799 . . . . 0.58999999999999997 109.4 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -145.11 115.19 0.82 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.364 -1.398 . . . . 0.29999999999999999 110.768 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.3 p90 -138.95 -174.49 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.984 -1.086 . . . . 0.23999999999999999 111.65 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -139.77 125.92 19.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.595 -0.842 . . . . 2.75 112.322 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.1 ttt180 -4.01 135.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.13 1.53 . . . . 1.6000000000000001 115.13 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 -21.68 3.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.289 -1.524 . . . . 0.60999999999999999 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -59.19 119.38 7.24 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.705 -1.198 . . . . 0.46000000000000002 108.399 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 48.1 m-85 -75.32 107.51 7.48 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.971 -1.092 . . . . 0.91000000000000003 113.525 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -75.17 143.92 12.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.029 -1.471 . . . . 0.16 107.029 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 71.0 t60 -101.0 102.39 13.38 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 117.79 -1.564 . . . . 1.3500000000000001 107.773 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.0 101.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 C-N-CA 118.444 -1.303 . . . . 0.32000000000000001 110.751 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.7 ttm -77.6 -32.42 53.55 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.591 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.21 108.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.447 -1.301 . . . . 3.5699999999999998 110.975 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 12.4 p-10 -58.03 107.6 0.49 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.985 -1.486 . . . . 0.93999999999999995 108.695 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -93.46 -57.08 2.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.85 -1.14 . . . . 1.5800000000000001 111.804 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -107.05 161.1 24.02 Favored Pre-proline 0 C--N 1.299 -1.615 0 C-N-CA 119.625 -0.83 . . . . 0.75 111.461 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.33 -58.25 0.82 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.063 1.842 . . . . 0.29999999999999999 111.606 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 41.2 t30 -98.96 13.35 32.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.725 -0.79 . . . . 0.40999999999999998 111.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 34.6 m95 -147.51 136.62 22.31 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.543 -0.863 . . . . 0.34000000000000002 109.478 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.659 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 34.4 m0 -139.44 168.35 20.01 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.889 -0.724 . . . . 0.42999999999999999 111.27 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -106.85 135.5 48.29 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.942 -1.503 . . . . 1.21 106.942 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -161.34 -152.0 6.48 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 117.839 -2.124 . . . . 0.25 109.519 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.12 160.08 18.36 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 117.772 -1.571 . . . . 0.56999999999999995 113.138 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.1 t -158.79 -86.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.127 -1.029 . . . . 0.25 112.104 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.649 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 6.4 p80 -62.95 74.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.325 -0.95 . . . . 0.52000000000000002 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.29 23.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.715 -1.231 . . . . 0.60999999999999999 111.095 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' HIS . 12.7 mt-30 -149.41 139.7 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.372 -1.331 . . . . 1.6000000000000001 111.499 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 41' ' ' ALA . 19.3 p -91.39 -172.46 3.27 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.665 -0.814 . . . . 0.45000000000000001 110.849 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.84 -167.91 27.61 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.288 -1.434 . . . . 0.20000000000000001 111.956 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 31.1 mtp -107.35 143.55 35.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.235 -0.586 . . . . 0.31 110.753 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -147.4 147.06 27.04 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.622 -0.831 . . . . 0.10000000000000001 109.049 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.05 124.72 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 120.189 0.592 . . . . 0.20000000000000001 111.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.659 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.36 -27.36 55.77 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.309 -0.86 . . . . 2.4100000000000001 110.227 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -83.27 -1.1 52.34 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.17 -1.012 . . . . 4.5800000000000001 113.091 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.7 12.68 31.02 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.811 -1.156 . . . . 0.29999999999999999 109.931 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -141.45 172.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.404 -1.271 . . . . 0.25 108.157 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -143.93 141.63 18.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 118.963 -1.095 . . . . 0.31 108.853 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 2.4 Cg_endo -55.29 158.27 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 120.119 0.546 . . . . 0.80000000000000004 110.764 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.77 111.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.394 -0.922 . . . . 2.2999999999999998 111.57 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -136.04 130.82 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.846 -0.742 . . . . 7.8099999999999996 110.69 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 116.235 -1.84 . . . . 8.4100000000000001 110.724 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 110.177 -1.169 . . . . 5.79 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 75.96 0.97 3.42 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.176 -0.61 . . . . 3.2400000000000002 111.292 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -161.61 87.84 0.69 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.542 -0.863 . . . . 3.1899999999999999 110.252 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.5 m-85 -170.79 154.69 4.43 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.493 -1.283 . . . . 0.81000000000000005 111.645 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 27' ' ' ILE . 15.7 m -146.14 174.69 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.835 -1.075 . . . . 0.65000000000000002 109.453 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.498 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.9 mt-30 -123.48 109.12 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.389 -1.337 . . . . 0.40999999999999998 107.389 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -32.2 116.13 0.19 Allowed 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.552 -0.859 . . . . 0.23999999999999999 112.371 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.535 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 11.8 tp -74.52 -42.26 59.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.435 -0.802 . . . . 1.8799999999999999 109.836 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.67 176.42 8.2 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.758 -1.11 . . . . 1.6200000000000001 108.129 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.37 125.46 32.98 Favored 'General case' 0 C--N 1.265 -3.107 0 N-CA-C 105.909 -1.886 . . . . 0.82999999999999996 105.909 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.29 106.56 17.06 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.869 -1.132 . . . . 0.23000000000000001 113.658 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.56 126.7 61.1 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 118.298 -1.361 . . . . 0.95999999999999996 107.856 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -40.39 128.35 2.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 120.805 1.004 . . . . 0.55000000000000004 114.073 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -114.49 2.36 14.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.439 -1.689 . . . . 1.6299999999999999 106.439 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.91 158.65 43.73 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.172 -1.831 . . . . 2.0499999999999998 109.89 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -96.56 3.58 52.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.131 -1.028 . . . . 3.1899999999999999 109.276 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.35 14.93 6.46 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.264 -1.134 . . . . 1.71 110.264 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.9 pt-20 -121.61 -176.41 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.711 1.004 . . . . 1.22 113.711 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -78.52 170.12 17.15 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 116.414 2.005 . . . . 0.41999999999999998 116.414 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.34 122.0 1.1 Allowed Glycine 0 N--CA 1.499 2.889 0 CA-C-N 113.286 -1.779 . . . . 0.22 109.292 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 p90 -149.14 -169.99 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.705 -1.198 . . . . 0.17000000000000001 112.393 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' A' ' 23' ' ' ARG . 6.2 mmm180 -135.45 134.57 39.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.52 -0.763 . . . . 3.5600000000000001 112.361 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.4 ttp180 -20.53 141.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.229 0.956 . . . . 1.95 113.146 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.41 -27.1 4.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.643 -1.383 . . . . 0.38 109.643 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.49 125.8 25.05 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.589 -1.245 . . . . 1.0600000000000001 108.127 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.58 111.62 14.83 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.302 -1.359 . . . . 0.92000000000000004 113.585 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -77.89 141.88 14.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.872 -1.529 . . . . 0.20999999999999999 106.872 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -100.07 97.18 8.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 117.598 -1.641 . . . . 1.1100000000000001 108.026 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.13 99.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 C-N-CA 118.624 -1.231 . . . . 0.27000000000000002 111.021 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.455 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 21.4 mtt -82.75 -26.22 32.1 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.274 -0.875 . . . . 1.3500000000000001 110.44 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -163.81 80.34 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 118.223 -1.391 . . . . 1.5900000000000001 111.656 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -61.04 87.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.46 -1.296 . . . . 3.5800000000000001 108.521 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 31' ' ' ASP . 6.4 t -103.76 -72.59 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.755 -0.778 . . . . 2.52 112.705 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 3.0 m-20 -60.59 153.96 58.73 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 118.859 -1.136 . . . . 1.77 111.021 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.26 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.106 1.871 . . . . 0.60999999999999999 112.87 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -83.39 14.38 3.69 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.599 -0.728 . . . . 0.84999999999999998 110.681 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 55.4 m95 -147.47 149.38 32.57 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.276 -0.875 . . . . 1.01 109.227 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.8 m0 -148.75 161.6 41.45 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.484 -0.886 . . . . 0.47999999999999998 111.302 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 132.33 48.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.929 -1.137 . . . . 1.1799999999999999 107.929 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.92 -152.58 6.98 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 118.255 -1.926 . . . . 0.17999999999999999 109.731 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.35 175.38 11.63 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.595 -1.242 . . . . 0.16 111.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.8 t -168.81 -79.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.001 -1.88 . . . . 0.52000000000000002 114.679 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.647 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 2.4 p80 -65.07 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.85 -0.614 . . . . 1.47 112.622 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 89.77 6.12 70.41 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.048 -1.549 . . . . 0.55000000000000004 109.75 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.04 151.22 47.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.656 -0.818 . . . . 4.3600000000000003 109.868 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.6 p -92.41 -175.71 4.09 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.871 -1.131 . . . . 0.26000000000000001 110.823 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.49 179.05 25.02 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.777 -1.202 . . . . 0.46999999999999997 110.13 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.3 mtp -100.87 147.16 26.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.41999999999999998 110.886 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 27' ' ' ILE . 7.0 p90 -147.57 147.02 26.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.702 -0.799 . . . . 0.23999999999999999 109.345 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.11 126.53 22.46 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.786 0.991 . . . . 0.13 111.484 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HD3' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -34.34 72.31 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.426 -0.806 . . . . 2.54 111.223 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.53 3.03 14.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.918 -1.113 . . . . 2.3700000000000001 112.763 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.54 8.45 44.88 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.085 -1.046 . . . . 0.14000000000000001 109.774 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.9 m -136.28 171.65 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 114.853 -1.067 . . . . 0.17000000000000001 109.113 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -142.88 139.13 16.61 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 119.102 -1.039 . . . . 0.28999999999999998 110.286 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.29 127.5 25.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.596 0.864 . . . . 1.05 110.872 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.1 p -87.1 7.4 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.751 -0.78 . . . . 2.8799999999999999 111.457 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -105.84 37.54 2.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.709 -0.796 . . . . 2.1699999999999999 111.277 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 116.28 -1.819 . . . . 10.99 111.063 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.972 -1.251 . . . . 5.1200000000000001 109.972 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 t -99.88 170.35 8.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.575 -0.85 . . . . 3.3999999999999999 110.847 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.676 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.6 OUTLIER -132.04 46.2 2.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.76000000000000001 110.013 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.41 135.19 47.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.366 -0.934 . . . . 1.3100000000000001 111.053 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 27' ' ' ILE . 5.9 m -125.94 -162.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.442 -1.253 . . . . 0.23000000000000001 109.781 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 7' ' ' ALA . 15.4 mt-30 -146.9 100.27 3.29 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.841 -1.17 . . . . 0.85999999999999999 107.841 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.09 111.52 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.58 -1.191 . . . . 0.25 113.11 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.81 -41.53 91.77 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.62 -0.718 . . . . 0.33000000000000002 109.104 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -173.09 3.59 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.602 -1.181 . . . . 0.80000000000000004 108.453 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.47 120.48 27.84 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.705 -1.589 . . . . 0.68000000000000005 109.583 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -104.68 103.15 12.74 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.228 -0.989 . . . . 0.26000000000000001 111.724 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.08 127.38 67.04 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 117.243 -1.783 . . . . 4.5899999999999999 109.838 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -41.18 113.85 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 120.925 1.084 . . . . 0.93999999999999995 114.153 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -94.46 8.4 42.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 105.427 -2.064 . . . . 3.79 105.427 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -155.6 161.6 40.8 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.75 -2.023 . . . . 3.3599999999999999 109.695 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -7.38 27.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.137 -1.025 . . . . 4.9800000000000004 108.876 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.26 -7.1 41.08 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.907 -1.277 . . . . 1.3 109.907 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.3 pt-20 -101.85 -168.72 1.58 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.607 -0.837 . . . . 1.22 112.01 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -87.04 175.73 7.97 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 115.454 1.65 . . . . 0.29999999999999999 115.454 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -162.19 128.61 1.91 Allowed Glycine 0 N--CA 1.502 3.045 0 CA-C-N 114.319 -1.309 . . . . 0.26000000000000001 110.072 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -158.11 -174.8 5.0 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.081 -1.448 . . . . 0.25 112.095 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' ARG . 23.4 mmt-85 -133.96 133.65 41.61 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.796 -0.762 . . . . 4.2199999999999998 112.698 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.42 138.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.418 1.074 . . . . 4.9699999999999998 113.731 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.6 5.98 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.469 -1.452 . . . . 0.46999999999999997 109.469 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.17 122.35 13.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.993 -1.083 . . . . 0.63 109.242 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 73.5 m-85 -78.74 108.91 12.5 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.054 -1.058 . . . . 1.03 113.114 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -78.42 148.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.338 -0.986 . . . . 0.20000000000000001 108.338 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 30' ' ' MET . 10.4 t60 -106.26 94.07 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.045 -1.062 . . . . 0.83999999999999997 108.857 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' O ' ' OG1' ' A' ' 3' ' ' THR . 5.3 t -57.64 85.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 C-N-CA 119.297 -0.961 . . . . 0.34000000000000002 112.43 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.621 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mmt -59.23 -35.89 74.47 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.893 -1.048 . . . . 1.4299999999999999 110.402 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 33' ' ' SER . 67.6 t0 -170.56 99.75 0.25 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.176 -1.409 . . . . 1.54 111.749 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -53.18 97.78 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.095 -1.442 . . . . 2.5699999999999998 108.784 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 31' ' ' ASP . 65.8 m -96.26 -71.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.307 -0.957 . . . . 1.3799999999999999 111.832 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.4 m-20 -81.93 161.17 61.63 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 119.249 -0.98 . . . . 0.68999999999999995 111.679 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.53 -69.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.743 1.629 . . . . 0.35999999999999999 110.92 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 4.9 t-20 -80.2 -5.01 55.37 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.552 -0.749 . . . . 0.90000000000000002 110.949 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' ASP . 28.4 m95 -131.99 150.59 52.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.092 -0.643 . . . . 0.38 109.625 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 9.8 m0 -145.9 162.56 37.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.381 -0.827 . . . . 0.5 111.722 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.05 129.46 46.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.867 -1.531 . . . . 0.29999999999999999 106.867 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.26 -156.79 7.99 Favored Glycine 0 C--N 1.304 -1.224 0 C-N-CA 117.835 -2.126 . . . . 0.20999999999999999 110.349 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.769 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -160.8 162.81 32.44 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 118.452 -1.299 . . . . 0.44 111.46 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 43.7 t -160.58 -114.55 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.295 -1.762 . . . . 0.56000000000000005 113.853 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.556 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.1 p80 -20.95 -45.11 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.277 0.985 . . . . 2.8900000000000001 113.044 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 167.1 18.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.338 -1.411 . . . . 1.01 109.884 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -150.34 161.19 42.95 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.637 -0.825 . . . . 2.54 110.049 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -100.33 -175.94 3.07 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.424 -0.911 . . . . 0.38 109.812 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.69 -169.14 29.89 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.132 -1.508 . . . . 0.28999999999999998 111.225 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 mtp -108.28 136.66 47.56 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.071 -0.652 . . . . 0.71999999999999997 110.963 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.0 p90 -139.11 146.48 49.49 Favored Pre-proline 0 C--N 1.304 -1.387 0 C-N-CA 119.714 -0.795 . . . . 0.14999999999999999 110.143 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.38 122.86 12.21 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 120.292 0.661 . . . . 0.19 110.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -11.45 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.397 -0.921 . . . . 2.9900000000000002 110.983 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -88.01 -9.1 54.48 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.041 -1.064 . . . . 1.8500000000000001 111.655 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 8' ' ' LEU . 4.8 m-85 -94.13 14.28 20.5 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.187 -1.005 . . . . 0.44 109.415 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.7 m -139.62 166.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.986 -1.006 . . . . 0.27000000000000002 109.439 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -136.84 99.86 10.09 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 119.738 -0.785 . . . . 0.82999999999999996 109.565 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -48.0 141.66 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.685 0.923 . . . . 2.9300000000000002 111.929 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.435 HG22 HE21 ' A' ' 6' ' ' GLN . 15.4 t -81.52 -22.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.127 -0.942 . . . . 3.0600000000000001 111.782 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -141.4 122.19 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.117 -1.033 . . . . 4.7599999999999998 111.623 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.283 -1.818 . . . . 13.630000000000001 109.946 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.579 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 113.98 1.104 . . . . 1.7 113.98 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 27' ' ' ILE . 17.6 m -138.39 -168.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 113.391 -1.731 . . . . 0.06 108.298 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 55' ' ' THR . 2.2 mt-30 -140.29 104.12 4.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.336 -1.357 . . . . 0.71 107.336 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.71 114.21 0.11 Allowed 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 113.666 0.987 . . . . 0.1 113.666 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.429 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 9.7 tp -69.39 -34.1 74.02 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.388 -0.824 . . . . 1.78 108.917 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.63 -174.2 4.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.943 -1.026 . . . . 0.53 109.669 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -86.4 126.48 34.41 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 113.434 -1.712 . . . . 0.44 110.336 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.11 106.32 13.6 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.307 -0.957 . . . . 0.27 112.804 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 C--N 1.304 -1.391 0 C-N-CA 117.734 -1.586 . . . . 3.34 108.336 179.592 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.504 -0.798 0 CA-C-O 123.231 1.491 . . . . 1.03 114.253 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tp -101.54 158.19 16.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 111.797 -2.456 . . . . 0.48 110.407 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.36 113.07 0.65 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.606 -1.283 . . . . 0.41 110.726 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -139.94 -172.7 3.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.841 -1.144 . . . . 0.26 112.192 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' ARG . 5.0 mmm-85 -139.61 126.08 20.34 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.574 -0.85 . . . . 2.49 113.187 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -7.65 132.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.493 1.121 . . . . 1.82 113.887 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -19.27 20.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.218 -1.553 . . . . 0.57 109.218 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.79 123.7 19.12 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.791 -1.164 . . . . 0.58 108.52 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.92 107.66 10.62 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.647 -1.221 . . . . 0.29 112.657 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -77.32 147.62 7.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.84 -1.17 . . . . 0.23 107.84 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.579 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 9.1 t-160 -105.65 96.21 6.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.687 -1.227 . . . . 0.18 107.687 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 t -63.29 91.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 114.584 -1.189 . . . . 0.39 110.219 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.525 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.3 ttm -78.31 -27.32 47.21 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.945 -1.479 . . . . 0.45 112.011 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.11 96.65 0.6 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.43 -1.708 . . . . 1.75 111.794 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.667 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -55.47 104.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.113 -1.435 . . . . 2.12 107.914 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m -90.86 -64.9 1.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.649 -1.22 . . . . 1.07 111.761 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -103.89 161.71 22.12 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 115.189 -0.914 . . . . 0.65 111.812 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' O ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 Cg_endo -57.95 -63.34 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.737 1.625 . . . . 0.57 111.478 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.2 t30 -92.15 6.8 45.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.558 -0.857 . . . . 2.92 111.392 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 20.0 m95 -139.23 139.32 37.43 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.75 -1.204 . . . . 0.32 107.75 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -141.86 169.38 17.7 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.281 -0.968 . . . . 0.66 112.939 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -101.78 146.53 27.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.332 -1.729 . . . . 0.68 106.332 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.1 -158.42 9.75 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 116.784 -2.627 . . . . 0.27 110.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.33 137.94 4.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.031 -1.067 . . . . 1.18 111.278 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' GLY . 32.9 t -145.03 -94.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.114 -1.035 . . . . 0.43 111.807 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.626 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.5 p80 -60.69 75.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.434 -0.907 . . . . 0.54 111.3 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.45 21.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.333 -0.937 . . . . 0.61 111.575 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' HIS . 70.2 mt-30 -144.49 134.95 24.56 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.011 -1.076 . . . . 2.23 111.096 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -90.97 -178.33 5.18 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.73 -0.788 . . . . 0.55 111.056 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.4 -172.77 27.72 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.377 -1.392 . . . . 0.36 110.884 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mtp -101.22 157.39 16.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.824 -0.751 . . . . 0.27 111.268 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.1 p90 -159.36 144.25 11.45 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 115.124 -0.944 . . . . 0.29 109.06 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.2 125.96 20.57 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 120.264 0.643 . . . . 0.33 110.801 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -64.53 -20.44 66.22 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.562 -0.855 . . . . 2.36 110.968 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.99 1.59 49.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.915 -1.114 . . . . 1.03 111.082 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.74 13.5 33.45 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.616 -0.834 . . . . 0.15 109.006 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.429 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 31.5 m -140.98 171.54 12.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.646 -1.161 . . . . 0.35 109.905 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 C-N-CA 119.441 -0.904 . . . . 0.26 109.242 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.481 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 69.9 m-85 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 122.039 0.923 . . . . 1.32 113.118 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 27' ' ' ILE . 25.1 m -140.22 -172.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 113.823 -1.535 . . . . 0.24 108.057 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -142.07 98.17 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.058 -1.089 . . . . 0.73 108.058 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -20.93 111.97 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.916 -1.493 . . . . 0.08 113.487 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.472 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -67.38 -36.42 81.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.167 -0.679 . . . . 0.52 109.167 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.16 -174.73 4.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.844 -1.071 . . . . 0.65 109.183 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.86 131.44 34.52 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 113.614 -1.63 . . . . 0.48 109.446 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -120.71 109.47 15.23 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.987 -1.085 . . . . 0.35 113.364 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 . . . . . 0 C--N 1.302 -1.474 0 N-CA-C 106.819 -1.548 . . . . 1.48 106.819 179.442 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.213 -0.839 0 CA-C-O 123.343 1.544 . . . . 1.24 115.087 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 tp -97.69 157.04 16.27 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 111.397 -2.638 . . . . 0.5 110.544 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -143.71 112.89 0.72 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.261 -1.447 . . . . 0.43 111.142 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.5 p90 -135.5 -179.25 5.52 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.266 -0.973 . . . . 0.31 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 23' ' ' ARG . 2.9 mmt85 -137.29 124.32 21.52 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.537 -0.865 . . . . 3.05 112.22 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -10.08 128.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.283 0.989 . . . . 2.37 113.281 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.48 -20.08 50.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.287 -1.525 . . . . 0.19 109.287 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.0 126.02 28.42 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.856 -1.138 . . . . 1.7 108.234 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 2.3 m-85 -78.39 108.39 11.71 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.78 113.38 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.12 142.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 105.765 -1.939 . . . . 0.28 105.765 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.481 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 9.9 t-160 -101.55 97.78 8.18 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.173 -1.411 . . . . 0.31 107.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.55 84.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.546 -1.207 . . . . 0.29 110.842 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.7 ttm -69.14 -30.79 69.11 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.112 -1.403 . . . . 0.79 111.547 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -169.3 90.99 0.22 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.707 -1.597 . . . . 1.64 111.983 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.436 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -50.2 104.35 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.075 -1.45 . . . . 1.59 108.386 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 m -94.6 -37.16 11.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.168 -1.013 . . . . 1.72 113.534 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -124.58 160.43 53.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.373 -0.931 . . . . 1.18 111.471 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.65 -68.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.736 1.624 . . . . 0.46 111.604 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.1 t30 -91.25 12.94 18.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.539 -0.864 . . . . 2.64 111.094 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.5 m95 -145.46 144.79 30.8 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.773 -0.825 . . . . 0.4 108.773 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 20.5 m0 -144.62 172.86 12.39 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.4 -0.92 . . . . 0.21 111.82 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -115.09 123.82 49.97 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.559 -1.645 . . . . 0.39 106.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -149.94 -148.03 4.67 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 118.241 -1.933 . . . . 0.11 108.831 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.828 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.77 165.52 20.62 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.117 -1.433 . . . . 0.24 111.95 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 23.4 t -161.14 -108.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 116.597 -2.041 . . . . 0.28 114.471 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 2.2 p80 -26.96 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.348 -0.842 . . . . 3.08 113.213 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 161.98 18.08 0.03 OUTLIER Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.046 -1.549 . . . . 0.88 109.991 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.5 162.21 37.44 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.153 -1.019 . . . . 4.16 110.221 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 ' HB2' ' A' ' 41' ' ' ALA . 18.7 p -95.66 -171.17 2.3 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.195 -1.002 . . . . 0.38 111.393 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.42 -170.89 28.91 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.657 -1.156 . . . . 0.22 110.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.3 mtp -105.25 143.35 33.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.827 -0.749 . . . . 0.36 110.746 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.9 p90 -147.65 146.02 23.2 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 119.705 -0.798 . . . . 0.23 108.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.99 126.9 23.06 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 N-CA-C 110.458 -0.632 . . . . 0.19 110.458 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.77 -36.16 78.25 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.462 -0.79 . . . . 2.54 111.045 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -74.25 -0.73 17.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.058 -1.057 . . . . 4.11 112.692 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -93.45 6.39 48.35 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 118.719 -1.192 . . . . 0.2 110.092 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.3 m -134.27 171.39 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 115.457 -0.792 . . . . 0.1 109.827 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 119.338 -0.945 . . . . 0.3 109.132 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.576 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 79.7 m-85 . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.928 0.87 . . . . 0.71 112.84 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 27' ' ' ILE . 16.4 m -136.61 -170.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.821 -1.536 . . . . 0.17 108.275 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -138.78 102.7 4.64 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.936 -1.135 . . . . 0.39 107.936 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.27 110.61 0.06 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.326 -0.852 . . . . 0.14 112.396 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -64.2 -37.14 86.41 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.132 -0.692 . . . . 0.57 109.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -174.4 4.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.146 0.974 . . . . 1.26 109.74 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -83.33 127.62 33.82 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.496 -1.684 . . . . 0.38 110.815 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -115.84 106.42 13.81 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.633 -0.827 . . . . 0.23 111.905 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.313 0 C-N-CA 117.724 -1.591 . . . . 3.88 109.439 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.374 0.607 . . . . 1.18 112.102 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.58 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -84.08 172.41 12.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 116.026 1.861 . . . . 0.4 116.026 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.08 120.97 1.01 Allowed Glycine 0 N--CA 1.497 2.743 0 CA-C-N 113.645 -1.616 . . . . 0.14 110.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.1 p90 -145.78 -170.94 3.59 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.319 -1.352 . . . . 0.25 112.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.0 mmt-85 -138.72 129.8 26.83 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.4 -0.818 . . . . 4.57 112.222 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -16.61 137.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.194 0.934 . . . . 2.88 113.239 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -21.65 10.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.816 -1.714 . . . . 0.26 108.816 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.64 118.88 10.18 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.94 -1.104 . . . . 1.11 108.055 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -76.55 112.92 13.61 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.662 -1.215 . . . . 0.84 112.482 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.26 147.62 7.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.702 -1.222 . . . . 0.15 107.702 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.7 t-80 -103.9 101.61 11.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.761 -1.175 . . . . 0.21 107.83 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 t -69.39 98.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.5 -1.227 . . . . 0.26 111.505 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.438 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.0 OUTLIER -79.6 -30.22 41.42 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.09 -1.414 . . . . 1.62 110.959 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.24 114.48 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.334 -1.346 . . . . 2.29 111.014 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 19.6 p30 -56.72 109.82 0.69 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.223 -1.391 . . . . 1.56 109.69 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 p -91.75 -38.58 12.3 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.04 -1.064 . . . . 3.16 112.049 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -138.63 161.91 56.02 Favored Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.496 -0.881 . . . . 0.74 110.747 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.27 -64.43 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.224 1.283 . . . . 0.56 111.254 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.8 t-20 -90.49 4.07 52.14 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.244 -0.982 . . . . 0.39 111.191 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 26.5 m95 -138.73 140.87 38.85 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 108.801 -0.815 . . . . 0.4 108.801 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -138.59 -177.72 4.99 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.68 -0.808 . . . . 0.84 111.928 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -124.2 124.74 43.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.578 -1.267 . . . . 0.31 107.578 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -155.86 -144.97 4.06 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 108.724 -1.751 . . . . 0.1 108.724 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.7 173.74 11.53 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.375 -1.33 . . . . 0.13 111.735 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 13.8 t -166.06 -103.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 116.871 -1.932 . . . . 0.41 114.407 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.605 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.9 p80 -29.92 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.403 -0.817 . . . . 2.82 112.943 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 152.51 13.7 0.07 OUTLIER Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.278 -1.529 . . . . 0.89 109.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' H ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -149.73 164.21 35.87 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.714 -0.794 . . . . 5.37 110.382 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 41' ' ' ALA . 12.3 p -97.52 -175.03 3.08 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.116 -1.034 . . . . 0.32 111.556 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.59 -174.58 29.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.112 -1.195 . . . . 0.13 110.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 mtp -102.59 146.56 27.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.705 -0.798 . . . . 0.41 110.748 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -151.39 147.24 19.99 Favored Pre-proline 0 C--N 1.303 -1.439 0 C-N-CA 119.441 -0.903 . . . . 0.31 109.892 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.38 124.77 15.83 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.051 -0.788 . . . . 0.28 110.051 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -17.87 63.89 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.632 -0.827 . . . . 2.75 111.526 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.97 -1.3 54.38 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.583 -1.247 . . . . 1.98 111.552 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -96.61 7.57 46.23 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.314 -0.955 . . . . 0.49 108.894 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.8 m -137.32 169.58 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.935 -1.029 . . . . 0.22 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 119.118 -1.033 . . . . 0.15 109.646 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.62 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 54.1 m-85 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.993 0.902 . . . . 2.61 113.218 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 27' ' ' ILE . 15.8 m -129.14 -167.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.921 -1.491 . . . . 0.16 108.741 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -142.78 97.81 3.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.895 -1.15 . . . . 0.32 107.895 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.69 110.93 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.496 -1.229 . . . . 0.27 113.915 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.507 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 2.9 tp -56.46 -50.04 72.88 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.573 -0.74 . . . . 1.75 109.634 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -174.52 4.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.987 -1.006 . . . . 1.53 108.451 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 126.53 31.18 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.086 -1.416 . . . . 0.64 110.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -111.77 102.42 10.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.428 -0.909 . . . . 0.29 111.892 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 117.312 -1.755 . . . . 3.8 109.052 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.373 0.606 . . . . 1.0 111.775 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.568 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -82.09 168.07 18.13 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 116.053 1.871 . . . . 0.2 116.053 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -156.94 123.19 1.26 Allowed Glycine 0 N--CA 1.496 2.69 0 CA-C-N 113.819 -1.537 . . . . 0.12 109.751 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.555 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -148.82 -175.68 5.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.369 -1.332 . . . . 0.22 112.377 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 23' ' ' ARG . 19.7 mmt180 -132.19 129.85 40.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.414 -0.812 . . . . 2.96 111.742 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -19.72 138.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 124.184 0.928 . . . . 3.62 113.256 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.73 39.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.528 -1.429 . . . . 0.1 109.528 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -73.71 120.36 19.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.356 -1.35 . . . . 0.52 107.356 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -74.23 112.99 10.92 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.711 -1.196 . . . . 1.1 113.195 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.559 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.74 141.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.517 -1.66 . . . . 0.23 106.517 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.62 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 12.2 t-160 -100.5 95.82 6.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.388 -1.325 . . . . 0.21 108.307 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.63 97.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 114.465 -1.243 . . . . 0.18 111.115 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.589 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 2.8 mmt -72.77 -32.14 65.41 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.209 -1.359 . . . . 1.68 110.983 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 101.2 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.053 -1.459 . . . . 3.21 111.213 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 7.4 p-10 -51.34 100.88 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.541 -1.264 . . . . 1.83 109.553 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.22 -77.34 0.46 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.953 -1.099 . . . . 0.77 110.674 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -78.22 159.09 76.06 Favored Pre-proline 0 C--N 1.296 -1.752 0 C-N-CA 119.255 -0.978 . . . . 0.99 110.696 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.47 -64.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.659 1.573 . . . . 0.6 111.399 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.1 t-20 -86.16 -1.81 57.77 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.711 -0.796 . . . . 0.51 111.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 16.2 m95 -132.01 153.49 50.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.022 -1.103 . . . . 0.48 108.022 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.5 m0 -148.34 176.12 10.53 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.256 -0.978 . . . . 0.49 111.728 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.4 131.1 55.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.466 -1.309 . . . . 0.55 107.466 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.589 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.01 -145.87 4.3 Favored Glycine 0 C--N 1.302 -1.31 0 C-N-CA 118.123 -1.989 . . . . 0.32 109.608 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.45 154.99 12.57 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 118.517 -1.273 . . . . 0.58 111.847 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.4 t -152.31 -94.62 0.05 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.875 -1.13 . . . . 0.37 111.33 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.703 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 4.6 p80 -59.96 77.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.509 -0.876 . . . . 0.25 110.878 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 24.53 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.177 -1.011 . . . . 0.2 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' HIS . 59.8 mt-30 -147.44 144.98 29.02 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.781 -1.167 . . . . 1.14 111.49 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.757 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.5 p -95.96 -177.06 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.811 -0.756 . . . . 0.19 110.335 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -174.91 27.66 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.45 -1.357 . . . . 0.16 110.62 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 mtp -102.18 146.79 27.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.854 -0.738 . . . . 0.67 111.477 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.5 p90 -149.32 143.94 17.43 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.137 -0.938 . . . . 0.22 108.958 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.81 126.62 22.84 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 N-CA-C 110.705 -0.537 . . . . 0.33 110.705 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.18 -27.68 68.59 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.454 -0.794 . . . . 1.95 112.055 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 2.46 33.59 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.31 -1.356 . . . . 1.04 112.175 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.03 6.33 49.1 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.248 -0.981 . . . . 0.71 109.213 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.507 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.6 m -135.32 176.26 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.582 -1.19 . . . . 0.26 108.997 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.293 -1.878 0 C-N-CA 119.236 -0.985 . . . . 0.31 109.205 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.5 m-85 . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 121.923 0.868 . . . . 0.25 113.197 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 HG22 HG22 ' A' ' 27' ' ' ILE . 21.8 m -136.1 -170.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.087 -1.415 . . . . 0.15 108.684 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -140.83 97.14 3.13 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.428 -0.952 . . . . 0.13 108.428 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -22.25 110.69 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.899 -1.501 . . . . 0.15 113.269 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 tp -64.52 -50.59 66.78 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.454 -0.794 . . . . 1.67 109.852 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -131.93 -178.81 5.05 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.279 -1.008 . . . . 0.9 108.279 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 131.62 35.21 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.159 -1.382 . . . . 0.22 108.325 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -118.51 107.14 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.194 -1.002 . . . . 0.35 112.746 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 117.725 -1.59 . . . . 3.92 109.307 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.456 0.646 . . . . 0.94 111.943 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.587 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -79.18 169.64 17.84 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 115.647 1.721 . . . . 0.25 115.647 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.08 121.42 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-N 113.848 -1.524 . . . . 0.16 110.743 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.6 p90 -147.61 -172.86 4.13 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.515 -1.274 . . . . 0.15 112.007 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.6 mmm180 -136.35 130.06 32.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.614 -0.721 . . . . 2.13 111.61 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 22' ' ' ARG . 4.3 ttp180 -19.11 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.126 0.891 . . . . 4.09 112.922 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.8 62.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.25 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.93 117.79 20.34 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.801 -1.185 . . . . 0.4 107.801 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -73.72 111.73 9.14 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.809 -1.156 . . . . 0.66 112.722 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.553 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.27 146.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.009 -1.478 . . . . 0.16 107.009 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 10.4 t-80 -103.43 100.21 10.07 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.463 -1.31 . . . . 0.38 107.463 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.46 89.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.771 -1.104 . . . . 0.17 110.949 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 7.7 tpp -78.55 -28.07 45.98 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 113.889 -1.505 . . . . 3.07 111.874 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 33' ' ' SER . 1.6 t70 -161.28 82.29 0.62 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 117.771 -1.572 . . . . 1.33 111.663 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 10.1 p-10 -54.1 96.62 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.689 -1.205 . . . . 0.76 109.038 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' ASP . 45.9 m -96.94 -84.96 0.36 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.225 -0.99 . . . . 1.0 111.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -65.45 158.88 71.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 C-N-CA 119.299 -0.96 . . . . 0.51 111.575 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.39 -65.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.616 1.544 . . . . 0.45 111.22 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 6.3 t-20 -82.23 -0.07 43.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.411 -0.813 . . . . 0.63 111.348 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.8 m95 -137.19 148.99 46.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.657 -0.868 . . . . 0.33 108.657 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 7.7 m0 -144.51 169.57 17.71 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.141 -1.023 . . . . 0.52 112.378 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -109.96 123.65 50.01 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 106.854 -1.536 . . . . 1.71 106.854 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -154.09 -150.26 5.44 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.296 -1.907 . . . . 0.16 109.188 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.36 172.97 12.76 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 117.983 -1.487 . . . . 0.21 112.448 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' GLY . 13.1 t -169.96 -96.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.826 -1.15 . . . . 0.31 111.478 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.646 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.1 p80 -57.85 77.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.762 -0.775 . . . . 0.37 111.378 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.6 22.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.318 -0.944 . . . . 0.28 111.765 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.9 mt-30 -146.6 136.24 23.08 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.927 -1.109 . . . . 2.68 111.121 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.0 p -88.93 -179.49 5.96 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.655 -0.818 . . . . 0.17 109.593 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.72 -172.97 31.79 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.623 -1.751 . . . . 0.13 111.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtp -103.98 141.04 36.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.311 -0.556 . . . . 0.36 110.716 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -145.76 145.89 27.06 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.558 -0.857 . . . . 0.14 109.835 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.43 128.89 31.96 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 N-CA-C 110.098 -0.77 . . . . 0.21 110.098 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 38' ' ' TRP . 2.1 tmt_? -65.44 -30.97 71.83 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.392 -0.923 . . . . 2.55 111.672 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -77.34 4.38 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.79 -1.164 . . . . 2.0 112.018 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.48 11.09 39.69 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.405 -0.918 . . . . 0.46 109.431 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.6 m -139.98 173.65 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.835 -1.075 . . . . 0.09 109.076 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.292 -1.911 0 C-N-CA 118.57 -1.252 . . . . 0.17 109.368 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.643 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 63.6 m-85 . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.399 0.618 . . . . 1.73 110.373 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 27' ' ' ILE . 11.4 m -123.29 -165.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.928 -1.033 . . . . 0.23 110.354 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 26' ' ' PHE . 3.0 mt-30 -143.92 100.08 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.169 -1.419 . . . . 0.61 107.169 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -25.5 111.76 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.366 -1.288 . . . . 0.12 113.279 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.0 tp -66.51 -47.74 72.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.58 -0.736 . . . . 1.56 109.671 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -131.06 -179.28 5.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.617 -1.253 . . . . 0.9 107.617 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.05 135.55 35.85 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 106.758 -1.571 . . . . 0.3 106.758 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -122.48 112.68 18.33 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.405 -1.318 . . . . 0.16 114.31 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 106.783 -1.562 . . . . 4.55 106.783 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.213 -0.826 0 N-CA-C 109.482 -0.562 . . . . 0.84 109.482 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.646 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 7.2 tp -77.91 158.35 29.42 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.549 0.944 . . . . 0.85 113.549 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -149.96 123.51 1.59 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.531 -1.428 . . . . 0.27 109.531 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.9 p90 -147.78 -168.39 3.05 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.783 -1.167 . . . . 0.26 111.91 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.8 mmm-85 -139.08 133.94 32.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.907 -0.717 . . . . 2.66 111.599 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -18.83 139.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.15 0.907 . . . . 3.38 113.224 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -19.37 31.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.291 -1.524 . . . . 0.17 109.291 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.74 121.66 15.92 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.871 -1.132 . . . . 0.56 108.947 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m-85 -77.13 104.65 7.74 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.687 -1.205 . . . . 0.77 112.175 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.556 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -74.31 147.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.412 -1.329 . . . . 0.12 107.412 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.643 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.6 t-160 -107.76 96.73 6.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.865 -1.134 . . . . 0.65 108.425 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.04 90.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.777 -1.101 . . . . 0.39 113.336 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -61.62 -33.86 74.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.033 -1.067 . . . . 1.93 109.984 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' O ' ' OD2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -178.56 111.74 0.06 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.676 -1.21 . . . . 2.3 111.105 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -57.29 99.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.232 -1.387 . . . . 2.24 109.272 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -94.19 -68.16 0.82 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.143 -1.023 . . . . 2.0 111.434 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.512 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -86.61 160.07 51.28 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 118.851 -1.139 . . . . 0.81 110.888 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.08 -68.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.428 1.419 . . . . 0.48 111.021 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.5 t-20 -81.85 -2.61 51.66 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.391 -0.822 . . . . 0.76 111.43 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 28.9 m95 -133.1 153.94 51.04 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 108.738 -0.838 . . . . 0.34 108.738 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.1 m0 -149.04 168.04 24.22 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.957 -0.697 . . . . 0.39 111.129 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -108.03 130.52 55.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.41 -1.33 . . . . 0.5 107.41 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.71 -152.19 6.34 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 117.71 -2.186 . . . . 0.16 110.106 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.758 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.46 161.54 27.18 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 117.921 -1.511 . . . . 0.4 112.425 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 41.7 t -158.39 -89.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.895 -1.122 . . . . 0.27 111.853 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.642 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 3.2 p80 -60.73 73.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.849 -0.74 . . . . 0.41 111.039 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.47 19.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.026 -1.083 . . . . 0.35 111.006 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' HIS . 9.1 mm100 -144.08 135.1 25.37 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.021 -1.071 . . . . 4.13 111.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.1 p -84.24 -174.78 5.47 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.724 -0.79 . . . . 0.35 110.727 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.96 -167.62 27.73 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.56 -1.305 . . . . 0.3 111.013 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.9 mtp -109.3 144.28 37.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.168 -0.613 . . . . 0.4 111.517 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 27' ' ' ILE . 9.5 p90 -145.54 144.3 22.38 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 115.384 -0.826 . . . . 0.3 109.567 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.71 126.2 21.65 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.303 0.668 . . . . 0.28 110.386 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -61.91 -30.77 71.11 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.428 -0.806 . . . . 3.04 111.543 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.79 1.93 18.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.848 -1.141 . . . . 3.28 112.595 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.92 12.8 36.94 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.301 -0.96 . . . . 0.2 109.635 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -139.93 174.74 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.265 -0.879 . . . . 0.09 110.347 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 C-N-CA 119.035 -1.066 . . . . 0.15 109.679 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 58.7 m-85 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 121.485 0.66 . . . . 1.5 110.916 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 27' ' ' ILE . 6.3 m -117.57 -165.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 114.821 -1.081 . . . . 0.24 109.555 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.517 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -145.46 94.52 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.818 -1.179 . . . . 0.3 107.818 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.46 110.97 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.251 -1.341 . . . . 0.11 113.211 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.52 -46.16 80.7 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.045 -0.525 . . . . 0.92 109.944 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.25 -179.32 5.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.028 -1.101 . . . . 0.65 108.028 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.72 136.3 36.74 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.278 -1.328 . . . . 0.67 108.225 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -127.61 109.37 11.63 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.755 -1.178 . . . . 0.17 114.002 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.306 -1.293 0 C-N-CA 117.722 -1.591 . . . . 1.8 106.744 179.469 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.733 0 N-CA-C 107.891 -1.152 . . . . 0.27 107.891 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -69.64 164.05 24.22 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 119.941 -0.704 . . . . 0.21 112.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.92 121.81 1.1 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.545 -1.022 . . . . 0.12 110.545 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 6.3 p90 -147.01 -170.49 3.55 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.465 -1.294 . . . . 0.15 112.516 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.5 mmt180 -136.51 130.74 32.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.181 -0.918 . . . . 3.53 111.435 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' ARG . 3.3 ttp85 -16.42 138.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.03 1.122 . . . . 1.84 114.03 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.32 -22.38 13.12 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.412 -1.475 . . . . 0.41 109.412 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.84 121.53 13.71 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.957 -1.097 . . . . 1.33 108.261 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -77.36 106.83 9.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.439 -1.304 . . . . 0.97 112.174 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -73.77 143.82 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.356 -1.349 . . . . 0.2 107.356 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.633 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.1 t-160 -103.56 94.01 5.24 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.6 -1.24 . . . . 0.23 108.796 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.24 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 114.56 -1.2 . . . . 0.31 112.783 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.603 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 30.7 mtt -72.5 -30.66 64.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.999 -1.0 . . . . 1.75 111.052 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -159.21 93.58 1.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.283 -1.367 . . . . 1.15 111.404 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.727 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -68.71 94.11 0.57 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.868 -1.133 . . . . 2.73 109.333 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t -98.16 -74.34 0.58 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.326 -0.95 . . . . 1.91 112.209 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -69.24 157.27 89.78 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.763 -1.175 . . . . 0.45 111.48 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.54 -65.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.176 1.918 . . . . 0.55 111.961 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 5.7 t30 -87.53 5.78 37.48 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.768 -0.773 . . . . 2.32 111.396 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 14.9 m95 -139.73 147.64 41.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.259 -1.015 . . . . 0.39 108.259 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.3 m0 -147.29 172.11 14.37 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.36 -0.936 . . . . 0.36 111.383 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -112.75 129.4 56.43 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.639 -1.245 . . . . 0.15 107.639 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.43 -144.71 4.06 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 118.261 -1.923 . . . . 0.12 109.335 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.09 174.96 9.82 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 117.824 -1.55 . . . . 0.08 112.704 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' GLY . 38.9 t -170.52 -95.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.147 -1.021 . . . . 0.22 112.071 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 6.5 p80 -58.61 78.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.458 -0.897 . . . . 0.55 111.415 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.75 25.64 0.22 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.101 -1.047 . . . . 0.43 111.956 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.48 149.24 25.31 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 117.941 -1.503 . . . . 4.78 111.902 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.9 p -95.68 -175.75 3.53 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.799 -0.76 . . . . 0.15 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.51 -164.73 29.08 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.237 -1.459 . . . . 0.13 111.392 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.4 mtp -109.39 145.66 35.74 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.466 -0.494 . . . . 0.23 111.258 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.2 p90 -148.82 142.49 16.2 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.369 -0.932 . . . . 0.15 109.408 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.46 123.81 14.75 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.712 -0.919 . . . . 0.27 109.712 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -61.85 -29.82 70.44 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.078 -1.049 . . . . 2.44 111.354 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -73.26 -5.0 36.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.839 -1.144 . . . . 2.98 112.176 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.82 10.4 35.41 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.052 -1.059 . . . . 0.25 109.778 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.504 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.8 m -136.85 172.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.335 -0.848 . . . . 0.19 109.859 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.466 0 C-N-CA 119.554 -0.859 . . . . 0.43 109.142 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 113.192 0.812 . . . . 1.91 113.192 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 27' ' ' ILE . 17.9 m -141.75 -170.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.788 -1.097 . . . . 0.25 108.557 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.499 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -141.8 100.63 3.79 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.762 -1.199 . . . . 0.48 107.762 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -26.49 113.45 0.05 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.582 -1.19 . . . . 0.16 112.913 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.465 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.6 -39.55 91.67 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.565 0.698 . . . . 0.71 109.753 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.62 -174.72 4.68 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.895 -1.048 . . . . 1.6 108.827 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.2 122.4 26.8 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.218 -1.355 . . . . 0.83 109.363 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -111.28 99.23 8.08 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.897 -1.121 . . . . 0.34 113.578 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.294 -1.819 0 C-N-CA 115.916 -2.314 . . . . 1.51 104.805 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.216 -0.708 0 N-CA-C 108.386 -0.968 . . . . 0.36 108.386 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.601 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.8 tp -71.93 164.21 26.48 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.75 0.786 . . . . 0.15 112.757 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.42 117.89 0.8 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.395 -1.882 . . . . 0.24 108.395 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 2.7 p90 -140.62 -168.94 2.68 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.66 -1.216 . . . . 0.16 113.029 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' ARG . 9.6 mmm-85 -137.07 129.58 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.75 . . . . 2.5 112.775 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -13.68 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.458 1.098 . . . . 2.77 113.633 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.28 -22.73 5.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.802 -1.719 . . . . 0.49 108.802 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' ARG . 4.4 m-20 -61.46 121.51 12.86 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 118.607 -1.237 . . . . 0.66 107.968 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -77.81 112.24 14.47 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.874 -1.13 . . . . 1.12 112.703 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -79.04 142.15 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.733 -1.21 . . . . 0.3 107.733 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.454 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 20.4 t-80 -99.44 99.66 10.6 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.244 -1.382 . . . . 1.01 107.87 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 29' ' ' VAL . 3.1 t -66.33 92.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 C-N-CA 118.7 -1.2 . . . . 0.45 110.35 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.511 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 5.1 mmt -71.9 -28.96 63.85 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.159 -1.382 . . . . 2.3 111.729 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.48 104.81 0.21 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.1 -1.44 . . . . 1.68 111.462 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 1.9 p30 -58.4 104.55 0.22 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.587 -1.245 . . . . 1.53 109.173 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -66.94 0.87 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.094 -1.042 . . . . 2.38 111.478 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -98.65 159.49 30.29 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 119.404 -0.919 . . . . 0.62 111.266 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.95 -60.88 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.965 1.777 . . . . 0.49 110.963 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -89.47 4.25 49.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.348 -0.842 . . . . 0.45 111.408 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' ASP . 21.9 m95 -142.0 141.72 32.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.881 -0.785 . . . . 0.15 108.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.6 m0 -141.92 169.72 17.06 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.651 -0.82 . . . . 0.52 111.805 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -108.41 134.12 51.64 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.07 -1.085 . . . . 1.47 108.07 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.87 -148.7 5.5 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 117.812 -2.137 . . . . 0.21 109.7 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.01 172.81 13.36 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.222 -1.391 . . . . 0.15 112.114 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -172.01 -94.0 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.733 -1.187 . . . . 0.23 112.005 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.627 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.9 p80 -58.42 77.64 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.539 -0.864 . . . . 0.57 111.397 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.32 27.36 0.25 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.115 -1.041 . . . . 0.78 111.499 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -156.61 151.83 26.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.162 -1.415 . . . . 1.04 111.757 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.1 p -97.51 -176.48 3.51 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.669 -0.812 . . . . 0.39 110.473 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.69 -176.83 24.46 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.337 -1.411 . . . . 0.39 111.628 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.9 mtp -100.45 150.63 22.44 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.327 0.584 . . . . 0.26 111.378 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.596 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.7 p90 -151.7 146.2 18.55 Favored Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.311 -0.858 . . . . 0.15 109.607 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.29 123.17 12.84 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 110.367 -0.666 . . . . 0.18 110.367 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.05 -18.45 60.67 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.396 -0.922 . . . . 2.09 111.078 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -86.64 0.4 54.6 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.737 -1.185 . . . . 2.77 111.733 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -100.27 9.64 42.42 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.365 -0.934 . . . . 0.39 109.407 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -136.2 171.6 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 114.886 -1.052 . . . . 0.28 108.989 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 C-N-CA 119.231 -0.988 . . . . 0.35 108.759 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.274 0.559 . . . . 1.97 111.996 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 27' ' ' ILE . 16.6 m -141.22 -164.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.16 -0.927 . . . . 0.18 109.88 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.87 101.45 3.65 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.304 -1.369 . . . . 0.27 107.304 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -28.13 115.66 0.09 Allowed 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.938 1.088 . . . . 0.16 113.938 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.81 -34.33 69.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.53 -0.915 . . . . 0.74 108.53 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -174.62 4.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.639 -1.164 . . . . 0.73 109.292 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 127.94 35.61 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.757 -1.565 . . . . 0.39 109.453 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.58 108.23 16.88 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.332 -0.947 . . . . 0.32 113.458 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.31 -1.145 0 C-N-CA 117.773 -1.571 . . . . 1.05 108.631 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--O 1.214 -0.775 0 N-CA-C 115.633 1.716 . . . . 1.1 115.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.33 170.06 8.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 110.747 -2.933 . . . . 0.4 110.528 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.69 113.94 0.59 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.851 -1.166 . . . . 0.37 110.21 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.1 p90 -138.49 -162.05 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.937 -1.105 . . . . 0.31 112.196 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -147.82 133.14 18.49 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.961 -1.096 . . . . 6.08 113.307 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.56 127.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.641 1.213 . . . . 2.32 112.259 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 7' ' ' ALA . . . 91.16 -32.62 5.09 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 119.715 -1.231 . . . . 0.85 110.484 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.59 125.99 24.66 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.393 -1.323 . . . . 2.04 108.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.94 113.66 14.88 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.024 -1.07 . . . . 0.73 113.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.53 140.85 16.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.668 -1.213 . . . . 0.28 108.062 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.6 t-80 -96.0 96.84 9.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.189 -1.404 . . . . 1.11 108.53 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.8 t -64.8 100.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 119.018 -1.073 . . . . 0.42 111.293 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.514 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mtt -67.08 -39.22 86.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.004 -1.078 . . . . 1.11 108.547 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -179.23 116.29 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.98 -1.009 . . . . 1.46 109.654 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 9.0 p-10 -47.17 111.64 0.43 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.297 -1.361 . . . . 2.37 109.346 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -42.43 11.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.138 -1.025 . . . . 1.23 112.208 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.94 162.12 58.67 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 119.906 -0.718 . . . . 1.07 111.015 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 -61.05 0.48 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.894 1.729 . . . . 0.81 111.985 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -99.65 17.83 19.57 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.604 -0.839 . . . . 0.96 110.667 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 23.4 m95 -151.47 139.46 20.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.414 -0.958 . . . . 0.39 108.414 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 26.4 m0 -138.79 175.9 9.16 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.334 -0.947 . . . . 0.23 112.128 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 129.91 56.53 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.784 -1.561 . . . . 0.73 106.784 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.24 -152.92 6.56 Favored Glycine 0 C--N 1.298 -1.573 0 C-N-CA 117.888 -2.101 . . . . 0.2 109.834 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.44 168.28 18.65 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 118.225 -1.39 . . . . 0.36 111.763 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 36.4 t -163.89 -91.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.689 -1.205 . . . . 0.52 111.522 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.705 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 2.9 p80 -59.98 77.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.63 -0.828 . . . . 0.4 111.429 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.93 23.74 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.098 -1.048 . . . . 0.46 111.93 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -152.96 153.44 32.96 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.071 -1.452 . . . . 4.45 111.201 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 41' ' ' ALA . 8.9 p -99.44 -174.89 2.84 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.652 -0.819 . . . . 0.35 111.37 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.23 -172.09 28.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.356 -1.098 . . . . 0.22 110.356 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.3 mtp -105.03 157.99 16.86 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.747 -0.781 . . . . 0.59 110.387 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.7 p90 -159.21 142.72 10.76 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.134 -1.061 . . . . 0.26 108.134 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -54.76 127.0 24.33 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 CA-C-N 118.613 0.541 . . . . 0.32 111.239 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.535 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -40.22 85.84 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.574 -0.851 . . . . 2.23 109.578 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.5 2.39 1.8 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.529 -0.868 . . . . 2.28 112.867 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.79 10.39 41.2 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.101 -1.039 . . . . 0.17 109.328 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 51' ' ' ARG . 14.2 m -141.58 175.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.13 109.463 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.545 0 C-N-CA 119.23 -0.988 . . . . 0.3 109.324 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.318 0.58 . . . . 0.89 112.553 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 27' ' ' ILE . 6.2 m -143.81 -170.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.078 -0.964 . . . . 0.29 110.011 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 55' ' ' THR . 1.9 mt-30 -141.72 101.13 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.678 -1.23 . . . . 0.36 107.678 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.26 110.55 0.06 Allowed 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.188 -0.915 . . . . 0.19 113.116 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.53 -42.04 87.82 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.469 0.652 . . . . 1.17 109.978 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.56 -178.24 4.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.741 -1.118 . . . . 1.4 108.758 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 140.59 32.44 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 113.435 -1.711 . . . . 1.01 106.995 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.57 106.99 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.031 1.493 . . . . 0.37 115.031 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.305 -1.343 0 N-CA-C 105.925 -1.88 . . . . 2.01 105.925 179.385 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 108.089 -1.078 . . . . 1.28 108.089 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.4 tp -69.0 154.61 41.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 112.858 0.688 . . . . 0.54 112.858 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.15 123.13 1.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.659 -1.377 . . . . 0.15 109.659 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.6 p90 -146.44 -176.11 5.05 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.582 -1.247 . . . . 0.13 112.03 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.5 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.9 mmt85 -135.73 127.72 29.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.498 -0.774 . . . . 2.35 111.305 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.5 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -13.56 135.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.03 1.122 . . . . 1.13 114.03 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.39 -21.82 30.11 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.21 109.402 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -69.09 117.52 10.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.731 -1.211 . . . . 0.94 107.731 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 67.3 m-85 -73.28 108.3 6.08 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.978 -1.089 . . . . 0.93 112.174 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -73.38 142.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.068 -1.456 . . . . 0.19 107.068 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 31.8 t-80 -101.45 99.17 9.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.861 -1.536 . . . . 1.31 108.125 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 29' ' ' VAL . 6.4 t -64.74 102.43 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 C-N-CA 118.731 -1.187 . . . . 0.27 110.12 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.492 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.6 ttp -93.32 -21.96 19.26 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.825 -1.08 . . . . 1.7 111.216 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.01 87.82 0.94 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.092 -1.443 . . . . 1.97 111.734 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.15 82.78 0.23 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.78 -1.168 . . . . 2.08 108.755 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -95.7 -83.14 0.37 Allowed 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.191 -1.003 . . . . 1.51 111.855 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.1 m-20 -57.85 156.15 19.93 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 118.675 -1.21 . . . . 0.85 111.352 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.17 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.896 1.731 . . . . 0.36 111.833 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.88 -3.26 53.72 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.225 -0.898 . . . . 0.31 111.556 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 32.8 m95 -129.67 151.8 49.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.18 -1.044 . . . . 0.8 108.18 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.2 m0 -151.81 164.85 36.17 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.04 -0.664 . . . . 0.6 110.905 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -108.16 137.79 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.579 -1.267 . . . . 0.6 107.579 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.492 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.52 -148.71 5.35 Favored Glycine 0 C--O 1.214 -1.145 0 C-N-CA 118.078 -2.01 . . . . 0.38 109.54 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.17 154.39 10.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.403 -1.319 . . . . 0.76 112.185 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 44' ' ' GLY . 35.1 t -155.25 -100.93 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.956 -1.098 . . . . 0.38 111.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.63 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 4.4 p80 -53.65 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.571 -0.74 . . . . 0.47 111.715 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 26.66 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.139 -1.029 . . . . 0.46 112.268 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -156.73 149.9 24.11 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.408 -1.317 . . . . 4.52 111.982 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.1 p -97.27 -172.9 2.53 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.604 -0.726 . . . . 0.21 110.855 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.52 -171.15 26.65 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.374 -1.393 . . . . 0.2 111.422 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 18.7 mtp -104.9 145.46 30.38 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.241 -0.584 . . . . 0.62 111.489 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.4 p90 -149.42 141.17 14.81 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 119.516 -0.874 . . . . 0.16 109.94 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.31 128.31 29.91 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 N-CA-C 110.067 -0.782 . . . . 0.29 110.067 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -23.01 64.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.411 -0.916 . . . . 2.8 111.56 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -84.38 10.18 11.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.712 -1.195 . . . . 4.67 111.383 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.01 6.85 29.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.814 -0.755 . . . . 0.33 109.112 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.0 m -134.7 175.07 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.553 -1.203 . . . . 0.26 109.603 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.305 -1.344 0 C-N-CA 119.414 -0.914 . . . . 0.39 108.949 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 113.24 0.83 . . . . 1.91 113.24 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 27' ' ' ILE . 16.9 m -137.87 -164.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 115.174 -0.921 . . . . 0.21 109.218 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.511 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -145.26 97.48 3.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.286 -1.005 . . . . 0.42 108.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.4 115.25 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.729 -1.123 . . . . 0.15 113.282 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 17.2 tp -64.95 -41.27 95.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.666 -0.697 . . . . 1.94 109.425 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.68 -174.92 4.6 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.962 -1.017 . . . . 1.45 109.489 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.57 127.63 33.56 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 113.903 -1.499 . . . . 0.6 107.456 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -114.44 103.89 11.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.453 1.279 . . . . 0.38 114.453 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 105.687 -1.968 . . . . 1.82 105.687 179.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.606 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.739 0 CA-C-O 121.429 0.633 . . . . 0.88 109.545 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.606 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 11.3 tp -72.16 155.99 39.65 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.003 -0.999 . . . . 1.08 113.291 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.48 117.2 0.86 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 107.999 -2.04 . . . . 0.42 107.999 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -139.52 -169.3 2.66 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.889 -1.124 . . . . 0.32 113.064 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -133.97 130.14 37.23 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.463 -0.79 . . . . 3.33 112.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -18.71 137.92 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.829 0.706 . . . . 2.63 112.879 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 -21.5 15.23 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.916 -1.674 . . . . 0.33 108.916 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -64.85 121.73 15.29 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.935 -1.106 . . . . 0.34 108.308 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 110.2 11.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.986 -1.086 . . . . 0.85 112.763 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.559 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -76.18 146.85 8.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.784 -1.191 . . . . 0.2 107.784 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -103.49 89.78 3.47 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.277 -1.369 . . . . 1.01 109.408 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.83 94.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 118.677 -1.209 . . . . 0.66 110.285 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.507 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 15.4 mtp -74.88 -29.57 61.05 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.655 -1.157 . . . . 1.98 110.482 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.25 99.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 117.946 -1.502 . . . . 2.32 111.805 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 2.1 p30 -54.56 101.53 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.103 -1.439 . . . . 1.45 108.326 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -94.04 -72.89 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.007 -1.077 . . . . 1.05 111.735 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.1 m-20 -80.34 160.55 67.53 Favored Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.049 -1.06 . . . . 0.64 111.0 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.34 -68.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.577 1.518 . . . . 0.46 111.127 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.5 t-20 -87.13 4.13 43.54 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.712 -0.795 . . . . 0.26 111.577 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.2 m95 -136.66 148.62 47.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.465 -0.939 . . . . 0.11 108.465 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 22.8 m0 -142.37 175.55 9.68 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.616 -0.834 . . . . 0.18 111.5 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 133.03 56.32 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.965 -1.494 . . . . 0.56 106.965 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.71 -150.68 5.91 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 117.918 -2.086 . . . . 0.15 109.261 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.68 159.66 19.1 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 118.226 -1.389 . . . . 0.53 111.662 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' GLY . 40.6 t -155.37 -100.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.553 -1.259 . . . . 0.32 112.097 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.517 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.7 p80 -52.77 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.584 -0.735 . . . . 0.7 111.899 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.2 24.05 0.1 OUTLIER Glycine 0 N--CA 1.489 2.216 0 CA-C-N 115.167 -0.924 . . . . 0.47 112.252 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 tp60 -156.16 163.71 39.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.814 -1.554 . . . . 4.28 111.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.719 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.8 p -99.82 -177.26 3.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.341 -0.845 . . . . 0.49 111.313 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.99 171.39 18.36 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.01 -1.567 . . . . 0.76 111.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 mtp -95.92 146.28 24.72 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 120.218 -0.593 . . . . 0.6 110.394 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 10.1 p90 -148.78 145.54 20.06 Favored Pre-proline 0 C--N 1.296 -1.743 0 C-N-CA 119.403 -0.919 . . . . 0.23 108.859 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.93 128.04 27.43 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.008 0.472 . . . . 0.15 110.973 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -59.16 -36.56 75.5 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 3.62 110.253 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 52' ' ' ASN . 26.7 t-20 -75.13 3.32 8.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.473 -0.891 . . . . 3.69 112.787 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.12 9.16 43.25 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.905 -1.118 . . . . 0.19 109.598 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.5 m -138.42 177.94 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.943 -1.026 . . . . 0.2 109.03 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.689 0 C-N-CA 119.18 -1.008 . . . . 0.2 109.259 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 113.091 0.775 . . . . 0.74 113.091 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 27' ' ' ILE . 16.0 m -147.45 -167.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 115.062 -0.972 . . . . 0.24 109.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.88 97.08 2.96 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.588 -1.264 . . . . 0.32 107.588 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HA ' HG12 ' A' ' 54' ' ' VAL . . . -24.22 115.54 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.359 -1.291 . . . . 0.16 113.663 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -70.77 -42.09 70.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.809 -0.632 . . . . 0.88 109.888 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 -179.94 5.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.478 1.132 . . . . 1.13 109.155 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -85.31 124.76 32.3 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.107 -1.86 . . . . 0.72 107.412 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -111.96 104.54 12.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.262 -0.975 . . . . 0.42 112.798 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.4 p-10 . . . . . 0 C--N 1.304 -1.37 0 C-N-CA 117.514 -1.675 . . . . 3.35 108.765 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.576 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.2 pt-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.327 0.584 . . . . 1.16 111.732 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.576 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -84.82 170.22 13.39 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 116.138 1.903 . . . . 0.24 116.138 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -158.93 119.66 0.91 Allowed Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.168 -1.833 . . . . 0.17 109.209 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.567 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.5 p90 -144.97 -170.81 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.367 -1.333 . . . . 0.11 112.455 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 23' ' ' ARG . 5.1 mmt85 -136.88 126.91 25.98 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.544 -0.753 . . . . 1.94 111.743 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.3 ttp85 -12.8 135.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.398 1.259 . . . . 2.84 114.398 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.11 -23.81 10.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.52 109.6 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -61.26 117.07 5.14 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.388 -1.325 . . . . 0.85 107.891 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -71.89 107.57 4.72 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.48 -1.288 . . . . 0.94 112.376 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.85 136.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.362 -1.347 . . . . 0.38 107.362 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.409 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 25.5 t-80 -94.36 94.12 8.09 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.454 -1.699 . . . . 1.22 108.29 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 29' ' ' VAL . 7.7 t -61.01 100.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 C-N-CA 118.967 -1.093 . . . . 0.27 111.388 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.42 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 8.6 tpp -61.51 -36.0 79.29 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.062 -1.055 . . . . 1.82 108.931 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 p30 171.58 126.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.026 -0.988 . . . . 2.84 109.39 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.559 ' N ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -49.97 109.78 0.32 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.914 -1.514 . . . . 2.75 109.716 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -92.51 -65.69 0.98 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.422 -0.911 . . . . 2.08 110.162 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -102.57 160.75 25.36 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.021 -0.99 . . . . 0.63 110.315 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -59.47 -60.57 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.309 1.34 . . . . 0.59 111.087 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -92.53 -3.58 54.87 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.666 -0.813 . . . . 0.48 111.708 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 17.0 m95 -131.01 152.85 49.88 Favored 'General case' 0 C--O 1.204 -1.327 0 N-CA-C 108.343 -0.984 . . . . 0.38 108.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.677 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 15.2 m0 -145.24 177.91 8.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.69 -0.804 . . . . 0.33 111.825 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -118.02 135.95 53.85 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.943 -1.132 . . . . 3.32 107.943 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -165.89 -150.36 6.26 Favored Glycine 0 C--N 1.3 -1.451 0 C-N-CA 118.031 -2.033 . . . . 0.11 109.268 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.44 174.27 12.95 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 118.264 -1.374 . . . . 0.18 111.877 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -170.33 -93.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.832 -1.147 . . . . 0.4 112.156 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 7.7 p80 -59.69 78.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.259 -0.977 . . . . 0.81 111.049 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.76 20.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.132 -0.94 . . . . 0.58 111.688 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' HIS . 54.8 mt-30 -148.3 151.79 35.99 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.393 -1.323 . . . . 1.14 111.745 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.2 p -96.14 -179.46 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.629 -0.828 . . . . 0.35 110.239 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -179.06 28.21 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.019 -1.562 . . . . 0.37 111.092 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.6 mtp -102.79 147.04 27.36 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.398 0.618 . . . . 0.44 110.81 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -149.16 149.7 30.2 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.359 -0.837 . . . . 0.23 108.799 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.11 131.16 37.6 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 N-CA-C 110.564 -0.591 . . . . 0.35 110.564 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.677 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.39 -51.41 68.91 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.204 -0.998 . . . . 4.17 109.755 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -61.1 9.12 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.522 0.934 . . . . 3.14 113.522 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -104.39 3.75 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.112 -1.035 . . . . 0.46 109.26 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ARG . 12.9 m -134.06 175.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.14 108.875 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.305 -0.958 . . . . 0.32 108.693 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.12 0.486 . . . . 1.32 112.068 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 27' ' ' ILE . 10.0 m -140.75 -168.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.556 -0.747 . . . . 0.15 109.52 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.6 mt-30 -143.05 89.67 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.828 -0.749 . . . . 0.28 109.031 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -14.55 111.69 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.023 -1.444 . . . . 0.15 114.139 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 6.1 tp -63.75 -52.98 57.97 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.639 -0.71 . . . . 1.76 109.537 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.23 -178.92 5.05 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.865 -1.161 . . . . 0.54 107.865 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.85 136.48 36.7 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 114.328 -1.305 . . . . 0.31 109.088 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -123.69 109.55 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.958 -1.097 . . . . 0.25 113.391 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.306 -1.297 0 C-N-CA 117.816 -1.554 . . . . 1.27 108.452 179.595 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.519 0.676 . . . . 0.98 112.049 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.563 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.6 tp -76.71 166.06 23.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 115.492 1.664 . . . . 0.25 115.492 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.08 120.9 1.05 Allowed Glycine 0 N--CA 1.499 2.88 0 CA-C-N 114.237 -1.347 . . . . 0.17 110.437 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.1 p90 -149.05 -175.54 5.0 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.073 -1.451 . . . . 0.2 112.861 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' ARG . 31.3 mmt-85 -135.6 130.55 34.62 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.189 -0.914 . . . . 5.95 111.603 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.98 140.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.456 1.28 . . . . 1.45 114.456 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.11 -15.07 29.67 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 114.067 -1.424 . . . . 0.17 109.594 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -72.68 118.81 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.555 -1.276 . . . . 0.41 107.555 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.69 107.21 5.8 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.687 -1.205 . . . . 0.74 113.276 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -73.04 142.84 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.819 -1.548 . . . . 0.26 106.819 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 15.8 t-80 -100.6 93.92 5.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.17 -1.412 . . . . 0.97 108.887 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 29' ' ' VAL . 2.0 t -63.07 96.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 118.135 -1.426 . . . . 0.6 110.5 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.469 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 57.6 ttm -82.48 -25.87 33.12 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.51 -1.223 . . . . 0.57 110.706 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.9 85.06 0.95 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.15 -1.42 . . . . 2.06 111.766 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.757 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.18 91.78 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.027 -1.069 . . . . 2.88 109.0 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.2 m -103.1 -85.86 0.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.285 -0.966 . . . . 1.69 111.936 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.44 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 8.4 m-20 -55.58 154.52 12.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 118.488 -1.285 . . . . 1.13 110.753 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.05 -71.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.876 1.717 . . . . 0.39 112.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.47 7.82 13.28 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.721 -0.792 . . . . 2.74 111.387 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.3 m95 -139.85 146.19 39.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.617 -0.882 . . . . 0.43 108.617 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.8 m0 -145.59 167.34 23.28 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.378 -0.929 . . . . 0.45 111.447 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -108.21 132.1 54.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.241 -1.022 . . . . 0.24 108.241 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.09 -146.66 4.62 Favored Glycine 0 C--N 1.3 -1.443 0 C-N-CA 117.883 -2.103 . . . . 0.16 109.116 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -163.76 159.21 21.11 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.173 -1.811 . . . . 0.42 113.495 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 8.2 t -175.61 -179.72 1.28 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 2.91 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.609 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 10.8 p80 40.78 26.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.802 -0.636 . . . . 1.35 111.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 81.27 31.04 35.38 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.732 -1.223 . . . . 0.77 112.778 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.6 tt0 -164.91 155.23 13.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.832 -1.547 . . . . 1.73 112.19 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.4 p -95.04 -179.5 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.399 -0.921 . . . . 0.2 110.814 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 -159.2 28.27 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.14 -1.505 . . . . 0.32 111.255 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.5 mtp -120.03 148.37 43.66 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.167 0.508 . . . . 0.28 110.759 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.5 p90 -151.08 143.9 16.64 Favored Pre-proline 0 C--N 1.297 -1.712 0 C-N-CA 119.563 -0.855 . . . . 0.22 109.146 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.91 126.92 24.02 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 109.864 -0.86 . . . . 0.23 109.864 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -60.88 -32.59 72.03 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.149 -1.02 . . . . 3.46 111.58 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 -74.54 0.12 15.86 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.494 -1.283 . . . . 1.7 112.349 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.39 12.56 32.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.93 -1.108 . . . . 0.19 109.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.6 m -139.38 171.0 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.983 -1.008 . . . . 0.14 109.741 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.576 -0.898 . . . . 0.55 108.576 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 112.66 0.615 . . . . 0.83 112.66 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' ILE . 14.7 m -128.42 -167.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.266 -0.879 . . . . 0.27 110.098 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.533 ' O ' HG22 ' A' ' 55' ' ' THR . 4.4 mt-30 -141.83 109.34 5.64 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.673 -1.603 . . . . 0.42 106.673 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -34.79 115.73 0.29 Allowed 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.927 -1.109 . . . . 0.31 111.79 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.531 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 1.4 tt -73.71 -39.82 64.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.018 -0.992 . . . . 0.74 109.837 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.99 -179.9 5.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.781 -1.1 . . . . 0.86 108.582 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.61 135.47 36.06 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.294 -1.775 . . . . 0.53 107.702 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -131.07 111.93 12.44 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.475 -1.29 . . . . 0.41 113.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.311 -1.077 0 C-N-CA 118.023 -1.471 . . . . 3.79 107.928 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.75 0 CA-C-O 121.28 0.562 . . . . 1.22 110.147 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.688 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -73.74 167.35 21.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.107 -0.951 . . . . 0.35 112.109 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.76 130.12 2.68 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.598 -1.001 . . . . 0.24 110.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 27' ' ' ILE . 9.4 p90 -156.75 -172.05 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.682 -1.607 . . . . 0.26 113.075 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . 10.8 mmm180 -138.77 128.57 24.98 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.278 -0.874 . . . . 4.3 112.153 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -12.7 135.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.295 1.22 . . . . 3.1 114.295 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.63 -19.51 32.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.095 -1.602 . . . . 0.16 109.095 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -65.39 118.81 9.92 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.166 -1.014 . . . . 0.81 108.777 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.78 107.79 7.1 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.068 -1.053 . . . . 1.33 112.696 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.92 143.4 12.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.139 -1.43 . . . . 0.29 107.139 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -100.82 95.24 6.5 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.739 -1.585 . . . . 1.26 108.767 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 29' ' ' VAL . 3.8 t -64.83 106.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 118.114 -1.434 . . . . 0.44 109.613 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.3 tpp -88.75 -26.34 21.8 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.122 -0.944 . . . . 2.35 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -172.06 108.52 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.691 -1.604 . . . . 1.6 111.595 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 3.7 p30 -62.33 100.01 0.16 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.381 -1.328 . . . . 1.72 109.249 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -91.25 -66.55 0.92 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.782 -1.167 . . . . 1.13 111.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 4.3 m-20 -90.19 159.9 41.2 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 119.226 -0.99 . . . . 2.35 110.726 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.54 -65.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.443 1.429 . . . . 0.38 111.066 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -83.14 -8.93 59.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.489 -0.778 . . . . 0.92 111.559 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 18.9 m95 -126.57 155.94 41.65 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.768 -0.827 . . . . 0.39 108.768 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.6 m0 -149.84 -179.31 7.03 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.507 -0.877 . . . . 0.58 112.151 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -122.43 128.13 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.879 -1.156 . . . . 0.65 107.879 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.87 -148.43 4.99 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.587 -1.805 . . . . 0.19 108.587 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.739 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.91 159.05 17.82 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 117.303 -1.759 . . . . 0.58 113.763 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' GLY . 43.2 t -172.7 -178.85 1.99 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.543 -1.208 . . . . 2.53 111.041 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 4.0 p80 39.6 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.874 -0.603 . . . . 1.55 111.616 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 85.9 30.47 23.31 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.718 -1.229 . . . . 0.41 112.907 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 46' ' ' THR . 1.3 tm0? -164.37 151.72 11.81 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.119 -1.433 . . . . 4.42 111.814 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.739 HG22 ' HB2' ' A' ' 41' ' ' ALA . 6.1 p -94.28 -175.69 3.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.55 -0.86 . . . . 0.28 110.689 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.15 -170.07 29.49 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.462 -1.351 . . . . 0.17 110.933 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.0 mtp -107.76 143.91 35.63 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.975 -0.69 . . . . 0.27 111.095 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.5 p90 -148.52 145.59 20.55 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 119.701 -0.8 . . . . 0.25 110.093 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.43 125.64 19.46 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 N-CA-C 109.966 -0.821 . . . . 0.35 109.966 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.31 -25.22 67.53 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.626 -0.829 . . . . 2.04 112.211 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.25 7.44 16.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.367 -1.333 . . . . 2.26 111.876 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.96 7.37 39.17 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.506 -0.878 . . . . 0.23 109.547 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 11.6 m -135.18 179.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.767 -1.106 . . . . 0.3 109.033 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 118.745 -1.182 . . . . 0.38 110.818 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.466 ' CE2' ' CD2' ' A' ' 28' ' ' HIS . 82.9 m-85 . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.765 0.793 . . . . 2.16 112.666 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 19.4 m -130.93 -166.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.308 -1.315 . . . . 0.21 108.708 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.1 mt-30 -144.45 95.41 2.71 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.928 -1.138 . . . . 0.19 107.928 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.54 111.15 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.481 -1.236 . . . . 0.15 113.186 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.523 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 14.0 tp -61.98 -45.72 92.39 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.514 0.673 . . . . 1.87 109.682 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.09 -174.44 3.85 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.709 -1.132 . . . . 0.86 108.252 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.84 148.31 30.02 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 114.168 -1.378 . . . . 0.27 107.805 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -139.21 119.35 13.56 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.125 -1.43 . . . . 0.45 113.704 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--N 1.311 -1.066 0 C-N-CA 118.643 -1.223 . . . . 1.73 108.64 179.571 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.76 0 CA-C-O 121.399 0.619 . . . . 1.12 110.103 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.69 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -74.88 161.62 29.38 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.674 0.99 . . . . 0.61 113.674 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -153.2 120.92 1.09 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.072 -1.211 . . . . 0.21 110.072 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.7 p90 -144.16 -169.61 3.16 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.778 -1.169 . . . . 0.22 111.796 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.1 mmm-85 -138.7 125.05 20.4 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.937 -0.705 . . . . 2.29 112.0 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.63 130.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.143 0.902 . . . . 2.21 113.282 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.52 -19.61 53.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.18 109.381 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' OD1' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -72.84 120.73 18.87 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.961 -1.096 . . . . 1.84 108.925 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -76.01 109.46 9.67 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.96 -1.096 . . . . 0.49 112.65 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -74.58 142.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.677 -1.231 . . . . 0.31 107.677 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.466 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 12.2 t-80 -100.74 97.99 8.57 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 118.29 -1.364 . . . . 0.72 108.032 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 29' ' ' VAL . 4.8 t -67.12 94.81 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.908 -1.042 . . . . 0.41 110.884 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.452 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 39.7 ttm -82.28 -27.21 32.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.56 -1.2 . . . . 0.89 111.343 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' SER . 11.8 t70 -160.46 83.44 0.69 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 117.701 -1.6 . . . . 1.87 111.903 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 1.6 p-10 -52.93 99.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.456 -1.297 . . . . 1.58 108.904 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 1.1 t -95.17 -78.06 0.46 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.126 -1.03 . . . . 2.06 111.554 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -72.63 158.48 87.27 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.064 -1.054 . . . . 0.62 111.498 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.49 -65.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.783 1.655 . . . . 0.23 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 6.67 35.33 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.689 -0.804 . . . . 2.8 111.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' ASP . 15.8 m95 -139.65 147.53 41.15 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.704 -1.221 . . . . 0.25 107.704 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -145.8 174.83 10.88 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.254 -0.978 . . . . 0.36 112.024 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.31 135.94 53.44 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.621 -1.251 . . . . 1.56 107.621 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -162.31 -145.11 4.22 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 117.895 -2.097 . . . . 0.43 109.643 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.12 155.58 11.8 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.543 -1.263 . . . . 0.74 112.237 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 44' ' ' GLY . 28.7 t -155.81 -98.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.012 -1.075 . . . . 0.2 111.751 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 3.9 p80 -55.47 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.563 -0.855 . . . . 0.53 111.029 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.56 26.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.327 -0.94 . . . . 0.48 111.866 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -154.78 153.01 30.54 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.15 -1.42 . . . . 2.55 111.792 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.0 p -98.15 -174.25 2.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.638 -0.71 . . . . 0.36 110.692 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.45 -169.55 27.0 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.371 -1.395 . . . . 0.28 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.5 mtp -110.2 151.41 27.35 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.355 0.598 . . . . 0.31 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.9 p90 -152.53 147.99 20.19 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.165 -0.925 . . . . 0.27 109.067 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.56 128.39 27.0 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 110.006 -0.805 . . . . 0.23 110.006 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.93 -39.1 90.89 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.877 -1.129 . . . . 1.99 110.674 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.03 2.43 2.71 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.017 -1.073 . . . . 2.26 112.694 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.29 9.23 41.94 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.275 -0.97 . . . . 0.17 109.342 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.7 m -138.28 176.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.972 -1.013 . . . . 0.19 109.451 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.292 -1.913 0 C-N-CA 118.555 -1.258 . . . . 0.28 109.627 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.529 0.681 . . . . 0.78 112.546 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 13.8 m -142.8 -171.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 114.738 -1.119 . . . . 0.18 109.328 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.5 mt-30 -140.66 93.63 2.63 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.821 -0.752 . . . . 0.39 109.341 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -19.92 110.57 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.864 -1.516 . . . . 0.15 114.739 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' ' NE ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -71.67 -44.35 64.42 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.102 -0.954 . . . . 1.32 109.291 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.85 -179.98 5.24 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.128 -1.064 . . . . 1.72 108.128 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.37 143.32 26.87 Favored 'General case' 0 C--N 1.268 -2.941 0 N-CA-C 106.848 -1.538 . . . . 0.64 106.848 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -131.41 115.09 15.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.205 -1.398 . . . . 0.42 114.415 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.307 -1.28 0 C-N-CA 118.638 -1.225 . . . . 4.09 107.915 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 CA--C 1.499 -0.998 0 CA-C-O 123.113 1.435 . . . . 1.8 113.697 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -104.06 160.11 15.12 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 111.385 -2.643 . . . . 0.49 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.77 105.23 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.933 -1.603 . . . . 0.5 110.767 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 3.2 p90 -132.03 -170.19 2.36 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.38 -0.928 . . . . 0.23 111.178 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 23' ' ' ARG . 1.3 mmm180 -144.04 124.9 14.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.398 -0.921 . . . . 3.26 112.046 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.5 ttt-85 -11.68 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 124.351 1.032 . . . . 1.87 113.542 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.7 -17.78 55.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.262 -1.535 . . . . 0.3 109.262 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.93 126.17 29.86 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.578 -1.249 . . . . 1.25 108.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -77.36 111.5 13.09 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.601 -1.24 . . . . 0.45 112.816 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.46 144.19 11.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 118.618 -1.233 . . . . 0.17 107.965 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 13.0 t-80 -101.16 101.24 11.93 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 106.658 -1.608 . . . . 0.51 106.658 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.26 91.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 115.106 -0.952 . . . . 0.45 112.781 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.551 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 4.4 mtt -57.68 -39.35 76.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.538 -1.21 . . . . 1.07 109.529 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.7 OUTLIER 179.8 119.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.591 -1.244 . . . . 3.23 110.594 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 6.4 p-10 -49.13 108.55 0.19 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.372 -1.331 . . . . 2.32 110.154 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.7 t -92.28 -47.78 7.02 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.186 -1.006 . . . . 1.54 111.481 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -125.73 161.19 52.36 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.397 -0.82 . . . . 1.44 110.181 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -58.27 -67.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.505 1.47 . . . . 0.54 111.648 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -87.9 7.05 32.65 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.57 111.348 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASP . 24.4 m95 -141.42 145.08 34.87 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.815 . . . . 0.38 108.801 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.549 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -143.93 173.05 12.04 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.402 -0.919 . . . . 0.46 112.218 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -116.15 132.44 56.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.936 -1.135 . . . . 0.97 107.936 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.551 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.08 -144.16 3.86 Favored Glycine 0 C--N 1.297 -1.594 0 C-N-CA 118.004 -2.046 . . . . 0.16 109.163 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.82 161.58 15.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.397 -1.321 . . . . 0.4 111.419 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 44' ' ' GLY . 47.1 t -161.29 -112.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.039 -1.865 . . . . 0.56 113.771 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.536 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 p80 -21.93 -42.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.413 1.071 . . . . 2.75 113.052 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 164.39 18.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.137 -1.506 . . . . 1.25 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -157.12 161.96 39.4 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.452 -0.899 . . . . 1.78 110.749 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -96.79 -174.11 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.313 -0.955 . . . . 0.58 110.475 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.19 -172.3 30.04 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.584 -1.293 . . . . 0.47 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtp -104.83 138.82 40.51 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.002 -0.679 . . . . 0.63 110.333 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.4 p90 -142.19 146.06 38.2 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 119.777 -0.769 . . . . 0.26 109.32 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.78 127.06 24.53 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 110.141 -0.754 . . . . 0.31 110.141 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.92 -29.53 70.69 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.282 -0.967 . . . . 3.44 111.747 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -76.51 -8.37 57.05 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.58 -1.248 . . . . 4.18 111.736 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.91 15.56 7.02 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.962 -1.095 . . . . 0.36 109.947 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.5 m -144.16 174.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 115.601 -0.727 . . . . 0.23 110.322 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.551 0 C-N-CA 119.673 -0.811 . . . . 0.58 109.121 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.353 0.597 . . . . 0.83 111.968 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 27' ' ' ILE . 3.9 m -143.81 -169.16 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 0.29 109.851 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' THR . 2.5 mt-30 -143.57 105.36 4.34 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.228 -1.397 . . . . 0.39 107.228 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -33.84 111.69 0.11 Allowed 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.01 -1.076 . . . . 0.34 112.162 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.03 -37.21 86.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.934 -0.706 . . . . 1.31 109.376 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.29 -173.55 4.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.891 -1.049 . . . . 1.54 109.522 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 129.13 34.19 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.383 -1.735 . . . . 0.46 109.731 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.28 109.56 17.0 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.85 -1.14 . . . . 0.35 113.133 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 . . . . . 0 C--N 1.295 -1.781 0 C-N-CA 117.234 -1.786 . . . . 1.58 106.848 179.451 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.661 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.561 0.696 . . . . 2.71 111.861 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.661 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -77.33 161.65 27.9 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 115.187 1.551 . . . . 0.72 115.187 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -150.58 131.57 3.61 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.138 -1.185 . . . . 0.24 110.138 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 27' ' ' ILE . 8.2 p90 -152.57 -168.43 3.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.432 -1.307 . . . . 0.24 112.029 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 23' ' ' ARG . 8.5 mmm180 -140.38 131.28 26.03 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.618 -0.833 . . . . 4.48 112.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -13.13 135.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.016 1.117 . . . . 2.22 114.016 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.13 14.01 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.367 -1.493 . . . . 0.37 109.367 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.26 119.23 7.52 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.841 -1.144 . . . . 0.65 108.435 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.458 ' CZ ' ' NE2' ' A' ' 6' ' ' GLN . 26.9 m-85 -77.07 105.36 8.1 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.568 -1.253 . . . . 2.29 112.569 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.577 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -75.54 144.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.017 -1.475 . . . . 0.23 107.017 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 16.0 t-80 -104.1 98.88 8.63 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.772 -1.171 . . . . 0.87 108.149 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.16 92.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 118.346 -1.342 . . . . 0.54 111.311 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.555 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -68.62 -36.09 78.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.803 -1.544 . . . . 1.62 110.372 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -164.23 92.53 0.65 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.582 -1.247 . . . . 2.22 111.106 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.75 99.24 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.346 -1.342 . . . . 1.74 109.282 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -96.47 -82.64 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.314 -0.954 . . . . 1.16 111.636 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.3 m-20 -64.27 158.23 66.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.052 -1.059 . . . . 0.59 110.86 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.06 -68.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.54 1.493 . . . . 0.3 111.539 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.6 t30 -84.13 3.71 33.68 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.577 -0.849 . . . . 1.91 111.332 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.447 ' O ' ' O ' ' A' ' 34' ' ' ASP . 22.9 m95 -136.47 144.4 44.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.541 -0.911 . . . . 0.52 108.541 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CZ2' ' HG3' ' A' ' 51' ' ' ARG . 12.6 m0 -143.01 171.63 13.79 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.679 -0.808 . . . . 0.32 111.692 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.08 130.33 55.55 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.533 -1.654 . . . . 0.36 106.533 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.555 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.48 -154.56 7.14 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 117.952 -2.071 . . . . 0.14 109.535 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -161.67 155.36 21.6 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 117.458 -1.697 . . . . 0.55 112.926 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 44' ' ' GLY . 5.7 t -167.55 178.8 5.21 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.658 -1.156 . . . . 2.34 110.777 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 42' ' ' CYS . 10.8 p80 41.01 23.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.096 -0.641 . . . . 1.69 110.75 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 79.13 35.59 29.99 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.804 -1.189 . . . . 0.69 111.812 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.7 mt-30 -160.23 144.16 14.14 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.895 -1.122 . . . . 1.22 111.352 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -93.6 -177.91 4.54 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.272 -0.971 . . . . 0.38 111.684 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.98 -163.88 28.6 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.642 -1.266 . . . . 0.35 111.066 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.2 mtp -113.89 147.98 37.52 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.263 -0.575 . . . . 0.54 111.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 27' ' ' ILE . 4.0 p90 -151.25 145.74 18.32 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.527 -0.869 . . . . 0.23 109.317 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.23 128.32 29.17 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 N-CA-C 109.884 -0.852 . . . . 0.36 109.884 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -62.03 -34.89 77.07 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.898 -0.721 . . . . 1.28 112.565 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.457 ' OD1' ' OD1' ' A' ' 36' ' ' ASN . 18.4 m120 -75.05 12.15 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.148 -1.021 . . . . 1.95 113.253 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.92 7.09 27.84 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.505 -0.878 . . . . 0.58 109.089 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -136.86 173.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 114.57 -1.196 . . . . 0.2 109.578 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.695 0 N-CA-C 108.392 -0.966 . . . . 0.51 108.392 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 113.003 0.742 . . . . 0.73 113.003 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 27' ' ' ILE . 15.9 m -141.05 -166.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.823 -1.08 . . . . 0.2 109.36 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 7' ' ' ALA . 4.6 mt-30 -145.37 105.07 3.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.975 -1.011 . . . . 0.64 108.438 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.05 116.63 0.11 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.793 -1.094 . . . . 0.16 113.681 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.38 -52.89 22.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.233 -1.025 . . . . 0.53 108.233 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -132.04 177.64 7.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.77 -1.196 . . . . 0.72 107.77 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -75.38 134.36 40.97 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.284 -1.325 . . . . 1.14 108.953 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -121.53 109.87 15.34 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.021 -1.072 . . . . 0.26 113.073 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 . . . . . 0 C--N 1.307 -1.265 0 C-N-CA 118.167 -1.413 . . . . 1.1 108.387 179.692 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 123.328 1.537 . . . . 1.74 114.412 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.4 161.29 14.95 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.043 -2.799 . . . . 0.59 109.4 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -145.11 115.19 0.82 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.364 -1.398 . . . . 0.3 110.768 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.3 p90 -138.95 -174.49 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.984 -1.086 . . . . 0.24 111.65 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -139.77 125.92 19.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.595 -0.842 . . . . 2.75 112.322 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.1 ttt180 -4.01 135.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.13 1.53 . . . . 1.6 115.13 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 -21.68 3.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.289 -1.524 . . . . 0.61 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -59.19 119.38 7.24 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.705 -1.198 . . . . 0.46 108.399 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 48.1 m-85 -75.32 107.51 7.48 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.971 -1.092 . . . . 0.91 113.525 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -75.17 143.92 12.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.029 -1.471 . . . . 0.16 107.029 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 39.2 t-80 -101.0 102.39 13.38 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 117.79 -1.564 . . . . 1.35 107.773 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.0 101.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 C-N-CA 118.444 -1.303 . . . . 0.32 110.751 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.7 ttm -77.6 -32.42 53.55 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.591 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.21 108.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.447 -1.301 . . . . 3.57 110.975 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 12.4 p-10 -58.03 107.6 0.49 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.985 -1.486 . . . . 0.94 108.695 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -93.46 -57.08 2.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.85 -1.14 . . . . 1.58 111.804 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -107.05 161.1 24.02 Favored Pre-proline 0 C--N 1.299 -1.615 0 C-N-CA 119.625 -0.83 . . . . 0.75 111.461 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.33 -58.25 0.82 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.063 1.842 . . . . 0.3 111.606 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 8.0 t-20 -98.96 13.35 32.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.725 -0.79 . . . . 0.41 111.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 34.6 m95 -147.51 136.62 22.31 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.543 -0.863 . . . . 0.34 109.478 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.659 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 34.4 m0 -139.44 168.35 20.01 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.889 -0.724 . . . . 0.43 111.27 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -106.85 135.5 48.29 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.942 -1.503 . . . . 1.21 106.942 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -161.34 -152.0 6.48 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 117.839 -2.124 . . . . 0.25 109.519 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.12 160.08 18.36 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 117.772 -1.571 . . . . 0.57 113.138 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.1 t -158.79 -86.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.127 -1.029 . . . . 0.25 112.104 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.649 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 6.4 p80 -62.95 74.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.325 -0.95 . . . . 0.52 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.29 23.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.715 -1.231 . . . . 0.61 111.095 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' HIS . 12.7 mt-30 -149.41 139.7 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.372 -1.331 . . . . 1.6 111.499 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 41' ' ' ALA . 19.3 p -91.39 -172.46 3.27 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.665 -0.814 . . . . 0.45 110.849 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.84 -167.91 27.61 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.288 -1.434 . . . . 0.2 111.956 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 31.1 mtp -107.35 143.55 35.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.235 -0.586 . . . . 0.31 110.753 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -147.4 147.06 27.04 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.622 -0.831 . . . . 0.1 109.049 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.05 124.72 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 120.189 0.592 . . . . 0.2 111.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.659 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.36 -27.36 55.77 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.309 -0.86 . . . . 2.41 110.227 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -1.1 52.34 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.17 -1.012 . . . . 4.58 113.091 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.7 12.68 31.02 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.811 -1.156 . . . . 0.3 109.931 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -141.45 172.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.404 -1.271 . . . . 0.25 108.157 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.294 -1.847 0 C-N-CA 118.963 -1.095 . . . . 0.31 108.853 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.448 0.642 . . . . 0.81 111.645 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 27' ' ' ILE . 15.7 m -146.14 174.69 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.835 -1.075 . . . . 0.65 109.453 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.498 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.9 mt-30 -123.48 109.12 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.389 -1.337 . . . . 0.41 107.389 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -32.2 116.13 0.19 Allowed 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.552 -0.859 . . . . 0.24 112.371 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.535 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 11.8 tp -74.52 -42.26 59.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.435 -0.802 . . . . 1.88 109.836 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.67 176.42 8.2 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.758 -1.11 . . . . 1.62 108.129 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.37 125.46 32.98 Favored 'General case' 0 C--N 1.265 -3.107 0 N-CA-C 105.909 -1.886 . . . . 0.83 105.909 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.29 106.56 17.06 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.869 -1.132 . . . . 0.23 113.658 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.306 -1.293 0 C-N-CA 118.298 -1.361 . . . . 0.96 107.856 179.56 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.9 pt-20 . . . . . 0 N--CA 1.494 1.737 0 N-CA-C 113.711 1.004 . . . . 1.22 113.711 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -78.52 170.12 17.15 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 116.414 2.005 . . . . 0.42 116.414 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.34 122.0 1.1 Allowed Glycine 0 N--CA 1.499 2.889 0 CA-C-N 113.286 -1.779 . . . . 0.22 109.292 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.1 p90 -149.14 -169.99 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.705 -1.198 . . . . 0.17 112.393 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' A' ' 23' ' ' ARG . 6.2 mmm180 -135.45 134.57 39.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.52 -0.763 . . . . 3.56 112.361 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.4 ttp180 -20.53 141.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.229 0.956 . . . . 1.95 113.146 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.41 -27.1 4.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.643 -1.383 . . . . 0.38 109.643 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.49 125.8 25.05 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.589 -1.245 . . . . 1.06 108.127 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.58 111.62 14.83 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.302 -1.359 . . . . 0.92 113.585 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -77.89 141.88 14.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.872 -1.529 . . . . 0.21 106.872 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -100.07 97.18 8.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 117.598 -1.641 . . . . 1.11 108.026 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.13 99.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 C-N-CA 118.624 -1.231 . . . . 0.27 111.021 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.455 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 21.4 mtt -82.75 -26.22 32.1 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.274 -0.875 . . . . 1.35 110.44 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -163.81 80.34 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 118.223 -1.391 . . . . 1.59 111.656 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.04 87.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.46 -1.296 . . . . 3.58 108.521 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 31' ' ' ASP . 6.4 t -103.76 -72.59 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.755 -0.778 . . . . 2.52 112.705 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 3.0 m-20 -60.59 153.96 58.73 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 118.859 -1.136 . . . . 1.77 111.021 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.26 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.106 1.871 . . . . 0.61 112.87 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.39 14.38 3.69 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.599 -0.728 . . . . 0.85 110.681 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 55.4 m95 -147.47 149.38 32.57 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.276 -0.875 . . . . 1.01 109.227 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.8 m0 -148.75 161.6 41.45 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.484 -0.886 . . . . 0.48 111.302 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 132.33 48.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.929 -1.137 . . . . 1.18 107.929 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.92 -152.58 6.98 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 118.255 -1.926 . . . . 0.18 109.731 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.35 175.38 11.63 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.595 -1.242 . . . . 0.16 111.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.8 t -168.81 -79.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.001 -1.88 . . . . 0.52 114.679 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.647 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 2.4 p80 -65.07 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.85 -0.614 . . . . 1.47 112.622 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 89.77 6.12 70.41 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.048 -1.549 . . . . 0.55 109.75 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.04 151.22 47.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.656 -0.818 . . . . 4.36 109.868 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.6 p -92.41 -175.71 4.09 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.871 -1.131 . . . . 0.26 110.823 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.49 179.05 25.02 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.777 -1.202 . . . . 0.47 110.13 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.3 mtp -100.87 147.16 26.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.42 110.886 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 27' ' ' ILE . 7.0 p90 -147.57 147.02 26.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.702 -0.799 . . . . 0.24 109.345 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.11 126.53 22.46 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.786 0.991 . . . . 0.13 111.484 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HD3' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -34.34 72.31 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.426 -0.806 . . . . 2.54 111.223 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.53 3.03 14.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.918 -1.113 . . . . 2.37 112.763 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.54 8.45 44.88 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.085 -1.046 . . . . 0.14 109.774 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.9 m -136.28 171.65 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 114.853 -1.067 . . . . 0.17 109.113 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 119.102 -1.039 . . . . 0.29 110.286 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.725 0.774 . . . . 1.31 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 27' ' ' ILE . 5.9 m -125.94 -162.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.442 -1.253 . . . . 0.23 109.781 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.2 mt-30 -146.9 100.27 3.29 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.841 -1.17 . . . . 0.86 107.841 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.09 111.52 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.58 -1.191 . . . . 0.25 113.11 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.517 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.81 -41.53 91.77 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.62 -0.718 . . . . 0.33 109.104 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -173.09 3.59 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.602 -1.181 . . . . 0.8 108.453 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.47 120.48 27.84 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.705 -1.589 . . . . 0.68 109.583 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -104.68 103.15 12.74 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.228 -0.989 . . . . 0.26 111.724 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 C-N-CA 117.243 -1.783 . . . . 4.59 109.838 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.3 pt-20 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.263 0.554 . . . . 1.22 112.01 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -87.04 175.73 7.97 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 115.454 1.65 . . . . 0.3 115.454 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -162.19 128.61 1.91 Allowed Glycine 0 N--CA 1.502 3.045 0 CA-C-N 114.319 -1.309 . . . . 0.26 110.072 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -158.11 -174.8 5.0 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.081 -1.448 . . . . 0.25 112.095 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' ARG . 23.4 mmt-85 -133.96 133.65 41.61 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.796 -0.762 . . . . 4.22 112.698 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.42 138.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.418 1.074 . . . . 4.97 113.731 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.6 5.98 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.469 -1.452 . . . . 0.47 109.469 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.17 122.35 13.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.993 -1.083 . . . . 0.63 109.242 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 73.5 m-85 -78.74 108.91 12.5 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.054 -1.058 . . . . 1.03 113.114 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -78.42 148.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.338 -0.986 . . . . 0.2 108.338 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 30' ' ' MET . 11.7 t-160 -106.26 94.07 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.045 -1.062 . . . . 0.84 108.857 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.64 85.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 C-N-CA 119.297 -0.961 . . . . 0.34 112.43 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.621 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mmt -59.23 -35.89 74.47 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.893 -1.048 . . . . 1.43 110.402 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 33' ' ' SER . 67.6 t0 -170.56 99.75 0.25 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.176 -1.409 . . . . 1.54 111.749 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -53.18 97.78 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.095 -1.442 . . . . 2.57 108.784 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 31' ' ' ASP . 65.8 m -96.26 -71.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.307 -0.957 . . . . 1.38 111.832 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.4 m-20 -81.93 161.17 61.63 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 119.249 -0.98 . . . . 0.69 111.679 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.53 -69.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.743 1.629 . . . . 0.36 110.92 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 4.9 t-20 -80.2 -5.01 55.37 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.552 -0.749 . . . . 0.9 110.949 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' ASP . 28.4 m95 -131.99 150.59 52.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.092 -0.643 . . . . 0.38 109.625 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 9.8 m0 -145.9 162.56 37.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.381 -0.827 . . . . 0.5 111.722 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.05 129.46 46.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.867 -1.531 . . . . 0.3 106.867 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.26 -156.79 7.99 Favored Glycine 0 C--N 1.304 -1.224 0 C-N-CA 117.835 -2.126 . . . . 0.21 110.349 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.769 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -160.8 162.81 32.44 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 118.452 -1.299 . . . . 0.44 111.46 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 43.7 t -160.58 -114.55 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.295 -1.762 . . . . 0.56 113.853 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.556 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.1 p80 -20.95 -45.11 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.277 0.985 . . . . 2.89 113.044 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 167.1 18.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.338 -1.411 . . . . 1.01 109.884 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -150.34 161.19 42.95 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.637 -0.825 . . . . 2.54 110.049 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -100.33 -175.94 3.07 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.424 -0.911 . . . . 0.38 109.812 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.69 -169.14 29.89 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.132 -1.508 . . . . 0.29 111.225 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 mtp -108.28 136.66 47.56 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.071 -0.652 . . . . 0.72 110.963 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.0 p90 -139.11 146.48 49.49 Favored Pre-proline 0 C--N 1.304 -1.387 0 C-N-CA 119.714 -0.795 . . . . 0.15 110.143 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.38 122.86 12.21 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 120.292 0.661 . . . . 0.19 110.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -11.45 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.397 -0.921 . . . . 2.99 110.983 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -88.01 -9.1 54.48 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.041 -1.064 . . . . 1.85 111.655 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 8' ' ' LEU . 4.8 m-85 -94.13 14.28 20.5 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.187 -1.005 . . . . 0.44 109.415 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.7 m -139.62 166.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.986 -1.006 . . . . 0.27 109.439 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 119.738 -0.785 . . . . 0.83 109.565 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 110.308 -1.117 . . . . 2.02 110.308 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 t -155.68 106.37 2.49 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.608 -0.837 . . . . 2.23 110.629 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -135.07 30.66 3.31 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.842 -0.743 . . . . 0.66 110.685 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.579 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 64.4 m-85 -88.62 160.07 17.58 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 118.658 -1.217 . . . . 1.7 113.98 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 27' ' ' ILE . 17.6 m -138.39 -168.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 113.391 -1.731 . . . . 0.06 108.298 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 55' ' ' THR . 2.2 mt-30 -140.29 104.12 4.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.336 -1.357 . . . . 0.71 107.336 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.71 114.21 0.11 Allowed 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 113.666 0.987 . . . . 0.1 113.666 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.429 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 9.7 tp -69.39 -34.1 74.02 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.388 -0.824 . . . . 1.78 108.917 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.63 -174.2 4.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.943 -1.026 . . . . 0.53 109.669 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -86.4 126.48 34.41 Favored 'General case' 0 C--N 1.273 -2.757 0 CA-C-N 113.434 -1.712 . . . . 0.44 110.336 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -116.11 106.32 13.6 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.307 -0.957 . . . . 0.27 112.804 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.0 133.73 33.15 Favored Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 117.734 -1.586 . . . . 3.34 108.336 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -43.91 152.85 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 120.532 0.821 . . . . 0.53 112.105 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 35.2 mt-30 -150.84 7.98 0.56 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.084 -1.08 . . . . 2.14 108.084 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -141.13 162.01 36.49 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.284 -1.325 . . . . 3.63 110.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.13 100.1 5.62 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.007 -1.077 . . . . 1.67 110.572 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' GLU . . . 113.14 -18.38 21.32 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.92 -1.134 . . . . 1.15 110.268 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.1 tt0 -42.34 177.82 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 123.231 1.491 . . . . 1.03 114.253 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 tp -101.54 158.19 16.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 111.797 -2.456 . . . . 0.48 110.407 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.36 113.07 0.65 Allowed Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.606 -1.283 . . . . 0.41 110.726 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -139.94 -172.7 3.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.841 -1.144 . . . . 0.26 112.192 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' ARG . 5.0 mmm-85 -139.61 126.08 20.34 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.574 -0.85 . . . . 2.49 113.187 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -7.65 132.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.493 1.121 . . . . 1.82 113.887 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -19.27 20.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.218 -1.553 . . . . 0.57 109.218 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.79 123.7 19.12 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.791 -1.164 . . . . 0.58 108.52 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -77.92 107.66 10.62 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 118.647 -1.221 . . . . 0.29 112.657 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -77.32 147.62 7.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.84 -1.17 . . . . 0.23 107.84 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.579 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 9.1 t-160 -105.65 96.21 6.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.687 -1.227 . . . . 0.18 107.687 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 3' ' ' THR . 4.1 t -63.29 91.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 114.584 -1.189 . . . . 0.39 110.219 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.525 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.3 ttm -78.31 -27.32 47.21 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 113.945 -1.479 . . . . 0.45 112.011 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.11 96.65 0.6 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.43 -1.708 . . . . 1.75 111.794 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.667 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -55.47 104.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.113 -1.435 . . . . 2.12 107.914 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m -90.86 -64.9 1.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.649 -1.22 . . . . 1.07 111.761 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -103.89 161.71 22.12 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 115.189 -0.914 . . . . 0.65 111.812 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' O ' ' NE ' ' A' ' 51' ' ' ARG . 3.4 Cg_endo -57.95 -63.34 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.737 1.625 . . . . 0.57 111.478 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.2 t30 -92.15 6.8 45.25 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.558 -0.857 . . . . 2.92 111.392 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 20.0 m95 -139.23 139.32 37.43 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.75 -1.204 . . . . 0.32 107.75 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -141.86 169.38 17.7 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.281 -0.968 . . . . 0.66 112.939 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -101.78 146.53 27.64 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.332 -1.729 . . . . 0.68 106.332 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.525 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.1 -158.42 9.75 Favored Glycine 0 C--N 1.298 -1.56 0 C-N-CA 116.784 -2.627 . . . . 0.27 110.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.716 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.33 137.94 4.35 Favored 'General case' 0 C--N 1.288 -2.105 0 C-N-CA 119.031 -1.067 . . . . 1.18 111.278 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' GLY . 32.9 t -145.03 -94.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.114 -1.035 . . . . 0.43 111.807 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.626 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.5 p80 -60.69 75.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.434 -0.907 . . . . 0.54 111.3 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.45 21.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.333 -0.937 . . . . 0.61 111.575 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 43' ' ' HIS . 70.2 mt-30 -144.49 134.95 24.56 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.011 -1.076 . . . . 2.23 111.096 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.716 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -90.97 -178.33 5.18 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.73 -0.788 . . . . 0.55 111.056 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.4 -172.77 27.72 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.377 -1.392 . . . . 0.36 110.884 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mtp -101.22 157.39 16.82 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.824 -0.751 . . . . 0.27 111.268 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.1 p90 -159.36 144.25 11.45 Favored Pre-proline 0 C--N 1.299 -1.615 0 CA-C-N 115.124 -0.944 . . . . 0.29 109.06 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.2 125.96 20.57 Favored 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 120.264 0.643 . . . . 0.33 110.801 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NE ' ' O ' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -64.53 -20.44 66.22 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.562 -0.855 . . . . 2.36 110.968 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.99 1.59 49.59 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.915 -1.114 . . . . 1.03 111.082 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -99.74 13.5 33.45 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.616 -0.834 . . . . 0.15 109.006 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.429 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 31.5 m -140.98 171.54 12.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.646 -1.161 . . . . 0.35 109.905 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -143.07 139.79 17.16 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 119.441 -0.904 . . . . 0.26 109.242 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -62.15 148.17 93.69 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 120.854 1.036 . . . . 0.77 112.44 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG22 ' CG ' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -105.83 -29.24 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.445 -0.798 . . . . 1.61 109.911 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.467 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 2.9 p30 -94.29 79.5 3.96 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.713 -0.795 . . . . 3.46 110.248 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 116.221 -1.847 . . . . 7.28 110.681 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.943 -1.263 . . . . 5.56 109.943 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.12 169.29 14.61 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.39 -0.924 . . . . 2.93 111.088 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.62 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -143.12 36.07 1.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.879 -0.728 . . . . 0.42 110.063 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.481 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 69.9 m-85 -104.97 153.96 20.74 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.966 -1.094 . . . . 1.32 113.118 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 27' ' ' ILE . 25.1 m -140.22 -172.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 113.823 -1.535 . . . . 0.24 108.057 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -142.07 98.17 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.058 -1.089 . . . . 0.73 108.058 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -20.93 111.97 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.916 -1.493 . . . . 0.08 113.487 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.472 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -67.38 -36.42 81.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.167 -0.679 . . . . 0.52 109.167 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.16 -174.73 4.37 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.844 -1.071 . . . . 0.65 109.183 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.86 131.44 34.52 Favored 'General case' 0 C--N 1.27 -2.863 0 CA-C-N 113.614 -1.63 . . . . 0.48 109.446 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -120.71 109.47 15.23 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.987 -1.085 . . . . 0.35 113.364 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -95.74 134.06 24.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 106.819 -1.548 . . . . 1.48 106.819 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -42.31 155.02 0.11 Allowed 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 120.512 0.808 . . . . 0.41 112.586 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.4 mt-30 -149.56 2.95 0.55 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.786 -1.097 . . . . 2.54 108.387 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' CG ' ' OE2' ' A' ' 18' ' ' GLU . 11.2 mm-40 -125.76 -179.09 4.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.454 -1.248 . . . . 1.84 109.635 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.15 80.82 5.04 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.014 -1.075 . . . . 4.08 110.975 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 18' ' ' GLU . . . 124.74 -9.44 8.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.254 -1.138 . . . . 1.09 110.254 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.6 tt0 -41.38 177.2 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 123.343 1.544 . . . . 1.24 115.087 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 tp -97.69 157.04 16.27 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 111.397 -2.638 . . . . 0.5 110.544 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -143.71 112.89 0.72 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.261 -1.447 . . . . 0.43 111.142 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.5 p90 -135.5 -179.25 5.52 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.266 -0.973 . . . . 0.31 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 23' ' ' ARG . 2.9 mmt85 -137.29 124.32 21.52 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.537 -0.865 . . . . 3.05 112.22 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -10.08 128.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.283 0.989 . . . . 2.37 113.281 179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.48 -20.08 50.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.287 -1.525 . . . . 0.19 109.287 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.0 126.02 28.42 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.856 -1.138 . . . . 1.7 108.234 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 2.3 m-85 -78.39 108.39 11.71 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.78 113.38 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -73.12 142.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 105.765 -1.939 . . . . 0.28 105.765 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.481 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 9.9 t-160 -101.55 97.78 8.18 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.173 -1.411 . . . . 0.31 107.599 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 3' ' ' THR . 6.0 t -63.55 84.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.546 -1.207 . . . . 0.29 110.842 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 3.7 ttm -69.14 -30.79 69.11 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.112 -1.403 . . . . 0.79 111.547 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -169.3 90.99 0.22 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.707 -1.597 . . . . 1.64 111.983 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.436 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -50.2 104.35 0.07 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.075 -1.45 . . . . 1.59 108.386 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 m -94.6 -37.16 11.48 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.168 -1.013 . . . . 1.72 113.534 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -124.58 160.43 53.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.373 -0.931 . . . . 1.18 111.471 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.65 -68.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.736 1.624 . . . . 0.46 111.604 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.1 t30 -91.25 12.94 18.63 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.539 -0.864 . . . . 2.64 111.094 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.47 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.5 m95 -145.46 144.79 30.8 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.773 -0.825 . . . . 0.4 108.773 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 20.5 m0 -144.62 172.86 12.39 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.4 -0.92 . . . . 0.21 111.82 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -115.09 123.82 49.97 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 106.559 -1.645 . . . . 0.39 106.559 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -149.94 -148.03 4.67 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 118.241 -1.933 . . . . 0.11 108.831 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.828 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.77 165.52 20.62 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.117 -1.433 . . . . 0.24 111.95 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 23.4 t -161.14 -108.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 116.597 -2.041 . . . . 0.28 114.471 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 2.2 p80 -26.96 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.348 -0.842 . . . . 3.08 113.213 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 161.98 18.08 0.03 OUTLIER Glycine 0 N--CA 1.486 1.97 0 C-N-CA 119.046 -1.549 . . . . 0.88 109.991 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.5 162.21 37.44 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.153 -1.019 . . . . 4.16 110.221 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.828 HG22 ' HB2' ' A' ' 41' ' ' ALA . 18.7 p -95.66 -171.17 2.3 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.195 -1.002 . . . . 0.38 111.393 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.42 -170.89 28.91 Favored Glycine 0 N--CA 1.492 2.432 0 CA-C-N 114.657 -1.156 . . . . 0.22 110.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 35.3 mtp -105.25 143.35 33.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.827 -0.749 . . . . 0.36 110.746 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.9 p90 -147.65 146.02 23.2 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 119.705 -0.798 . . . . 0.23 108.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.99 126.9 23.06 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 N-CA-C 110.458 -0.632 . . . . 0.19 110.458 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.77 -36.16 78.25 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.462 -0.79 . . . . 2.54 111.045 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -74.25 -0.73 17.87 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.058 -1.057 . . . . 4.11 112.692 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -93.45 6.39 48.35 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 118.719 -1.192 . . . . 0.2 110.092 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.3 m -134.27 171.39 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 115.457 -0.792 . . . . 0.1 109.827 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -146.3 149.17 37.12 Favored Pre-proline 0 C--N 1.303 -1.424 0 C-N-CA 119.338 -0.945 . . . . 0.3 109.132 179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.96 154.61 31.9 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 120.882 1.055 . . . . 0.43 111.885 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.92 153.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.982 -0.687 . . . . 1.5 111.62 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -79.25 161.33 26.41 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.38 -0.928 . . . . 9.09 110.224 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.543 0 CA-C-O 116.354 -1.784 . . . . 8.91 111.106 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.974 -1.25 . . . . 3.84 109.974 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 69.98 145.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.271 -0.972 . . . . 4.37 111.012 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.6 26.72 6.66 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.969 -0.693 . . . . 0.59 110.686 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.576 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 79.7 m-85 -88.15 160.76 17.62 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 118.308 -1.357 . . . . 0.71 112.84 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 27' ' ' ILE . 16.4 m -136.61 -170.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.821 -1.536 . . . . 0.17 108.275 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.536 ' OE1' HG13 ' A' ' 57' ' ' VAL . 2.9 mt-30 -138.78 102.7 4.64 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.936 -1.135 . . . . 0.39 107.936 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -30.27 110.61 0.06 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.326 -0.852 . . . . 0.14 112.396 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -64.2 -37.14 86.41 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.132 -0.692 . . . . 0.57 109.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.24 -174.4 4.57 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.146 0.974 . . . . 1.26 109.74 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -83.33 127.62 33.82 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 113.496 -1.684 . . . . 0.38 110.815 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -115.84 106.42 13.81 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.633 -0.827 . . . . 0.23 111.905 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.86 127.5 53.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 117.724 -1.591 . . . . 3.88 109.439 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -40.87 117.17 0.48 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 121.138 1.226 . . . . 1.1 114.215 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -102.65 6.69 39.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.333 -1.729 . . . . 2.16 106.333 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -134.43 -174.63 3.62 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.019 -1.9 . . . . 1.65 110.415 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -122.76 1.22 9.37 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.324 -0.853 . . . . 3.04 109.123 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.42 12.71 5.19 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 109.703 -1.359 . . . . 1.6 109.703 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -113.93 -174.13 2.41 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.567 -0.853 . . . . 1.18 112.102 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.58 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -84.08 172.41 12.0 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 116.026 1.861 . . . . 0.4 116.026 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.08 120.97 1.01 Allowed Glycine 0 N--CA 1.497 2.743 0 CA-C-N 113.645 -1.616 . . . . 0.14 110.017 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.566 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.1 p90 -145.78 -170.94 3.59 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.319 -1.352 . . . . 0.25 112.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 23' ' ' ARG . 31.0 mmt-85 -138.72 129.8 26.83 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.4 -0.818 . . . . 4.57 112.222 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -16.61 137.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.194 0.934 . . . . 2.88 113.239 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.48 -21.65 10.29 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.816 -1.714 . . . . 0.26 108.816 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -65.64 118.88 10.18 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.94 -1.104 . . . . 1.11 108.055 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -76.55 112.92 13.61 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 118.662 -1.215 . . . . 0.84 112.482 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -77.26 147.62 7.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.702 -1.222 . . . . 0.15 107.702 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.7 t-80 -103.9 101.61 11.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.761 -1.175 . . . . 0.21 107.83 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 3' ' ' THR . 4.1 t -69.39 98.84 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.5 -1.227 . . . . 0.26 111.505 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.438 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.0 OUTLIER -79.6 -30.22 41.42 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.09 -1.414 . . . . 1.62 110.959 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.24 114.48 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.334 -1.346 . . . . 2.29 111.014 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 19.6 p30 -56.72 109.82 0.69 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.223 -1.391 . . . . 1.56 109.69 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.6 p -91.75 -38.58 12.3 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.04 -1.064 . . . . 3.16 112.049 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -138.63 161.91 56.02 Favored Pre-proline 0 C--N 1.3 -1.572 0 C-N-CA 119.496 -0.881 . . . . 0.74 110.747 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.27 -64.43 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.224 1.283 . . . . 0.56 111.254 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 1.8 t-20 -90.49 4.07 52.14 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.244 -0.982 . . . . 0.39 111.191 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASP . 26.5 m95 -138.73 140.87 38.85 Favored 'General case' 0 C--O 1.208 -1.083 0 N-CA-C 108.801 -0.815 . . . . 0.4 108.801 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.0 m0 -138.59 -177.72 4.99 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.68 -0.808 . . . . 0.84 111.928 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -124.2 124.74 43.12 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.578 -1.267 . . . . 0.31 107.578 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -155.86 -144.97 4.06 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 108.724 -1.751 . . . . 0.1 108.724 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.7 173.74 11.53 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 118.375 -1.33 . . . . 0.13 111.735 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 13.8 t -166.06 -103.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 116.871 -1.932 . . . . 0.41 114.407 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.605 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.9 p80 -29.92 -30.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.403 -0.817 . . . . 2.82 112.943 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 152.51 13.7 0.07 OUTLIER Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.278 -1.529 . . . . 0.89 109.278 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' H ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -149.73 164.21 35.87 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.714 -0.794 . . . . 5.37 110.382 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 41' ' ' ALA . 12.3 p -97.52 -175.03 3.08 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.116 -1.034 . . . . 0.32 111.556 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.59 -174.58 29.9 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.112 -1.195 . . . . 0.13 110.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 53.8 mtp -102.59 146.56 27.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.705 -0.798 . . . . 0.41 110.748 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -151.39 147.24 19.99 Favored Pre-proline 0 C--N 1.303 -1.439 0 C-N-CA 119.441 -0.903 . . . . 0.31 109.892 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.38 124.77 15.83 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 N-CA-C 110.051 -0.788 . . . . 0.28 110.051 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -17.87 63.89 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.632 -0.827 . . . . 2.75 111.526 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.97 -1.3 54.38 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.583 -1.247 . . . . 1.98 111.552 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -96.61 7.57 46.23 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.314 -0.955 . . . . 0.49 108.894 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.8 m -137.32 169.58 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.935 -1.029 . . . . 0.22 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.94 144.41 21.9 Favored Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 119.118 -1.033 . . . . 0.15 109.646 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -61.48 142.15 94.25 Favored 'Trans proline' 0 C--N 1.322 -0.854 0 C-N-CA 121.074 1.182 . . . . 0.7 112.444 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER -91.16 -168.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.384 -0.826 . . . . 2.61 109.838 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.602 ' H ' HG12 ' A' ' 57' ' ' VAL . 15.7 m120 -79.94 -109.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.278 -0.969 . . . . 7.45 109.567 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 116.253 -1.832 . . . . 9.78 110.94 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 110.073 -1.211 . . . . 3.64 110.073 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.504 ' C ' HG22 ' A' ' 3' ' ' THR . 32.3 t 57.93 65.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.298 -0.561 . . . . 2.32 111.628 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.6 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -168.83 24.47 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.906 -0.718 . . . . 0.39 110.333 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.62 ' CE1' ' CD2' ' A' ' 28' ' ' HIS . 54.1 m-85 -99.15 149.27 23.23 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.63 -1.228 . . . . 2.61 113.218 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 27' ' ' ILE . 15.8 m -129.14 -167.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 113.921 -1.491 . . . . 0.16 108.741 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -142.78 97.81 3.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.895 -1.15 . . . . 0.32 107.895 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.69 110.93 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.496 -1.229 . . . . 0.27 113.915 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.507 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 2.9 tp -56.46 -50.04 72.88 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.573 -0.74 . . . . 1.75 109.634 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -143.41 -174.52 4.24 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.987 -1.006 . . . . 1.53 108.451 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 126.53 31.18 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.086 -1.416 . . . . 0.64 110.487 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -111.77 102.42 10.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.428 -0.909 . . . . 0.29 111.892 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.82 126.98 64.31 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 117.312 -1.755 . . . . 3.8 109.052 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -40.51 115.03 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.195 1.264 . . . . 1.01 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -93.74 3.42 55.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.676 -1.972 . . . . 2.96 105.676 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -134.35 -173.33 3.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.542 -2.117 . . . . 3.52 109.943 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.64 0.27 7.49 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.676 -0.861 . . . . 3.37 108.676 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -126.66 3.22 7.56 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.48 -1.448 . . . . 1.12 109.48 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -105.97 -172.44 2.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.756 -0.778 . . . . 1.0 111.775 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.568 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -82.09 168.07 18.13 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 116.053 1.871 . . . . 0.2 116.053 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -156.94 123.19 1.26 Allowed Glycine 0 N--CA 1.496 2.69 0 CA-C-N 113.819 -1.537 . . . . 0.12 109.751 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.555 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.4 p90 -148.82 -175.68 5.04 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.369 -1.332 . . . . 0.22 112.377 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 23' ' ' ARG . 19.7 mmt180 -132.19 129.85 40.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.414 -0.812 . . . . 2.96 111.742 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -19.72 138.07 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 O-C-N 124.184 0.928 . . . . 3.62 113.256 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.91 -17.73 39.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.528 -1.429 . . . . 0.1 109.528 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -73.71 120.36 19.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.356 -1.35 . . . . 0.52 107.356 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -74.23 112.99 10.92 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.711 -1.196 . . . . 1.1 113.195 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.559 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.74 141.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.517 -1.66 . . . . 0.23 106.517 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.62 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 12.2 t-160 -100.5 95.82 6.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 118.388 -1.325 . . . . 0.21 108.307 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 3' ' ' THR . 5.2 t -60.63 97.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 114.465 -1.243 . . . . 0.18 111.115 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.589 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 2.8 mmt -72.77 -32.14 65.41 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.209 -1.359 . . . . 1.68 110.983 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.25 101.2 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 118.053 -1.459 . . . . 3.21 111.213 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 7.4 p-10 -51.34 100.88 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 118.541 -1.264 . . . . 1.83 109.553 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.22 -77.34 0.46 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 118.953 -1.099 . . . . 0.77 110.674 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -78.22 159.09 76.06 Favored Pre-proline 0 C--N 1.296 -1.752 0 C-N-CA 119.255 -0.978 . . . . 0.99 110.696 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -64.47 -64.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.659 1.573 . . . . 0.6 111.399 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.1 t-20 -86.16 -1.81 57.77 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.711 -0.796 . . . . 0.51 111.583 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.502 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 16.2 m95 -132.01 153.49 50.31 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.022 -1.103 . . . . 0.48 108.022 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.502 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.5 m0 -148.34 176.12 10.53 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.256 -0.978 . . . . 0.49 111.728 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -119.4 131.1 55.6 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.466 -1.309 . . . . 0.55 107.466 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.589 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.01 -145.87 4.3 Favored Glycine 0 C--N 1.302 -1.31 0 C-N-CA 118.123 -1.989 . . . . 0.32 109.608 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.45 154.99 12.57 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 118.517 -1.273 . . . . 0.58 111.847 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.4 t -152.31 -94.62 0.05 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.875 -1.13 . . . . 0.37 111.33 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.703 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 4.6 p80 -59.96 77.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.509 -0.876 . . . . 0.25 110.878 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 24.53 0.03 OUTLIER Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.177 -1.011 . . . . 0.2 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' HIS . 59.8 mt-30 -147.44 144.98 29.02 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.781 -1.167 . . . . 1.14 111.49 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.757 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.5 p -95.96 -177.06 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.811 -0.756 . . . . 0.19 110.335 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.11 -174.91 27.66 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.45 -1.357 . . . . 0.16 110.62 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 mtp -102.18 146.79 27.47 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.854 -0.738 . . . . 0.67 111.477 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.5 p90 -149.32 143.94 17.43 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.137 -0.938 . . . . 0.22 108.958 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.81 126.62 22.84 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 N-CA-C 110.705 -0.537 . . . . 0.33 110.705 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.18 -27.68 68.59 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.454 -0.794 . . . . 1.95 112.055 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 2.46 33.59 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.31 -1.356 . . . . 1.04 112.175 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -96.03 6.33 49.1 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.248 -0.981 . . . . 0.71 109.213 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.507 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.6 m -135.32 176.26 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.582 -1.19 . . . . 0.26 108.997 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -149.68 133.0 8.46 Favored Pre-proline 0 C--N 1.293 -1.878 0 C-N-CA 119.236 -0.985 . . . . 0.31 109.205 179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.88 149.58 60.05 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 120.413 0.742 . . . . 1.17 111.834 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 57' ' ' VAL . 95.3 t -79.05 72.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.67 -0.812 . . . . 2.1 111.015 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -90.64 128.58 36.66 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.271 -0.972 . . . . 7.32 110.646 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 116.32 -1.8 . . . . 12.41 110.627 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 110.159 -1.176 . . . . 5.27 110.159 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.19 6.1 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.457 -0.897 . . . . 2.11 110.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -97.95 33.27 2.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.796 -0.762 . . . . 0.5 110.27 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.5 m-85 -97.1 155.16 16.93 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.056 -1.058 . . . . 0.25 113.197 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG22 HG22 ' A' ' 27' ' ' ILE . 21.8 m -136.1 -170.14 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.087 -1.415 . . . . 0.15 108.684 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.9 mt-30 -140.83 97.14 3.13 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.428 -0.952 . . . . 0.13 108.428 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -22.25 110.69 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 113.899 -1.501 . . . . 0.15 113.269 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 tp -64.52 -50.59 66.78 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.454 -0.794 . . . . 1.67 109.852 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -131.93 -178.81 5.05 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.279 -1.008 . . . . 0.9 108.279 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 131.62 35.21 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.159 -1.382 . . . . 0.22 108.325 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -118.51 107.14 13.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.194 -1.002 . . . . 0.35 112.746 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.57 129.29 45.46 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 117.725 -1.59 . . . . 3.92 109.307 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -43.94 106.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 121.121 1.214 . . . . 1.43 114.048 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.52 5.51 47.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.089 -2.189 . . . . 4.03 105.089 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -127.95 178.51 6.14 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 112.392 -2.186 . . . . 2.32 110.077 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -122.24 15.86 10.62 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.761 -0.776 . . . . 3.62 109.099 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.6 9.69 1.23 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.463 -1.455 . . . . 1.17 109.463 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -111.3 -174.44 2.47 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.849 -0.741 . . . . 0.94 111.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.587 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -79.18 169.64 17.84 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 115.647 1.721 . . . . 0.25 115.647 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.08 121.42 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 CA-C-N 113.848 -1.524 . . . . 0.16 110.743 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.6 p90 -147.61 -172.86 4.13 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.515 -1.274 . . . . 0.15 112.007 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.6 mmm180 -136.35 130.06 32.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 115.614 -0.721 . . . . 2.13 111.61 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 22' ' ' ARG . 4.3 ttp180 -19.11 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.126 0.891 . . . . 4.09 112.922 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.11 -14.8 62.58 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.25 109.532 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.93 117.79 20.34 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.801 -1.185 . . . . 0.4 107.801 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -73.72 111.73 9.14 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 118.809 -1.156 . . . . 0.66 112.722 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.553 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -75.27 146.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.009 -1.478 . . . . 0.16 107.009 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 10.4 t-80 -103.43 100.21 10.07 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.463 -1.31 . . . . 0.38 107.463 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 3' ' ' THR . 3.9 t -65.46 89.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 114.771 -1.104 . . . . 0.17 110.949 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 7.7 tpp -78.55 -28.07 45.98 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 113.889 -1.505 . . . . 3.07 111.874 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 33' ' ' SER . 1.6 t70 -161.28 82.29 0.62 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 117.771 -1.572 . . . . 1.33 111.663 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 10.1 p-10 -54.1 96.62 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.689 -1.205 . . . . 0.76 109.038 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' ASP . 45.9 m -96.94 -84.96 0.36 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.225 -0.99 . . . . 1.0 111.507 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -65.45 158.88 71.1 Favored Pre-proline 0 C--N 1.298 -1.652 0 C-N-CA 119.299 -0.96 . . . . 0.51 111.575 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.39 -65.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.616 1.544 . . . . 0.45 111.22 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 6.3 t-20 -82.23 -0.07 43.56 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.411 -0.813 . . . . 0.63 111.348 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.8 m95 -137.19 148.99 46.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.657 -0.868 . . . . 0.33 108.657 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 7.7 m0 -144.51 169.57 17.71 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.141 -1.023 . . . . 0.52 112.378 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HB2' ' HZ2' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -109.96 123.65 50.01 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 106.854 -1.536 . . . . 1.71 106.854 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -154.09 -150.26 5.44 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.296 -1.907 . . . . 0.16 109.188 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.36 172.97 12.76 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 117.983 -1.487 . . . . 0.21 112.448 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' GLY . 13.1 t -169.96 -96.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.826 -1.15 . . . . 0.31 111.478 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.646 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.1 p80 -57.85 77.41 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.762 -0.775 . . . . 0.37 111.378 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.6 22.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.318 -0.944 . . . . 0.28 111.765 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.9 mt-30 -146.6 136.24 23.08 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.927 -1.109 . . . . 2.68 111.121 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.0 p -88.93 -179.49 5.96 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.655 -0.818 . . . . 0.17 109.593 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.72 -172.97 31.79 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 118.623 -1.751 . . . . 0.13 111.931 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtp -103.98 141.04 36.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.311 -0.556 . . . . 0.36 110.716 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.3 p90 -145.76 145.89 27.06 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.558 -0.857 . . . . 0.14 109.835 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.43 128.89 31.96 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 N-CA-C 110.098 -0.77 . . . . 0.21 110.098 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 38' ' ' TRP . 2.1 tmt_? -65.44 -30.97 71.83 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.392 -0.923 . . . . 2.55 111.672 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -77.34 4.38 10.93 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.79 -1.164 . . . . 2.0 112.018 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -101.48 11.09 39.69 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.405 -0.918 . . . . 0.46 109.431 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.6 m -139.98 173.65 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.835 -1.075 . . . . 0.09 109.076 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 146.83 18.25 Favored Pre-proline 0 C--N 1.292 -1.911 0 C-N-CA 118.57 -1.252 . . . . 0.17 109.368 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.91 154.44 44.39 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 120.503 0.802 . . . . 0.29 111.013 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.8 t -75.44 89.5 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.241 -0.983 . . . . 1.27 110.298 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.23 -175.76 4.81 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.383 -0.927 . . . . 9.85 111.072 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.7 ttp-105 . . . . . 0 C--N 1.303 -1.451 0 CA-C-O 116.46 -1.733 . . . . 10.17 111.099 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 110.049 -1.22 . . . . 2.47 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 m -82.49 98.28 8.85 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.495 -0.882 . . . . 2.62 110.801 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.631 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.6 OUTLIER -135.11 38.17 2.98 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.045 0.926 . . . . 0.97 109.879 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.643 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 63.6 m-85 -126.89 130.67 50.61 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.082 -0.963 . . . . 1.73 110.373 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 27' ' ' ILE . 11.4 m -123.29 -165.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.928 -1.033 . . . . 0.23 110.354 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 26' ' ' PHE . 3.0 mt-30 -143.92 100.08 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.169 -1.419 . . . . 0.61 107.169 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -25.5 111.76 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.366 -1.288 . . . . 0.12 113.279 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 4.0 tp -66.51 -47.74 72.02 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.58 -0.736 . . . . 1.56 109.671 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -131.06 -179.28 5.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.617 -1.253 . . . . 0.9 107.617 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.05 135.55 35.85 Favored 'General case' 0 C--N 1.269 -2.908 0 N-CA-C 106.758 -1.571 . . . . 0.3 106.758 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -122.48 112.68 18.33 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.405 -1.318 . . . . 0.16 114.31 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER -94.15 142.81 25.43 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 106.783 -1.562 . . . . 4.55 106.783 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 12' ' ' ASP . 82.9 Cg_exo -49.63 -160.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 120.527 0.818 . . . . 1.23 113.568 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.599 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 158.34 -16.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.651 -1.159 . . . . 4.38 107.934 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -106.71 156.07 19.02 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.436 -1.256 . . . . 4.62 109.306 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -65.03 115.05 5.03 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.694 -1.202 . . . . 4.85 111.487 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.11 95.85 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 119.644 -1.265 . . . . 0.46 110.632 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -92.21 171.76 8.87 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 118.946 -1.102 . . . . 0.84 109.482 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.646 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 7.2 tp -77.91 158.35 29.42 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 113.549 0.944 . . . . 0.85 113.549 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.531 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -149.96 123.51 1.59 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.531 -1.428 . . . . 0.27 109.531 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.9 p90 -147.78 -168.39 3.05 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.783 -1.167 . . . . 0.26 111.91 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.8 mmm-85 -139.08 133.94 32.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.907 -0.717 . . . . 2.66 111.599 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -18.83 139.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.15 0.907 . . . . 3.38 113.224 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -19.37 31.24 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.291 -1.524 . . . . 0.17 109.291 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.74 121.66 15.92 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.871 -1.132 . . . . 0.56 108.947 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m-85 -77.13 104.65 7.74 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.687 -1.205 . . . . 0.77 112.175 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.556 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -74.31 147.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.412 -1.329 . . . . 0.12 107.412 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.643 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.6 t-160 -107.76 96.73 6.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.865 -1.134 . . . . 0.65 108.425 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.518 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.4 t -60.04 90.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.777 -1.101 . . . . 0.39 113.336 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.55 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -61.62 -33.86 74.66 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.033 -1.067 . . . . 1.93 109.984 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' O ' ' OD2' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -178.56 111.74 0.06 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 118.676 -1.21 . . . . 2.3 111.105 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -57.29 99.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.232 -1.387 . . . . 2.24 109.272 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -94.19 -68.16 0.82 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.143 -1.023 . . . . 2.0 111.434 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.512 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -86.61 160.07 51.28 Favored Pre-proline 0 C--N 1.298 -1.656 0 C-N-CA 118.851 -1.139 . . . . 0.81 110.888 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.08 -68.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.428 1.419 . . . . 0.48 111.021 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.5 t-20 -81.85 -2.61 51.66 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.391 -0.822 . . . . 0.76 111.43 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 28.9 m95 -133.1 153.94 51.04 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 108.738 -0.838 . . . . 0.34 108.738 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.1 m0 -149.04 168.04 24.22 Favored 'General case' 0 C--N 1.288 -2.106 0 C-N-CA 119.957 -0.697 . . . . 0.39 111.129 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -108.03 130.52 55.07 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.41 -1.33 . . . . 0.5 107.41 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.71 -152.19 6.34 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 117.71 -2.186 . . . . 0.16 110.106 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.758 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.46 161.54 27.18 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 117.921 -1.511 . . . . 0.4 112.425 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 41.7 t -158.39 -89.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.895 -1.122 . . . . 0.27 111.853 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.642 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 3.2 p80 -60.73 73.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.849 -0.74 . . . . 0.41 111.039 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.47 19.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.118 0 C-N-CA 120.026 -1.083 . . . . 0.35 111.006 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 43' ' ' HIS . 9.1 mm100 -144.08 135.1 25.37 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.021 -1.071 . . . . 4.13 111.327 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.758 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.1 p -84.24 -174.78 5.47 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.724 -0.79 . . . . 0.35 110.727 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.96 -167.62 27.73 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.56 -1.305 . . . . 0.3 111.013 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 70.9 mtp -109.3 144.28 37.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 120.168 -0.613 . . . . 0.4 111.517 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 27' ' ' ILE . 9.5 p90 -145.54 144.3 22.38 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 115.384 -0.826 . . . . 0.3 109.567 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.71 126.2 21.65 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.303 0.668 . . . . 0.28 110.386 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -61.91 -30.77 71.11 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.428 -0.806 . . . . 3.04 111.543 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -77.79 1.93 18.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.848 -1.141 . . . . 3.28 112.595 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -100.92 12.8 36.94 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 119.301 -0.96 . . . . 0.2 109.635 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -139.93 174.74 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.265 -0.879 . . . . 0.09 110.347 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.15 139.65 12.52 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.035 -1.066 . . . . 0.15 109.679 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.82 152.31 64.67 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.125 1.217 . . . . 0.64 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG22 ' CG ' ' A' ' 6' ' ' GLN . 1.9 t -95.46 42.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 115.582 -0.735 . . . . 1.84 109.826 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -77.85 109.79 12.18 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.569 -0.852 . . . . 5.28 111.145 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 116.394 -1.765 . . . . 6.77 111.054 -179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 110.052 -1.219 . . . . 2.95 110.052 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.98 103.56 16.26 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.314 -0.954 . . . . 3.09 110.587 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.636 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.5 OUTLIER -133.8 37.62 3.25 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.849 0.833 . . . . 0.85 110.535 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 58.7 m-85 -126.31 126.28 43.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.442 -0.903 . . . . 1.5 110.916 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG22 HG22 ' A' ' 27' ' ' ILE . 6.3 m -117.57 -165.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 114.821 -1.081 . . . . 0.24 109.555 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.517 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.8 mt-30 -145.46 94.52 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.818 -1.179 . . . . 0.3 107.818 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.46 110.97 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.251 -1.341 . . . . 0.11 113.211 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.52 -46.16 80.7 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.045 -0.525 . . . . 0.92 109.944 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -133.25 -179.32 5.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.028 -1.101 . . . . 0.65 108.028 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.72 136.3 36.74 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.278 -1.328 . . . . 0.67 108.225 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -127.61 109.37 11.63 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.755 -1.178 . . . . 0.17 114.002 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.94 143.19 27.34 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 117.722 -1.591 . . . . 1.8 106.744 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.1 163.12 1.63 Allowed 'Trans proline' 0 C--N 1.295 -2.252 0 CA-C-O 121.536 0.557 . . . . 0.31 112.708 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.558 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 25.9 mt-30 -154.42 -11.62 0.13 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.546 -1.206 . . . . 1.3 108.44 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.21 174.2 6.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.486 -1.234 . . . . 4.01 110.33 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.14 4.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.887 -1.125 . . . . 5.89 110.936 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.37 32.89 31.0 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.48 -1.343 . . . . 1.06 110.777 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -74.27 173.63 9.92 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.891 -1.152 . . . . 0.27 107.891 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -69.64 164.05 24.22 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 119.941 -0.704 . . . . 0.21 112.686 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.92 121.81 1.1 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.545 -1.022 . . . . 0.12 110.545 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 6.3 p90 -147.01 -170.49 3.55 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.465 -1.294 . . . . 0.15 112.516 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.5 mmt180 -136.51 130.74 32.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.181 -0.918 . . . . 3.53 111.435 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' ARG . 3.3 ttp85 -16.42 138.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.03 1.122 . . . . 1.84 114.03 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.32 -22.38 13.12 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.412 -1.475 . . . . 0.41 109.412 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.84 121.53 13.71 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.957 -1.097 . . . . 1.33 108.261 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -77.36 106.83 9.35 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.439 -1.304 . . . . 0.97 112.174 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.545 HG22 HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -73.77 143.82 13.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.356 -1.349 . . . . 0.2 107.356 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.633 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 11.1 t-160 -103.56 94.01 5.24 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.6 -1.24 . . . . 0.23 108.796 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.521 ' O ' ' OG1' ' A' ' 3' ' ' THR . 3.4 t -59.24 86.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 114.56 -1.2 . . . . 0.31 112.783 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.603 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 30.7 mtt -72.5 -30.66 64.7 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.999 -1.0 . . . . 1.75 111.052 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -159.21 93.58 1.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.283 -1.367 . . . . 1.15 111.404 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.727 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -68.71 94.11 0.57 Allowed 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.868 -1.133 . . . . 2.73 109.333 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t -98.16 -74.34 0.58 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.326 -0.95 . . . . 1.91 112.209 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -69.24 157.27 89.78 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.763 -1.175 . . . . 0.45 111.48 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.54 -65.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.176 1.918 . . . . 0.55 111.961 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 5.7 t30 -87.53 5.78 37.48 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.768 -0.773 . . . . 2.32 111.396 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 14.9 m95 -139.73 147.64 41.17 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.259 -1.015 . . . . 0.39 108.259 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.3 m0 -147.29 172.11 14.37 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 119.36 -0.936 . . . . 0.36 111.383 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -112.75 129.4 56.43 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.639 -1.245 . . . . 0.15 107.639 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.603 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.43 -144.71 4.06 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 118.261 -1.923 . . . . 0.12 109.335 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.09 174.96 9.82 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 117.824 -1.55 . . . . 0.08 112.704 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' GLY . 38.9 t -170.52 -95.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.147 -1.021 . . . . 0.22 112.071 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 6.5 p80 -58.61 78.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.458 -0.897 . . . . 0.55 111.415 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.75 25.64 0.22 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 120.101 -1.047 . . . . 0.43 111.956 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.48 149.24 25.31 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 117.941 -1.503 . . . . 4.78 111.902 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.9 p -95.68 -175.75 3.53 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.799 -0.76 . . . . 0.15 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.51 -164.73 29.08 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.237 -1.459 . . . . 0.13 111.392 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.4 mtp -109.39 145.66 35.74 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.466 -0.494 . . . . 0.23 111.258 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.2 p90 -148.82 142.49 16.2 Favored Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.369 -0.932 . . . . 0.15 109.408 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.46 123.81 14.75 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.712 -0.919 . . . . 0.27 109.712 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -61.85 -29.82 70.44 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.078 -1.049 . . . . 2.44 111.354 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -73.26 -5.0 36.63 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.839 -1.144 . . . . 2.98 112.176 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.82 10.4 35.41 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.052 -1.059 . . . . 0.25 109.778 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.504 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.8 m -136.85 172.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 115.335 -0.848 . . . . 0.19 109.859 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -142.65 122.95 8.1 Favored Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.554 -0.859 . . . . 0.43 109.142 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.06 145.19 98.5 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.345 0.697 . . . . 1.87 112.241 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.59 78.3 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 115.353 -0.84 . . . . 3.3 111.154 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -149.57 164.53 34.84 Favored 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 119.678 -0.809 . . . . 4.51 110.313 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 116.262 -1.827 . . . . 8.09 110.878 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.106 0 N-CA-C 110.01 -1.236 . . . . 4.5 110.01 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.04 142.79 18.98 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.565 -0.854 . . . . 6.57 111.033 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.541 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 1.5 p -64.48 162.0 16.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.611 -0.836 . . . . 2.41 110.869 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 178.84 154.73 0.42 Allowed 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.323 -1.351 . . . . 1.91 113.192 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 27' ' ' ILE . 17.9 m -141.75 -170.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 114.788 -1.097 . . . . 0.25 108.557 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.499 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -141.8 100.63 3.79 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.762 -1.199 . . . . 0.48 107.762 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -26.49 113.45 0.05 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.582 -1.19 . . . . 0.16 112.913 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.465 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.6 -39.55 91.67 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.565 0.698 . . . . 0.71 109.753 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.62 -174.72 4.68 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.895 -1.048 . . . . 1.6 108.827 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.2 122.4 26.8 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.218 -1.355 . . . . 0.83 109.363 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -111.28 99.23 8.08 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.897 -1.121 . . . . 0.34 113.578 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -77.17 148.77 78.6 Favored Pre-proline 0 C--N 1.294 -1.819 0 C-N-CA 115.916 -2.314 . . . . 1.51 104.805 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' A' ' 12' ' ' ASP . 84.0 Cg_exo -50.54 -147.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 120.7 0.933 . . . . 1.72 112.915 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 1.6 mt-30 159.25 -30.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.557 -0.905 . . . . 1.57 108.557 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.49 176.1 6.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.8 -1.091 . . . . 0.74 110.136 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 110.68 16.42 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.78 -1.168 . . . . 5.4 110.59 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.39 32.41 79.27 Favored Glycine 0 N--CA 1.483 1.809 0 C-N-CA 119.023 -1.56 . . . . 0.46 109.931 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -87.16 171.77 10.43 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.386 -0.968 . . . . 0.36 108.386 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.601 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.8 tp -71.93 164.21 26.48 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.75 0.786 . . . . 0.15 112.757 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.547 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -160.42 117.89 0.8 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.395 -1.882 . . . . 0.24 108.395 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 2.7 p90 -140.62 -168.94 2.68 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.66 -1.216 . . . . 0.16 113.029 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' ARG . 9.6 mmm-85 -137.07 129.58 30.02 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.549 -0.75 . . . . 2.5 112.775 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -13.68 138.46 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.458 1.098 . . . . 2.77 113.633 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.28 -22.73 5.07 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.802 -1.719 . . . . 0.49 108.802 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 23' ' ' ARG . 4.4 m-20 -61.46 121.51 12.86 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 118.607 -1.237 . . . . 0.66 107.968 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -77.81 112.24 14.47 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.874 -1.13 . . . . 1.12 112.703 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -79.04 142.15 14.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.733 -1.21 . . . . 0.3 107.733 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.454 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 20.4 t-80 -99.44 99.66 10.6 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.244 -1.382 . . . . 1.01 107.87 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 29' ' ' VAL . 3.1 t -66.33 92.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 C-N-CA 118.7 -1.2 . . . . 0.45 110.35 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.511 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 5.1 mmt -71.9 -28.96 63.85 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.159 -1.382 . . . . 2.3 111.729 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.48 104.81 0.21 Allowed 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 118.1 -1.44 . . . . 1.68 111.462 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 1.9 p30 -58.4 104.55 0.22 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.587 -1.245 . . . . 1.53 109.173 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.5 -66.94 0.87 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.094 -1.042 . . . . 2.38 111.478 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -98.65 159.49 30.29 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 119.404 -0.919 . . . . 0.62 111.266 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.95 -60.88 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.965 1.777 . . . . 0.49 110.963 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -89.47 4.25 49.73 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.348 -0.842 . . . . 0.45 111.408 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.457 ' O ' ' O ' ' A' ' 34' ' ' ASP . 21.9 m95 -142.0 141.72 32.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.881 -0.785 . . . . 0.15 108.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.6 m0 -141.92 169.72 17.06 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.651 -0.82 . . . . 0.52 111.805 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -108.41 134.12 51.64 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.07 -1.085 . . . . 1.47 108.07 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.87 -148.7 5.5 Favored Glycine 0 C--N 1.3 -1.42 0 C-N-CA 117.812 -2.137 . . . . 0.21 109.7 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.01 172.81 13.36 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 118.222 -1.391 . . . . 0.15 112.114 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -172.01 -94.0 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.733 -1.187 . . . . 0.23 112.005 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.627 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.9 p80 -58.42 77.64 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.539 -0.864 . . . . 0.57 111.397 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.32 27.36 0.25 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.115 -1.041 . . . . 0.78 111.499 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -156.61 151.83 26.45 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.162 -1.415 . . . . 1.04 111.757 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.1 p -97.51 -176.48 3.51 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.669 -0.812 . . . . 0.39 110.473 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.69 -176.83 24.46 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.337 -1.411 . . . . 0.39 111.628 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.9 mtp -100.45 150.63 22.44 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.327 0.584 . . . . 0.26 111.378 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.596 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.7 p90 -151.7 146.2 18.55 Favored Pre-proline 0 C--N 1.299 -1.618 0 CA-C-N 115.311 -0.858 . . . . 0.15 109.607 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.29 123.17 12.84 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 110.367 -0.666 . . . . 0.18 110.367 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.05 -18.45 60.67 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.396 -0.922 . . . . 2.09 111.078 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -86.64 0.4 54.6 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.737 -1.185 . . . . 2.77 111.733 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -100.27 9.64 42.42 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.365 -0.934 . . . . 0.39 109.407 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -136.2 171.6 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 114.886 -1.052 . . . . 0.28 108.989 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.39 144.55 19.68 Favored Pre-proline 0 C--N 1.296 -1.753 0 C-N-CA 119.231 -0.988 . . . . 0.35 108.759 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.97 156.7 18.91 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 120.519 0.813 . . . . 0.61 111.607 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.67 -54.47 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 1.07 111.773 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -147.95 -176.59 5.33 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.136 -1.026 . . . . 6.74 111.028 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 116.348 -1.786 . . . . 4.81 110.629 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.782 -1.327 . . . . 1.76 109.782 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.1 t 165.65 -70.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.928 -0.709 . . . . 4.13 109.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER 37.92 90.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.29 -0.868 . . . . 2.8 112.287 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -176.27 150.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.578 -1.249 . . . . 1.97 111.996 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.543 HG22 HG22 ' A' ' 27' ' ' ILE . 16.6 m -141.22 -164.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 115.16 -0.927 . . . . 0.18 109.88 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.87 101.45 3.65 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.304 -1.369 . . . . 0.27 107.304 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -28.13 115.66 0.09 Allowed 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 113.938 1.088 . . . . 0.16 113.938 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.81 -34.33 69.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.53 -0.915 . . . . 0.74 108.53 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.42 -174.62 4.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.639 -1.164 . . . . 0.73 109.292 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.75 127.94 35.61 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.757 -1.565 . . . . 0.39 109.453 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -113.58 108.23 16.88 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.332 -0.947 . . . . 0.32 113.458 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.24 128.24 54.15 Favored Pre-proline 0 C--N 1.31 -1.145 0 C-N-CA 117.773 -1.571 . . . . 1.05 108.631 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.75 108.73 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 120.707 0.938 . . . . 1.47 113.851 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.539 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -90.03 -10.79 43.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.294 -1.002 . . . . 4.4 108.294 179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.12 179.19 5.36 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 114.727 -1.124 . . . . 1.07 109.472 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -85.4 -57.62 3.0 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.814 -1.154 . . . . 3.44 111.581 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.94 -7.65 66.86 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.81 -1.662 . . . . 1.38 110.214 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 1.8 tt0 -54.4 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 115.633 1.716 . . . . 1.1 115.633 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tp -107.33 170.06 8.19 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 110.747 -2.933 . . . . 0.4 110.528 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -157.69 113.94 0.59 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.851 -1.166 . . . . 0.37 110.21 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 4.1 p90 -138.49 -162.05 1.26 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.937 -1.105 . . . . 0.31 112.196 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -147.82 133.14 18.49 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 118.961 -1.096 . . . . 6.08 113.307 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.56 127.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.641 1.213 . . . . 2.32 112.259 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 7' ' ' ALA . . . 91.16 -32.62 5.09 Favored Glycine 0 C--N 1.286 -2.244 0 C-N-CA 119.715 -1.231 . . . . 0.85 110.484 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.59 125.99 24.66 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 118.393 -1.323 . . . . 2.04 108.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.94 113.66 14.88 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.024 -1.07 . . . . 0.73 113.217 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.53 140.85 16.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 C-N-CA 118.668 -1.213 . . . . 0.28 108.062 179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 22.6 t-80 -96.0 96.84 9.16 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.189 -1.404 . . . . 1.11 108.53 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 3' ' ' THR . 10.8 t -64.8 100.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 C-N-CA 119.018 -1.073 . . . . 0.42 111.293 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.514 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mtt -67.08 -39.22 86.74 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.004 -1.078 . . . . 1.11 108.547 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -179.23 116.29 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.98 -1.009 . . . . 1.46 109.654 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 9.0 p-10 -47.17 111.64 0.43 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.297 -1.361 . . . . 2.37 109.346 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -42.43 11.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.138 -1.025 . . . . 1.23 112.208 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.94 162.12 58.67 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 119.906 -0.718 . . . . 1.07 111.015 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 -61.05 0.48 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.894 1.729 . . . . 0.81 111.985 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -99.65 17.83 19.57 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.604 -0.839 . . . . 0.96 110.667 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 23.4 m95 -151.47 139.46 20.04 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.414 -0.958 . . . . 0.39 108.414 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 26.4 m0 -138.79 175.9 9.16 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.334 -0.947 . . . . 0.23 112.128 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 129.91 56.53 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.784 -1.561 . . . . 0.73 106.784 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -158.24 -152.92 6.56 Favored Glycine 0 C--N 1.298 -1.573 0 C-N-CA 117.888 -2.101 . . . . 0.2 109.834 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.44 168.28 18.65 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 118.225 -1.39 . . . . 0.36 111.763 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' GLY . 36.4 t -163.89 -91.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.689 -1.205 . . . . 0.52 111.522 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.705 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 2.9 p80 -59.98 77.11 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.63 -0.828 . . . . 0.4 111.429 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.93 23.74 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.098 -1.048 . . . . 0.46 111.93 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -152.96 153.44 32.96 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.071 -1.452 . . . . 4.45 111.201 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.775 HG22 ' HB2' ' A' ' 41' ' ' ALA . 8.9 p -99.44 -174.89 2.84 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.652 -0.819 . . . . 0.35 111.37 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.23 -172.09 28.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.356 -1.098 . . . . 0.22 110.356 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.3 mtp -105.03 157.99 16.86 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.747 -0.781 . . . . 0.59 110.387 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.7 p90 -159.21 142.72 10.76 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 108.134 -1.061 . . . . 0.26 108.134 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -54.76 127.0 24.33 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 CA-C-N 118.613 0.541 . . . . 0.32 111.239 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.535 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -40.22 85.84 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.574 -0.851 . . . . 2.23 109.578 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.5 2.39 1.8 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.529 -0.868 . . . . 2.28 112.867 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -100.79 10.39 41.2 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.101 -1.039 . . . . 0.17 109.328 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 51' ' ' ARG . 14.2 m -141.58 175.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 115.027 -0.988 . . . . 0.13 109.463 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -147.21 128.09 7.06 Favored Pre-proline 0 C--N 1.3 -1.545 0 C-N-CA 119.23 -0.988 . . . . 0.3 109.324 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.69 145.83 94.3 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.633 0.889 . . . . 1.58 112.47 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -92.25 -170.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.393 -0.821 . . . . 3.6 110.794 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.41 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -92.88 172.36 8.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.327 -0.949 . . . . 6.33 110.776 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 . . . . . 0 C--N 1.304 -1.403 0 CA-C-O 116.34 -1.791 . . . . 8.69 111.035 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 110.066 -1.214 . . . . 6.7 110.066 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -112.28 -163.52 0.86 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.897 -0.721 . . . . 2.27 111.215 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 95.3 2.65 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.857 -0.737 . . . . 2.77 110.706 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -171.08 153.19 3.67 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.357 -1.337 . . . . 0.89 112.553 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 27' ' ' ILE . 6.2 m -143.81 -170.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 115.078 -0.964 . . . . 0.29 110.011 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.576 ' O ' HG22 ' A' ' 55' ' ' THR . 1.9 mt-30 -141.72 101.13 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.678 -1.23 . . . . 0.36 107.678 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.26 110.55 0.06 Allowed 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.188 -0.915 . . . . 0.19 113.116 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.53 -42.04 87.82 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.469 0.652 . . . . 1.17 109.978 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.56 -178.24 4.91 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.741 -1.118 . . . . 1.4 108.758 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 140.59 32.44 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 113.435 -1.711 . . . . 1.01 106.995 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.57 106.99 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.031 1.493 . . . . 0.37 115.031 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.13 137.72 29.31 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 105.925 -1.88 . . . . 2.01 105.925 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.62 162.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.293 -2.348 0 CA-C-O 121.794 0.664 . . . . 0.41 112.969 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.54 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 91.0 mt-30 -151.61 -12.18 0.2 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.966 -1.47 . . . . 1.63 108.1 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 1.7 mt-10 -114.9 166.97 11.21 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.335 -1.302 . . . . 4.23 109.651 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -64.5 123.72 19.96 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.259 -1.376 . . . . 5.95 110.202 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 47.03 37.96 10.26 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 119.349 -1.405 . . . . 0.75 111.161 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -83.78 172.2 12.43 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.941 -1.104 . . . . 1.28 108.089 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.4 tp -69.0 154.61 41.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 112.858 0.688 . . . . 0.54 112.858 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -146.15 123.13 1.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.659 -1.377 . . . . 0.15 109.659 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.6 p90 -146.44 -176.11 5.05 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.582 -1.247 . . . . 0.13 112.03 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' O ' ' C ' ' A' ' 23' ' ' ARG . 3.9 mmt85 -135.73 127.72 29.61 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.498 -0.774 . . . . 2.35 111.305 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -13.56 135.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.03 1.122 . . . . 1.13 114.03 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.39 -21.82 30.11 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.21 109.402 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -69.09 117.52 10.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.731 -1.211 . . . . 0.94 107.731 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CE2' ' NE2' ' A' ' 6' ' ' GLN . 67.3 m-85 -73.28 108.3 6.08 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 118.978 -1.089 . . . . 0.93 112.174 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -73.38 142.7 14.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 107.068 -1.456 . . . . 0.19 107.068 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 31.8 t-80 -101.45 99.17 9.47 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.861 -1.536 . . . . 1.31 108.125 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 29' ' ' VAL . 6.4 t -64.74 102.43 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 C-N-CA 118.731 -1.187 . . . . 0.27 110.12 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.492 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.6 ttp -93.32 -21.96 19.26 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.825 -1.08 . . . . 1.7 111.216 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.01 87.82 0.94 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.092 -1.443 . . . . 1.97 111.734 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.15 82.78 0.23 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 118.78 -1.168 . . . . 2.08 108.755 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -95.7 -83.14 0.37 Allowed 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.191 -1.003 . . . . 1.51 111.855 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.1 m-20 -57.85 156.15 19.93 Favored Pre-proline 0 C--N 1.3 -1.578 0 C-N-CA 118.675 -1.21 . . . . 0.85 111.352 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.17 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.896 1.731 . . . . 0.36 111.833 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -81.88 -3.26 53.72 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.225 -0.898 . . . . 0.31 111.556 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 32.8 m95 -129.67 151.8 49.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.18 -1.044 . . . . 0.8 108.18 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.2 m0 -151.81 164.85 36.17 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.04 -0.664 . . . . 0.6 110.905 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -108.16 137.79 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.579 -1.267 . . . . 0.6 107.579 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.492 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -160.52 -148.71 5.35 Favored Glycine 0 C--O 1.214 -1.145 0 C-N-CA 118.078 -2.01 . . . . 0.38 109.54 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.17 154.39 10.66 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.403 -1.319 . . . . 0.76 112.185 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 44' ' ' GLY . 35.1 t -155.25 -100.93 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.956 -1.098 . . . . 0.38 111.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.63 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 4.4 p80 -53.65 80.29 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.571 -0.74 . . . . 0.47 111.715 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 39.1 26.66 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 C-N-CA 120.139 -1.029 . . . . 0.46 112.268 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.476 ' NE2' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -156.73 149.9 24.11 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 118.408 -1.317 . . . . 4.52 111.982 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.1 p -97.27 -172.9 2.53 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.604 -0.726 . . . . 0.21 110.855 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.52 -171.15 26.65 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.374 -1.393 . . . . 0.2 111.422 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 18.7 mtp -104.9 145.46 30.38 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 120.241 -0.584 . . . . 0.62 111.489 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 7.4 p90 -149.42 141.17 14.81 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 119.516 -0.874 . . . . 0.16 109.94 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -55.31 128.31 29.91 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 N-CA-C 110.067 -0.782 . . . . 0.29 110.067 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -23.01 64.97 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.411 -0.916 . . . . 2.8 111.56 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -84.38 10.18 11.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.712 -1.195 . . . . 4.67 111.383 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.01 6.85 29.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.814 -0.755 . . . . 0.33 109.112 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 12.0 m -134.7 175.07 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 114.553 -1.203 . . . . 0.26 109.603 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -140.88 135.03 15.13 Favored Pre-proline 0 C--N 1.305 -1.344 0 C-N-CA 119.414 -0.914 . . . . 0.39 108.949 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -66.11 144.19 74.59 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 120.576 0.851 . . . . 1.36 113.114 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.18 -1.77 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.502 -0.925 . . . . 2.27 108.502 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 59' ' ' ARG . 21.4 t-20 -143.51 -105.1 0.12 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.723 -1.126 . . . . 4.45 110.106 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 58' ' ' ASN . 16.3 ttm180 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 116.446 -1.74 . . . . 13.68 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.832 -1.307 . . . . 4.8 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -162.01 152.79 17.62 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.124 -1.03 . . . . 5.32 111.513 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.56 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -131.75 172.43 12.29 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.233 -0.894 . . . . 2.57 109.554 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.4 OUTLIER 175.21 148.79 0.09 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 118.135 -1.426 . . . . 1.91 113.24 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 27' ' ' ILE . 16.9 m -137.87 -164.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 115.174 -0.921 . . . . 0.21 109.218 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.511 ' O ' ' C ' ' A' ' 7' ' ' ALA . 5.0 mt-30 -145.26 97.48 3.01 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.286 -1.005 . . . . 0.42 108.286 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.4 115.25 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.729 -1.123 . . . . 0.15 113.282 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 17.2 tp -64.95 -41.27 95.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.666 -0.697 . . . . 1.94 109.425 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.68 -174.92 4.6 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.962 -1.017 . . . . 1.45 109.489 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.57 127.63 33.56 Favored 'General case' 0 C--N 1.27 -2.882 0 CA-C-N 113.903 -1.499 . . . . 0.6 107.456 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -114.44 103.89 11.49 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 114.453 1.279 . . . . 0.38 114.453 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 13' ' ' PRO . 5.0 m-20 -86.06 142.11 35.9 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 105.687 -1.968 . . . . 1.82 105.687 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 12' ' ' ASP . 80.4 Cg_exo -47.55 -158.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 120.8 1.0 . . . . 1.6 114.066 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 1.2 mm-40 165.67 -23.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.44 -1.254 . . . . 2.6 107.635 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -102.57 148.64 25.3 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.379 -1.282 . . . . 5.41 109.007 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.29 105.52 1.14 Allowed 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.494 -1.282 . . . . 4.16 111.211 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.12 32.15 29.73 Favored Glycine 0 N--CA 1.485 1.901 0 C-N-CA 119.712 -1.233 . . . . 0.35 110.666 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' OE2' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -93.63 170.75 9.35 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.195 -1.002 . . . . 0.88 109.545 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.606 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 11.3 tp -72.16 155.99 39.65 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.003 -0.999 . . . . 1.08 113.291 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.481 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.48 117.2 0.86 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 107.999 -2.04 . . . . 0.42 107.999 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -139.52 -169.3 2.66 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.889 -1.124 . . . . 0.32 113.064 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -133.97 130.14 37.23 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.463 -0.79 . . . . 3.33 112.39 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -18.71 137.92 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 O-C-N 123.829 0.706 . . . . 2.63 112.879 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.92 -21.5 15.23 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.916 -1.674 . . . . 0.33 108.916 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -64.85 121.73 15.29 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 118.935 -1.106 . . . . 0.34 108.308 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 110.2 11.95 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.986 -1.086 . . . . 0.85 112.763 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.559 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -76.18 146.85 8.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 107.784 -1.191 . . . . 0.2 107.784 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -103.49 89.78 3.47 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.277 -1.369 . . . . 1.01 109.408 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 3' ' ' THR . 2.3 t -59.83 94.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 C-N-CA 118.677 -1.209 . . . . 0.66 110.285 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.507 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 15.4 mtp -74.88 -29.57 61.05 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.655 -1.157 . . . . 1.98 110.482 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.25 99.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 117.946 -1.502 . . . . 2.32 111.805 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 2.1 p30 -54.56 101.53 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.103 -1.439 . . . . 1.45 108.326 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -94.04 -72.89 0.59 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.007 -1.077 . . . . 1.05 111.735 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.1 m-20 -80.34 160.55 67.53 Favored Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.049 -1.06 . . . . 0.64 111.0 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.34 -68.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.577 1.518 . . . . 0.46 111.127 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 3.5 t-20 -87.13 4.13 43.54 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.712 -0.795 . . . . 0.26 111.577 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.456 ' O ' ' O ' ' A' ' 34' ' ' ASP . 18.2 m95 -136.66 148.62 47.5 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.465 -0.939 . . . . 0.11 108.465 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 22.8 m0 -142.37 175.55 9.68 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 119.616 -0.834 . . . . 0.18 111.5 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 133.03 56.32 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 106.965 -1.494 . . . . 0.56 106.965 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.71 -150.68 5.91 Favored Glycine 0 C--N 1.297 -1.627 0 C-N-CA 117.918 -2.086 . . . . 0.15 109.261 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.68 159.66 19.1 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 118.226 -1.389 . . . . 0.53 111.662 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' GLY . 40.6 t -155.37 -100.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.553 -1.259 . . . . 0.32 112.097 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.517 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 5.7 p80 -52.77 82.19 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.584 -0.735 . . . . 0.7 111.899 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.2 24.05 0.1 OUTLIER Glycine 0 N--CA 1.489 2.216 0 CA-C-N 115.167 -0.924 . . . . 0.47 112.252 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.5 tp60 -156.16 163.71 39.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.814 -1.554 . . . . 4.28 111.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.719 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.8 p -99.82 -177.26 3.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.341 -0.845 . . . . 0.49 111.313 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.99 171.39 18.36 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.01 -1.567 . . . . 0.76 111.346 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 64.3 mtp -95.92 146.28 24.72 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 120.218 -0.593 . . . . 0.6 110.394 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 27' ' ' ILE . 10.1 p90 -148.78 145.54 20.06 Favored Pre-proline 0 C--N 1.296 -1.743 0 C-N-CA 119.403 -0.919 . . . . 0.23 108.859 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.93 128.04 27.43 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 120.008 0.472 . . . . 0.15 110.973 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -59.16 -36.56 75.5 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.812 -0.755 . . . . 3.62 110.253 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.402 ' CG ' ' O ' ' A' ' 52' ' ' ASN . 26.7 t-20 -75.13 3.32 8.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.473 -0.891 . . . . 3.69 112.787 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -100.12 9.16 43.25 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.905 -1.118 . . . . 0.19 109.598 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.5 m -138.42 177.94 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 114.943 -1.026 . . . . 0.2 109.03 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -148.8 133.18 8.86 Favored Pre-proline 0 C--N 1.297 -1.689 0 C-N-CA 119.18 -1.008 . . . . 0.2 109.259 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.09 149.8 60.69 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 120.363 0.709 . . . . 1.12 111.632 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.54 -15.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.268 -0.973 . . . . 1.31 110.702 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -90.03 -175.57 4.61 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.48 -0.888 . . . . 2.96 110.452 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.388 0 CA-C-O 116.216 -1.85 . . . . 7.66 110.739 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 109.954 -1.258 . . . . 8.84 109.954 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m 46.45 -105.1 0.11 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.497 -0.881 . . . . 2.61 110.77 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -109.1 94.34 4.99 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.718 -0.674 . . . . 2.9 110.448 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 3' ' ' THR . 1.8 m-85 -172.17 159.52 4.88 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.681 -1.608 . . . . 0.74 113.091 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 27' ' ' ILE . 16.0 m -147.45 -167.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 115.062 -0.972 . . . . 0.24 109.9 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.3 mt-30 -144.88 97.08 2.96 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.588 -1.264 . . . . 0.32 107.588 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HA ' HG12 ' A' ' 54' ' ' VAL . . . -24.22 115.54 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.359 -1.291 . . . . 0.16 113.663 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -70.77 -42.09 70.87 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.809 -0.632 . . . . 0.88 109.888 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.86 -179.94 5.92 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 122.478 1.132 . . . . 1.13 109.155 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -85.31 124.76 32.3 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.107 -1.86 . . . . 0.72 107.412 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -111.96 104.54 12.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.262 -0.975 . . . . 0.42 112.798 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.4 p-10 -86.23 128.51 57.24 Favored Pre-proline 0 C--N 1.304 -1.37 0 C-N-CA 117.514 -1.675 . . . . 3.35 108.765 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -39.84 149.23 0.13 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.146 1.23 . . . . 0.52 114.095 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -137.97 4.72 2.53 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.87 -1.9 . . . . 2.11 105.87 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -141.55 139.48 33.2 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 112.707 -2.042 . . . . 1.35 109.657 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -89.03 42.88 1.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.282 -1.367 . . . . 4.49 109.134 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -162.15 -9.05 0.04 OUTLIER Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.646 -1.381 . . . . 1.08 109.646 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.576 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.2 pt-20 -99.75 -170.76 1.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.313 -0.955 . . . . 1.16 111.732 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.576 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -84.82 170.22 13.39 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 116.138 1.903 . . . . 0.24 116.138 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -158.93 119.66 0.91 Allowed Glycine 0 N--CA 1.492 2.418 0 CA-C-N 113.168 -1.833 . . . . 0.17 109.209 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.567 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.5 p90 -144.97 -170.81 3.51 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.367 -1.333 . . . . 0.11 112.455 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 23' ' ' ARG . 5.1 mmt85 -136.88 126.91 25.98 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.544 -0.753 . . . . 1.94 111.743 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.3 ttp85 -12.8 135.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.398 1.259 . . . . 2.84 114.398 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.11 -23.81 10.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.52 109.6 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' OD2' ' SG ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -61.26 117.07 5.14 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.388 -1.325 . . . . 0.85 107.891 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -71.89 107.57 4.72 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.48 -1.288 . . . . 0.94 112.376 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.85 136.63 25.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.362 -1.347 . . . . 0.38 107.362 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.409 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 25.5 t-80 -94.36 94.12 8.09 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.454 -1.699 . . . . 1.22 108.29 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 29' ' ' VAL . 7.7 t -61.01 100.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.612 0 C-N-CA 118.967 -1.093 . . . . 0.27 111.388 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.42 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 8.6 tpp -61.51 -36.0 79.29 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.062 -1.055 . . . . 1.82 108.931 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 2.0 p30 171.58 126.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 115.026 -0.988 . . . . 2.84 109.39 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.559 ' N ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -49.97 109.78 0.32 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.914 -1.514 . . . . 2.75 109.716 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -92.51 -65.69 0.98 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.422 -0.911 . . . . 2.08 110.162 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -102.57 160.75 25.36 Favored Pre-proline 0 C--N 1.297 -1.708 0 CA-C-N 115.021 -0.99 . . . . 0.63 110.315 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -59.47 -60.57 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.309 1.34 . . . . 0.59 111.087 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -92.53 -3.58 54.87 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.666 -0.813 . . . . 0.48 111.708 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 17.0 m95 -131.01 152.85 49.88 Favored 'General case' 0 C--O 1.204 -1.327 0 N-CA-C 108.343 -0.984 . . . . 0.38 108.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.677 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 15.2 m0 -145.24 177.91 8.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.69 -0.804 . . . . 0.33 111.825 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -118.02 135.95 53.85 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.943 -1.132 . . . . 3.32 107.943 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -165.89 -150.36 6.26 Favored Glycine 0 C--N 1.3 -1.451 0 C-N-CA 118.031 -2.033 . . . . 0.11 109.268 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.44 174.27 12.95 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 118.264 -1.374 . . . . 0.18 111.877 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 44' ' ' GLY . 12.6 t -170.33 -93.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 118.832 -1.147 . . . . 0.4 112.156 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.558 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 7.7 p80 -59.69 78.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.259 -0.977 . . . . 0.81 111.049 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.76 20.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.132 -0.94 . . . . 0.58 111.688 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' HIS . 54.8 mt-30 -148.3 151.79 35.99 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.393 -1.323 . . . . 1.14 111.745 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 1.2 p -96.14 -179.46 4.67 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.629 -0.828 . . . . 0.35 110.239 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -179.06 28.21 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.019 -1.562 . . . . 0.37 111.092 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.6 mtp -102.79 147.04 27.36 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.398 0.618 . . . . 0.44 110.81 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -149.16 149.7 30.2 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.359 -0.837 . . . . 0.23 108.799 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -60.11 131.16 37.6 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 N-CA-C 110.564 -0.591 . . . . 0.35 110.564 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.677 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.39 -51.41 68.91 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.204 -0.998 . . . . 4.17 109.755 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -61.1 9.12 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.522 0.934 . . . . 3.14 113.522 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -104.39 3.75 32.67 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.112 -1.035 . . . . 0.46 109.26 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 51' ' ' ARG . 12.9 m -134.06 175.06 12.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.14 108.875 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.21 130.47 10.8 Favored Pre-proline 0 C--N 1.299 -1.599 0 C-N-CA 119.305 -0.958 . . . . 0.32 108.693 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.406 ' HD3' HH12 ' A' ' 51' ' ' ARG . 6.0 Cg_exo -54.47 147.17 48.83 Favored 'Trans proline' 0 C--N 1.323 -0.781 0 CA-C-N 118.756 0.591 . . . . 1.01 111.426 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' H ' HG23 ' A' ' 57' ' ' VAL . 1.3 t -70.23 -58.54 5.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.765 -1.198 . . . . 1.23 107.765 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.63 -170.98 1.78 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.936 -1.135 . . . . 4.68 107.936 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 116.326 -1.797 . . . . 5.15 111.093 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.825 -1.31 . . . . 4.93 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.4 p -170.54 16.66 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.703 -0.799 . . . . 3.91 110.374 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.553 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -76.13 164.68 25.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.789 -0.764 . . . . 2.52 111.359 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 3' ' ' THR . 0.6 OUTLIER 175.84 151.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.264 -0.975 . . . . 1.32 112.068 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 27' ' ' ILE . 10.0 m -140.75 -168.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-N 115.556 -0.747 . . . . 0.15 109.52 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.522 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.6 mt-30 -143.05 89.67 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.828 -0.749 . . . . 0.28 109.031 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -14.55 111.69 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.023 -1.444 . . . . 0.15 114.139 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.514 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 6.1 tp -63.75 -52.98 57.97 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.639 -0.71 . . . . 1.76 109.537 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.23 -178.92 5.05 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.865 -1.161 . . . . 0.54 107.865 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.85 136.48 36.7 Favored 'General case' 0 C--N 1.265 -3.098 0 CA-C-N 114.328 -1.305 . . . . 0.31 109.088 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -123.69 109.55 13.86 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.958 -1.097 . . . . 0.25 113.391 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.4 133.81 32.33 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 117.816 -1.554 . . . . 1.27 108.452 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 15' ' ' GLU . 95.3 Cg_exo -43.64 106.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 120.703 0.935 . . . . 1.38 112.986 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -86.02 12.19 10.01 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 106.271 -1.751 . . . . 2.56 106.271 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' PRO . 4.9 mm-40 -141.01 -178.56 5.62 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 112.947 -1.933 . . . . 1.9 110.251 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -120.46 26.54 9.11 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.684 0.754 . . . . 3.89 109.28 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -158.6 1.02 0.1 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 109.209 -1.556 . . . . 0.84 109.209 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -100.95 -174.21 2.56 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.29 -0.964 . . . . 0.98 112.049 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.563 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.6 tp -76.71 166.06 23.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 115.492 1.664 . . . . 0.25 115.492 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.08 120.9 1.05 Allowed Glycine 0 N--CA 1.499 2.88 0 CA-C-N 114.237 -1.347 . . . . 0.17 110.437 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.1 p90 -149.05 -175.54 5.0 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.073 -1.451 . . . . 0.2 112.861 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 23' ' ' ARG . 31.3 mmt-85 -135.6 130.55 34.62 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.189 -0.914 . . . . 5.95 111.603 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.98 140.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.456 1.28 . . . . 1.45 114.456 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.11 -15.07 29.67 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 114.067 -1.424 . . . . 0.17 109.594 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -72.68 118.81 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.555 -1.276 . . . . 0.41 107.555 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -73.69 107.21 5.8 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.687 -1.205 . . . . 0.74 113.276 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -73.04 142.84 14.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 106.819 -1.548 . . . . 0.26 106.819 179.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 15.8 t-80 -100.6 93.92 5.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.17 -1.412 . . . . 0.97 108.887 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 29' ' ' VAL . 2.0 t -63.07 96.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 118.135 -1.426 . . . . 0.6 110.5 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.469 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 57.6 ttm -82.48 -25.87 33.12 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.51 -1.223 . . . . 0.57 110.706 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -156.9 85.06 0.95 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.15 -1.42 . . . . 2.06 111.766 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.757 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.18 91.78 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.027 -1.069 . . . . 2.88 109.0 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.2 m -103.1 -85.86 0.44 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.285 -0.966 . . . . 1.69 111.936 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.44 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 8.4 m-20 -55.58 154.52 12.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 118.488 -1.285 . . . . 1.13 110.753 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -65.05 -71.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.876 1.717 . . . . 0.39 112.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.47 7.82 13.28 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.721 -0.792 . . . . 2.74 111.387 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 34' ' ' ASP . 23.3 m95 -139.85 146.19 39.03 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.617 -0.882 . . . . 0.43 108.617 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 11.8 m0 -145.59 167.34 23.28 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.378 -0.929 . . . . 0.45 111.447 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -108.21 132.1 54.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.241 -1.022 . . . . 0.24 108.241 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -159.09 -146.66 4.62 Favored Glycine 0 C--N 1.3 -1.443 0 C-N-CA 117.883 -2.103 . . . . 0.16 109.116 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -163.76 159.21 21.11 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 117.173 -1.811 . . . . 0.42 113.495 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 8.2 t -175.61 -179.72 1.28 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 2.91 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.609 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 10.8 p80 40.78 26.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.802 -0.636 . . . . 1.35 111.173 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 81.27 31.04 35.38 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.732 -1.223 . . . . 0.77 112.778 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.6 tt0 -164.91 155.23 13.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.832 -1.547 . . . . 1.73 112.19 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.4 p -95.04 -179.5 4.84 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.399 -0.921 . . . . 0.2 110.814 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.41 -159.2 28.27 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.14 -1.505 . . . . 0.32 111.255 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 55.5 mtp -120.03 148.37 43.66 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.167 0.508 . . . . 0.28 110.759 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 27' ' ' ILE . 8.5 p90 -151.08 143.9 16.64 Favored Pre-proline 0 C--N 1.297 -1.712 0 C-N-CA 119.563 -0.855 . . . . 0.22 109.146 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.91 126.92 24.02 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 N-CA-C 109.864 -0.86 . . . . 0.23 109.864 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -60.88 -32.59 72.03 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.149 -1.02 . . . . 3.46 111.58 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 1.5 t30 -74.54 0.12 15.86 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 118.494 -1.283 . . . . 1.7 112.349 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -97.39 12.56 32.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.93 -1.108 . . . . 0.19 109.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.6 m -139.38 171.0 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 114.983 -1.008 . . . . 0.14 109.741 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -135.76 122.54 14.43 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.576 -0.898 . . . . 0.55 108.576 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -64.05 144.47 87.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 CA-C-N 118.948 0.66 . . . . 1.7 112.04 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.14 99.11 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.435 -0.802 . . . . 4.08 109.042 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -138.14 76.59 1.58 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.749 -0.78 . . . . 6.48 111.773 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.43 0 CA-C-O 116.298 -1.81 . . . . 7.47 110.753 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 110.345 -1.102 . . . . 1.5 110.345 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m -149.15 34.59 0.73 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.574 -0.851 . . . . 1.71 110.926 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.456 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -64.54 94.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.87 -0.732 . . . . 2.88 111.091 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.456 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -173.26 138.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.224 -1.391 . . . . 0.83 112.66 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' ILE . 14.7 m -128.42 -167.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 115.266 -0.879 . . . . 0.27 110.098 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.533 ' O ' HG22 ' A' ' 55' ' ' THR . 4.4 mt-30 -141.83 109.34 5.64 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.673 -1.603 . . . . 0.42 106.673 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -34.79 115.73 0.29 Allowed 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 118.927 -1.109 . . . . 0.31 111.79 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.531 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 1.4 tt -73.71 -39.82 64.05 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.018 -0.992 . . . . 0.74 109.837 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.99 -179.9 5.98 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.781 -1.1 . . . . 0.86 108.582 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -80.61 135.47 36.06 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 113.294 -1.775 . . . . 0.53 107.702 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -131.07 111.93 12.44 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.475 -1.29 . . . . 0.41 113.979 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -94.26 131.58 31.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 118.023 -1.471 . . . . 3.79 107.928 179.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -42.55 110.97 0.17 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 120.616 0.878 . . . . 1.19 112.658 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.559 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 14.5 mm-40 -111.82 15.75 20.73 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.921 -1.036 . . . . 2.65 109.881 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 17.4 mm-40 -138.7 -178.16 5.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.814 -0.754 . . . . 3.11 110.012 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 17' ' ' GLY . 5.5 p30 -73.21 129.21 37.55 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.509 -0.877 . . . . 6.74 112.029 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 16' ' ' ASP . . . 34.42 38.37 0.11 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.975 -0.85 . . . . 0.57 110.975 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.688 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -84.43 177.42 8.14 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.689 -0.804 . . . . 1.22 110.147 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.688 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.7 tp -73.74 167.35 21.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.107 -0.951 . . . . 0.35 112.109 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.56 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.76 130.12 2.68 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.598 -1.001 . . . . 0.24 110.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 27' ' ' ILE . 9.4 p90 -156.75 -172.05 3.9 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 117.682 -1.607 . . . . 0.26 113.075 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' ARG . 10.8 mmm180 -138.77 128.57 24.98 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.278 -0.874 . . . . 4.3 112.153 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -12.7 135.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.295 1.22 . . . . 3.1 114.295 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.63 -19.51 32.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.095 -1.602 . . . . 0.16 109.095 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -65.39 118.81 9.92 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.166 -1.014 . . . . 0.81 108.777 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.78 107.79 7.1 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.068 -1.053 . . . . 1.33 112.696 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.617 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -77.92 143.4 12.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.139 -1.43 . . . . 0.29 107.139 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -100.82 95.24 6.5 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.739 -1.585 . . . . 1.26 108.767 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 3' ' ' THR . 3.8 t -64.83 106.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 C-N-CA 118.114 -1.434 . . . . 0.44 109.613 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.3 tpp -88.75 -26.34 21.8 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.122 -0.944 . . . . 2.35 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -172.06 108.52 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.691 -1.604 . . . . 1.6 111.595 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 3.7 p30 -62.33 100.01 0.16 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.381 -1.328 . . . . 1.72 109.249 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -91.25 -66.55 0.92 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.782 -1.167 . . . . 1.13 111.219 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 4.3 m-20 -90.19 159.9 41.2 Favored Pre-proline 0 C--N 1.294 -1.82 0 C-N-CA 119.226 -0.99 . . . . 2.35 110.726 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.54 -65.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.443 1.429 . . . . 0.38 111.066 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 4.2 t-20 -83.14 -8.93 59.44 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.489 -0.778 . . . . 0.92 111.559 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.517 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 18.9 m95 -126.57 155.94 41.65 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.768 -0.827 . . . . 0.39 108.768 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 7.6 m0 -149.84 -179.31 7.03 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.507 -0.877 . . . . 0.58 112.151 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -122.43 128.13 50.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.879 -1.156 . . . . 0.65 107.879 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.87 -148.43 4.99 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.587 -1.805 . . . . 0.19 108.587 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.739 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.91 159.05 17.82 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 117.303 -1.759 . . . . 0.58 113.763 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' GLY . 43.2 t -172.7 -178.85 1.99 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 114.543 -1.208 . . . . 2.53 111.041 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 20' ' ' GLY . 4.0 p80 39.6 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.874 -0.603 . . . . 1.55 111.616 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 85.9 30.47 23.31 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.718 -1.229 . . . . 0.41 112.907 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' A' ' 46' ' ' THR . 1.3 tm0? -164.37 151.72 11.81 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.119 -1.433 . . . . 4.42 111.814 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.739 HG22 ' HB2' ' A' ' 41' ' ' ALA . 6.1 p -94.28 -175.69 3.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.55 -0.86 . . . . 0.28 110.689 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.15 -170.07 29.49 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.462 -1.351 . . . . 0.17 110.933 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.0 mtp -107.76 143.91 35.63 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.975 -0.69 . . . . 0.27 111.095 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' HG21 ' A' ' 27' ' ' ILE . 3.5 p90 -148.52 145.59 20.55 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 119.701 -0.8 . . . . 0.25 110.093 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.43 125.64 19.46 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 N-CA-C 109.966 -0.821 . . . . 0.35 109.966 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.31 -25.22 67.53 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.626 -0.829 . . . . 2.04 112.211 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.25 7.44 16.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.367 -1.333 . . . . 2.26 111.876 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.96 7.37 39.17 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.506 -0.878 . . . . 0.23 109.547 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 11.6 m -135.18 179.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.767 -1.106 . . . . 0.3 109.033 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -149.72 121.63 4.18 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 118.745 -1.182 . . . . 0.38 110.818 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.13 149.67 78.62 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 120.576 0.851 . . . . 1.96 111.747 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.474 ' O ' ' ND2' ' A' ' 58' ' ' ASN . 0.8 OUTLIER -97.35 124.96 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.649 -0.82 . . . . 3.73 110.617 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 57' ' ' VAL . 1.6 m120 -138.49 -13.13 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.358 -0.937 . . . . 7.07 110.46 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 . . . . . 0 C--N 1.298 -1.643 0 CA-C-O 116.197 -1.859 . . . . 8.09 110.491 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 110.186 -1.166 . . . . 2.65 110.186 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 p -142.67 146.6 34.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.739 -0.784 . . . . 2.35 110.628 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.522 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -127.39 22.88 6.45 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.694 -0.802 . . . . 0.89 111.181 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.466 ' CE2' ' CD2' ' A' ' 28' ' ' HIS . 82.9 m-85 -87.94 155.17 19.98 Favored 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.329 -1.348 . . . . 2.16 112.666 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 19.4 m -130.93 -166.14 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.308 -1.315 . . . . 0.21 108.708 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.526 ' OE1' HG13 ' A' ' 57' ' ' VAL . 3.1 mt-30 -144.45 95.41 2.71 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.928 -1.138 . . . . 0.19 107.928 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -21.54 111.15 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.481 -1.236 . . . . 0.15 113.186 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.523 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 14.0 tp -61.98 -45.72 92.39 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.514 0.673 . . . . 1.87 109.682 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.09 -174.44 3.85 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.709 -1.132 . . . . 0.86 108.252 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.84 148.31 30.02 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 114.168 -1.378 . . . . 0.27 107.805 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -139.21 119.35 13.56 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.125 -1.43 . . . . 0.45 113.704 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -101.1 132.42 22.0 Favored Pre-proline 0 C--N 1.311 -1.066 0 C-N-CA 118.643 -1.223 . . . . 1.73 108.64 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -45.39 119.3 2.54 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 120.82 1.013 . . . . 1.16 114.191 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 5.1 mt-30 -116.56 8.7 13.99 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.756 -1.111 . . . . 2.6 108.375 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 4.4 mm-40 -130.37 170.11 14.6 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.913 -1.039 . . . . 3.67 109.146 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 127.06 31.99 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.736 -1.186 . . . . 1.75 111.481 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 52.25 41.91 55.05 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.976 -1.107 . . . . 0.48 111.179 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -99.19 175.63 5.82 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.667 -0.813 . . . . 1.12 110.103 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.69 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -74.88 161.62 29.38 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 113.674 0.99 . . . . 0.61 113.674 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -153.2 120.92 1.09 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.072 -1.211 . . . . 0.21 110.072 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 27' ' ' ILE . 5.7 p90 -144.16 -169.61 3.16 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.778 -1.169 . . . . 0.22 111.796 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.1 mmm-85 -138.7 125.05 20.4 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.937 -0.705 . . . . 2.29 112.0 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.529 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.63 130.25 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.143 0.902 . . . . 2.21 113.282 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.52 -19.61 53.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.381 -1.487 . . . . 0.18 109.381 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' OD1' ' SG ' ' A' ' 42' ' ' CYS . 0.2 OUTLIER -72.84 120.73 18.87 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.961 -1.096 . . . . 1.84 108.925 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -76.01 109.46 9.67 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.96 -1.096 . . . . 0.49 112.65 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -74.58 142.83 14.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.677 -1.231 . . . . 0.31 107.677 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' CD2' ' CE2' ' A' ' 4' ' ' TYR . 12.2 t-80 -100.74 97.99 8.57 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 118.29 -1.364 . . . . 0.72 108.032 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 3' ' ' THR . 4.8 t -67.12 94.81 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 114.908 -1.042 . . . . 0.41 110.884 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.452 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 39.7 ttm -82.28 -27.21 32.49 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.56 -1.2 . . . . 0.89 111.343 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 33' ' ' SER . 11.8 t70 -160.46 83.44 0.69 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 117.701 -1.6 . . . . 1.87 111.903 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 32' ' ' ASN . 1.6 p-10 -52.93 99.46 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.456 -1.297 . . . . 1.58 108.904 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 34' ' ' ASP . 1.1 t -95.17 -78.06 0.46 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.126 -1.03 . . . . 2.06 111.554 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' N ' ' OG ' ' A' ' 33' ' ' SER . 0.4 OUTLIER -72.63 158.48 87.27 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.064 -1.054 . . . . 0.62 111.498 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -64.49 -65.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.783 1.655 . . . . 0.23 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 6.67 35.33 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.689 -0.804 . . . . 2.8 111.551 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' ASP . 15.8 m95 -139.65 147.53 41.15 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.704 -1.221 . . . . 0.25 107.704 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -145.8 174.83 10.88 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.254 -0.978 . . . . 0.36 112.024 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.31 135.94 53.44 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.621 -1.251 . . . . 1.56 107.621 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -162.31 -145.11 4.22 Favored Glycine 0 C--N 1.303 -1.265 0 C-N-CA 117.895 -2.097 . . . . 0.43 109.643 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.12 155.58 11.8 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.543 -1.263 . . . . 0.74 112.237 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 44' ' ' GLY . 28.7 t -155.81 -98.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.012 -1.075 . . . . 0.2 111.751 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 3.9 p80 -55.47 80.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.563 -0.855 . . . . 0.53 111.029 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 38.56 26.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 C-N-CA 120.327 -0.94 . . . . 0.48 111.866 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -154.78 153.01 30.54 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.15 -1.42 . . . . 2.55 111.792 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.744 HG22 ' HB2' ' A' ' 41' ' ' ALA . 3.0 p -98.15 -174.25 2.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.638 -0.71 . . . . 0.36 110.692 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.45 -169.55 27.0 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.371 -1.395 . . . . 0.28 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.5 mtp -110.2 151.41 27.35 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.355 0.598 . . . . 0.31 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.9 p90 -152.53 147.99 20.19 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.165 -0.925 . . . . 0.27 109.067 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.56 128.39 27.0 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 N-CA-C 110.006 -0.805 . . . . 0.23 110.006 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.514 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.93 -39.1 90.89 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.877 -1.129 . . . . 1.99 110.674 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.03 2.43 2.71 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.017 -1.073 . . . . 2.26 112.694 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.29 9.23 41.94 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.275 -0.97 . . . . 0.17 109.342 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.7 m -138.28 176.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-N 114.972 -1.013 . . . . 0.19 109.451 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.83 142.28 13.23 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 118.555 -1.258 . . . . 0.28 109.627 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.78 145.93 88.04 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 120.628 0.885 . . . . 0.64 111.481 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.526 HG13 ' OE1' ' A' ' 6' ' ' GLN . 1.8 t -79.19 -11.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.328 -0.949 . . . . 0.61 110.292 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -154.1 126.44 7.96 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.395 -0.922 . . . . 1.78 110.502 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--N 1.302 -1.469 0 CA-C-O 116.42 -1.753 . . . . 6.98 110.84 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 110.033 -1.227 . . . . 5.51 110.033 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.3 p 72.66 24.71 2.73 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.873 -0.731 . . . . 4.37 110.939 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -156.25 30.23 0.34 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.289 -0.965 . . . . 0.65 110.909 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.67 160.63 14.91 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 118.654 -1.218 . . . . 0.78 112.546 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 27' ' ' ILE . 13.8 m -142.8 -171.16 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 114.738 -1.119 . . . . 0.18 109.328 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 7' ' ' ALA . 2.5 mt-30 -140.66 93.63 2.63 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.821 -0.752 . . . . 0.39 109.341 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -19.92 110.57 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.864 -1.516 . . . . 0.15 114.739 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' O ' ' NE ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -71.67 -44.35 64.42 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.102 -0.954 . . . . 1.32 109.291 179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.85 -179.98 5.24 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.128 -1.064 . . . . 1.72 108.128 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.37 143.32 26.87 Favored 'General case' 0 C--N 1.268 -2.941 0 N-CA-C 106.848 -1.538 . . . . 0.64 106.848 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -131.41 115.09 15.76 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.205 -1.398 . . . . 0.42 114.415 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.34 129.75 32.67 Favored Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 118.638 -1.225 . . . . 4.09 107.915 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -43.66 159.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 120.502 0.802 . . . . 0.64 112.767 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.562 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 40.4 mt-30 -146.55 -4.5 0.59 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.261 -1.385 . . . . 1.51 107.261 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' CG ' ' OE2' ' A' ' 18' ' ' GLU . 17.4 mm-40 -129.33 150.75 50.56 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.679 -1.6 . . . . 1.88 109.351 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.02 55.4 2.12 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.164 -1.414 . . . . 1.89 110.036 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.34 -18.78 0.03 OUTLIER Glycine 0 C--N 1.296 -1.668 0 N-CA-C 107.994 -2.042 . . . . 0.98 107.994 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.4 mt-10 -49.97 -179.3 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 123.113 1.435 . . . . 1.8 113.697 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -104.06 160.11 15.12 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 111.385 -2.643 . . . . 0.49 109.509 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -148.77 105.23 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.933 -1.603 . . . . 0.5 110.767 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 3.2 p90 -132.03 -170.19 2.36 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.38 -0.928 . . . . 0.23 111.178 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 23' ' ' ARG . 1.3 mmm180 -144.04 124.9 14.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.398 -0.921 . . . . 3.26 112.046 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.5 ttt-85 -11.68 131.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 124.351 1.032 . . . . 1.87 113.542 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.7 -17.78 55.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.262 -1.535 . . . . 0.3 109.262 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.93 126.17 29.86 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.578 -1.249 . . . . 1.25 108.46 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -77.36 111.5 13.09 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.601 -1.24 . . . . 0.45 112.816 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -77.46 144.19 11.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 118.618 -1.233 . . . . 0.17 107.965 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.489 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 13.0 t-80 -101.16 101.24 11.93 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 106.658 -1.608 . . . . 0.51 106.658 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 3' ' ' THR . 3.3 t -70.26 91.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.484 0 CA-C-N 115.106 -0.952 . . . . 0.45 112.781 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.551 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 4.4 mtt -57.68 -39.35 76.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.538 -1.21 . . . . 1.07 109.529 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 0.7 OUTLIER 179.8 119.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.591 -1.244 . . . . 3.23 110.594 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.491 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 6.4 p-10 -49.13 108.55 0.19 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.372 -1.331 . . . . 2.32 110.154 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.7 t -92.28 -47.78 7.02 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.186 -1.006 . . . . 1.54 111.481 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -125.73 161.19 52.36 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.397 -0.82 . . . . 1.44 110.181 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -58.27 -67.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.505 1.47 . . . . 0.54 111.648 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -87.9 7.05 32.65 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.62 -0.832 . . . . 0.57 111.348 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASP . 24.4 m95 -141.42 145.08 34.87 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.815 . . . . 0.38 108.801 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.549 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 12.1 m0 -143.93 173.05 12.04 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 119.402 -0.919 . . . . 0.46 112.218 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -116.15 132.44 56.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.936 -1.135 . . . . 0.97 107.936 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.551 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.08 -144.16 3.86 Favored Glycine 0 C--N 1.297 -1.594 0 C-N-CA 118.004 -2.046 . . . . 0.16 109.163 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -166.82 161.58 15.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 118.397 -1.321 . . . . 0.4 111.419 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 44' ' ' GLY . 47.1 t -161.29 -112.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.039 -1.865 . . . . 0.56 113.771 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.536 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 p80 -21.93 -42.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.413 1.071 . . . . 2.75 113.052 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 164.39 18.95 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.137 -1.506 . . . . 1.25 109.574 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -157.12 161.96 39.4 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.452 -0.899 . . . . 1.78 110.749 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -96.79 -174.11 2.91 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.313 -0.955 . . . . 0.58 110.475 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.19 -172.3 30.04 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.584 -1.293 . . . . 0.47 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtp -104.83 138.82 40.51 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.002 -0.679 . . . . 0.63 110.333 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.4 p90 -142.19 146.06 38.2 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 119.777 -0.769 . . . . 0.26 109.32 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.78 127.06 24.53 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 110.141 -0.754 . . . . 0.31 110.141 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -63.92 -29.53 70.69 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.282 -0.967 . . . . 3.44 111.747 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -76.51 -8.37 57.05 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.58 -1.248 . . . . 4.18 111.736 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.91 15.56 7.02 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 118.962 -1.095 . . . . 0.36 109.947 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 15.5 m -144.16 174.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 115.601 -0.727 . . . . 0.23 110.322 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -148.06 135.04 10.28 Favored Pre-proline 0 C--N 1.3 -1.551 0 C-N-CA 119.673 -0.811 . . . . 0.58 109.121 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -65.67 155.58 68.32 Favored 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 121.077 1.185 . . . . 1.17 113.554 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.25 -144.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 114.769 -1.105 . . . . 3.55 108.918 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.436 ' ND2' ' N ' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -157.51 8.47 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.058 -1.457 . . . . 5.83 112.722 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp85 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 116.405 -1.759 . . . . 11.1 111.049 179.937 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 110.094 -1.203 . . . . 2.75 110.094 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.69 36.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.243 -0.983 . . . . 5.34 110.978 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.558 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -44.05 158.03 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.571 -0.852 . . . . 2.55 111.124 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.558 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.4 m-85 179.22 156.77 0.53 Allowed 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 119.395 -0.922 . . . . 0.83 111.968 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 27' ' ' ILE . 3.9 m -143.81 -169.16 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.102 -0.954 . . . . 0.29 109.851 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.642 ' O ' HG22 ' A' ' 55' ' ' THR . 2.5 mt-30 -143.57 105.36 4.34 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.228 -1.397 . . . . 0.39 107.228 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -33.84 111.69 0.11 Allowed 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.01 -1.076 . . . . 0.34 112.162 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.493 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.03 -37.21 86.61 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.934 -0.706 . . . . 1.31 109.376 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.29 -173.55 4.28 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.891 -1.049 . . . . 1.54 109.522 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.58 129.13 34.19 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.383 -1.735 . . . . 0.46 109.731 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.28 109.56 17.0 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.85 -1.14 . . . . 0.35 113.133 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 13' ' ' PRO . 22.7 m-20 -81.6 133.77 52.1 Favored Pre-proline 0 C--N 1.295 -1.781 0 C-N-CA 117.234 -1.786 . . . . 1.58 106.848 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.594 ' C ' ' H ' ' A' ' 15' ' ' GLU . 28.3 Cg_exo -34.46 -45.73 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 121.211 1.274 . . . . 3.4 113.605 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 58.79 2.76 0.26 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.158 -1.417 . . . . 1.96 108.896 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.594 ' H ' ' C ' ' A' ' 13' ' ' PRO . 42.2 mm-40 -150.87 137.74 19.03 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.733 -1.121 . . . . 2.04 109.748 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -86.89 30.84 0.72 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.22 -1.392 . . . . 4.58 109.394 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -155.68 10.43 0.34 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 119.389 -1.386 . . . . 1.64 110.673 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.661 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -120.08 -177.26 3.38 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.463 -0.895 . . . . 2.71 111.861 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.661 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 6.3 tp -77.33 161.65 27.9 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 115.187 1.551 . . . . 0.72 115.187 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -150.58 131.57 3.61 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.138 -1.185 . . . . 0.24 110.138 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' CD1' HD11 ' A' ' 27' ' ' ILE . 8.2 p90 -152.57 -168.43 3.05 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.432 -1.307 . . . . 0.24 112.029 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' O ' ' C ' ' A' ' 23' ' ' ARG . 8.5 mmm180 -140.38 131.28 26.03 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.618 -0.833 . . . . 4.48 112.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -13.13 135.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.016 1.117 . . . . 2.22 114.016 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.26 -22.13 14.01 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.367 -1.493 . . . . 0.37 109.367 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.26 119.23 7.52 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 118.841 -1.144 . . . . 0.65 108.435 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.458 ' CZ ' ' NE2' ' A' ' 6' ' ' GLN . 26.9 m-85 -77.07 105.36 8.1 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.568 -1.253 . . . . 2.29 112.569 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.577 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -75.54 144.39 12.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.017 -1.475 . . . . 0.23 107.017 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' O ' ' HA2' ' A' ' 40' ' ' GLY . 16.0 t-80 -104.1 98.88 8.63 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.772 -1.171 . . . . 0.87 108.149 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.16 92.46 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 C-N-CA 118.346 -1.342 . . . . 0.54 111.311 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.555 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -68.62 -36.09 78.18 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 113.803 -1.544 . . . . 1.62 110.372 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -164.23 92.53 0.65 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.582 -1.247 . . . . 2.22 111.106 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.75 99.24 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.346 -1.342 . . . . 1.74 109.282 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -96.47 -82.64 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.314 -0.954 . . . . 1.16 111.636 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' TRP . 1.3 m-20 -64.27 158.23 66.15 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.052 -1.059 . . . . 0.59 110.86 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.06 -68.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.54 1.493 . . . . 0.3 111.539 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.6 t30 -84.13 3.71 33.68 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.577 -0.849 . . . . 1.91 111.332 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.447 ' O ' ' O ' ' A' ' 34' ' ' ASP . 22.9 m95 -136.47 144.4 44.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.541 -0.911 . . . . 0.52 108.541 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CZ2' ' HG3' ' A' ' 51' ' ' ARG . 12.6 m0 -143.01 171.63 13.79 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 119.679 -0.808 . . . . 0.32 111.692 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.08 130.33 55.55 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.533 -1.654 . . . . 0.36 106.533 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.555 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.48 -154.56 7.14 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 117.952 -2.071 . . . . 0.14 109.535 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -161.67 155.36 21.6 Favored 'General case' 0 C--N 1.285 -2.217 0 C-N-CA 117.458 -1.697 . . . . 0.55 112.926 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 44' ' ' GLY . 5.7 t -167.55 178.8 5.21 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.658 -1.156 . . . . 2.34 110.777 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 42' ' ' CYS . 10.8 p80 41.01 23.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.096 -0.641 . . . . 1.69 110.75 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 79.13 35.59 29.99 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.804 -1.189 . . . . 0.69 111.812 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' CYS . 4.7 mt-30 -160.23 144.16 14.14 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.895 -1.122 . . . . 1.22 111.352 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.717 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.3 p -93.6 -177.91 4.54 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.272 -0.971 . . . . 0.38 111.684 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.98 -163.88 28.6 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.642 -1.266 . . . . 0.35 111.066 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 65.2 mtp -113.89 147.98 37.52 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.263 -0.575 . . . . 0.54 111.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' CE2' HG21 ' A' ' 27' ' ' ILE . 4.0 p90 -151.25 145.74 18.32 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 119.527 -0.869 . . . . 0.23 109.317 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.23 128.32 29.17 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 N-CA-C 109.884 -0.852 . . . . 0.36 109.884 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.422 ' HG3' ' CZ2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -62.03 -34.89 77.07 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.898 -0.721 . . . . 1.28 112.565 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.457 ' OD1' ' OD1' ' A' ' 36' ' ' ASN . 18.4 m120 -75.05 12.15 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.148 -1.021 . . . . 1.95 113.253 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.92 7.09 27.84 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.505 -0.878 . . . . 0.58 109.089 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.7 m -136.86 173.02 14.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 114.57 -1.196 . . . . 0.2 109.578 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -136.29 125.09 15.47 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.392 -0.966 . . . . 0.51 108.392 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.3 140.94 88.98 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 120.445 0.763 . . . . 1.73 113.186 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.2 p -137.8 132.38 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 115.099 -0.955 . . . . 4.9 109.971 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.662 HD22 ' H ' ' A' ' 59' ' ' ARG . 6.6 p-10 -157.12 -135.01 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.955 -1.098 . . . . 4.67 111.063 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.662 ' H ' HD22 ' A' ' 58' ' ' ASN . 48.1 ttt180 . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 116.388 -1.767 . . . . 12.33 110.565 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' O ' ' OG1' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 110.094 -1.202 . . . . 5.37 110.094 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 60.13 6.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.299 -0.96 . . . . 3.68 111.108 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.454 ' O ' ' CG ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -135.94 107.67 7.03 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.716 -0.674 . . . . 2.64 110.45 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 3' ' ' THR . 2.5 m-85 -169.15 155.39 6.51 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 117.584 -1.646 . . . . 0.73 113.003 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 27' ' ' ILE . 15.9 m -141.05 -166.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 114.823 -1.08 . . . . 0.2 109.36 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 7' ' ' ALA . 4.6 mt-30 -145.37 105.07 3.99 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.975 -1.011 . . . . 0.64 108.438 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -29.05 116.63 0.11 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.793 -1.094 . . . . 0.16 113.681 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.38 -52.89 22.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.233 -1.025 . . . . 0.53 108.233 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -132.04 177.64 7.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.77 -1.196 . . . . 0.72 107.77 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -75.38 134.36 40.97 Favored 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 114.284 -1.325 . . . . 1.14 108.953 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -121.53 109.87 15.34 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.021 -1.072 . . . . 0.26 113.073 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -93.26 131.76 32.11 Favored Pre-proline 0 C--N 1.307 -1.265 0 C-N-CA 118.167 -1.413 . . . . 1.1 108.387 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -43.95 157.27 0.15 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 120.575 0.85 . . . . 0.28 112.746 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.576 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 89.7 mt-30 -145.3 -3.53 0.74 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.324 -1.362 . . . . 0.58 107.324 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' H ' ' H ' ' A' ' 14' ' ' GLN . 28.1 mt-10 -131.86 151.1 51.92 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.432 -1.713 . . . . 3.78 108.171 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.74 -5.51 30.51 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.236 -1.385 . . . . 2.38 111.308 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.12 -5.47 13.25 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.411 -1.475 . . . . 1.9 109.411 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.576 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 2.4 mt-10 -61.7 176.74 0.48 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 123.328 1.537 . . . . 1.74 114.412 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -107.4 161.29 14.95 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 111.043 -2.799 . . . . 0.59 109.4 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -145.11 115.19 0.82 Allowed Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.364 -1.398 . . . . 0.3 110.768 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.615 ' CD1' HD11 ' A' ' 27' ' ' ILE . 3.3 p90 -138.95 -174.49 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.984 -1.086 . . . . 0.24 111.65 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -139.77 125.92 19.94 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.595 -0.842 . . . . 2.75 112.322 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.1 ttt180 -4.01 135.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.13 1.53 . . . . 1.6 115.13 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.42 -21.68 3.52 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.289 -1.524 . . . . 0.61 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -59.19 119.38 7.24 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 118.705 -1.198 . . . . 0.46 108.399 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 48.1 m-85 -75.32 107.51 7.48 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.971 -1.092 . . . . 0.91 113.525 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.615 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -75.17 143.92 12.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.029 -1.471 . . . . 0.16 107.029 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.471 ' O ' ' CA ' ' A' ' 40' ' ' GLY . 39.2 t-80 -101.0 102.39 13.38 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 117.79 -1.564 . . . . 1.35 107.773 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.0 101.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 C-N-CA 118.444 -1.303 . . . . 0.32 110.751 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.7 ttm -77.6 -32.42 53.55 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.591 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -174.21 108.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 118.447 -1.301 . . . . 3.57 110.975 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 12.4 p-10 -58.03 107.6 0.49 Allowed 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.985 -1.486 . . . . 0.94 108.695 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -93.46 -57.08 2.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.85 -1.14 . . . . 1.58 111.804 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -107.05 161.1 24.02 Favored Pre-proline 0 C--N 1.299 -1.615 0 C-N-CA 119.625 -0.83 . . . . 0.75 111.461 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.33 -58.25 0.82 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 122.063 1.842 . . . . 0.3 111.606 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 37' ' ' TRP . 8.0 t-20 -98.96 13.35 32.98 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.725 -0.79 . . . . 0.41 111.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 34.6 m95 -147.51 136.62 22.31 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.543 -0.863 . . . . 0.34 109.478 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.659 ' CH2' ' NE ' ' A' ' 51' ' ' ARG . 34.4 m0 -139.44 168.35 20.01 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.889 -0.724 . . . . 0.43 111.27 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -106.85 135.5 48.29 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.942 -1.503 . . . . 1.21 106.942 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 28' ' ' HIS . . . -161.34 -152.0 6.48 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 117.839 -2.124 . . . . 0.25 109.519 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -165.12 160.08 18.36 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 117.772 -1.571 . . . . 0.57 113.138 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.507 ' O ' ' N ' ' A' ' 44' ' ' GLY . 8.1 t -158.79 -86.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.127 -1.029 . . . . 0.25 112.104 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.649 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 6.4 p80 -62.95 74.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.325 -0.95 . . . . 0.52 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 41.29 23.12 0.08 OUTLIER Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.715 -1.231 . . . . 0.61 111.095 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' HIS . 12.7 mt-30 -149.41 139.7 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.372 -1.331 . . . . 1.6 111.499 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 41' ' ' ALA . 19.3 p -91.39 -172.46 3.27 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.665 -0.814 . . . . 0.45 110.849 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.84 -167.91 27.61 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.288 -1.434 . . . . 0.2 111.956 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 31.1 mtp -107.35 143.55 35.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 120.235 -0.586 . . . . 0.31 110.753 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -147.4 147.06 27.04 Favored Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.622 -0.831 . . . . 0.1 109.049 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.05 124.72 15.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 120.189 0.592 . . . . 0.2 111.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.659 ' NE ' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.36 -27.36 55.77 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.309 -0.86 . . . . 2.41 110.227 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.27 -1.1 52.34 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.17 -1.012 . . . . 4.58 113.091 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.7 12.68 31.02 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.811 -1.156 . . . . 0.3 109.931 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 13.5 m -141.45 172.48 10.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 114.404 -1.271 . . . . 0.25 108.157 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -143.93 141.63 18.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 C-N-CA 118.963 -1.095 . . . . 0.31 108.853 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' O ' ' OD1' ' A' ' 58' ' ' ASN . 2.4 Cg_endo -55.29 158.27 12.59 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 120.119 0.546 . . . . 0.8 110.764 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.77 111.26 14.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 119.394 -0.922 . . . . 2.3 111.57 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -136.04 130.82 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.846 -0.742 . . . . 7.81 110.69 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 116.235 -1.84 . . . . 8.41 110.724 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 110.177 -1.169 . . . . 5.79 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 75.96 0.97 3.42 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.176 -0.61 . . . . 3.24 111.292 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -161.61 87.84 0.69 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.542 -0.863 . . . . 3.19 110.252 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 3' ' ' THR . 1.5 m-85 -170.79 154.69 4.43 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.493 -1.283 . . . . 0.81 111.645 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 27' ' ' ILE . 15.7 m -146.14 174.69 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 114.835 -1.075 . . . . 0.65 109.453 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.498 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.9 mt-30 -123.48 109.12 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.389 -1.337 . . . . 0.41 107.389 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -32.2 116.13 0.19 Allowed 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.552 -0.859 . . . . 0.24 112.371 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.535 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 11.8 tp -74.52 -42.26 59.22 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.435 -0.802 . . . . 1.88 109.836 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.67 176.42 8.2 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.758 -1.11 . . . . 1.62 108.129 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.37 125.46 32.98 Favored 'General case' 0 C--N 1.265 -3.107 0 N-CA-C 105.909 -1.886 . . . . 0.83 105.909 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -107.29 106.56 17.06 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.869 -1.132 . . . . 0.23 113.658 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.56 126.7 61.1 Favored Pre-proline 0 C--N 1.306 -1.293 0 C-N-CA 118.298 -1.361 . . . . 0.96 107.856 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -40.39 128.35 2.36 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 120.805 1.004 . . . . 0.55 114.073 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -114.49 2.36 14.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.439 -1.689 . . . . 1.63 106.439 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -139.91 158.65 43.73 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 113.172 -1.831 . . . . 2.05 109.89 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -96.56 3.58 52.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.131 -1.028 . . . . 3.19 109.276 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.35 14.93 6.46 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.264 -1.134 . . . . 1.71 110.264 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.9 pt-20 -121.61 -176.41 3.31 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.711 1.004 . . . . 1.22 113.711 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 tp -78.52 170.12 17.15 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 116.414 2.005 . . . . 0.42 116.414 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.34 122.0 1.1 Allowed Glycine 0 N--CA 1.499 2.889 0 CA-C-N 113.286 -1.779 . . . . 0.22 109.292 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 5.1 p90 -149.14 -169.99 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.705 -1.198 . . . . 0.17 112.393 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' O ' ' C ' ' A' ' 23' ' ' ARG . 6.2 mmm180 -135.45 134.57 39.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.52 -0.763 . . . . 3.56 112.361 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 22' ' ' ARG . 2.4 ttp180 -20.53 141.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.229 0.956 . . . . 1.95 113.146 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.41 -27.1 4.24 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.643 -1.383 . . . . 0.38 109.643 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.49 125.8 25.05 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 118.589 -1.245 . . . . 1.06 108.127 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.58 111.62 14.83 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.302 -1.359 . . . . 0.92 113.585 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HG22 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -77.89 141.88 14.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.872 -1.529 . . . . 0.21 106.872 179.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -100.07 97.18 8.05 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 117.598 -1.641 . . . . 1.11 108.026 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -61.13 99.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 C-N-CA 118.624 -1.231 . . . . 0.27 111.021 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.455 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 21.4 mtt -82.75 -26.22 32.1 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.274 -0.875 . . . . 1.35 110.44 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -163.81 80.34 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 118.223 -1.391 . . . . 1.59 111.656 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -61.04 87.02 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.46 -1.296 . . . . 3.58 108.521 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 31' ' ' ASP . 6.4 t -103.76 -72.59 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.755 -0.778 . . . . 2.52 112.705 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 3.0 m-20 -60.59 153.96 58.73 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 118.859 -1.136 . . . . 1.77 111.021 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -66.26 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.106 1.871 . . . . 0.61 112.87 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -83.39 14.38 3.69 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.599 -0.728 . . . . 0.85 110.681 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 55.4 m95 -147.47 149.38 32.57 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.276 -0.875 . . . . 1.01 109.227 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 37' ' ' TRP . 10.8 m0 -148.75 161.6 41.45 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.484 -0.886 . . . . 0.48 111.302 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 132.33 48.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.929 -1.137 . . . . 1.18 107.929 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -163.92 -152.58 6.98 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 118.255 -1.926 . . . . 0.18 109.731 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.733 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -162.35 175.38 11.63 Favored 'General case' 0 C--N 1.287 -2.142 0 C-N-CA 118.595 -1.242 . . . . 0.16 111.202 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.8 t -168.81 -79.74 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.001 -1.88 . . . . 0.52 114.679 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.647 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 2.4 p80 -65.07 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.85 -0.614 . . . . 1.47 112.622 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 89.77 6.12 70.41 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.048 -1.549 . . . . 0.55 109.75 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.04 151.22 47.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.656 -0.818 . . . . 4.36 109.868 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.733 HG22 ' HB2' ' A' ' 41' ' ' ALA . 2.6 p -92.41 -175.71 4.09 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.871 -1.131 . . . . 0.26 110.823 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.49 179.05 25.02 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.777 -1.202 . . . . 0.47 110.13 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 56.3 mtp -100.87 147.16 26.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.42 110.886 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 27' ' ' ILE . 7.0 p90 -147.57 147.02 26.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 119.702 -0.799 . . . . 0.24 109.345 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.11 126.53 22.46 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.786 0.991 . . . . 0.13 111.484 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.433 ' HD3' ' CH2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -59.38 -34.34 72.31 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.426 -0.806 . . . . 2.54 111.223 -179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.53 3.03 14.58 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.918 -1.113 . . . . 2.37 112.763 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.54 8.45 44.88 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.085 -1.046 . . . . 0.14 109.774 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.535 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 14.9 m -136.28 171.65 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 114.853 -1.067 . . . . 0.17 109.113 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -142.88 139.13 16.61 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 119.102 -1.039 . . . . 0.29 110.286 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.29 127.5 25.03 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.596 0.864 . . . . 1.05 110.872 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 57' ' ' VAL . 3.1 p -87.1 7.4 2.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.751 -0.78 . . . . 2.88 111.457 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -105.84 37.54 2.22 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.709 -0.796 . . . . 2.17 111.277 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 116.28 -1.819 . . . . 10.99 111.063 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.972 -1.251 . . . . 5.12 109.972 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 t -99.88 170.35 8.59 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.575 -0.85 . . . . 3.4 110.847 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.676 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.6 OUTLIER -132.04 46.2 2.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.76 110.013 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -130.41 135.19 47.75 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.366 -0.934 . . . . 1.31 111.053 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 27' ' ' ILE . 5.9 m -125.94 -162.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.442 -1.253 . . . . 0.23 109.781 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.2 mt-30 -146.9 100.27 3.29 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.841 -1.17 . . . . 0.86 107.841 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.09 111.52 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.58 -1.191 . . . . 0.25 113.11 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -65.81 -41.53 91.77 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.62 -0.718 . . . . 0.33 109.104 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.54 -173.09 3.59 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.602 -1.181 . . . . 0.8 108.453 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.47 120.48 27.84 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.705 -1.589 . . . . 0.68 109.583 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -104.68 103.15 12.74 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.228 -0.989 . . . . 0.26 111.724 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.08 127.38 67.04 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 117.243 -1.783 . . . . 4.59 109.838 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -41.18 113.85 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 120.925 1.084 . . . . 0.94 114.153 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -94.46 8.4 42.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 105.427 -2.064 . . . . 3.79 105.427 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -155.6 161.6 40.8 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 112.75 -2.023 . . . . 3.36 109.695 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -7.38 27.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.137 -1.025 . . . . 4.98 108.876 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.26 -7.1 41.08 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.907 -1.277 . . . . 1.3 109.907 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.569 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 1.3 pt-20 -101.85 -168.72 1.58 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.607 -0.837 . . . . 1.22 112.01 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 1.1 tp -87.04 175.73 7.97 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 115.454 1.65 . . . . 0.3 115.454 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -162.19 128.61 1.91 Allowed Glycine 0 N--CA 1.502 3.045 0 CA-C-N 114.319 -1.309 . . . . 0.26 110.072 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CD1' HD11 ' A' ' 27' ' ' ILE . 7.9 p90 -158.11 -174.8 5.0 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.081 -1.448 . . . . 0.25 112.095 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' ARG . 23.4 mmt-85 -133.96 133.65 41.61 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.796 -0.762 . . . . 4.22 112.698 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -15.42 138.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 124.418 1.074 . . . . 4.97 113.731 179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.15 -23.6 5.98 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.469 -1.452 . . . . 0.47 109.469 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.17 122.35 13.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 118.993 -1.083 . . . . 0.63 109.242 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 73.5 m-85 -78.74 108.91 12.5 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.054 -1.058 . . . . 1.03 113.114 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -78.42 148.79 6.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.338 -0.986 . . . . 0.2 108.338 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 30' ' ' MET . 11.7 t-160 -106.26 94.07 4.95 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.045 -1.062 . . . . 0.84 108.857 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' O ' ' OG1' ' A' ' 3' ' ' THR . 5.3 t -57.64 85.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 C-N-CA 119.297 -0.961 . . . . 0.34 112.43 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.621 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 1.3 mmt -59.23 -35.89 74.47 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 114.893 -1.048 . . . . 1.43 110.402 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 33' ' ' SER . 67.6 t0 -170.56 99.75 0.25 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.176 -1.409 . . . . 1.54 111.749 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.4 ' HA ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -53.18 97.78 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.095 -1.442 . . . . 2.57 108.784 179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 31' ' ' ASP . 65.8 m -96.26 -71.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.307 -0.957 . . . . 1.38 111.832 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' O ' ' CD1' ' A' ' 38' ' ' TRP . 1.4 m-20 -81.93 161.17 61.63 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 119.249 -0.98 . . . . 0.69 111.679 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.53 -69.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.743 1.629 . . . . 0.36 110.92 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 36' ' ' ASN . 4.9 t-20 -80.2 -5.01 55.37 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.552 -0.749 . . . . 0.9 110.949 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.453 ' O ' ' O ' ' A' ' 34' ' ' ASP . 28.4 m95 -131.99 150.59 52.11 Favored 'General case' 0 C--O 1.207 -1.18 0 C-N-CA 120.092 -0.643 . . . . 0.38 109.625 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' A' ' 34' ' ' ASP . 9.8 m0 -145.9 162.56 37.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.381 -0.827 . . . . 0.5 111.722 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -101.05 129.46 46.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.867 -1.531 . . . . 0.3 106.867 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -156.26 -156.79 7.99 Favored Glycine 0 C--N 1.304 -1.224 0 C-N-CA 117.835 -2.126 . . . . 0.21 110.349 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.769 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -160.8 162.81 32.44 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 118.452 -1.299 . . . . 0.44 111.46 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 43' ' ' HIS . 43.7 t -160.58 -114.55 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.295 -1.762 . . . . 0.56 113.853 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.556 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 1.1 p80 -20.95 -45.11 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.277 0.985 . . . . 2.89 113.044 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 167.1 18.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.338 -1.411 . . . . 1.01 109.884 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -150.34 161.19 42.95 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.637 -0.825 . . . . 2.54 110.049 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 41' ' ' ALA . 7.4 p -100.33 -175.94 3.07 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.424 -0.911 . . . . 0.38 109.812 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.69 -169.14 29.89 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.132 -1.508 . . . . 0.29 111.225 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.6 mtp -108.28 136.66 47.56 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.071 -0.652 . . . . 0.72 110.963 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 27' ' ' ILE . 6.0 p90 -139.11 146.48 49.49 Favored Pre-proline 0 C--N 1.304 -1.387 0 C-N-CA 119.714 -0.795 . . . . 0.15 110.143 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -59.38 122.86 12.21 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 120.292 0.661 . . . . 0.19 110.437 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -11.45 17.06 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.397 -0.921 . . . . 2.99 110.983 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -88.01 -9.1 54.48 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.041 -1.064 . . . . 1.85 111.655 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 8' ' ' LEU . 4.8 m-85 -94.13 14.28 20.5 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.187 -1.005 . . . . 0.44 109.415 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 16.7 m -139.62 166.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 114.986 -1.006 . . . . 0.27 109.439 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -136.84 99.86 10.09 Favored Pre-proline 0 C--N 1.301 -1.515 0 C-N-CA 119.738 -0.785 . . . . 0.83 109.565 179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -48.0 141.66 16.84 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.685 0.923 . . . . 2.93 111.929 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.52 -22.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.127 -0.942 . . . . 3.06 111.782 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -141.4 122.19 14.4 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.117 -1.033 . . . . 4.76 111.623 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt85 . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.283 -1.818 . . . . 13.63 109.946 -179.97 . . . . . . . . 0 0 . 1 stop_ save_